data_1d7q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d7q _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.817 0.341 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.459 ' CD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -81.58 142.78 32.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.455 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 21.8 t -116.11 138.5 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.07 0.462 . . . . 0.0 111.626 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.607 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.8 m-85 -107.48 170.49 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.364 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 2.6 ttpt -52.86 145.39 12.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 0.0 110.738 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -111.73 156.58 21.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.4 130.1 45.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.92 -15.47 61.72 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.423 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -116.32 144.91 43.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.639 0.257 . . . . 0.0 110.326 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -118.1 155.3 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.468 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 65' ' ' PHE . 3.3 p90 -84.45 157.71 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.88 173.25 13.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.193 0.521 . . . . 0.0 112.328 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -129.27 130.77 46.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.915 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 43.9 t -82.08 139.92 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.084 0.469 . . . . 0.0 112.051 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.0 -39.74 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -141.65 157.81 44.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.463 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.53 142.62 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.813 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.412 ' CD1' ' HG3' ' A' ' 59' ' ' ARG . 3.3 mt -103.79 -155.83 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -44.55 -84.57 0.01 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.194 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -159.76 -43.81 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.42 -0.22 71.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.007 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HG3' ' CD1' ' A' ' 55' ' ' LEU . 26.3 ptt180 -151.76 167.2 28.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.094 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 2.0 pp -147.66 154.54 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.04 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 1.5 tt0 -91.78 121.75 33.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.042 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -149.78 164.82 34.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.473 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -138.75 133.27 31.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.536 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.4 ' O ' ' HE3' ' A' ' 63' ' ' MET . 49.2 t -64.41 141.6 58.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.974 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.3 m-85 -48.66 -23.19 0.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.782 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -13.78 61.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.331 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.02 34.64 3.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.76 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 110.74 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 111.037 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 63' ' ' MET . 5.5 mmtm -85.69 118.34 25.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -145.12 156.61 43.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.003 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.99 105.77 17.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.1 m -85.41 118.77 25.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.732 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.45 141.25 36.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.697 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.401 ' CD1' ' CD1' ' A' ' 84' ' ' ILE . 2.1 tt -68.6 140.28 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 26.6 tpt180 -67.27 155.33 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.352 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.08 -61.53 2.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.269 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.42 -39.75 91.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.501 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.4 ' CB ' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -69.15 -17.88 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.987 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HA ' ' CG1' ' A' ' 82' ' ' VAL . 1.2 ptt180 -48.67 -28.72 3.73 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.292 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -75.01 -29.38 60.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.344 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.67 44.6 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.424 ' CG1' ' HA ' ' A' ' 79' ' ' ARG . 11.0 p -117.45 115.7 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 110.955 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -110.74 110.27 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.401 ' CD1' ' CD1' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -106.1 147.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.758 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.439 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.2 m-20 -137.57 165.51 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.904 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 52' ' ' ILE . 27.7 m -80.28 -6.16 57.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.596 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.08 68.62 0.94 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.579 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -150.8 164.27 36.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 32.0 mm -87.63 144.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.229 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.438 HG21 ' O ' ' A' ' 106' ' ' LEU . 1.3 mt -150.68 171.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 111.241 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.493 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -127.2 122.34 33.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 102' ' ' ALA . 17.0 m -120.4 139.18 48.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.432 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.5 146.17 27.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.293 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 95' ' ' ARG . 1.4 mt -114.64 167.3 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' CB ' ' O ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER 82.03 -8.08 1.31 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.835 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -35.7 27.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.642 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -105.66 22.83 14.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.435 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 55.5 mm-40 68.92 30.53 4.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.766 0.317 . . . . 0.0 110.77 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 1.3 t0 82.99 -175.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 99' ' ' ASP . 8.5 t-20 69.62 -60.93 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.777 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -98.77 155.73 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -145.84 131.08 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -88.99 123.93 33.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.276 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 80.6 t -52.09 112.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.653 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -78.84 -39.46 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 109.971 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.482 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -150.56 166.61 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.372 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' HA ' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -108.31 123.27 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 111.813 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.606 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 20.3 m-85 -87.45 106.73 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.56 166.69 6.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -74.58 -38.61 62.6 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.515 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.36 -40.14 95.44 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.705 ' O ' HD21 ' A' ' 116' ' ' LEU . 1.3 mm-40 -62.25 -27.47 69.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.76 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.911 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.55 -36.61 2.14 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.846 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -63.82 -33.05 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -78.48 -22.8 46.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.902 177.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.911 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.75 -31.75 27.89 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.165 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -33.33 62.82 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.47 -22.05 41.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.748 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.63 ' CD1' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.2 -11.65 57.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.07 29.28 74.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.497 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.477 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 34.2 mt-10 -117.09 -52.42 2.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.206 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -102.89 141.4 22.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 -179.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.419 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 71.4 Cg_endo -74.54 179.11 6.24 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.51 2.14 . . . . 0.0 112.206 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -71.03 -17.22 62.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.246 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 11.9 p-80 -97.72 -1.91 42.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.638 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.66 154.31 18.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 111.178 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -115.37 125.87 53.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 113' ' ' ALA . 13.3 mt . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.011 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.799 0.333 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.415 HD12 ' OH ' ' A' ' 119' ' ' TYR . 21.6 tp -89.96 125.91 35.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.705 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.73 140.65 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.688 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.758 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -110.75 170.41 8.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.347 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -47.78 144.13 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.709 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -119.51 164.6 15.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.405 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -56.53 131.49 48.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.726 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.03 -15.41 61.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.379 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -124.95 148.34 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -124.21 154.41 40.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.231 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.0 p90 -84.18 157.89 21.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.788 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.72 14.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.27 0.557 . . . . 0.0 112.5 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.432 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 33.4 tp60 -129.94 109.14 10.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.12 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 26.7 t -56.32 141.18 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.464 HD12 ' HB2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -115.67 -43.04 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.833 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 160.59 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -108.83 131.87 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.454 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.401 ' CD2' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -93.45 -29.19 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.991 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.15 -175.37 32.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -73.33 95.28 2.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.01 -28.16 2.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' HIS . 26.2 ptt180 -150.27 160.22 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.66 154.77 41.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.401 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 17.1 tt0 -99.72 121.6 41.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.771 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.11 157.41 42.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.084 0.469 . . . . 0.0 111.879 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.464 ' HB2' HD12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -114.9 105.36 12.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.31 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.1 m -56.98 127.55 32.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.47 -25.45 1.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.672 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 -9.94 59.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.265 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.02 37.23 4.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.01 118.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 111.342 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' CA ' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.41 118.01 25.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.622 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -145.09 161.99 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.247 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.34 117.75 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.795 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.3 m -99.71 119.44 38.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -77.05 149.22 35.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.573 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.83 129.51 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.767 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -53.08 159.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.316 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.03 -52.21 2.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -74.31 -33.94 63.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 110.399 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -74.71 -19.79 60.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.784 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.46 ' HA ' ' CG1' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -50.36 -27.26 5.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.04 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -60.31 -30.46 69.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -153.97 36.53 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 79' ' ' ARG . 7.7 p -105.08 111.0 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.083 0.468 . . . . 0.0 110.957 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -111.23 110.21 20.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.789 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -90.06 147.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.896 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -129.5 161.52 30.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 52' ' ' ILE . 88.2 m -80.0 -6.63 57.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.049 0.452 . . . . 0.0 111.73 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 p -144.61 71.74 1.32 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.7 159.55 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.141 0.496 . . . . 0.0 111.537 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.513 ' CG2' HD12 ' A' ' 116' ' ' LEU . 30.1 mm -86.88 147.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 90' ' ' ILE . 1.2 mt -150.54 171.23 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.399 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.493 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -127.81 122.28 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.596 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 104' ' ' VAL . 33.2 m -121.73 153.69 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.443 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.77 140.51 15.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.37 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mt -113.86 177.12 4.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 0.0 111.003 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.81 8.7 6.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.454 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -93.44 -38.84 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.845 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -105.63 22.86 14.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 69.1 30.54 4.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 11.1 t0 81.07 162.79 0.16 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 9.0 t-20 84.86 -18.69 0.38 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.448 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -142.0 151.43 42.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.416 ' CB ' ' CG2' ' A' ' 92' ' ' VAL . . . -139.67 -177.06 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.9 116.04 10.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.432 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . 91.4 t -51.22 111.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.979 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -83.18 -50.37 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 0.0 109.813 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.496 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -136.19 168.95 18.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.443 ' N ' HD12 ' A' ' 106' ' ' LEU . 11.1 ttpt -111.37 121.74 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.672 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 21.6 m-85 -86.77 106.47 17.71 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.93 175.4 5.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -75.68 -41.79 52.9 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.768 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -61.5 -40.22 93.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.692 ' O ' HD22 ' A' ' 116' ' ' LEU . 18.4 mt-10 -67.12 -28.23 67.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.544 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.72 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.56 -47.83 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.876 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -56.52 -29.49 61.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.396 0.617 . . . . 0.0 109.503 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -75.89 -22.18 56.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.246 178.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.72 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.34 -35.68 28.89 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.287 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -54.55 -34.78 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.17 -20.46 44.78 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.932 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.758 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.8 m-30 -66.35 -5.49 10.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.781 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 24.9 57.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.582 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.479 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 57.0 mm-40 -114.11 -60.37 1.89 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.278 . . . . 0.0 111.318 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.76 139.16 24.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.083 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.429 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 24.2 Cg_exo -63.13 -178.99 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.531 2.154 . . . . 0.0 112.129 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.66 -26.86 62.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.064 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.429 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 15.6 p-80 -82.98 -9.67 59.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.503 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -55.96 135.25 52.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.333 . . . . 0.0 111.182 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -121.99 127.6 50.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.34 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.501 HD13 ' HG2' ' A' ' 112' ' ' GLU . 25.4 tp -77.17 117.27 18.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.415 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 21.4 t -105.34 139.15 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.609 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 81.0 m-85 -114.28 170.42 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.672 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -47.09 152.64 0.53 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.14 159.52 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.933 0.397 . . . . 0.0 111.155 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.35 127.66 33.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.853 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.24 61.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.618 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HB3' HD13 ' A' ' 91' ' ' LEU . 12.8 mt-30 -115.84 146.38 42.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -120.6 156.05 32.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 111.405 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 65' ' ' PHE . 1.9 p90 -84.48 157.79 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.985 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.62 173.3 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 112.141 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 62.8 tp60 -128.68 109.59 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 2.7 t -54.25 135.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.975 0.417 . . . . 0.0 111.853 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.67 -44.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.842 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -141.51 162.25 35.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.3 ttt -116.22 143.14 45.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -111.24 -57.74 2.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.705 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 149.02 9.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.607 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.89 74.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.045 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.469 ' HA2' ' CG2' ' A' ' 74' ' ' ILE . . . 55.1 34.04 58.1 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.705 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' A' ' 55' ' ' LEU . 14.7 mmt180 -144.94 129.73 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.411 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 pp -147.03 138.92 24.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.95 121.25 32.62 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . . . -122.37 164.62 17.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 112.026 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.9 tpt -130.6 95.29 3.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.27 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.3 130.66 43.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.301 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 8.5 m-85 -49.57 -24.59 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.765 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.31 -9.19 58.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.258 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.5 5.34 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.65 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.18 110.98 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.197 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.25 122.27 35.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -145.23 165.67 27.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.075 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.6 mm? -93.5 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 32.8 m -90.92 134.28 34.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.572 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.39 131.29 34.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.469 ' CG2' ' HA2' ' A' ' 58' ' ' GLY . 17.4 tt -68.52 140.77 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.941 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.424 ' CB ' ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -62.72 151.95 37.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.82 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.36 -43.0 26.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.667 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -76.03 -31.38 58.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 75' ' ' ARG . 3.1 mm? -75.73 -50.61 14.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.6 -25.33 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -51.36 -39.76 57.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.014 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -141.52 13.0 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.32 120.69 59.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.982 0.42 . . . . 0.0 111.092 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -110.96 115.04 28.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.655 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.492 ' CG2' HD11 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -64.06 131.83 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 110.597 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -98.18 156.46 16.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.172 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 77.0 m -76.28 -6.45 51.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.887 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.58 80.71 1.77 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.86 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 162.85 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.967 0.413 . . . . 0.0 111.302 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 29.8 mm -86.84 146.78 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.328 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.503 HG22 HD11 ' A' ' 90' ' ' ILE . 1.4 mt -150.68 171.22 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.679 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.511 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -128.61 121.81 29.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.661 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 104' ' ' VAL . 26.3 m -118.63 148.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.115 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.79 139.19 15.68 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.795 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.43 137.11 53.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.726 0.298 . . . . 0.0 110.623 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -177.23 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.109 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.71 -20.61 61.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.254 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -72.3 -10.58 59.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.309 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 9.2 mt-30 68.57 28.35 5.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.367 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 8.8 t0 79.17 -47.25 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.668 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -43.0 -30.3 0.41 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.33 164.09 29.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.404 ' CB ' ' CG2' ' A' ' 92' ' ' VAL . . . -146.77 -177.31 5.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -137.9 112.92 9.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.44 ' N ' HG12 ' A' ' 92' ' ' VAL . 60.3 t -50.36 111.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.9 mm -87.9 -55.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.157 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 90' ' ' ILE . 1.9 pp -131.28 163.79 27.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.503 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.403 ' N ' HD13 ' A' ' 106' ' ' LEU . 0.7 OUTLIER -109.41 115.63 30.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.645 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 22.7 m-85 -79.02 106.29 10.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -69.52 175.72 3.92 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -76.72 -40.2 49.4 Favored 'General case' 0 C--O 1.229 0.023 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.796 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.43 -40.11 93.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.722 ' O ' HD23 ' A' ' 116' ' ' LEU . 17.4 mt-10 -66.94 -28.35 68.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.84 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.55 -46.31 7.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.871 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -30.26 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.584 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -77.91 -22.29 49.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.153 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.84 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.16 -32.65 23.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.147 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -54.93 -33.85 62.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -21.91 41.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.76 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.645 ' HE2' ' CG ' ' A' ' 108' ' ' TYR . 4.1 m-30 -66.93 -13.16 61.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.75 28.23 69.67 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.635 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.523 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.4 mt-10 -113.2 -53.74 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 111.255 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -87.58 140.51 31.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.66 179.41 5.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -28.05 66.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.987 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -87.07 2.45 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.535 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.09 127.75 32.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.883 0.373 . . . . 0.0 110.99 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.22 137.22 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.765 0.317 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.2 tp -119.54 116.19 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.402 ' O ' ' CE1' ' A' ' 108' ' ' TYR . 18.3 t -129.22 141.04 47.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.802 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.745 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 1.7 m-85 -108.24 170.3 8.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.117 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 159.66 25.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.719 0.295 . . . . 0.0 110.697 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.12 175.44 10.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.128 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -47.15 130.87 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.18 -15.33 62.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.435 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -136.67 146.61 46.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.316 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.72 158.72 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.488 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.51 157.98 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.212 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 173.88 12.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.205 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.433 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -129.78 110.99 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.303 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 41.7 t -62.66 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.008 0.432 . . . . 0.0 111.799 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 86' ' ' THR . 25.0 mt -116.11 -39.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.917 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 151.06 42.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.977 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.417 ' CE ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -110.73 125.85 53.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.14 -166.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.611 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.81 69.85 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.77 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 3.8 p-10 178.41 55.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 110.965 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.63 28.05 62.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.835 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -144.81 167.27 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.734 0.302 . . . . 0.0 110.912 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.22 146.48 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.108 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -91.83 122.61 34.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.188 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -137.39 163.23 31.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.263 0.554 . . . . 0.0 112.315 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.418 ' HB2' HD12 ' A' ' 52' ' ' ILE . 8.2 tpp -123.35 110.81 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -60.32 134.26 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.9 m-85 -47.8 -26.3 1.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.804 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.39 -8.04 54.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.427 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.08 44.17 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 t -127.12 118.35 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 0.0 111.288 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' N ' ' HE2' ' A' ' 63' ' ' MET . 2.8 ttmt -87.61 114.89 24.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.75 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -144.07 163.53 33.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.42 108.27 19.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 4.4 m -84.19 119.14 24.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.303 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -76.6 155.7 33.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.34 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.401 HD13 HD13 ' A' ' 84' ' ' ILE . 5.3 mm -68.36 123.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.416 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 13.5 tpt180 -53.93 162.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.434 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.01 -53.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.272 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -35.15 76.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 82' ' ' VAL . 3.2 mm? -78.64 -11.28 59.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.181 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -48.79 -33.88 11.25 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.847 0.356 . . . . 0.0 111.334 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -56.31 -23.25 35.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -162.27 40.9 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.252 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 14.6 p -82.7 110.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 110.742 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -112.21 110.14 20.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.626 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.417 HD12 ' CE ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -112.3 145.53 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.255 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.468 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m120 -132.05 163.65 27.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 52' ' ' ILE . 39.4 m -76.47 -6.63 52.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 111.653 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 m -148.36 72.34 1.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.658 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 159.79 39.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.167 0.508 . . . . 0.0 111.364 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 39.9 mm -87.11 145.99 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.183 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.487 HG22 HD12 ' A' ' 90' ' ' ILE . 1.3 mt -150.93 171.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.119 0.485 . . . . 0.0 111.392 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -128.4 125.83 39.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.53 178.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.409 ' CG2' ' HB2' ' A' ' 102' ' ' ALA . 15.9 m -122.23 155.61 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.27 126.27 8.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.706 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.89 126.74 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 110.76 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 -177.94 -72.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.056 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.94 -12.08 60.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.371 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 103' ' ' ASP . 39.5 m-85 -90.49 17.51 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.686 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 65.81 23.54 11.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.563 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 t0 73.42 -58.12 0.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.544 0.211 . . . . 0.0 111.556 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -41.73 -33.44 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -113.91 161.94 17.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.555 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -157.67 131.59 8.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 31.9 t70 -90.7 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 91.5 t -51.56 111.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.53 -36.52 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.559 . . . . 0.0 109.86 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.541 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.3 pp -155.11 170.75 21.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.358 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.439 ' N ' HD12 ' A' ' 106' ' ' LEU . 15.1 pttm -112.12 126.17 54.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.65 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 23.1 m-85 -92.98 106.71 18.63 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.411 ' OD1' ' CG ' ' A' ' 112' ' ' GLU . 47.0 p30 -85.55 -174.35 5.13 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.71 -41.31 60.42 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.199 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.27 -40.67 91.19 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.738 ' O ' HD22 ' A' ' 116' ' ' LEU . 18.0 mt-10 -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.305 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.881 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.51 -48.31 7.37 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.021 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -57.23 -28.85 63.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.413 0.625 . . . . 0.0 109.498 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -80.19 -22.96 41.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.296 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.881 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.34 -34.74 24.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.09 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -54.86 -33.95 62.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -20.05 45.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.142 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.745 ' CD1' ' CD1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.08 -6.8 14.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.759 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.33 66.68 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.377 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 55.3 mm-40 -119.95 -60.02 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.419 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.426 ' CD2' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -90.9 128.82 46.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.446 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 38.4 Cg_exo -59.8 -179.19 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.384 2.056 . . . . 0.0 111.914 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.72 -21.92 63.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.5 p-80 -88.08 -0.94 57.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.614 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.17 158.33 11.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -117.4 147.57 42.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.7 mm . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.856 0.36 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.472 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 20.3 tp -72.99 101.57 3.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.416 ' CG1' HD22 ' A' ' 106' ' ' LEU . 14.4 t -91.38 139.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 111.377 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.2 m-85 -110.88 170.44 8.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.881 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -52.98 152.5 3.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -123.8 157.61 33.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.44 . . . . 0.0 111.45 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.95 132.47 49.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.93 -15.55 60.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -116.8 151.46 36.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.704 0.288 . . . . 0.0 110.521 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.42 149.45 46.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.18 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 3.2 p90 -84.21 157.58 21.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.703 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.82 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.287 0.565 . . . . 0.0 112.502 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.405 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 34.1 tp60 -130.31 119.79 23.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.808 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 86' ' ' THR . 10.7 t -70.24 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.447 ' CD1' ' CB ' ' A' ' 63' ' ' MET . 0.9 OUTLIER -115.7 -43.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.867 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 162.04 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.755 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.35 143.64 34.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.652 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' ' HG3' ' A' ' 59' ' ' ARG . 6.2 mt -108.09 -30.4 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.34 -166.25 31.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.38 99.18 8.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.67 -24.84 3.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.616 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 55' ' ' LEU . 8.7 ptp180 -152.88 159.78 43.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' CD2' HG22 ' A' ' 84' ' ' ILE . 1.1 pp -147.41 158.25 43.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.94 121.56 33.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.535 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.29 165.93 24.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.274 0.559 . . . . 0.0 112.276 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.447 ' CB ' ' CD1' ' A' ' 52' ' ' ILE . 2.1 tpp -134.84 111.97 10.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.186 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.08 132.91 55.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.21 -26.3 1.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.876 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -74.47 -14.22 60.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.402 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.97 42.9 1.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.39 112.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.187 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' N ' ' HE2' ' A' ' 63' ' ' MET . 23.5 tttt -84.27 112.76 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.624 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 101' ' ' LYS . 11.4 ptp180 -145.28 161.72 38.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.4 mm? -102.57 108.32 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.7 m -83.74 118.38 23.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.629 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -79.52 131.89 36.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.768 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 1.4 tt -68.5 137.12 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 171.59 -161.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.315 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.54 171.45 47.12 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.232 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.85 -25.74 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.646 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -75.62 -19.82 58.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.127 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -28.22 2.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 111.231 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -26.41 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -169.18 46.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.822 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 78' ' ' LEU . 14.9 p -87.23 126.64 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -106.92 110.22 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.404 HG22 ' CD2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -94.72 147.31 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.571 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -128.2 153.54 46.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.407 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 91.7 m -80.28 -7.01 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.715 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.7 m -142.98 53.49 1.37 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.526 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.2 167.02 23.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.488 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 27.9 mm -90.67 146.02 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.233 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.445 HD12 HG22 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -150.12 171.2 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.095 0.474 . . . . 0.0 111.237 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.499 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -130.18 122.43 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.866 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 104' ' ' VAL . 27.0 m -117.51 147.85 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.88 132.05 11.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.784 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.92 107.9 14.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -162.6 -79.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.939 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.6 -15.99 63.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.115 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.487 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 4.7 m-85 -72.22 -8.37 54.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.648 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 68.16 29.41 6.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.263 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 72.24 -174.42 0.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.69 -61.59 0.5 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.82 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -111.98 171.09 7.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.85 170.91 21.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -119.73 124.98 47.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.426 ' N ' HG12 ' A' ' 92' ' ' VAL . 86.9 t -53.08 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.03 -54.99 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.638 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 2.0 pp -133.19 166.62 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.414 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' N ' HD13 ' A' ' 106' ' ' LEU . 14.7 pttm -110.56 118.62 36.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.072 0.463 . . . . 0.0 112.185 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.637 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 23.0 m-85 -82.82 106.54 14.74 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.63 176.69 7.41 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.07 -44.41 60.6 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.105 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.25 -39.98 88.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.701 ' O ' HD23 ' A' ' 116' ' ' LEU . 8.5 mt-10 -69.16 -29.31 67.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.586 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.718 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.96 -48.33 8.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.902 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 109.599 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.608 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -75.13 -22.07 58.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.147 178.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.718 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.24 -34.03 21.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 121.124 -0.231 . . . . 0.0 111.118 -179.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -34.63 63.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.44 42.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.612 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.662 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.2 m-30 -66.55 -11.98 55.5 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.13 29.21 67.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.521 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 25.3 mm-40 -115.69 -50.24 2.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.738 0.304 . . . . 0.0 111.243 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.453 HD13 HD12 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -94.92 140.65 22.57 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.09 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.433 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 24.4 Cg_exo -63.09 -178.86 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.477 2.118 . . . . 0.0 112.05 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.26 -28.03 63.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.002 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 13.7 p-80 -78.92 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.24 130.89 36.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 111.272 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.63 148.55 33.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.816 0.341 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.412 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 14.2 tp -84.32 113.5 21.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.549 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.01 140.9 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.745 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.7 m-85 -107.75 169.84 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.089 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 137.83 58.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.506 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.87 175.27 5.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.063 0.458 . . . . 0.0 111.478 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -50.71 133.92 25.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.129 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.27 -15.36 60.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.94 148.31 52.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 110.573 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -130.22 159.89 35.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.31 158.16 21.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.007 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.99 173.56 14.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.246 0.546 . . . . 0.0 112.189 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.71 129.73 44.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.029 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 47.4 t -81.82 140.77 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 0.0 112.019 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -116.42 -41.45 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.1 160.39 40.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.698 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -117.04 146.67 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -110.21 -29.79 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.913 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.94 176.77 18.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.62 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.08 107.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.821 0.344 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.61 -33.9 2.57 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.527 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -153.31 159.52 42.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.995 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 1.6 pp -147.59 155.81 42.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.048 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -92.1 121.71 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.081 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.21 165.6 32.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.53 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.444 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.47 134.6 39.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.324 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.8 m -63.92 142.6 58.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.608 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 1.6 m-85 -51.17 -23.98 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.346 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.13 -11.1 60.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.35 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.98 41.13 2.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.783 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.02 110.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.007 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -82.2 116.41 21.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.051 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 62' ' ' ALA . 8.9 ptp180 -145.05 155.77 43.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.68 106.93 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 13.6 m -84.27 118.66 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.676 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -81.92 137.9 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.1 tt -68.68 140.13 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.782 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.433 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.31 143.45 44.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.25 38.87 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -62.88 -32.69 73.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 1.1 mm? -82.91 -29.4 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.636 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -49.25 -27.74 4.03 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.267 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -64.32 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.0 45.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.3 p -121.33 120.99 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.974 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 110.19 20.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.69 147.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.453 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -123.12 159.28 28.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.247 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 52' ' ' ILE . 63.3 m -80.32 -5.91 57.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.442 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 70.05 0.95 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.636 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.14 165.73 35.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.224 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 45.9 mm -87.22 143.97 10.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.236 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.43 HG23 ' HA ' ' A' ' 107' ' ' LYS . 1.3 mt -150.35 171.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.046 0.45 . . . . 0.0 111.213 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.508 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -126.54 122.26 34.62 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.587 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 104' ' ' VAL . 12.8 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.049 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.45 120.21 6.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.671 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.86 117.28 33.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.896 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -73.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.29 -25.97 62.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.424 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -91.62 14.25 15.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.547 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 20.2 mt-30 65.79 24.57 11.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.32 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 5.5 m-20 81.6 -45.65 0.2 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -42.29 -38.3 1.77 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.553 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.56 165.25 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.365 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -158.91 132.05 7.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.18 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -88.96 128.02 35.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.416 ' N ' HG13 ' A' ' 92' ' ' VAL . 94.1 t -53.24 111.85 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.849 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.1 mm -78.21 -45.65 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.509 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -144.29 169.93 16.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.401 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.438 ' N ' HD11 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -111.79 123.77 50.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.634 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 22.6 m-85 -88.5 106.41 18.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -75.4 179.86 4.96 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.455 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -77.0 -42.21 39.6 Favored 'General case' 0 C--O 1.228 -0.068 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.431 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -61.15 -40.03 92.32 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.701 ' O ' HD21 ' A' ' 116' ' ' LEU . 7.5 mt-10 -67.54 -27.85 67.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.461 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.815 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.4 -49.31 7.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.032 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -56.3 -27.4 55.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 109.577 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.09 -22.7 41.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.136 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.815 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.46 -34.36 24.54 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.028 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -55.0 -34.12 63.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.11 -20.59 44.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.849 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.56 -5.98 13.39 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.802 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.41 26.29 61.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.448 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.494 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 56.2 mm-40 -115.91 -60.76 1.83 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.443 ' CD2' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -91.87 124.89 59.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.432 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 40.6 Cg_exo -56.88 179.75 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.431 2.088 . . . . 0.0 112.257 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -25.06 65.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.095 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 37.1 p-80 -85.89 -17.13 36.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.39 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -52.86 139.4 27.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.808 0.337 . . . . 0.0 111.24 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -117.76 137.89 52.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.8 0.333 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.406 HD12 ' HG2' ' A' ' 112' ' ' GLU . 24.8 tp -86.81 128.63 35.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.793 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 t -127.31 140.68 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.832 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.749 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -112.72 170.39 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.346 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -52.68 149.58 5.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.729 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.82 164.61 27.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 111.5 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.89 132.99 37.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.76 -15.34 60.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.469 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -134.73 137.21 43.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -117.23 155.22 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 111.276 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 5.3 p90 -84.02 157.65 21.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.622 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.76 173.89 12.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.593 . . . . 0.0 112.521 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.01 117.13 18.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.037 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.496 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 41.5 t -67.46 138.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 112.065 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.437 ' CD1' ' HE2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.09 -41.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.556 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 161.33 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.745 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.4 144.2 44.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.722 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.54 -27.98 11.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.026 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.04 59.14 10.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -177.61 63.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.1 20.73 50.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.403 ' HD3' ' CE1' ' A' ' 73' ' ' HIS . 1.3 mtm105 -152.36 163.53 39.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.447 ' HB3' HD11 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -147.85 145.23 28.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.609 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -91.09 120.77 32.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.496 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.44 165.62 32.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 111.665 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.49 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 9.8 ptp -138.98 128.0 23.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.59 146.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.286 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.462 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.9 m-85 -50.33 -20.68 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.811 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.1 p30 -73.62 -8.18 54.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.61 0.243 . . . . 0.0 111.324 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 41.03 4.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 63' ' ' MET . 20.1 t -127.15 110.27 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.659 0.266 . . . . 0.0 111.1 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.59 120.14 25.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 165.7 27.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.303 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 71' ' ' LEU . 2.8 mm? -95.68 105.69 17.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 11.8 m -89.14 118.47 28.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.403 ' CE1' ' HD3' ' A' ' 59' ' ' ARG . 2.1 m-70 -76.6 139.15 40.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.6 tt -68.52 138.49 22.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.86 151.92 24.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.073 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.66 -39.28 18.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.46 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -78.52 -30.75 47.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 4.3 mm? -77.86 -29.56 50.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -48.97 -26.9 2.77 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.34 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -38.91 74.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.313 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 48.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.363 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 8.5 p -124.18 119.74 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -110.75 109.96 20.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.991 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -80.95 139.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.2 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -110.57 160.51 16.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 0.0 111.529 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.414 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 66.1 m -80.3 -6.2 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.525 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -147.79 70.33 1.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.19 164.63 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.223 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 46.7 mm -89.4 144.39 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.341 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.45 HG23 ' HA ' ' A' ' 107' ' ' LYS . 1.1 mt -150.22 171.13 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.047 0.451 . . . . 0.0 111.101 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.507 ' HB2' ' CE2' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -126.94 125.75 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.638 178.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 104' ' ' VAL . 26.4 m -125.62 156.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.259 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.25 127.88 9.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.54 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.24 177.45 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.76 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.27 -51.12 0.43 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.522 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -41.07 12.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 111.452 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.53 23.08 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 69.17 30.24 4.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.801 0.334 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.6 175.94 0.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.618 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.34 -57.19 0.56 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.063 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.83 149.24 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.24 -179.37 5.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.962 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.79 121.37 19.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.419 ' N ' HG11 ' A' ' 92' ' ' VAL . 85.5 t -51.07 111.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.683 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.27 -37.44 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 0.0 109.768 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.503 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -150.93 168.54 24.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.36 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -112.32 121.2 44.22 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.625 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 23.3 m-85 -86.34 106.29 17.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.42 176.6 5.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.46 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -76.9 -39.75 49.78 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.967 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -40.95 98.52 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.671 ' O ' HD22 ' A' ' 116' ' ' LEU . 10.4 mt-10 -66.27 -27.78 68.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.417 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.791 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.38 -48.26 6.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.055 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -27.66 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.425 0.631 . . . . 0.0 109.492 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -79.17 -22.71 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.202 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.791 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.37 -35.28 27.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.221 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -34.42 62.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.23 -20.3 44.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.013 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.749 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.51 -4.36 8.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.808 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 24.77 58.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.597 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.479 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 42.3 mm-40 -115.35 -60.93 1.82 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.808 0.337 . . . . 0.0 111.266 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.32 126.36 46.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 36.7 Cg_exo -57.41 179.82 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.417 2.078 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.39 -23.36 64.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.416 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 37.2 p-80 -90.67 2.48 55.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.582 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.24 147.71 50.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -115.61 136.68 52.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.048 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.438 HG21 ' CB ' ' A' ' 113' ' ' ALA . 7.3 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.836 0.35 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.47 HD12 ' OH ' ' A' ' 119' ' ' TYR . 39.4 tp -96.48 125.38 40.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.558 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.57 140.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.944 0.402 . . . . 0.0 111.897 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.77 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.3 m-30 -112.34 170.44 8.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.466 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.42 150.74 4.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -127.76 165.12 20.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.701 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.35 133.05 49.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.97 -15.5 60.72 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -126.43 140.04 52.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.9 150.32 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.147 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 6.4 p90 -84.35 156.32 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.887 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.76 173.26 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.19 0.519 . . . . 0.0 112.219 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -119.08 153.9 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.362 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.413 ' CB ' ' O ' ' A' ' 85' ' ' ASN . 12.9 t -97.29 141.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.022 0.439 . . . . 0.0 112.142 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 63' ' ' MET . 0.7 OUTLIER -114.13 -52.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.44 162.22 36.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.66 126.48 54.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.431 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -96.59 -29.78 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.63 178.18 21.8 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -56.39 112.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.77 0.319 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.5 -13.68 58.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.727 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -138.78 121.88 16.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.242 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 1.3 pp -142.36 142.23 32.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.539 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.7 121.67 32.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 50' ' ' GLN . . . -127.2 162.12 26.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.425 ' HB2' HD12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -123.08 101.62 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.216 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.17 133.32 49.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.402 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.405 ' CD2' ' OH ' ' A' ' 48' ' ' TYR . 1.5 m-85 -49.34 -25.94 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.523 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -13.7 60.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.177 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.39 36.02 3.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.49 122.66 59.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 111.453 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -95.12 121.72 37.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.603 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -144.12 165.59 27.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.17 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.6 mm? -94.02 105.68 17.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.8 m -88.82 125.05 34.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -83.27 142.02 31.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.619 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.79 138.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.94 155.23 20.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 0.0 111.001 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.17 -46.08 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.548 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -76.71 -42.22 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 0.0 110.783 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -67.03 -19.72 65.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.402 ' HA ' ' CG1' ' A' ' 82' ' ' VAL . 1.4 ptm180 -50.64 -28.11 8.22 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.827 0.346 . . . . 0.0 111.322 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -64.86 -29.54 70.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.618 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.99 40.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 7.6 p -120.87 110.88 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 110.983 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 32.2 m0 -111.39 110.36 20.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.157 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.408 HG21 HD21 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -86.45 145.47 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 52.4 m-20 -132.11 164.93 25.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.8 m -78.08 -6.5 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.761 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.4 73.99 1.45 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -165.34 161.24 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.261 0.553 . . . . 0.0 111.481 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 32.8 mm -92.28 149.12 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.011 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 90' ' ' ILE . 1.4 mt -150.19 173.56 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.638 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -130.11 126.88 38.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.566 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 104' ' ' VAL . 21.0 m -121.73 156.51 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.391 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.44 149.79 19.02 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.648 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.46 135.66 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.705 0.288 . . . . 0.0 110.799 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 -177.57 -76.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.188 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.9 -18.09 38.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.407 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CD1' ' HB3' ' A' ' 101' ' ' LYS . 42.9 m-85 -72.38 -9.26 58.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.551 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 72.16 29.39 2.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.746 0.307 . . . . 0.0 111.304 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.1 -55.75 0.64 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.42 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -42.03 -31.95 0.4 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.427 ' HB3' ' CD1' ' A' ' 97' ' ' TYR . 24.5 mttt -128.22 164.45 22.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.673 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -151.41 177.28 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.19 116.95 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.438 ' N ' HG12 ' A' ' 92' ' ' VAL . 80.5 t -49.93 111.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.972 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mm -82.26 -45.56 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.191 0.52 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.471 ' CD1' ' CD1' ' A' ' 108' ' ' TYR . 1.6 pp -142.41 161.15 38.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.779 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.53 118.1 35.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.999 0.428 . . . . 0.0 111.792 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.597 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 22.0 m-85 -81.11 106.47 13.13 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 167.15 4.78 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -76.73 -39.52 51.56 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.422 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.57 -40.06 95.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.655 ' O ' HD21 ' A' ' 116' ' ' LEU . 1.4 mm-40 -68.09 -26.52 65.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.275 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.704 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -42.75 -48.98 5.72 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.835 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -29.76 63.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.399 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -73.39 -22.03 60.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.013 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.704 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -48.95 -35.52 15.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.236 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -54.53 -35.06 62.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.14 -20.31 45.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.927 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.77 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.6 m-30 -65.98 -7.69 18.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.559 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.49 27.31 67.72 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.511 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.453 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 50.4 mm-40 -118.49 -59.79 1.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.321 . . . . 0.0 111.289 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.0 142.17 24.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.061 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 31.5 Cg_exo -61.06 -179.75 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.583 2.189 . . . . 0.0 112.146 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.94 -25.88 59.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.993 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -82.56 1.46 37.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.534 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.41 138.35 55.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.375 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 148.2 32.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.431 -179.589 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.539 ' CD1' ' HG3' ' A' ' 112' ' ' GLU . 33.4 tp -118.52 119.82 35.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.79 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.52 139.47 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.046 0.451 . . . . 0.0 111.369 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 74.7 m-85 -114.09 170.4 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.862 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -48.6 153.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.941 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -116.09 162.05 17.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.19 125.97 25.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.83 -15.28 63.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.662 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -113.74 148.08 37.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.636 0.255 . . . . 0.0 110.567 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -121.1 156.72 31.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.219 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.8 p90 -84.25 157.58 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.94 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.27 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.52 138.84 53.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.746 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 15.2 t -88.92 144.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -116.38 -46.12 4.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.84 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.3 162.18 37.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.874 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.93 136.26 52.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.401 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -99.53 -32.4 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.91 169.84 17.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.526 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.83 101.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 110.986 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.83 -32.69 2.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.354 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 ptt-85 -151.35 159.61 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' CD2' ' CD1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.65 152.55 38.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -91.66 121.66 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.43 165.8 24.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 112.181 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.478 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -127.18 113.07 15.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.8 m -59.01 133.86 56.47 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.444 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 1.3 m-85 -48.83 -25.36 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -9.82 58.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.76 42.96 2.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.684 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.41 125.61 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.339 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HB2' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.7 115.46 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.567 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -145.27 165.06 29.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.415 . . . . 0.0 111.276 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -106.36 108.41 19.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.4 m -84.16 118.85 24.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.42 ' CD2' ' OH ' ' A' ' 97' ' ' TYR . 1.7 m-70 -81.46 143.18 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.787 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -71.93 129.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.835 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 14.2 tpt180 -69.45 143.84 53.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.733 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 79' ' ' ARG . . . -70.01 -57.34 7.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.362 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -52.71 -30.66 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.69 -28.37 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.421 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -49.34 -27.36 3.88 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.317 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.29 -33.34 67.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.3 45.17 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 79' ' ' ARG . 11.6 p -115.91 116.25 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 111.071 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CH2' ' HE2' ' A' ' 107' ' ' LYS . 44.1 p90 -110.5 110.18 20.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -83.26 147.11 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.414 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -115.44 152.97 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 52' ' ' ILE . 75.6 m -80.28 -6.35 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 111.886 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 p -148.38 55.07 1.02 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.705 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -140.2 169.09 18.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.174 0.511 . . . . 0.0 111.564 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 45.3 mm -89.24 144.81 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.024 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 106' ' ' LEU . 1.2 mt -150.57 171.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.046 0.451 . . . . 0.0 111.228 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -126.01 121.97 34.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.706 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 104' ' ' VAL . 30.4 m -122.48 155.3 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.156 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 105' ' ' ILE . . . -93.13 140.63 15.16 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.574 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.67 105.52 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 110.834 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.46 -63.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.189 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.14 -28.17 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 73' ' ' HIS . 16.4 m-85 -89.32 1.91 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.768 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 65.71 30.02 10.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 7.0 t0 78.04 162.05 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.963 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 84.53 -19.8 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.411 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.47 150.96 38.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.417 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -137.96 173.18 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 111.256 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -130.1 116.61 18.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.462 ' N ' HG12 ' A' ' 92' ' ' VAL . 70.4 t -52.4 111.54 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 93' ' ' GLY . 2.4 mp -81.81 -39.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.495 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -147.1 168.45 21.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.795 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HA ' HG22 ' A' ' 90' ' ' ILE . 4.5 pttp -111.94 119.9 40.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.631 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 23.0 m-85 -84.23 106.9 16.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.19 173.18 8.01 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -73.46 -51.19 18.03 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.313 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.37 -38.45 87.05 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.539 ' HG3' ' CD1' ' A' ' 39' ' ' LEU . 1.1 tp10 -66.63 -31.67 72.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.396 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.631 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -46.05 -43.25 14.34 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.821 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -48.93 -47.11 43.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.157 0.504 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.6 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -58.69 -20.82 51.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.629 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.695 ' HA ' ' CG ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -50.66 -33.26 21.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.45 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -54.98 -34.34 63.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.38 -21.81 41.96 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.733 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.695 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.4 m-30 -67.01 -9.75 42.33 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.03 25.03 63.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.538 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.452 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 5.3 mm-40 -112.7 -47.41 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -108.75 150.07 40.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.411 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 70.8 Cg_endo -75.18 174.15 13.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.592 2.194 . . . . 0.0 112.242 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.48 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.4 p-80 -87.76 2.79 50.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.578 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.89 130.27 46.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.162 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -82.5 131.35 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.0 mm . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.984 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.841 0.353 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HG ' ' CE1' ' A' ' 41' ' ' PHE . 20.1 tp -71.04 134.59 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.46 140.08 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.884 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 11.8 m-30 -113.7 170.94 7.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.42 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -42.01 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.78 168.12 13.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.169 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -67.72 123.59 20.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.35 62.95 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -115.66 145.3 42.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.395 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -120.26 152.06 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 111.531 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.6 p90 -84.71 158.17 20.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.872 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.37 173.4 14.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 112.376 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -128.61 115.11 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.161 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 14.8 t -65.9 139.99 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 112.077 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 63' ' ' MET . 7.0 mm -116.01 -42.77 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.011 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -140.7 158.57 43.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.875 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 tpt -111.74 132.1 54.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.44 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -109.17 -163.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.485 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.75 156.71 4.54 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.64 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -56.76 109.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.03 -19.77 3.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.5 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 73' ' ' HIS . 22.1 ptt180 -146.92 163.57 35.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 111.053 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.44 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -147.68 150.78 34.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -91.89 121.58 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.02 165.64 24.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 0.0 112.342 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.453 ' HB3' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -123.53 107.37 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.938 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.1 m -57.91 130.89 48.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.04 -25.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.705 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -74.42 -13.35 60.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.257 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.27 40.72 2.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.542 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.99 120.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.307 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' CA ' ' CE ' ' A' ' 63' ' ' MET . 0.4 OUTLIER -88.68 114.44 25.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -143.81 165.53 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.27 109.81 21.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.8 m -84.28 118.33 24.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 2.4 m-70 -80.62 130.43 35.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.427 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 2.0 tt -68.59 140.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.475 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER 166.32 -167.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.002 0.43 . . . . 0.0 111.446 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.67 174.66 36.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.04 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -52.41 -23.83 6.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.968 0.413 . . . . 0.0 110.701 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -78.83 -18.61 53.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.205 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -48.09 -28.67 3.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.502 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -58.34 -22.9 55.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.883 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.79 46.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.417 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 78' ' ' LEU . 14.2 p -84.81 128.82 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.36 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -110.72 110.04 20.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.008 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.2 147.34 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.613 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m-20 -122.32 152.3 40.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.7 m -80.18 -6.81 58.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 0.0 111.769 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.2 p -143.95 56.53 1.33 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.595 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 85' ' ' ASN . 0.4 OUTLIER -146.93 164.77 31.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.281 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 38.1 mm -87.28 146.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.233 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 90' ' ' ILE . 1.1 mt -150.15 170.99 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 111.184 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.513 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -129.18 121.84 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.753 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 104' ' ' VAL . 16.0 m -116.16 150.38 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.75 131.41 10.72 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.401 HD23 ' CB ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -117.86 133.19 56.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.62 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -178.06 -75.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.28 -12.65 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.322 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 34.5 m-85 -83.11 2.93 32.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.678 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 65.81 25.64 11.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.658 0.266 . . . . 0.0 111.219 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.22 -54.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.758 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -39.7 -35.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 97' ' ' TYR . 8.3 mmmm -127.27 162.76 25.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.808 0.337 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.401 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -158.61 162.65 37.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -113.1 126.7 55.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.442 ' N ' HG12 ' A' ' 92' ' ' VAL . 61.5 t -55.02 112.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.99 -58.95 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.106 0.479 . . . . 0.0 110.023 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.517 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 1.3 pp -127.71 160.11 32.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.376 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.404 ' N ' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -107.04 117.47 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.633 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 25.0 m-85 -81.73 106.11 13.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -68.17 168.76 11.56 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.435 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -70.8 -40.77 72.33 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.477 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.26 -40.35 95.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.727 ' O ' HD23 ' A' ' 116' ' ' LEU . 26.3 mt-10 -66.79 -28.54 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.49 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.673 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.43 -48.97 7.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.78 -178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -56.11 -30.67 62.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -73.93 -22.12 59.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -50.32 -34.94 25.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.379 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -54.6 -34.76 62.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -20.9 42.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.97 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.0 m-30 -66.56 -6.18 14.17 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.829 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.52 64.59 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.593 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.576 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 48.0 mt-10 -113.87 -64.55 1.29 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.927 0.394 . . . . 0.0 111.234 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -92.49 149.94 39.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.999 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.7 179.55 4.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.634 2.223 . . . . 0.0 112.432 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.23 -32.17 68.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -75.83 -19.22 59.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.332 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.65 121.91 8.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -108.18 132.21 53.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.001 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.129 -179.906 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.416 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 14.6 tp -84.7 120.82 26.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 t -126.95 141.05 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.694 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 4.3 m-30 -109.19 170.45 8.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.612 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -45.6 141.48 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.902 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -111.46 166.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 111.333 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -58.4 129.71 43.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.43 -15.37 60.24 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.589 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.4 ' HB3' HD12 ' A' ' 91' ' ' LEU . 8.4 mt-30 -118.45 154.62 32.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.624 0.25 . . . . 0.0 110.458 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -130.02 152.63 49.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 111.064 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 2.9 p90 -84.39 157.24 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.986 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.16 173.79 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.251 0.548 . . . . 0.0 112.112 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -128.89 109.62 11.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.13 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 17.5 t -56.31 139.69 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 111.882 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.408 ' O ' HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -116.42 -42.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.935 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.4 ttmm -147.71 157.58 43.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.319 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.1 ttt -108.2 143.35 37.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.789 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.89 -25.61 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.118 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.69 -174.63 29.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.61 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -75.37 102.87 5.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.28 -26.28 3.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.407 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -151.47 155.41 38.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.337 . . . . 0.0 110.927 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.74 150.91 35.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 53' ' ' LYS . 4.4 tp10 -91.74 121.42 33.36 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.79 165.74 23.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.203 0.525 . . . . 0.0 112.145 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.16 107.07 9.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.419 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.5 133.25 55.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.063 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 3.5 m-85 -49.91 -25.22 3.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.724 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -8.46 56.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.235 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.92 43.1 3.4 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.451 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.03 113.94 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.3 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -84.22 113.51 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.751 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -145.15 165.5 28.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.2 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.34 108.56 20.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.979 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 34.0 m -84.31 118.4 24.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 20.3 m80 -82.56 134.5 35.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.628 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 tt -68.65 141.03 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.353 . . . . 0.0 111.01 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 2.3 mmt180 -63.95 155.59 30.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.18 -46.78 6.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.484 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -77.33 -40.53 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.6 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -64.02 -16.69 62.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.007 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.441 ' HA ' ' CG1' ' A' ' 82' ' ' VAL . 12.3 ptm180 -48.72 -26.13 2.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.684 0.278 . . . . 0.0 111.498 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -76.05 -35.03 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.554 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.35 34.93 3.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.652 0.263 . . . . 0.0 111.613 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 79' ' ' ARG . 8.5 p -123.79 111.34 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.159 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.98 110.23 20.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.852 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.95 147.16 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.408 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 13.3 m120 -139.88 157.86 45.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.636 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 52' ' ' ILE . 59.6 m -75.33 -6.45 49.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 111.772 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -143.31 76.12 1.51 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.796 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.46 161.16 16.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 51.3 mm -86.96 146.57 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.501 HG23 HD11 ' A' ' 90' ' ' ILE . 1.1 mt -150.49 171.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.362 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.498 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -130.27 122.43 28.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.866 178.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 104' ' ' VAL . 34.9 m -119.57 146.97 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.83 141.69 15.71 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.862 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -116.3 142.05 47.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.65 0.262 . . . . 0.0 110.575 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -149.11 -81.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.183 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.57 -12.16 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.328 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.417 ' CG ' ' HB2' ' A' ' 101' ' ' LYS . 35.0 m-85 -71.9 -10.18 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.404 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 4.6 mt-30 65.85 25.4 11.24 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.205 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 2.8 t0 83.36 -21.88 0.26 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.36 -29.51 68.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 0.0 110.699 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HB2' ' CG ' ' A' ' 97' ' ' TYR . 10.1 mtpt -144.27 164.85 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.688 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -163.3 171.66 15.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.106 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.34 125.65 50.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.432 ' N ' HG12 ' A' ' 92' ' ' VAL . 99.3 t -49.96 111.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.47 -46.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.196 0.522 . . . . 0.0 109.737 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.502 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -142.06 166.93 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.31 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.421 ' N ' HD13 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -110.44 120.56 42.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.628 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 22.7 m-85 -84.23 105.94 15.47 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -71.78 177.19 4.34 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -77.1 -40.03 47.38 Favored 'General case' 0 CA--C 1.524 -0.045 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.055 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -62.62 -40.99 98.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.717 ' O ' HD21 ' A' ' 116' ' ' LEU . 14.0 mt-10 -65.93 -27.93 68.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.345 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.795 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.26 -50.28 6.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.23 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -56.42 -26.8 54.66 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.246 -0.581 . . . . 0.0 109.714 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -80.17 -22.29 42.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.14 178.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.795 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -49.92 -33.98 19.06 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 121.22 -0.192 . . . . 0.0 111.002 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -54.75 -34.37 62.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.12 -20.39 45.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.059 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.6 m-30 -66.42 -4.37 8.07 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.927 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.55 21.08 53.8 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.735 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 58.5 mm-40 -111.45 -60.42 1.84 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.457 ' CD2' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -95.02 144.79 28.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.834 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.442 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 72.6 Cg_endo -76.08 179.8 5.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.631 2.221 . . . . 0.0 112.353 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.77 -29.31 67.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.442 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 25.6 p-80 -81.43 -0.49 41.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.473 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.28 145.15 56.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.836 0.35 . . . . 0.0 110.976 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -124.78 120.82 32.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.992 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.86 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.946 0.403 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.468 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 16.0 tp -83.14 109.59 17.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.478 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.78 139.66 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.701 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 79.6 m-85 -113.45 170.5 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.714 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -47.68 163.41 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -132.51 156.38 46.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 111.294 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -59.04 129.16 40.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.697 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.45 61.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.558 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' HB3' HD13 ' A' ' 91' ' ' LEU . 26.3 mt-30 -116.43 148.17 40.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.585 0.231 . . . . 0.0 110.439 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.09 152.56 38.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 111.613 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 11.9 p90 -84.5 157.71 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.899 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.3 173.28 15.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 112.42 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -126.5 125.5 42.17 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.082 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 86' ' ' THR . 12.2 t -79.32 138.3 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 63' ' ' MET . 1.1 mt -116.1 -45.75 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.169 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -137.76 157.15 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 7.8 ttm -111.41 143.53 42.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -37.62 6.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.816 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.38 171.66 27.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -60.07 103.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.32 -22.57 3.95 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.616 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -154.5 157.76 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.95 160.27 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.298 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -102.18 121.47 42.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.98 166.18 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.352 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.451 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 4.3 tpp -126.89 111.61 14.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.056 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 46.6 t -58.67 134.76 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -25.28 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.581 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -74.31 -14.17 60.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.233 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.72 41.19 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.583 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.3 t -127.23 125.79 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.99 115.25 29.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -144.19 160.8 40.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.81 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.32 105.68 17.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.801 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.2 m -85.16 118.75 24.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.673 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -81.39 127.77 33.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 tt -68.43 140.58 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.44 -165.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 0.0 111.514 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.23 169.91 46.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.179 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -48.58 -27.18 2.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.432 . . . . 0.0 110.763 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 1.0 OUTLIER -66.41 -32.86 74.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -48.83 -28.18 3.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.248 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.84 -26.53 58.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 46.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.251 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 9.3 p -124.34 123.07 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.705 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -111.21 109.97 20.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.538 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.457 ' CG2' HD11 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -65.06 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -102.06 151.48 22.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.462 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.449 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 86.2 m -80.25 -6.55 58.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.62 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.95 72.06 1.34 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.639 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -165.65 167.39 17.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 26.5 mm -86.9 146.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.192 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 90' ' ' ILE . 1.1 mt -150.3 171.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.383 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.521 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -129.57 122.31 28.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.785 178.678 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 104' ' ' VAL . 26.9 m -117.83 146.68 21.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.155 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.97 140.08 14.91 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.911 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.51 132.6 53.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.648 0.261 . . . . 0.0 110.616 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.55 -80.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.01 -15.95 63.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.449 ' CE2' ' HB2' ' A' ' 103' ' ' ASP . 48.5 m-85 -72.44 -8.8 56.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.547 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 67.29 29.94 7.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.34 -175.94 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.57 -61.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.836 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.15 156.66 17.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.967 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.408 ' CB ' ' CG2' ' A' ' 92' ' ' VAL . . . -141.28 -177.71 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.829 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.449 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 10.5 t70 -133.96 120.31 20.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.459 ' N ' HG11 ' A' ' 92' ' ' VAL . 59.8 t -52.87 112.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.845 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.75 -62.16 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.077 0.465 . . . . 0.0 110.057 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.553 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 1.5 pp -124.8 159.62 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.46 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.92 118.73 37.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.644 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 22.8 m-85 -82.24 106.28 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.09 173.39 5.58 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -74.48 -40.23 61.97 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.693 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.06 -40.48 95.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.729 ' O ' HD21 ' A' ' 116' ' ' LEU . 19.4 mt-10 -66.99 -28.37 68.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.505 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.754 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.63 -48.94 7.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.909 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -55.9 -30.26 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.386 0.612 . . . . 0.0 109.528 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.607 ' O ' ' N ' ' A' ' 118' ' ' ALA . 1.4 m -76.14 -22.46 55.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.173 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.754 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.22 -32.95 17.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.067 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.51 -34.3 61.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.74 42.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.778 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.644 ' HE2' ' CG ' ' A' ' 108' ' ' TYR . 4.2 m-30 -66.97 -11.64 57.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.86 23.27 65.39 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.633 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.54 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 50.8 mt-10 -109.54 -52.05 2.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.933 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.466 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -100.1 148.09 34.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.723 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.401 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 60.0 Cg_endo -72.52 178.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 0.0 112.339 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -30.8 69.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.401 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 56.7 p-80 -84.2 -3.49 58.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.405 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.35 147.64 30.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.887 0.375 . . . . 0.0 111.164 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -115.07 148.39 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.011 179.875 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.85 0.357 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 41' ' ' PHE . 30.1 tp -68.31 130.63 43.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.71 140.34 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.804 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.767 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.4 m-30 -112.51 170.95 7.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -45.24 148.61 0.6 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.952 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.75 162.43 20.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.39 . . . . 0.0 111.347 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -57.04 130.44 46.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.72 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.65 -15.36 61.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.369 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.41 ' HB3' HD12 ' A' ' 91' ' ' LEU . 2.0 mt-30 -123.62 144.49 49.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -118.85 153.64 34.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 111.383 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 10.1 p90 -84.22 157.71 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.698 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.31 173.52 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.362 0.601 . . . . 0.0 112.389 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -128.19 120.83 28.05 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.189 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 29.6 t -70.8 134.91 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.985 0.421 . . . . 0.0 111.664 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -116.45 -38.58 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -140.68 159.82 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.74 143.07 45.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.66 -58.74 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.944 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.77 -168.1 16.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.647 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -83.72 0.89 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.517 0.199 . . . . 0.0 111.49 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.58 -8.39 7.62 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.883 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -153.36 160.17 42.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 110.779 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.411 HD21 HG22 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -147.94 149.77 32.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -91.84 121.41 33.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.97 165.62 25.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 112.141 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.43 ' CE ' ' CB ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -126.1 111.84 15.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.169 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.48 135.96 57.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.3 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.0 m-85 -49.73 -25.39 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.34 -7.17 51.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.289 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.84 44.42 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.446 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.21 130.64 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 111.303 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' CB ' ' CE ' ' A' ' 63' ' ' MET . 8.6 tttt -95.7 113.73 25.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -145.04 165.59 27.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.7 mm? -103.12 109.23 20.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.406 ' HB3' ' CG1' ' A' ' 92' ' ' VAL . 25.7 m -84.41 119.8 25.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.99 136.53 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.0 tt -68.73 140.73 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -73.75 145.11 45.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.108 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -48.26 34.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.311 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -29.13 70.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.363 . . . . 0.0 110.628 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 3.8 mm? -84.67 -29.14 25.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.805 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HA ' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -48.97 -27.2 2.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -59.05 -42.16 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.266 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.83 46.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 111.434 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 9.8 p -123.95 117.9 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -110.93 110.06 20.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.066 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.411 HG22 HD21 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -83.1 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.251 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.444 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 t30 -108.33 159.35 16.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.106 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.6 m -80.12 -5.72 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 p -147.67 55.41 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.629 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.6 162.19 35.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.205 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.507 ' CG2' HD13 ' A' ' 116' ' ' LEU . 30.4 mm -87.03 146.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.288 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 90' ' ' ILE . 1.2 mt -150.58 171.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.152 0.501 . . . . 0.0 111.327 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.496 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -129.56 122.39 29.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.448 178.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 72' ' ' CYS . 27.2 m -121.94 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.406 ' HA2' ' CB ' ' A' ' 46' ' ' GLN . . . -90.78 143.79 16.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mt -113.73 26.31 10.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.956 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.02 19.41 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.2 -49.2 6.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.682 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -105.46 -11.19 16.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.221 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 65.48 29.61 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -135.48 178.45 7.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -57.38 -18.26 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.856 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 132.37 34.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.816 0.341 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.72 158.14 23.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.472 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -115.45 120.48 39.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.032 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.406 ' O ' ' CG ' ' A' ' 75' ' ' ARG . 94.5 t -50.33 111.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.738 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.1 mm -77.94 -36.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 109.679 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.518 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -154.13 167.45 29.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.452 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.417 ' N ' HD13 ' A' ' 106' ' ' LEU . 14.6 pttt -110.28 121.64 45.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.15 0.5 . . . . 0.0 112.274 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.636 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 23.2 m-85 -86.4 106.6 17.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -73.86 178.29 4.98 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -76.54 -41.76 45.45 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.071 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -61.65 -40.05 93.52 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.699 ' O ' HD22 ' A' ' 116' ' ' LEU . 9.6 mt-10 -68.63 -28.0 66.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.351 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.721 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.54 -51.63 6.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.955 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -55.72 -27.22 49.36 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.662 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.584 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -76.58 -22.11 54.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.001 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.721 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.0 -34.43 21.13 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -54.85 -34.55 63.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.35 -20.92 43.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.921 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.767 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.9 m-30 -66.77 -7.28 20.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.827 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.22 24.53 65.46 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.566 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.567 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.8 mt-10 -114.05 -63.5 1.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.876 0.369 . . . . 0.0 111.191 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.42 144.59 29.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.957 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.448 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.7 Cg_endo -71.38 179.78 4.28 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.657 2.238 . . . . 0.0 112.401 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -70.89 -34.61 71.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.448 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 20.7 p-80 -72.44 -17.98 61.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -56.84 133.66 54.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.732 0.301 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -114.36 134.35 55.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.097 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 112' ' ' GLU . 13.5 tp -68.81 99.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.704 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.4 ' CG1' HD22 ' A' ' 106' ' ' LEU . 18.9 t -88.35 139.15 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.624 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 86.5 m-85 -110.69 170.27 8.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -52.79 148.43 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.887 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -116.85 160.52 20.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.402 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.63 130.07 45.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.48 61.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.541 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.412 ' HB3' HD11 ' A' ' 91' ' ' LEU . 1.5 mt-30 -117.53 140.97 48.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.53 0.205 . . . . 0.0 110.559 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -115.66 154.36 29.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 111.408 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 5.3 p90 -84.55 157.78 21.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.21 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.01 173.18 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.225 0.536 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.04 109.05 11.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.273 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 20.6 t -57.2 135.47 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.769 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.07 -40.48 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.697 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.63 158.82 43.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.735 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -115.7 139.02 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.63 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -110.72 -48.79 3.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.773 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.88 -179.27 30.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.54 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 67.65 19.53 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.304 . . . . 0.0 111.239 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.47 28.79 9.33 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.839 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -154.82 155.88 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.422 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 1.2 pp -147.6 152.5 38.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.156 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -91.75 121.39 33.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . . . -124.25 165.06 18.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 112.331 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.407 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 1.2 tpt -125.8 100.24 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.86 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.37 132.17 50.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.637 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.2 m-85 -49.93 -27.0 4.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.453 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -8.09 55.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.434 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.72 40.71 3.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.531 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.13 123.06 61.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.262 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 1.9 tppp? -94.14 117.19 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -145.08 164.71 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.037 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.21 106.52 18.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.729 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.8 m -84.07 118.77 24.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 137.71 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -68.66 139.18 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.704 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.11 143.9 56.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.143 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.58 -38.28 57.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.51 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -75.87 -29.4 58.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.659 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 2.7 mm? -82.7 -28.65 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HA ' HG11 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -49.63 -27.62 4.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.248 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -35.56 69.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.304 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.24 48.74 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 10.7 p -120.95 119.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.143 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -110.81 110.27 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.419 ' CD1' ' CD2' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -87.11 147.14 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.435 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -118.84 156.32 29.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.3 m -80.15 -6.45 57.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.168 0.509 . . . . 0.0 111.377 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -145.34 71.24 1.28 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.43 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.73 165.18 33.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.085 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 38.4 mm -86.78 144.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 90' ' ' ILE . 1.1 mt -150.52 172.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 111.063 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -129.01 127.11 40.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.795 178.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 104' ' ' VAL . 31.6 m -122.2 149.51 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.92 135.85 12.96 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.87 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 123.78 42.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.6 0.238 . . . . 0.0 110.72 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.57 -80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -61.12 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -73.52 -8.03 54.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.433 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 66.71 30.2 8.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.823 0.344 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.73 -169.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.14 -62.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.775 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -108.59 168.68 9.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.761 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 92' ' ' VAL . . . -152.68 177.2 10.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.98 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.33 119.1 21.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.833 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.444 ' N ' HG12 ' A' ' 92' ' ' VAL . 70.9 t -49.89 111.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.906 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -82.5 -47.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.13 0.491 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.453 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.4 pp -141.52 169.16 18.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.59 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.407 ' HA ' HG22 ' A' ' 90' ' ' ILE . 12.0 pttp -110.28 122.51 47.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 111.96 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.651 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 20.1 m-85 -85.44 107.0 17.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -64.27 168.08 5.98 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.82 -51.06 11.08 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.4 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.457 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 46.2 t0 -62.02 -38.2 87.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.477 ' OE2' ' HA ' ' A' ' 108' ' ' TYR . 0.7 OUTLIER -75.28 -26.16 58.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.018 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.589 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . . . -45.44 -41.89 9.83 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.765 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.457 ' CG ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -53.11 -36.71 61.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.318 0.58 . . . . 0.0 109.488 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 118' ' ' ALA . 1.0 OUTLIER -61.61 -21.04 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.971 177.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.681 ' HA ' ' CG ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -50.32 -32.93 18.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.354 -178.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -34.48 65.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.1 -21.64 43.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.639 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.681 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -67.24 -10.5 51.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.077 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.72 64.83 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.619 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.473 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 65.4 mm-40 -111.3 -53.53 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.772 0.32 . . . . 0.0 111.013 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -98.04 147.2 32.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.78 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.414 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.1 Cg_endo -70.91 175.1 9.52 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.56 2.173 . . . . 0.0 112.193 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.29 -27.12 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.414 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 21.3 p-80 -81.62 -10.84 59.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.429 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.91 164.51 0.58 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -129.77 144.74 51.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.871 0.367 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 19.7 tp -127.59 124.47 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.8 t -126.47 140.5 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.93 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.754 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 5.3 m-30 -110.6 170.64 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.442 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -46.45 147.62 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.039 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -128.1 165.05 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.283 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.47 130.51 46.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.739 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.44 -15.26 61.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.386 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -127.31 146.52 50.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -125.29 153.88 42.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.022 0.439 . . . . 0.0 111.492 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 7.8 p90 -84.32 157.88 21.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.84 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.81 173.55 15.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 112.388 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.406 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 tm0? -128.75 124.27 35.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 21.7 t -76.58 140.94 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 111.95 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 63' ' ' MET . 0.8 OUTLIER -115.95 -41.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.072 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -147.66 161.25 41.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -110.15 142.04 42.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.441 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 1.8 mt -97.04 -30.28 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.29 61.03 3.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.704 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -177.73 51.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.568 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.59 11.07 64.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.424 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 73' ' ' HIS . 24.8 ptt180 -147.25 164.17 34.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -147.19 155.61 42.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -91.71 122.09 33.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.01 165.76 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.174 0.512 . . . . 0.0 111.941 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.456 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 4.6 tpp -131.28 111.79 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.116 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -59.27 131.76 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.361 . . . . 0.0 110.463 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.64 -26.3 2.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.789 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.33 -14.22 60.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.84 1.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.58 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -126.92 126.28 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 111.038 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.01 113.23 24.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.29 163.52 34.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.5 mm? -102.82 114.25 28.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.706 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.2 m -83.99 118.71 24.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 4.9 m80 -83.99 146.32 28.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.7 mm -68.6 120.12 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.31 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 28.5 tpt180 -64.79 137.98 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.19 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.96 -65.96 2.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.656 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.34 9.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.48 -17.78 33.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -48.73 -29.73 4.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.238 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -55.32 -27.07 44.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.98 38.78 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.058 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.2 p -81.74 111.15 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.398 . . . . 0.0 110.758 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -111.15 110.52 21.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.482 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -115.05 147.47 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -132.27 160.77 35.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.686 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.43 HG21 ' O ' ' A' ' 52' ' ' ILE . 74.7 m -80.59 -6.73 58.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.153 0.501 . . . . 0.0 111.805 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -147.51 69.86 1.16 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.746 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.96 161.98 36.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.133 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 1.5 mp -86.76 147.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.5 HD13 HG21 ' A' ' 90' ' ' ILE . 1.6 mt -150.42 172.37 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 111.58 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.504 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -128.2 122.0 30.79 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.48 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 104' ' ' VAL . 13.6 m -117.86 157.01 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.55 123.23 7.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.539 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.39 111.79 21.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.764 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -176.98 -71.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.44 -12.48 61.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.52 10.74 16.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.62 29.75 10.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.977 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.7 t0 68.45 -178.9 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.29 -61.06 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -96.36 163.6 13.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.676 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -163.74 139.82 6.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.96 129.4 36.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 96.2 t -55.01 111.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.808 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 mm -77.53 -48.76 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.135 0.493 . . . . 0.0 109.853 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.521 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -140.94 167.3 22.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.255 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.439 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -111.82 119.59 39.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 112.305 -178.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.631 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 24.2 m-85 -83.86 106.08 15.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -72.2 177.86 4.21 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -77.13 -40.54 45.33 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.175 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -61.41 -40.49 94.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.711 ' O ' HD23 ' A' ' 116' ' ' LEU . 11.5 mt-10 -67.03 -27.91 67.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.508 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.847 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.31 -49.47 6.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.984 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -28.15 56.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.348 0.594 . . . . 0.0 109.5 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.98 -22.79 42.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.167 178.414 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.847 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.89 -33.75 25.43 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.064 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -55.2 -34.18 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.02 -20.32 45.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.932 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.754 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.4 -6.14 13.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.83 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.46 24.8 53.55 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.791 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.454 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 49.2 mm-40 -114.27 -56.28 2.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -90.85 153.29 45.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 73.5 Cg_endo -75.81 -179.79 5.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.723 2.282 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.0 -31.28 67.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.088 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 29.4 p-80 -84.17 2.71 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.532 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.1 122.28 14.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.158 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -108.82 121.53 45.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 -179.792 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.809 0.337 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.417 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 22.9 tp -68.09 122.73 18.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 15.4 t -114.69 139.88 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.617 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 24.5 m-85 -116.9 170.07 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.582 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 158.19 19.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.792 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -144.46 178.04 8.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.361 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -44.52 137.02 3.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.27 61.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.425 ' HB3' HD13 ' A' ' 91' ' ' LEU . 2.5 mt-30 -141.73 139.2 32.82 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -123.4 157.63 32.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.007 0.432 . . . . 0.0 111.535 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 4.9 p90 -84.5 158.05 21.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.93 173.86 14.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.248 0.547 . . . . 0.0 112.2 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.78 120.6 26.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.019 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.419 ' CG2' HD11 ' A' ' 60' ' ' LEU . 23.4 t -70.89 135.46 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 112.039 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.433 HD11 ' HB2' ' A' ' 63' ' ' MET . 14.0 mt -116.29 -40.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 157.62 46.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.12 131.6 56.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.747 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -105.89 -32.68 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.8 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.42 -171.67 48.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.57 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 m120 61.9 26.49 16.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.718 0.294 . . . . 0.0 111.049 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.85 32.19 24.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.616 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -155.4 157.27 36.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.605 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.432 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 2.6 pp -148.04 160.91 42.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 111.611 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -104.41 120.83 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.51 164.68 27.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.23 0.538 . . . . 0.0 112.033 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.433 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -120.08 114.8 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.191 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.2 m -59.45 133.47 56.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.502 ' CG ' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -48.2 -25.54 1.54 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.622 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.0 -14.07 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.339 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.89 39.75 2.45 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.664 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.34 129.6 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 111.428 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.402 ' CB ' ' CE ' ' A' ' 63' ' ' MET . 1.7 ttmp? -91.66 117.94 30.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' NH2' ' CG2' ' A' ' 92' ' ' VAL . 33.2 ptt180 -142.7 165.57 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.981 0.42 . . . . 0.0 111.165 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.4 mm? -104.29 108.08 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.5 m -84.87 118.75 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.416 ' CD2' ' CE2' ' A' ' 97' ' ' TYR . 2.2 m-70 -85.01 130.32 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.0 tt -68.64 140.91 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.047 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 14.2 tpt180 -76.6 148.51 36.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.087 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.22 -79.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.984 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.39 -26.1 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.722 0.296 . . . . 0.0 111.544 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -79.93 -45.33 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.186 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -58.46 -24.12 59.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -58.64 -33.43 70.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 8.44 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.585 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.451 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -124.18 119.69 57.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.132 0.491 . . . . 0.0 111.167 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -111.07 110.32 20.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.766 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.408 HG23 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.49 147.59 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.3 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -118.97 159.33 24.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.2 m -76.12 -6.09 49.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.697 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.1 p -145.83 71.57 1.27 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.702 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.59 160.52 39.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.079 0.466 . . . . 0.0 111.208 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 38.3 mm -86.94 146.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.489 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.506 HG22 HD12 ' A' ' 90' ' ' ILE . 1.4 mt -150.41 171.14 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.241 0.543 . . . . 0.0 111.631 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.498 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -129.07 124.37 34.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.429 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 102' ' ' ALA . 16.9 m -122.69 160.26 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.351 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.93 135.77 12.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -100.45 159.1 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 60.87 22.82 12.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.178 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.04 -47.37 7.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.674 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.416 ' CE2' ' CD2' ' A' ' 73' ' ' HIS . 46.2 m-85 -96.95 4.15 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.136 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 65.82 29.71 10.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.722 0.296 . . . . 0.0 110.796 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.61 175.32 13.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.438 . . . . 0.0 111.109 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -17.58 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.109 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -77.67 124.79 28.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 111.369 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB2' ' CG2' ' A' ' 92' ' ' VAL . . . -111.5 156.16 22.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.053 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 13.1 p30 -102.82 120.67 41.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.881 0.372 . . . . 0.0 111.426 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 80.3 t -52.62 111.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.325 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.6 mm -79.02 -33.25 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.266 0.555 . . . . 0.0 109.81 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.479 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.6 pp -159.1 166.83 30.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.442 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HA ' HG23 ' A' ' 90' ' ' ILE . 1.6 tttt -109.9 116.94 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.061 0.457 . . . . 0.0 112.145 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.654 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 22.3 m-85 -79.23 106.12 11.04 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -73.44 177.15 5.45 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -76.03 -40.16 54.03 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.001 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.07 -40.81 97.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.696 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.9 mt-10 -67.76 -28.1 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.381 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.838 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.44 -49.13 7.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.829 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.39 -29.21 61.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.31 0.576 . . . . 0.0 109.489 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -78.32 -22.56 47.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.181 178.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.838 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.08 -33.86 27.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.024 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -33.76 61.54 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -21.01 43.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.729 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.654 ' HE2' ' CD1' ' A' ' 108' ' ' TYR . 4.0 m-30 -66.73 -8.44 28.08 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.89 23.46 51.18 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.418 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 2.9 mm-40 -109.93 -51.55 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.99 125.21 44.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.426 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 35.6 Cg_exo -57.27 179.0 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.327 2.018 . . . . 0.0 112.15 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.59 -28.63 67.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.426 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 10.3 p-80 -80.78 -23.28 39.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.222 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -55.39 141.21 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.284 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -124.14 146.51 48.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.02 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.44 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 13.7 tp -118.9 130.51 55.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.439 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 17.7 t -121.84 139.58 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.097 0.475 . . . . 0.0 111.402 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 119' ' ' TYR . 53.8 m-85 -115.22 171.7 7.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -39.44 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -133.81 158.49 43.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 126.78 28.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.74 78.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.97 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -115.12 143.77 44.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.824 0.312 . . . . 0.0 110.658 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -119.22 166.21 13.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.129 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.597 ' CZ ' ' CE2' ' A' ' 108' ' ' TYR . 3.8 m-85 -84.78 156.82 21.21 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.706 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 64' ' ' CYS . . . -149.5 142.75 25.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.681 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.29 108.43 16.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.946 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 21.5 t -55.42 137.56 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 86' ' ' THR . 0.3 OUTLIER -116.13 -42.62 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.15 151.95 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.47 134.04 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.679 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 61' ' ' GLU . 1.2 mt -93.72 -35.63 12.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.825 0.345 . . . . 0.0 110.772 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.25 -132.35 3.2 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -112.6 89.52 3.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.324 . . . . 0.0 110.976 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 147.75 -24.21 1.48 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -152.87 160.25 43.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.634 0.254 . . . . 0.0 110.534 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.451 ' CD2' ' CD1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.21 150.05 34.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 111.367 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.3 tt0 -91.72 121.64 33.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.56 166.11 24.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.237 0.541 . . . . 0.0 112.318 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.415 ' HE1' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -115.17 95.92 5.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.095 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 18.7 t -45.8 125.91 6.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' CZ ' HD23 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -48.46 -23.35 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.91 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -13.2 60.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.599 0.238 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.43 34.36 4.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.687 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.19 124.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 0.0 OUTLIER -85.86 112.47 21.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.58 165.77 27.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.907 0.385 . . . . 0.0 111.304 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -97.12 108.01 20.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.6 m -84.24 125.76 32.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.614 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.75 137.08 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.1 tt -68.87 140.3 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.821 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -74.31 145.69 43.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.913 0.387 . . . . 0.0 111.348 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.89 -51.23 15.61 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.272 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -31.56 64.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.986 0.422 . . . . 0.0 110.501 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 4.5 mm? -85.9 -31.71 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.453 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -49.01 -28.84 4.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.314 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -56.9 -27.48 60.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -169.37 49.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.36 . . . . 0.0 111.165 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 9.4 p -123.0 122.94 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.644 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -111.03 109.58 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.673 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.451 ' CD1' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -81.12 123.77 38.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 179.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.489 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -84.72 152.82 23.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 52' ' ' ILE . 63.0 m -79.92 -5.92 56.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.512 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 p -146.54 51.77 1.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -133.71 165.0 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 111.57 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 1.5 mp -87.72 146.58 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.875 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 106' ' ' LEU . 1.3 mt -150.42 170.5 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.054 0.454 . . . . 0.0 111.195 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.538 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -123.27 122.4 38.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.93 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.449 HG13 ' N ' ' A' ' 104' ' ' VAL . 19.4 m -120.55 154.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.04 153.81 20.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.851 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.409 ' CD2' ' CB ' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -137.17 131.25 32.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 179.55 -68.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.094 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.28 -15.02 60.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -72.58 -11.4 60.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.582 0.229 . . . . 0.0 111.556 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 64.87 29.72 12.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.857 0.36 . . . . 0.0 110.807 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.9 OUTLIER 62.85 97.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 99' ' ' ASP . 4.3 t-20 165.12 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -141.94 162.39 35.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.474 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.419 ' CB ' ' CG2' ' A' ' 92' ' ' VAL . . . -139.29 170.99 14.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -128.79 111.33 13.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.449 ' N ' HG13 ' A' ' 92' ' ' VAL . 68.5 t -49.94 112.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.3 mm -83.94 -43.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.175 0.512 . . . . 0.0 109.764 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 90' ' ' ILE . 2.0 pp -144.46 165.82 26.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.421 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -111.87 120.7 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.923 -179.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.668 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 27.3 m-85 -83.11 105.91 14.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.97 166.77 4.31 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -73.12 -35.96 66.63 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.402 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.96 -40.22 97.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.742 ' O ' HD23 ' A' ' 116' ' ' LEU . 51.7 mt-10 -64.18 -28.19 69.58 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.561 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.912 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.58 -38.43 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.675 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -33.98 77.16 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.1 p -77.58 -23.09 50.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.867 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.912 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -52.54 -31.36 35.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.18 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -33.11 62.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.31 -21.79 42.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.731 177.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.68 ' CG ' HD21 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.44 -7.55 26.23 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.858 0.361 . . . . 0.0 110.218 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.11 84.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.003 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.458 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 38.2 mm-40 -125.83 -56.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.505 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.62 118.64 67.51 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.442 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 51.2 Cg_exo -54.3 178.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.206 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.442 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 10.0 p-80 -77.23 -17.85 58.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.246 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -52.62 128.73 27.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.363 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -106.76 133.03 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.465 HG22 ' CB ' ' A' ' 113' ' ' ALA . 5.4 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.826 0.346 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.534 ' CD1' ' CG ' ' A' ' 112' ' ' GLU . 16.4 tp -127.21 123.73 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.4 140.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.6 m-85 -111.04 170.06 8.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.085 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 149.13 48.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.685 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.25 176.41 7.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.346 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -49.64 134.1 20.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.081 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.45 -15.09 60.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.12 139.42 45.9 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -125.06 157.2 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.07 0.462 . . . . 0.0 111.496 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CE2' ' CD1' ' A' ' 65' ' ' PHE . 2.9 p90 -84.6 158.12 20.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.034 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.37 173.65 13.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.233 0.539 . . . . 0.0 111.997 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 38.4 tp60 -128.64 108.94 10.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.92 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 12.0 t -60.98 136.14 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.047 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 mp -116.2 -40.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.703 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 157.95 44.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.5 ttt -116.9 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.66 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -117.35 -167.62 1.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.729 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.37 -178.53 19.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.441 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.36 39.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.73 52.15 53.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.76 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' HIS . 8.2 ptt180 -154.81 162.66 41.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.311 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' CD2' ' CD1' ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.06 152.26 38.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.291 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -94.02 121.82 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.907 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.29 161.36 30.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.235 0.54 . . . . 0.0 112.093 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -119.97 101.65 8.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.146 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.05 129.22 40.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.37 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 3.4 m-85 -50.63 -24.54 3.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.468 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -8.42 56.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 35.63 5.0 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.685 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.23 124.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.377 . . . . 0.0 111.087 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -96.36 115.21 27.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -141.48 160.99 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.4 mm? -95.67 110.79 22.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.5 m -84.25 119.02 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -79.85 141.49 36.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.373 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.435 HD13 ' CD1' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -68.63 126.76 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -179.23 -168.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.645 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.47 171.16 40.97 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.298 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -21.6 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.848 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -68.71 -10.81 58.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.412 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -47.6 -28.52 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.611 0.243 . . . . 0.0 111.48 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -61.96 -26.28 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.426 ' HE3' ' CZ2' ' A' ' 83' ' ' TRP . 10.2 mtpt -170.31 52.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 78' ' ' LEU . 14.3 p -81.97 111.07 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.426 ' CZ2' ' HE3' ' A' ' 81' ' ' LYS . 10.3 m0 -111.62 109.62 19.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.606 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.435 ' CD1' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -97.06 147.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.63 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.458 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.4 m-80 -119.58 153.38 35.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.927 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.9 m -80.25 -6.4 57.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 111.675 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.7 62.37 1.32 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.98 165.73 34.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.261 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.522 ' C ' ' HB2' ' A' ' 108' ' ' TYR . 37.2 mm -86.93 145.7 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.29 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.529 HG22 HD11 ' A' ' 90' ' ' ILE . 1.1 mt -150.84 171.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.508 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -129.01 122.24 29.62 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.536 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 104' ' ' VAL . 10.1 m -115.18 164.14 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.92 123.21 6.86 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.532 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.418 ' N ' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -109.98 119.76 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.755 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -163.96 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -12.16 60.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -84.81 10.99 10.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.685 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 66.79 26.79 9.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 72.8 -57.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.462 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -40.71 -32.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.717 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -123.61 158.96 30.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -153.07 156.34 38.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -107.23 126.5 52.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.424 ' N ' HG12 ' A' ' 92' ' ' VAL . 87.2 t -52.5 111.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.686 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 12.7 mm -80.93 -58.4 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.867 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.509 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -129.67 167.22 18.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.358 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' N ' HD13 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -110.84 119.31 38.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.644 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 23.3 m-85 -84.01 106.38 15.62 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -70.46 172.84 7.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -75.61 -51.05 13.71 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.636 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -61.32 -39.14 89.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.534 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 23.6 tt0 -67.1 -29.94 69.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.607 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.617 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -45.84 -42.87 12.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.543 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -41.89 58.65 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 110.149 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.577 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -61.87 -21.32 64.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.516 178.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.704 ' HA ' ' CG ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -50.7 -33.35 22.43 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.049 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -55.24 -34.74 64.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.3 -20.58 44.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.009 177.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.2 m-30 -66.58 -8.28 25.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.876 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 22.93 56.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.493 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 66.6 mm-40 -109.77 -61.0 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.912 0.387 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.474 ' CD2' ' CE2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -82.18 139.45 45.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.745 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.441 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 64.3 Cg_endo -73.78 178.03 7.32 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.45 -29.8 70.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 27.3 p-80 -84.19 2.48 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.5 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.15 126.37 30.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 110.994 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -123.59 127.58 48.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 179.893 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.846 0.355 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' HG2' ' A' ' 112' ' ' GLU . 23.3 tp -103.29 118.38 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.404 ' CG1' HD23 ' A' ' 106' ' ' LEU . 19.1 t -108.08 139.11 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.628 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 66.9 m-85 -112.75 170.43 8.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.711 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -48.28 143.42 4.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.47 156.17 19.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -56.1 129.85 41.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.838 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.23 -15.35 62.31 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.391 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -116.38 152.95 32.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.636 0.255 . . . . 0.0 110.401 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -125.93 154.48 42.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 111.335 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 10.0 p90 -84.34 157.87 21.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.76 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.83 173.42 15.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.327 0.584 . . . . 0.0 112.204 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -123.77 142.43 51.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.813 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 22.7 t -92.16 139.02 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 111.799 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 63' ' ' MET . 1.0 OUTLIER -115.85 -48.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.274 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -141.77 162.2 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.0 mmm -113.96 137.09 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -106.19 -69.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.896 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.23 179.65 16.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.565 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -72.37 -13.99 61.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.565 0.221 . . . . 0.0 111.259 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 74' ' ' ILE . . . -118.78 8.85 12.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.4 155.98 34.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.752 0.311 . . . . 0.0 111.0 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.401 HD21 ' CD1' ' A' ' 84' ' ' ILE . 1.6 pp -147.89 164.1 34.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.379 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -104.23 121.42 43.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.05 165.96 23.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.274 0.559 . . . . 0.0 112.262 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.454 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 3.7 tpp -130.14 110.92 11.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.078 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.25 133.5 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -27.27 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.502 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.37 -13.24 60.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.58 43.04 1.9 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.497 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.05 117.8 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.64 112.99 24.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.1 156.84 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.66 107.89 19.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 32.3 m -84.17 118.42 24.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.376 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.84 123.7 29.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.765 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.409 ' CG2' ' HA2' ' A' ' 58' ' ' GLY . 5.5 tt -68.73 140.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 176.73 -161.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.793 0.33 . . . . 0.0 111.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.3 168.93 39.01 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.028 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.72 2.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.575 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 1.2 mm? -64.47 -34.57 78.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.784 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -27.16 3.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.292 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -56.76 -37.66 71.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -157.64 48.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.196 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.51 121.19 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.261 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.55 109.86 20.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.401 ' CD1' HD21 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.38 147.17 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.086 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.412 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -108.75 152.84 24.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.957 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 52' ' ' ILE . 70.3 m -80.17 -6.36 57.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 111.69 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 p -146.2 61.69 1.24 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.687 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.96 168.52 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.186 0.517 . . . . 0.0 111.45 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.502 ' C ' ' HB2' ' A' ' 108' ' ' TYR . 47.6 mm -91.81 146.78 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.213 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.491 HG22 HD12 ' A' ' 90' ' ' ILE . 1.2 mt -150.9 170.7 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 111.449 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.483 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -128.68 121.66 29.05 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.519 178.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 104' ' ' VAL . 15.3 m -118.66 148.4 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.13 128.4 8.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 111.54 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.735 0.302 . . . . 0.0 110.73 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.33 -75.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -55.35 -23.22 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.335 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -85.28 4.88 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.633 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 65.78 30.02 10.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 76.36 178.86 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 73.28 -60.67 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.809 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.26 151.05 22.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.674 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.406 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -148.83 151.22 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.991 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -99.44 127.96 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.431 ' N ' HG13 ' A' ' 92' ' ' VAL . 62.0 t -54.86 111.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.471 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -82.73 -56.74 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 109.923 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.526 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -130.91 166.08 21.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.48 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.425 ' N ' HD11 ' A' ' 106' ' ' LEU . 10.4 tttt -111.74 117.93 34.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.702 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 23.2 m-85 -84.15 106.55 15.88 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -87.48 -178.94 6.26 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . . . -68.38 -45.35 72.99 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.363 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.86 -39.48 77.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.742 ' O ' HD22 ' A' ' 116' ' ' LEU . 54.2 mt-10 -71.15 -28.7 64.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.593 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.863 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.81 -47.46 8.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.637 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.85 -28.98 64.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 109.399 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -79.7 -22.86 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.253 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.863 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.74 -34.07 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.095 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -55.18 -33.22 62.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.27 -21.1 43.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.806 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.702 ' HE2' ' CD1' ' A' ' 108' ' ' TYR . 4.0 m-30 -66.57 -9.95 40.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.11 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.55 56.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.595 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 3.0 mm-40 -108.95 -52.74 2.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.055 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -93.06 130.65 35.4 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.825 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 178.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.346 2.031 . . . . 0.0 112.138 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -73.42 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -84.04 1.39 44.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.57 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.94 138.12 55.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.878 0.371 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.71 125.32 44.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 -179.858 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.819 0.343 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 112' ' ' GLU . 13.0 tp -68.56 105.74 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 106' ' ' LEU . 17.8 t -97.78 139.35 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.204 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 78.6 m-85 -108.58 170.72 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.995 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -44.31 158.28 0.05 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.43 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.0 156.17 35.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.087 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.86 126.2 26.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.85 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.94 -15.35 62.02 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.604 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -111.21 152.61 26.91 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -122.89 150.6 42.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 4.4 p90 -84.79 157.86 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.295 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.82 174.0 12.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.335 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.423 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 tm0? -127.58 114.4 17.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.298 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.431 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 38.4 t -68.64 131.06 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.907 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 63' ' ' MET . 30.4 mt -116.04 -37.14 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.875 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -141.14 155.86 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.7 mtp -117.16 146.94 42.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.529 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -110.68 -46.13 3.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 110.802 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.7 -137.51 2.49 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.73 -26.8 9.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.666 0.269 . . . . 0.0 110.982 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 74' ' ' ILE . . . -103.57 3.72 46.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.075 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -155.28 156.37 35.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.905 0.353 . . . . 0.0 111.036 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' CD2' HG21 ' A' ' 84' ' ' ILE . 2.3 pp -148.08 167.19 25.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.505 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -112.9 121.25 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.161 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -135.85 164.91 26.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.213 0.53 . . . . 0.0 112.293 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.414 ' HB3' ' CD1' ' A' ' 52' ' ' ILE . 8.0 tpp -118.24 110.3 17.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.165 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -59.14 133.25 55.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.8 m-85 -48.04 -24.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.07 -11.31 60.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.367 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.24 42.21 2.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.729 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.11 133.01 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.313 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.86 112.5 25.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -145.54 164.81 30.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.003 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' CD1' HD13 ' A' ' 55' ' ' LEU . 2.9 mm? -98.35 108.9 21.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.4 m -89.92 118.8 29.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.922 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.43 132.67 36.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.67 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.432 ' CG2' ' HA2' ' A' ' 58' ' ' GLY . 10.8 tt -68.93 140.99 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -56.24 174.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.074 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.15 -49.82 2.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.229 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -33.52 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -71.18 -45.98 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.639 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.497 ' HA ' HG12 ' A' ' 82' ' ' VAL . 11.4 ptm180 -56.59 -25.7 53.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -28.41 64.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm -137.35 8.24 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.851 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -124.35 124.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.956 0.407 . . . . 0.0 111.487 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -110.79 110.41 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.405 HG21 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.32 147.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 111.416 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -117.51 157.76 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.04 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.1 m -76.06 -6.36 50.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.751 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -144.45 73.55 1.38 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.649 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.79 162.28 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 33.5 mm -86.94 147.31 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.603 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.522 HD12 HG22 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -150.7 171.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.43 . . . . 0.0 111.438 179.703 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -130.12 122.92 29.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.9 178.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 104' ' ' VAL . 31.0 m -121.6 157.34 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.994 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.62 136.14 12.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.862 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.41 ' CD2' ' HB3' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -118.27 110.27 17.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.0 110.743 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.67 -68.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 111.108 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.2 -27.77 23.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.245 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -85.71 -0.24 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.65 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 65.8 30.27 10.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 5.6 m-20 77.88 162.55 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 85.56 -23.34 0.16 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.36 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -141.22 157.01 45.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.662 0.268 . . . . 0.0 110.449 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' A' ' 94' ' ' LEU . . . -148.54 174.28 12.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 0.0 111.141 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -128.64 124.22 35.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.589 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.46 ' N ' HG12 ' A' ' 92' ' ' VAL . 49.8 t -52.55 111.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.667 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -83.41 -37.44 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 109.819 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 90' ' ' ILE . 2.4 pp -152.48 164.08 38.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.419 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 4.8 tmtt? -109.32 118.21 36.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 111.911 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.66 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 22.4 m-85 -79.83 106.6 11.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 112' ' ' GLU . 9.8 m-20 -60.17 166.91 2.62 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . . . -78.0 -50.66 11.69 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.62 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.31 -42.91 99.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -68.85 -26.6 65.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.01 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.621 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . . . -45.68 -34.06 3.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.305 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -55.82 -39.56 71.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.421 0.629 . . . . 0.0 109.396 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 118' ' ' ALA . 12.0 m -61.01 -20.85 62.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.089 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.685 ' HA ' ' CG ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -49.55 -34.89 18.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.38 -178.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.03 -34.96 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.39 42.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.78 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.685 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -66.82 -10.53 48.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 27.55 66.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 7.8 mm-40 -114.02 -51.87 2.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.685 0.279 . . . . 0.0 111.035 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -97.89 139.86 21.57 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.44 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 35.1 Cg_exo -59.21 179.41 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.415 2.077 . . . . 0.0 112.103 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -72.76 -27.74 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.44 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 9.2 p-80 -79.1 -18.83 52.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.379 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.57 135.86 39.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.827 0.346 . . . . 0.0 111.411 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.46 131.1 45.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 mt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.271 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.769 0.319 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.12 119.0 32.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.36 90.45 0.78 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.504 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.15 -75.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 110.831 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -166.03 78.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 68.29 -70.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.941 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -163.67 109.18 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.35 -178.83 5.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -151.46 131.6 13.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.029 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.28 85.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.002 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -126.71 36.76 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -138.16 97.56 9.66 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.72 112.37 2.64 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.464 2.109 . . . . 0.0 112.276 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 3.7 mtp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.803 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.815 0.256 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.25 -179.93 6.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 60.22 93.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -92.27 91.64 7.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.08 -138.6 7.17 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.12 -67.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.08 131.37 10.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.522 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.43 -97.49 0.12 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.57 36.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.9 0.381 . . . . 0.0 110.971 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.12 160.51 32.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.41 -65.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.27 128.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -169.75 179.49 3.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.78 54.13 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.567 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -107.88 -31.15 8.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.752 0.31 . . . . 0.0 110.843 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.9 t30 60.28 46.56 10.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 67.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 61.63 97.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.798 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -64.34 131.07 46.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.36 32.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -140.32 133.76 29.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -177.57 132.17 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.61 144.81 46.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.76 87.02 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.187 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.459 ' CD2' ' CZ ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -81.58 142.78 32.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.455 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 21.8 t -116.11 138.5 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.07 0.462 . . . . 0.0 111.626 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.607 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.8 m-85 -107.48 170.49 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.364 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 2.6 ttpt -52.86 145.39 12.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 0.0 110.738 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -111.73 156.58 21.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.4 130.1 45.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.92 -15.47 61.72 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.423 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -116.32 144.91 43.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.639 0.257 . . . . 0.0 110.326 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -118.1 155.3 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.468 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 65' ' ' PHE . 3.3 p90 -84.45 157.71 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.88 173.25 13.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.193 0.521 . . . . 0.0 112.328 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -129.27 130.77 46.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.915 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 43.9 t -82.08 139.92 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.084 0.469 . . . . 0.0 112.051 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.0 -39.74 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -141.65 157.81 44.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.463 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.53 142.62 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.813 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.412 ' CD1' ' HG3' ' A' ' 59' ' ' ARG . 3.3 mt -103.79 -155.83 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -44.55 -84.57 0.01 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.194 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -159.76 -43.81 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.42 -0.22 71.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.007 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.412 ' HG3' ' CD1' ' A' ' 55' ' ' LEU . 26.3 ptt180 -151.76 167.2 28.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.094 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 2.0 pp -147.66 154.54 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.04 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 1.5 tt0 -91.78 121.75 33.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.042 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -149.78 164.82 34.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.473 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -138.75 133.27 31.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.536 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.4 ' O ' ' HE3' ' A' ' 63' ' ' MET . 49.2 t -64.41 141.6 58.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.974 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.3 m-85 -48.66 -23.19 0.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.782 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -13.78 61.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.331 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.02 34.64 3.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.76 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 110.74 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 111.037 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 63' ' ' MET . 5.5 mmtm -85.69 118.34 25.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -145.12 156.61 43.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.003 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.99 105.77 17.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.1 m -85.41 118.77 25.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.732 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.45 141.25 36.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.697 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.401 ' CD1' ' CD1' ' A' ' 84' ' ' ILE . 2.1 tt -68.6 140.28 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 26.6 tpt180 -67.27 155.33 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.352 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.08 -61.53 2.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.269 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.42 -39.75 91.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.501 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.4 ' CB ' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -69.15 -17.88 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.987 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HA ' ' CG1' ' A' ' 82' ' ' VAL . 1.2 ptt180 -48.67 -28.72 3.73 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.292 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -75.01 -29.38 60.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.344 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.67 44.6 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.424 ' CG1' ' HA ' ' A' ' 79' ' ' ARG . 11.0 p -117.45 115.7 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 110.955 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -110.74 110.27 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.401 ' CD1' ' CD1' ' A' ' 74' ' ' ILE . 0.7 OUTLIER -106.1 147.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.758 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.439 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.2 m-20 -137.57 165.51 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.904 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 52' ' ' ILE . 27.7 m -80.28 -6.16 57.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.596 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.08 68.62 0.94 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.579 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -150.8 164.27 36.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 32.0 mm -87.63 144.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.229 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.438 HG21 ' O ' ' A' ' 106' ' ' LEU . 1.3 mt -150.68 171.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 111.241 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.493 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -127.2 122.34 33.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 102' ' ' ALA . 17.0 m -120.4 139.18 48.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.432 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -80.5 146.17 27.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.293 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 95' ' ' ARG . 1.4 mt -114.64 167.3 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' CB ' ' O ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER 82.03 -8.08 1.31 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.835 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -35.7 27.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.642 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -105.66 22.83 14.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.435 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 55.5 mm-40 68.92 30.53 4.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.766 0.317 . . . . 0.0 110.77 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 1.3 t0 82.99 -175.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 99' ' ' ASP . 8.5 t-20 69.62 -60.93 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.777 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -98.77 155.73 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -145.84 131.08 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -88.99 123.93 33.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.276 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 80.6 t -52.09 112.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.653 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -78.84 -39.46 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 109.971 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.482 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -150.56 166.61 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.372 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.415 ' HA ' HG21 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -108.31 123.27 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 111.813 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.606 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 20.3 m-85 -87.45 106.73 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.56 166.69 6.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -74.58 -38.61 62.6 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.515 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.36 -40.14 95.44 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.705 ' O ' HD21 ' A' ' 116' ' ' LEU . 1.3 mm-40 -62.25 -27.47 69.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.76 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.911 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.55 -36.61 2.14 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.846 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -63.82 -33.05 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -78.48 -22.8 46.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.902 177.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.911 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.75 -31.75 27.89 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.165 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -33.33 62.82 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.47 -22.05 41.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.748 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.63 ' CD1' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.2 -11.65 57.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.07 29.28 74.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.497 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.477 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 34.2 mt-10 -117.09 -52.42 2.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.206 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -102.89 141.4 22.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 -179.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.419 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 71.4 Cg_endo -74.54 179.11 6.24 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.51 2.14 . . . . 0.0 112.206 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -71.03 -17.22 62.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.246 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 11.9 p-80 -97.72 -1.91 42.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.638 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.66 154.31 18.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 111.178 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -115.37 125.87 53.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 113' ' ' ALA . 13.3 mt -103.77 140.24 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.011 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -101.17 152.8 20.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.13 145.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -148.8 -46.71 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.13 145.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.4 m -67.76 76.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 61.91 118.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.51 173.23 6.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.11 174.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.592 2.194 . . . . 0.0 112.361 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -123.03 -153.52 8.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.623 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.52 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.608 0.242 . . . . 0.0 110.945 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.8 t0 47.3 71.25 0.34 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.808 0.337 . . . . 0.0 111.244 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -66.65 162.87 20.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 63.58 140.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 28.3 mt -141.57 146.52 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.015 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -114.35 166.78 11.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.014 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 62.73 -80.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 56.9 30.66 18.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.885 0.374 . . . . 0.0 110.92 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.63 -177.64 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.947 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.9 mm 65.35 82.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.109 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.24 -98.05 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.443 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.5 -69.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 111.014 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -89.84 9.97 25.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.367 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 68.41 -67.09 0.21 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.802 0.335 . . . . 0.0 111.078 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 64.79 154.88 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.48 -65.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.28 138.89 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.138 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.03 -45.26 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.028 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.45 -27.1 12.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.112 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.4 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.121 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.79 125.24 50.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.21 50.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.501 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 5.0 t -63.78 -31.9 73.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.745 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -74.65 -23.05 58.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.011 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -80.18 92.04 5.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.054 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -130.08 146.58 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -177.87 -36.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.069 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -47.9 100.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.219 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.95 118.85 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.96 -173.28 2.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 24.5 t0 67.99 75.64 0.28 Allowed Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.93 96.81 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.565 2.177 . . . . 0.0 112.227 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 6.8 ttp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 -179.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.785 0.244 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.6 mttt 61.69 102.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -60.77 136.91 58.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.43 93.82 4.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.63 -90.16 0.24 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.449 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.07 53.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.9 -140.1 3.73 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.74 -95.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.418 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -103.93 -31.2 9.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.56 152.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.79 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -95.55 43.8 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.973 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.35 -41.54 80.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.964 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.61 -76.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.19 40.26 0.45 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -158.96 -51.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.925 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 68.91 -67.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.37 128.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 62.37 123.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -108.11 59.6 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.42 29.34 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.861 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -64.79 127.8 33.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm 63.45 28.21 15.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -144.56 142.9 30.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -118.91 78.52 1.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.415 HD12 ' OH ' ' A' ' 119' ' ' TYR . 21.6 tp -89.96 125.91 35.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.705 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.73 140.65 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.688 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.758 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -110.75 170.41 8.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.347 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -47.78 144.13 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.709 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -119.51 164.6 15.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.405 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -56.53 131.49 48.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.726 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.03 -15.41 61.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.379 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -124.95 148.34 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -124.21 154.41 40.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.231 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.0 p90 -84.18 157.89 21.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.788 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.72 14.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.27 0.557 . . . . 0.0 112.5 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.432 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 33.4 tp60 -129.94 109.14 10.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.12 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 26.7 t -56.32 141.18 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.464 HD12 ' HB2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -115.67 -43.04 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.833 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 160.59 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -108.83 131.87 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.454 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.401 ' CD2' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -93.45 -29.19 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.991 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.15 -175.37 32.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -73.33 95.28 2.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.01 -28.16 2.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' HIS . 26.2 ptt180 -150.27 160.22 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.66 154.77 41.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' HB2' ' CD2' ' A' ' 55' ' ' LEU . 17.1 tt0 -99.72 121.6 41.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.771 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.11 157.41 42.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.084 0.469 . . . . 0.0 111.879 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.464 ' HB2' HD12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -114.9 105.36 12.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.31 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.1 m -56.98 127.55 32.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.47 -25.45 1.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.672 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 -9.94 59.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.265 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.02 37.23 4.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.01 118.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 111.342 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' CA ' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.41 118.01 25.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.622 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -145.09 161.99 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.247 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.34 117.75 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.795 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.3 m -99.71 119.44 38.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -77.05 149.22 35.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.573 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.83 129.51 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.767 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -53.08 159.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.316 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.03 -52.21 2.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -74.31 -33.94 63.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 110.399 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -74.71 -19.79 60.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.784 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.46 ' HA ' ' CG1' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -50.36 -27.26 5.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.04 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -60.31 -30.46 69.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -153.97 36.53 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 79' ' ' ARG . 7.7 p -105.08 111.0 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.083 0.468 . . . . 0.0 110.957 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -111.23 110.21 20.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.789 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -90.06 147.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.896 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -129.5 161.52 30.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 52' ' ' ILE . 88.2 m -80.0 -6.63 57.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.049 0.452 . . . . 0.0 111.73 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 p -144.61 71.74 1.32 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.7 159.55 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.141 0.496 . . . . 0.0 111.537 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.513 ' CG2' HD12 ' A' ' 116' ' ' LEU . 30.1 mm -86.88 147.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 90' ' ' ILE . 1.2 mt -150.54 171.23 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.399 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.493 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -127.81 122.28 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.596 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.432 ' CG1' ' HA ' ' A' ' 104' ' ' VAL . 33.2 m -121.73 153.69 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.443 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.77 140.51 15.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.37 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mt -113.86 177.12 4.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 0.0 111.003 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.81 8.7 6.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.454 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -93.44 -38.84 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.845 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -105.63 22.86 14.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 69.1 30.54 4.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 11.1 t0 81.07 162.79 0.16 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 9.0 t-20 84.86 -18.69 0.38 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.448 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -142.0 151.43 42.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.416 ' CB ' ' CG2' ' A' ' 92' ' ' VAL . . . -139.67 -177.06 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.9 116.04 10.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.432 ' HA ' ' CG1' ' A' ' 92' ' ' VAL . 91.4 t -51.22 111.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.979 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -83.18 -50.37 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 0.0 109.813 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.496 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -136.19 168.95 18.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.443 ' N ' HD12 ' A' ' 106' ' ' LEU . 11.1 ttpt -111.37 121.74 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.672 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 21.6 m-85 -86.77 106.47 17.71 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.93 175.4 5.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.444 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -75.68 -41.79 52.9 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.768 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -61.5 -40.22 93.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.692 ' O ' HD22 ' A' ' 116' ' ' LEU . 18.4 mt-10 -67.12 -28.23 67.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.544 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.72 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.56 -47.83 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.876 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -56.52 -29.49 61.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.396 0.617 . . . . 0.0 109.503 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.566 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -75.89 -22.18 56.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.246 178.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.72 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.34 -35.68 28.89 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.287 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -54.55 -34.78 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.17 -20.46 44.78 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.932 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.758 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.8 m-30 -66.35 -5.49 10.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.781 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 24.9 57.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.582 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.479 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 57.0 mm-40 -114.11 -60.37 1.89 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.278 . . . . 0.0 111.318 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.76 139.16 24.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.083 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.429 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 24.2 Cg_exo -63.13 -178.99 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.531 2.154 . . . . 0.0 112.129 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.66 -26.86 62.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.064 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.429 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 15.6 p-80 -82.98 -9.67 59.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.503 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -55.96 135.25 52.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.333 . . . . 0.0 111.182 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -121.99 127.6 50.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.16 152.01 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -68.31 95.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.796 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 45.65 -169.59 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.357 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.4 m -141.58 156.44 45.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.46 119.23 1.05 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.734 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 114.92 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.35 103.26 4.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -133.49 83.36 0.29 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.416 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.77 -32.09 19.23 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.536 2.157 . . . . 0.0 112.339 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.48 161.65 50.61 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.51 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 60.23 107.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.29 34.36 5.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -150.23 143.74 25.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 69.31 -64.95 0.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.062 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.22 150.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.075 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 61.74 77.23 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.76 -49.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.11 -21.72 17.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.09 22.42 11.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.6 mp 50.1 31.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.893 0.378 . . . . 0.0 111.383 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.08 -120.53 10.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.458 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.7 t0 59.56 165.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.33 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -89.35 109.93 20.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -172.25 -44.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 63.53 143.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -126.4 71.9 1.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.4 pt -148.58 99.74 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -128.98 102.47 6.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -115.51 30.83 7.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.764 179.915 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.29 48.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.05 80.22 0.88 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.548 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -117.66 145.15 44.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.342 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -120.86 50.13 1.39 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.84 175.56 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' B' ' 8' ' ' HIS . 0.1 OUTLIER -65.77 -75.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' B' ' 7' ' ' HIS . 1.9 m170 -159.43 78.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.88 -27.32 21.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.411 ' O ' ' N ' ' B' ' 12' ' ' ASP . 15.3 m-70 69.97 -66.54 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' B' ' 12' ' ' ASP . 5.9 p 64.53 -71.45 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.177 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . 0.469 ' N ' ' OG1' ' B' ' 11' ' ' THR . 1.0 OUTLIER 49.55 63.39 10.34 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 111.171 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.59 -173.71 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.531 2.154 . . . . 0.0 112.284 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.816 -179.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.789 0.246 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -76.53 -175.79 3.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.53 66.28 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -30.52 70.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.96 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.44 134.98 12.01 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -152.43 156.57 39.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.87 -40.99 2.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.343 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.83 101.49 2.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.372 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -58.31 9.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 0.0 110.981 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -118.35 171.49 8.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.965 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.56 175.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.714 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 25.39 10.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.09 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.68 68.74 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.866 0.365 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 177.96 1.98 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.594 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.96 52.88 2.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 110.781 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 62.25 62.51 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.811 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 64.08 16.1 9.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.352 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t30 47.49 92.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.774 0.321 . . . . 0.0 111.163 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -161.28 -169.34 2.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.3 p 62.9 32.81 15.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -100.65 122.8 43.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 175.43 5.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -80.81 103.46 10.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.42 128.98 53.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.896 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.501 HD13 ' HG2' ' A' ' 112' ' ' GLU . 25.4 tp -77.17 117.27 18.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.415 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 21.4 t -105.34 139.15 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.609 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 81.0 m-85 -114.28 170.42 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.672 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -47.09 152.64 0.53 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.14 159.52 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.933 0.397 . . . . 0.0 111.155 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.35 127.66 33.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.853 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.24 61.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.618 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.429 ' HB3' HD13 ' A' ' 91' ' ' LEU . 12.8 mt-30 -115.84 146.38 42.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -120.6 156.05 32.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 111.405 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 65' ' ' PHE . 1.9 p90 -84.48 157.79 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.985 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.62 173.3 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 112.141 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 62.8 tp60 -128.68 109.59 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.446 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 2.7 t -54.25 135.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.975 0.417 . . . . 0.0 111.853 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.67 -44.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.842 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -141.51 162.25 35.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.3 ttt -116.22 143.14 45.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -111.24 -57.74 2.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.705 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 149.02 9.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.607 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.89 74.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.045 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.469 ' HA2' ' CG2' ' A' ' 74' ' ' ILE . . . 55.1 34.04 58.1 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.705 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' A' ' 55' ' ' LEU . 14.7 mmt180 -144.94 129.73 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.411 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 pp -147.03 138.92 24.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.95 121.25 32.62 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . . . -122.37 164.62 17.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 112.026 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.9 tpt -130.6 95.29 3.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.27 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.3 130.66 43.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.301 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 8.5 m-85 -49.57 -24.59 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.765 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.31 -9.19 58.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.258 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.5 5.34 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.65 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.18 110.98 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.197 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.25 122.27 35.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -145.23 165.67 27.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.075 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.6 mm? -93.5 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 32.8 m -90.92 134.28 34.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.572 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.39 131.29 34.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.469 ' CG2' ' HA2' ' A' ' 58' ' ' GLY . 17.4 tt -68.52 140.77 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.941 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.424 ' CB ' ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -62.72 151.95 37.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.82 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.36 -43.0 26.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.667 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -76.03 -31.38 58.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 75' ' ' ARG . 3.1 mm? -75.73 -50.61 14.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.6 -25.33 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -51.36 -39.76 57.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.014 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -141.52 13.0 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.32 120.69 59.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.982 0.42 . . . . 0.0 111.092 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -110.96 115.04 28.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.655 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.492 ' CG2' HD11 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -64.06 131.83 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 110.597 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -98.18 156.46 16.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.172 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 77.0 m -76.28 -6.45 51.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.887 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.58 80.71 1.77 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.86 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 162.85 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.967 0.413 . . . . 0.0 111.302 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 29.8 mm -86.84 146.78 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.328 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.503 HG22 HD11 ' A' ' 90' ' ' ILE . 1.4 mt -150.68 171.22 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.679 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.511 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -128.61 121.81 29.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.661 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 104' ' ' VAL . 26.3 m -118.63 148.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.115 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.79 139.19 15.68 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.795 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.43 137.11 53.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.726 0.298 . . . . 0.0 110.623 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -177.23 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.109 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.71 -20.61 61.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.254 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -72.3 -10.58 59.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.309 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 9.2 mt-30 68.57 28.35 5.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.367 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 8.8 t0 79.17 -47.25 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.668 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -43.0 -30.3 0.41 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.33 164.09 29.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.404 ' CB ' ' CG2' ' A' ' 92' ' ' VAL . . . -146.77 -177.31 5.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -137.9 112.92 9.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 ' N ' HG12 ' A' ' 92' ' ' VAL . 60.3 t -50.36 111.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.9 mm -87.9 -55.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.157 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 90' ' ' ILE . 1.9 pp -131.28 163.79 27.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.503 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.403 ' N ' HD13 ' A' ' 106' ' ' LEU . 0.7 OUTLIER -109.41 115.63 30.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.645 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 22.7 m-85 -79.02 106.29 10.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -69.52 175.72 3.92 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -76.72 -40.2 49.4 Favored 'General case' 0 C--O 1.229 0.023 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.796 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.43 -40.11 93.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.722 ' O ' HD23 ' A' ' 116' ' ' LEU . 17.4 mt-10 -66.94 -28.35 68.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.84 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.55 -46.31 7.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.871 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -30.26 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.584 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -77.91 -22.29 49.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.153 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.84 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.16 -32.65 23.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.147 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -54.93 -33.85 62.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -21.91 41.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.76 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.645 ' HE2' ' CG ' ' A' ' 108' ' ' TYR . 4.1 m-30 -66.93 -13.16 61.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.75 28.23 69.67 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.635 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.523 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.4 mt-10 -113.2 -53.74 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 111.255 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -87.58 140.51 31.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.66 179.41 5.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -28.05 66.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.987 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -87.07 2.45 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.535 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.09 127.75 32.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.883 0.373 . . . . 0.0 110.99 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.22 137.22 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.5 mt -94.58 152.2 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -70.55 66.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.99 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.07 -169.47 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.113 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.4 m -78.37 -35.18 47.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t0 63.49 133.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.0 p -60.98 -176.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -75.23 60.92 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.247 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.36 -147.06 25.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.493 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.71 111.42 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.518 2.145 . . . . 0.0 112.303 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.81 13.97 64.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.722 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.5 t70 67.91 -68.3 0.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.734 0.302 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -81.31 68.15 7.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.876 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -79.14 151.36 31.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.23 106.77 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mp -136.06 -46.63 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -95.64 -175.78 3.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 60.95 82.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -100.8 -46.54 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.988 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.31 34.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.8 mt -123.19 78.26 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.07 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.6 -30.61 8.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.52 114.27 3.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -169.05 133.22 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -153.08 149.74 28.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.845 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -125.22 -79.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 55.46 61.17 2.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 29.2 mt -89.63 89.04 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 59.44 69.74 0.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -98.5 101.02 12.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.2 tt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.029 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mmt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.855 0.359 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -145.37 106.11 4.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.969 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.86 -137.83 5.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.35 87.39 2.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 63.13 114.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 65.2 m170 -61.25 174.97 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 71.51 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.832 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -90.6 175.6 6.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.66 161.27 13.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.798 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.53 87.76 2.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 19.5 p -71.24 -31.12 67.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.12 82.22 1.11 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.77 148.56 65.3 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.619 2.213 . . . . 0.0 112.338 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' MET . . . . . 0.408 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' B' ' 14' ' ' MET . 48.0 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.863 0.276 . . . . 0.0 112.24 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.91 145.54 13.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -142.9 60.21 1.42 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? 59.38 80.31 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.74 -83.58 1.73 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -123.14 -174.24 2.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.49 -134.14 8.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.426 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.94 -177.91 44.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.499 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.15 164.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 110.96 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -175.89 135.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.68 42.46 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 61.14 164.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.6 -51.25 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.014 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 146.02 -18.17 1.76 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.749 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -55.95 -22.93 29.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.709 0.29 . . . . 0.0 111.268 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.44 39.66 6.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 0.0 110.778 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -179.49 -37.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.918 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.94 -62.14 0.46 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.035 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.31 46.56 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.096 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.9 t -97.88 54.05 1.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.65 70.64 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -101.24 115.92 31.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 63.16 120.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -68.3 78.98 0.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.2 tp -119.54 116.19 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.402 ' O ' ' CE1' ' A' ' 108' ' ' TYR . 18.3 t -129.22 141.04 47.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.802 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.745 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 1.7 m-85 -108.24 170.3 8.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.117 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 159.66 25.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.719 0.295 . . . . 0.0 110.697 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.12 175.44 10.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.128 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -47.15 130.87 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.18 -15.33 62.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.435 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -136.67 146.61 46.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.316 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.72 158.72 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.488 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.51 157.98 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.212 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 173.88 12.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.205 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.433 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -129.78 110.99 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.303 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 41.7 t -62.66 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.008 0.432 . . . . 0.0 111.799 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 86' ' ' THR . 25.0 mt -116.11 -39.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.917 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 151.06 42.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.977 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.417 ' CE ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -110.73 125.85 53.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.14 -166.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.611 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.81 69.85 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.77 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 3.8 p-10 178.41 55.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 110.965 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.63 28.05 62.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.835 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -144.81 167.27 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.734 0.302 . . . . 0.0 110.912 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.22 146.48 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.108 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -91.83 122.61 34.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.188 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -137.39 163.23 31.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.263 0.554 . . . . 0.0 112.315 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.418 ' HB2' HD12 ' A' ' 52' ' ' ILE . 8.2 tpp -123.35 110.81 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -60.32 134.26 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.9 m-85 -47.8 -26.3 1.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.804 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.39 -8.04 54.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.427 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.08 44.17 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 t -127.12 118.35 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 0.0 111.288 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' N ' ' HE2' ' A' ' 63' ' ' MET . 2.8 ttmt -87.61 114.89 24.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.75 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -144.07 163.53 33.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -105.42 108.27 19.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 4.4 m -84.19 119.14 24.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.303 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -76.6 155.7 33.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.34 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.401 HD13 HD13 ' A' ' 84' ' ' ILE . 5.3 mm -68.36 123.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.416 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 13.5 tpt180 -53.93 162.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.434 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.01 -53.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.272 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -35.15 76.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 82' ' ' VAL . 3.2 mm? -78.64 -11.28 59.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.181 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -48.79 -33.88 11.25 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.847 0.356 . . . . 0.0 111.334 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -56.31 -23.25 35.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -162.27 40.9 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.252 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 14.6 p -82.7 110.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 110.742 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -112.21 110.14 20.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.626 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.417 HD12 ' CE ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -112.3 145.53 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.255 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.468 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m120 -132.05 163.65 27.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 52' ' ' ILE . 39.4 m -76.47 -6.63 52.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 111.653 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 m -148.36 72.34 1.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.658 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 159.79 39.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.167 0.508 . . . . 0.0 111.364 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 39.9 mm -87.11 145.99 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.183 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.487 HG22 HD12 ' A' ' 90' ' ' ILE . 1.3 mt -150.93 171.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.119 0.485 . . . . 0.0 111.392 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -128.4 125.83 39.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.53 178.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.409 ' CG2' ' HB2' ' A' ' 102' ' ' ALA . 15.9 m -122.23 155.61 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.27 126.27 8.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.706 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.89 126.74 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 110.76 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 -177.94 -72.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.056 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.94 -12.08 60.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.371 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 103' ' ' ASP . 39.5 m-85 -90.49 17.51 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.686 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 65.81 23.54 11.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.563 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 t0 73.42 -58.12 0.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.544 0.211 . . . . 0.0 111.556 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -41.73 -33.44 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -113.91 161.94 17.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.555 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -157.67 131.59 8.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 31.9 t70 -90.7 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 91.5 t -51.56 111.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.53 -36.52 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.559 . . . . 0.0 109.86 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.541 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.3 pp -155.11 170.75 21.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.358 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.439 ' N ' HD12 ' A' ' 106' ' ' LEU . 15.1 pttm -112.12 126.17 54.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.65 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 23.1 m-85 -92.98 106.71 18.63 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.411 ' OD1' ' CG ' ' A' ' 112' ' ' GLU . 47.0 p30 -85.55 -174.35 5.13 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.71 -41.31 60.42 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.199 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.27 -40.67 91.19 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.738 ' O ' HD22 ' A' ' 116' ' ' LEU . 18.0 mt-10 -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.305 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.881 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.51 -48.31 7.37 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.021 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -57.23 -28.85 63.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.413 0.625 . . . . 0.0 109.498 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -80.19 -22.96 41.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.296 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.881 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.34 -34.74 24.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.09 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -54.86 -33.95 62.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -20.05 45.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.142 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.745 ' CD1' ' CD1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.08 -6.8 14.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.759 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.33 66.68 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.377 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 55.3 mm-40 -119.95 -60.02 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.419 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.426 ' CD2' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -90.9 128.82 46.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.446 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 38.4 Cg_exo -59.8 -179.19 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.384 2.056 . . . . 0.0 111.914 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.72 -21.92 63.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.5 p-80 -88.08 -0.94 57.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.614 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.17 158.33 11.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -117.4 147.57 42.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.7 mm -98.74 158.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.88 166.96 11.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 134' ' ' PHE . 0.7 OUTLIER -59.99 153.19 21.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.878 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 m -109.74 -61.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -41.1 -76.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.71 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.29 149.35 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.752 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 130' ' ' GLU . 22.3 p90 -165.2 46.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.49 -90.48 2.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.26 -32.6 6.47 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.57 2.18 . . . . 0.0 112.368 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.86 -162.32 25.17 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.2 t0 59.43 171.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.85 140.82 29.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -130.14 98.38 4.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -84.14 72.42 10.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.5 tt -64.66 131.97 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.048 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -129.24 179.08 5.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -62.85 103.38 0.44 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -103.91 30.26 5.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 178.5 93.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 23.6 mt -94.21 67.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.11 -30.49 75.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.418 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -136.13 171.85 13.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.75 105.48 3.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.32 85.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.36 144.91 51.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.853 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 142.11 30.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.9 mt -70.89 126.15 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 61.44 168.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -101.24 -28.62 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 157' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.19 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.747 0.308 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -176.47 -61.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.86 67.45 0.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 93.2 p -114.95 150.82 35.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.762 0.315 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 159.42 18.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -170.28 -50.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.11 142.06 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.56 -60.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -160.79 -78.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.94 61.19 2.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 110.945 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.38 139.69 56.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 59.99 81.91 0.24 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.44 70.77 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.493 2.129 . . . . 0.0 112.285 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 5.0 mtt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.844 0.268 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -133.67 113.38 12.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -105.12 -80.74 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.46 93.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.836 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.73 -150.18 18.2 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.589 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -62.13 -35.8 79.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.97 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.59 -105.54 0.23 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.482 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.52 117.63 0.63 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.44 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.36 -43.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 69.42 -65.58 0.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.026 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 mtm-85 65.53 102.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -158.52 102.68 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -136.16 133.75 37.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.28 131.19 1.19 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.499 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.3 -26.85 12.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 0.0 110.977 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 63.18 41.97 7.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -109.44 103.07 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.768 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 59.9 70.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.796 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.93 105.29 8.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.24 140.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -123.11 137.68 54.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -60.36 119.86 8.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -62.91 115.19 4.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.811 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -57.77 109.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.472 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 20.3 tp -72.99 101.57 3.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.416 ' CG1' HD22 ' A' ' 106' ' ' LEU . 14.4 t -91.38 139.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 111.377 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.2 m-85 -110.88 170.44 8.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.881 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -52.98 152.5 3.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -123.8 157.61 33.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.44 . . . . 0.0 111.45 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.95 132.47 49.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.93 -15.55 60.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -116.8 151.46 36.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.704 0.288 . . . . 0.0 110.521 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.42 149.45 46.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.18 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 3.2 p90 -84.21 157.58 21.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.703 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.82 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.287 0.565 . . . . 0.0 112.502 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.405 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 34.1 tp60 -130.31 119.79 23.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.808 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 86' ' ' THR . 10.7 t -70.24 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.447 ' CD1' ' CB ' ' A' ' 63' ' ' MET . 0.9 OUTLIER -115.7 -43.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.867 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 162.04 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.755 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.35 143.64 34.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.652 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' ' HG3' ' A' ' 59' ' ' ARG . 6.2 mt -108.09 -30.4 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.34 -166.25 31.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.38 99.18 8.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.67 -24.84 3.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.616 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 55' ' ' LEU . 8.7 ptp180 -152.88 159.78 43.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' CD2' HG22 ' A' ' 84' ' ' ILE . 1.1 pp -147.41 158.25 43.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.94 121.56 33.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.535 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.29 165.93 24.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.274 0.559 . . . . 0.0 112.276 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.447 ' CB ' ' CD1' ' A' ' 52' ' ' ILE . 2.1 tpp -134.84 111.97 10.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.186 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.08 132.91 55.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.21 -26.3 1.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.876 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -74.47 -14.22 60.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.402 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.97 42.9 1.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.39 112.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.187 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' N ' ' HE2' ' A' ' 63' ' ' MET . 23.5 tttt -84.27 112.76 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.624 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 101' ' ' LYS . 11.4 ptp180 -145.28 161.72 38.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.4 mm? -102.57 108.32 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 9.7 m -83.74 118.38 23.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.629 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -79.52 131.89 36.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.768 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 1.4 tt -68.5 137.12 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 171.59 -161.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.315 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.54 171.45 47.12 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.232 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.85 -25.74 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.646 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.638 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -75.62 -19.82 58.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.127 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -28.22 2.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 111.231 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -26.41 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -169.18 46.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.822 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 78' ' ' LEU . 14.9 p -87.23 126.64 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -106.92 110.22 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.404 HG22 ' CD2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -94.72 147.31 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.571 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -128.2 153.54 46.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.407 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 91.7 m -80.28 -7.01 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.715 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.7 m -142.98 53.49 1.37 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.526 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.2 167.02 23.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.488 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.51 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 27.9 mm -90.67 146.02 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.233 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.445 HD12 HG22 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -150.12 171.2 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.095 0.474 . . . . 0.0 111.237 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.499 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -130.18 122.43 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.866 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 104' ' ' VAL . 27.0 m -117.51 147.85 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.88 132.05 11.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.784 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.92 107.9 14.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -162.6 -79.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.939 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.6 -15.99 63.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.115 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.487 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 4.7 m-85 -72.22 -8.37 54.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.648 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 68.16 29.41 6.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.263 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 72.24 -174.42 0.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.69 -61.59 0.5 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.82 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -111.98 171.09 7.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -156.85 170.91 21.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -119.73 124.98 47.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.426 ' N ' HG12 ' A' ' 92' ' ' VAL . 86.9 t -53.08 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.03 -54.99 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.638 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 2.0 pp -133.19 166.62 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.414 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' N ' HD13 ' A' ' 106' ' ' LEU . 14.7 pttm -110.56 118.62 36.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.072 0.463 . . . . 0.0 112.185 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.637 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 23.0 m-85 -82.82 106.54 14.74 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.63 176.69 7.41 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.07 -44.41 60.6 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.105 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.25 -39.98 88.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.701 ' O ' HD23 ' A' ' 116' ' ' LEU . 8.5 mt-10 -69.16 -29.31 67.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.586 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.718 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.96 -48.33 8.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.902 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 109.599 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.608 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -75.13 -22.07 58.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.147 178.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.718 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.24 -34.03 21.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 121.124 -0.231 . . . . 0.0 111.118 -179.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -34.63 63.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.608 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.44 42.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.612 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.662 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.2 m-30 -66.55 -11.98 55.5 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.13 29.21 67.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.521 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 25.3 mm-40 -115.69 -50.24 2.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.738 0.304 . . . . 0.0 111.243 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.453 HD13 HD12 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -94.92 140.65 22.57 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.09 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.433 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 24.4 Cg_exo -63.09 -178.86 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.477 2.118 . . . . 0.0 112.05 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.26 -28.03 63.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.002 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 13.7 p-80 -78.92 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.24 130.89 36.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 111.272 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.63 148.55 33.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.7 mm -91.09 154.45 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.44 172.84 8.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.15 133.59 47.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.08 -169.48 1.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.833 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.85 173.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.02 -176.28 3.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.92 63.67 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.843 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.78 85.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.516 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.65 147.45 63.59 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.586 2.191 . . . . 0.0 112.303 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -139.34 168.03 25.03 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.8 t0 61.81 34.45 17.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -141.87 83.45 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -68.44 151.65 46.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 59.96 176.88 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 8.4 tt -105.39 59.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.004 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.63 -16.67 13.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.256 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 68.24 -75.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.808 0.337 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -148.48 -75.06 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.7 t0 59.74 89.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.828 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.401 HD11 HG23 ' A' ' 147' ' ' ILE . 15.7 mt 65.87 125.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.34 96.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -128.16 -54.53 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -68.23 146.46 53.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -59.89 126.61 28.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -157.87 35.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 -30.2 11.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.3 mp -60.6 109.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.001 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -164.79 -46.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -102.09 -72.0 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.394 -0.813 . . . . 0.0 111.461 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.858 0.361 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 59.82 78.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.22 -59.72 0.14 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.0 t -174.77 120.02 0.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.815 0.341 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.5 166.63 32.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.957 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.65 31.62 20.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -133.24 -176.52 4.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.79 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -104.14 95.04 5.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 143.06 49.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -68.03 73.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 7.8 p -99.75 -31.93 11.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -148.51 82.78 7.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.97 79.34 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.501 2.134 . . . . 0.0 112.291 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 3.7 mtt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.823 0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -155.55 87.52 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -114.43 36.39 3.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -76.11 76.72 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.78 131.96 9.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 90.68 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.837 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.24 63.65 4.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.533 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.93 179.74 26.42 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.71 166.33 21.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -163.7 36.03 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.788 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -97.25 -34.86 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -97.86 133.0 42.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -112.58 -46.95 3.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -127.98 -110.15 1.55 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.503 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttp 68.46 -68.9 0.16 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.309 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 51.5 -176.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -99.44 -82.4 0.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.879 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 58.87 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.994 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 31' ' ' GLU . 21.1 mt-10 -146.5 28.78 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 110.887 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 m -108.29 33.16 4.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.89 84.16 2.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.39 160.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -59.64 129.49 42.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -112.4 73.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.042 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.412 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 14.2 tp -84.32 113.5 21.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.549 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.01 140.9 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.745 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.7 m-85 -107.75 169.84 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.089 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 137.83 58.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.506 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.87 175.27 5.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.063 0.458 . . . . 0.0 111.478 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -50.71 133.92 25.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.129 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.27 -15.36 60.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.94 148.31 52.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 110.573 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -130.22 159.89 35.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.086 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.31 158.16 21.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.007 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.99 173.56 14.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.246 0.546 . . . . 0.0 112.189 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.71 129.73 44.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.029 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 47.4 t -81.82 140.77 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 0.0 112.019 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -116.42 -41.45 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.1 160.39 40.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.698 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -117.04 146.67 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -110.21 -29.79 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.913 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.94 176.77 18.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.62 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.08 107.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.821 0.344 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.61 -33.9 2.57 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.527 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -153.31 159.52 42.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.995 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 1.6 pp -147.59 155.81 42.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.048 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -92.1 121.71 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.081 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.21 165.6 32.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.53 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.444 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.47 134.6 39.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.324 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.8 m -63.92 142.6 58.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.608 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 1.6 m-85 -51.17 -23.98 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.346 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.13 -11.1 60.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.35 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.98 41.13 2.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.783 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.02 110.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.007 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -82.2 116.41 21.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.051 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' O ' ' O ' ' A' ' 62' ' ' ALA . 8.9 ptp180 -145.05 155.77 43.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.68 106.93 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 13.6 m -84.27 118.66 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.676 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -81.92 137.9 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.1 tt -68.68 140.13 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.782 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.433 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.31 143.45 44.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.25 38.87 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -62.88 -32.69 73.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 1.1 mm? -82.91 -29.4 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.636 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -49.25 -27.74 4.03 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.267 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -64.32 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.0 45.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.3 p -121.33 120.99 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.974 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 110.19 20.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.69 147.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.453 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -123.12 159.28 28.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.247 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 52' ' ' ILE . 63.3 m -80.32 -5.91 57.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.442 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 70.05 0.95 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.636 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.14 165.73 35.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.224 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.507 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 45.9 mm -87.22 143.97 10.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.236 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.43 HG23 ' HA ' ' A' ' 107' ' ' LYS . 1.3 mt -150.35 171.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.046 0.45 . . . . 0.0 111.213 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.508 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -126.54 122.26 34.62 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.587 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 104' ' ' VAL . 12.8 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.049 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.45 120.21 6.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.671 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.411 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.86 117.28 33.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.896 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -73.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.29 -25.97 62.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.424 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -91.62 14.25 15.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.547 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 20.2 mt-30 65.79 24.57 11.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.32 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 5.5 m-20 81.6 -45.65 0.2 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -42.29 -38.3 1.77 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.553 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.56 165.25 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.365 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -158.91 132.05 7.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.18 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -88.96 128.02 35.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.416 ' N ' HG13 ' A' ' 92' ' ' VAL . 94.1 t -53.24 111.85 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.849 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.1 mm -78.21 -45.65 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.509 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -144.29 169.93 16.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.401 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.438 ' N ' HD11 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -111.79 123.77 50.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.634 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 22.6 m-85 -88.5 106.41 18.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -75.4 179.86 4.96 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.455 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -77.0 -42.21 39.6 Favored 'General case' 0 C--O 1.228 -0.068 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.431 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -61.15 -40.03 92.32 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.701 ' O ' HD21 ' A' ' 116' ' ' LEU . 7.5 mt-10 -67.54 -27.85 67.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.461 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.815 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.4 -49.31 7.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.032 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -56.3 -27.4 55.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 109.577 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.09 -22.7 41.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.136 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.815 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.46 -34.36 24.54 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.028 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -55.0 -34.12 63.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.11 -20.59 44.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.849 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.56 -5.98 13.39 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.802 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.41 26.29 61.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.448 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.494 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 56.2 mm-40 -115.91 -60.76 1.83 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.443 ' CD2' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -91.87 124.89 59.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.432 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 40.6 Cg_exo -56.88 179.75 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.431 2.088 . . . . 0.0 112.257 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -25.06 65.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.095 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 37.1 p-80 -85.89 -17.13 36.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.39 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -52.86 139.4 27.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.808 0.337 . . . . 0.0 111.24 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -117.76 137.89 52.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 mt -99.45 148.84 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -61.05 164.49 5.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.45 141.07 56.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 171.88 14.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -41.02 117.08 0.81 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.702 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -94.03 150.92 19.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.02 72.44 10.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.13 -93.78 2.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.54 166.59 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.571 2.181 . . . . 0.0 112.264 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -172.65 167.11 39.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 165.13 121.64 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.86 0.362 . . . . 0.0 110.683 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.31 31.28 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 p30 43.19 50.97 5.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.378 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -168.88 153.98 6.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.744 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 30.0 mm -73.7 -39.58 53.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -134.34 144.45 48.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -171.78 83.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -174.83 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.967 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 60.75 -174.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.0 pt -131.69 81.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.296 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.16 91.31 0.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.566 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.7 p30 -57.95 162.22 3.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.27 69.39 4.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.09 -48.66 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.34 146.34 55.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.45 -47.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 25.6 mm -80.32 76.91 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -140.48 31.85 1.88 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.37 -30.49 68.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.082 -179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.871 0.367 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -101.16 96.47 7.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 129.5 173.58 13.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.79 158.35 3.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -149.09 173.86 12.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -117.94 37.98 3.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 92.81 3.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.08 93.1 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.862 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.27 156.12 2.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.988 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -117.79 -177.42 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.6 m -134.2 135.17 42.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -116.83 88.08 24.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.39 172.01 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.551 2.168 . . . . 0.0 112.331 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.749 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 CA-C-O 120.814 0.256 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -80.62 60.45 3.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.801 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -148.74 64.52 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.86 137.99 58.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.943 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.12 -142.16 17.2 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.553 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 tttm 60.8 74.71 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.982 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.43 48.35 0.95 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.42 47.63 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.572 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -106.64 42.25 1.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -63.51 113.11 3.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.61 177.3 5.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.009 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -35.0 77.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.983 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 60.43 90.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.07 -105.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER 62.15 157.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.704 0.288 . . . . 0.0 110.776 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 37.0 t30 172.69 58.11 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.472 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 61.55 28.21 17.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.19 40.93 27.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.985 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.39 141.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.834 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -94.44 101.84 13.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -176.02 79.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.9 mttt 179.97 122.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.829 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -69.87 137.71 51.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -112.75 86.01 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.406 HD12 ' HG2' ' A' ' 112' ' ' GLU . 24.8 tp -86.81 128.63 35.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.793 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 t -127.31 140.68 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.832 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.749 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -112.72 170.39 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.346 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -52.68 149.58 5.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.729 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.82 164.61 27.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 111.5 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.89 132.99 37.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.76 -15.34 60.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.469 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -134.73 137.21 43.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -117.23 155.22 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 111.276 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 5.3 p90 -84.02 157.65 21.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.622 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.76 173.89 12.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.593 . . . . 0.0 112.521 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.01 117.13 18.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.037 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.496 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 41.5 t -67.46 138.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 112.065 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.437 ' CD1' ' HE2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.09 -41.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.556 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 161.33 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.745 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.4 144.2 44.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.722 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.54 -27.98 11.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.026 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.04 59.14 10.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -177.61 63.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.1 20.73 50.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.403 ' HD3' ' CE1' ' A' ' 73' ' ' HIS . 1.3 mtm105 -152.36 163.53 39.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.447 ' HB3' HD11 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -147.85 145.23 28.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.609 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -91.09 120.77 32.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.496 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.44 165.62 32.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 111.665 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.49 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 9.8 ptp -138.98 128.0 23.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.59 146.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.286 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.462 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.9 m-85 -50.33 -20.68 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.811 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.1 p30 -73.62 -8.18 54.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.61 0.243 . . . . 0.0 111.324 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 41.03 4.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 63' ' ' MET . 20.1 t -127.15 110.27 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.659 0.266 . . . . 0.0 111.1 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.59 120.14 25.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 165.7 27.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.303 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 71' ' ' LEU . 2.8 mm? -95.68 105.69 17.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 11.8 m -89.14 118.47 28.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.403 ' CE1' ' HD3' ' A' ' 59' ' ' ARG . 2.1 m-70 -76.6 139.15 40.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.6 tt -68.52 138.49 22.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.86 151.92 24.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.073 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.66 -39.28 18.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.46 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -78.52 -30.75 47.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 4.3 mm? -77.86 -29.56 50.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -48.97 -26.9 2.77 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.34 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -38.91 74.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.313 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 48.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.363 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 8.5 p -124.18 119.74 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -110.75 109.96 20.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.991 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -80.95 139.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.2 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -110.57 160.51 16.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 0.0 111.529 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.414 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 66.1 m -80.3 -6.2 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.525 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -147.79 70.33 1.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.19 164.63 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.223 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 46.7 mm -89.4 144.39 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.341 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.45 HG23 ' HA ' ' A' ' 107' ' ' LYS . 1.1 mt -150.22 171.13 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.047 0.451 . . . . 0.0 111.101 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.507 ' HB2' ' CE2' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -126.94 125.75 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.638 178.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 104' ' ' VAL . 26.4 m -125.62 156.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.259 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.25 127.88 9.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.54 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.24 177.45 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.76 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.27 -51.12 0.43 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.522 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -41.07 12.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 111.452 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.53 23.08 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 69.17 30.24 4.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.801 0.334 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.6 175.94 0.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.618 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.34 -57.19 0.56 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.063 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.83 149.24 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.24 -179.37 5.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.962 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.79 121.37 19.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.419 ' N ' HG11 ' A' ' 92' ' ' VAL . 85.5 t -51.07 111.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.683 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.27 -37.44 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 0.0 109.768 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.503 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -150.93 168.54 24.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.36 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -112.32 121.2 44.22 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.625 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 23.3 m-85 -86.34 106.29 17.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.42 176.6 5.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.46 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -76.9 -39.75 49.78 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.967 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -40.95 98.52 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.671 ' O ' HD22 ' A' ' 116' ' ' LEU . 10.4 mt-10 -66.27 -27.78 68.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.417 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.791 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.38 -48.26 6.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.055 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -27.66 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.425 0.631 . . . . 0.0 109.492 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.571 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -79.17 -22.71 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.202 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.791 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.37 -35.28 27.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.221 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -34.42 62.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.23 -20.3 44.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.013 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.749 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.51 -4.36 8.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.808 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 24.77 58.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.597 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.479 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 42.3 mm-40 -115.35 -60.93 1.82 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.808 0.337 . . . . 0.0 111.266 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.32 126.36 46.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 36.7 Cg_exo -57.41 179.82 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.417 2.078 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.39 -23.36 64.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.416 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 37.2 p-80 -90.67 2.48 55.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.582 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.24 147.71 50.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -115.61 136.68 52.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.048 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.438 HG21 ' CB ' ' A' ' 113' ' ' ALA . 7.3 mt -109.98 157.66 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 128' ' ' ILE . 9.6 t-20 -103.53 130.0 50.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.973 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 56.86 104.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.101 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 -23.48 16.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.065 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 44.4 67.34 0.7 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.905 0.383 . . . . 0.0 111.45 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 m -85.05 149.81 25.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -134.88 45.82 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.54 -150.78 26.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.606 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -51.06 162.97 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.671 2.248 . . . . 0.0 112.348 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.18 93.61 1.87 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.584 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.7 t70 62.94 127.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 111.06 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -133.25 87.67 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -61.27 104.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -103.73 136.11 44.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.89 -55.06 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 62.55 146.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.817 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.3 39.68 3.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -74.4 96.3 2.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.29 141.95 40.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.6 tp -133.85 73.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.77 -157.27 7.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.388 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.39 132.69 50.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 110.848 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -107.8 142.16 38.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -152.21 150.58 29.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -166.97 150.82 6.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.19 115.86 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 21.4 mt -109.41 140.8 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -97.36 143.6 27.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.5 t70 60.71 110.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.009 -179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 30.6 ttp . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.822 0.344 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.2 82.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.41 142.25 4.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.408 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m 69.52 -65.12 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.729 0.3 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.82 131.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -130.83 130.04 43.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -61.89 108.05 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -92.49 96.25 10.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.13 135.97 48.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 124.19 20.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 69.7 p -75.73 -6.58 51.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.46 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -55.8 109.36 1.59 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.638 0.256 . . . . 0.0 111.038 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.27 -59.45 1.19 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.502 2.135 . . . . 0.0 112.441 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.731 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 CA--C 1.527 0.156 0 CA-C-O 120.695 0.206 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 56.35 35.1 25.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.005 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -59.64 158.14 10.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -59.66 93.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.38 -162.67 25.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.76 103.68 1.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.742 0.306 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.29 140.55 4.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.451 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.57 76.18 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.461 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.42 93.54 2.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -84.98 -175.78 5.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.04 123.46 27.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.71 82.35 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -113.62 -51.73 2.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.52 -74.89 0.43 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.507 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.85 -176.31 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.686 0.279 . . . . 0.0 110.875 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 45.78 -171.28 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.551 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.87 -176.87 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.718 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.6 t30 63.78 77.54 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -139.9 55.66 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -137.4 73.83 1.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -101.01 111.31 23.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -108.22 166.82 10.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.51 158.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.65 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -148.75 130.06 14.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD12 ' OH ' ' A' ' 119' ' ' TYR . 39.4 tp -96.48 125.38 40.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.558 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.57 140.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.944 0.402 . . . . 0.0 111.897 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.77 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.3 m-30 -112.34 170.44 8.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.466 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.42 150.74 4.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -127.76 165.12 20.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.701 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.35 133.05 49.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.97 -15.5 60.72 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -126.43 140.04 52.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.9 150.32 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.147 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 6.4 p90 -84.35 156.32 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.887 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.76 173.26 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.19 0.519 . . . . 0.0 112.219 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -119.08 153.9 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.362 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.413 ' CB ' ' O ' ' A' ' 85' ' ' ASN . 12.9 t -97.29 141.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.022 0.439 . . . . 0.0 112.142 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' A' ' 63' ' ' MET . 0.7 OUTLIER -114.13 -52.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.44 162.22 36.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.66 126.48 54.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.431 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -96.59 -29.78 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.63 178.18 21.8 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -56.39 112.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.77 0.319 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.5 -13.68 58.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.727 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -138.78 121.88 16.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.242 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.42 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 1.3 pp -142.36 142.23 32.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.539 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.7 121.67 32.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 50' ' ' GLN . . . -127.2 162.12 26.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.425 ' HB2' HD12 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -123.08 101.62 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.216 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.17 133.32 49.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.402 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.405 ' CD2' ' OH ' ' A' ' 48' ' ' TYR . 1.5 m-85 -49.34 -25.94 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.523 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -13.7 60.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.177 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.39 36.02 3.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.49 122.66 59.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 111.453 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -95.12 121.72 37.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.603 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -144.12 165.59 27.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.17 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.6 mm? -94.02 105.68 17.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.8 m -88.82 125.05 34.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -83.27 142.02 31.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.619 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.79 138.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.94 155.23 20.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 0.0 111.001 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.17 -46.08 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.548 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -76.71 -42.22 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 0.0 110.783 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -67.03 -19.72 65.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.402 ' HA ' ' CG1' ' A' ' 82' ' ' VAL . 1.4 ptm180 -50.64 -28.11 8.22 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.827 0.346 . . . . 0.0 111.322 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -64.86 -29.54 70.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.618 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.99 40.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 7.6 p -120.87 110.88 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 110.983 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 32.2 m0 -111.39 110.36 20.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.157 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.408 HG21 HD21 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -86.45 145.47 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 51' ' ' VAL . 52.4 m-20 -132.11 164.93 25.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.8 m -78.08 -6.5 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.761 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.4 73.99 1.45 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -165.34 161.24 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.261 0.553 . . . . 0.0 111.481 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 32.8 mm -92.28 149.12 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.011 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 90' ' ' ILE . 1.4 mt -150.19 173.56 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.638 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -130.11 126.88 38.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.566 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 104' ' ' VAL . 21.0 m -121.73 156.51 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.391 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.44 149.79 19.02 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.648 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.46 135.66 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.705 0.288 . . . . 0.0 110.799 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 -177.57 -76.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.188 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.9 -18.09 38.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.407 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CD1' ' HB3' ' A' ' 101' ' ' LYS . 42.9 m-85 -72.38 -9.26 58.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.551 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 72.16 29.39 2.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.746 0.307 . . . . 0.0 111.304 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.1 -55.75 0.64 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.42 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -42.03 -31.95 0.4 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.427 ' HB3' ' CD1' ' A' ' 97' ' ' TYR . 24.5 mttt -128.22 164.45 22.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.673 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -151.41 177.28 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.19 116.95 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.438 ' N ' HG12 ' A' ' 92' ' ' VAL . 80.5 t -49.93 111.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.972 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mm -82.26 -45.56 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.191 0.52 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.471 ' CD1' ' CD1' ' A' ' 108' ' ' TYR . 1.6 pp -142.41 161.15 38.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.779 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.53 118.1 35.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.999 0.428 . . . . 0.0 111.792 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.597 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 22.0 m-85 -81.11 106.47 13.13 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 167.15 4.78 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -76.73 -39.52 51.56 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.422 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.57 -40.06 95.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.655 ' O ' HD21 ' A' ' 116' ' ' LEU . 1.4 mm-40 -68.09 -26.52 65.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.275 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.704 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -42.75 -48.98 5.72 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.835 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -29.76 63.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.399 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -73.39 -22.03 60.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.013 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.704 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -48.95 -35.52 15.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.236 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -54.53 -35.06 62.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.14 -20.31 45.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.927 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.77 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.6 m-30 -65.98 -7.69 18.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.559 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.49 27.31 67.72 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.511 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.453 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 50.4 mm-40 -118.49 -59.79 1.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.321 . . . . 0.0 111.289 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.0 142.17 24.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.061 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 31.5 Cg_exo -61.06 -179.75 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.583 2.189 . . . . 0.0 112.146 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.94 -25.88 59.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.993 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -82.56 1.46 37.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.534 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.41 138.35 55.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.375 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 148.2 32.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 21.7 mm -91.96 156.56 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.431 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.75 96.71 7.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.771 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 64.41 131.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 m -104.94 -47.61 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.949 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.54 95.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.845 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.68 174.71 7.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.973 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.38 110.05 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.65 -54.54 25.16 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.639 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.74 160.56 2.7 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.608 2.205 . . . . 0.0 112.346 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.97 -115.03 4.38 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.3 t0 61.76 18.88 10.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.616 0.246 . . . . 0.0 111.184 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 51.48 29.64 5.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.771 0.32 . . . . 0.0 111.159 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -88.73 -69.08 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -173.85 98.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.5 mt -85.11 78.25 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.22 -32.28 9.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -97.6 83.78 3.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.01 -76.38 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -164.22 94.32 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.816 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 18.6 tt -162.86 116.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.011 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.18 -163.55 34.5 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.516 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 59.87 168.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.0 110.822 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.15 117.32 5.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.75 163.92 37.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.69 -76.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.837 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 59.94 79.77 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.92 104.98 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -60.25 110.82 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.8 82.49 1.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.4 mm . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.109 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.803 0.335 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -77.36 71.52 3.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.31 -42.83 17.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -151.59 150.19 30.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.804 0.335 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -76.07 -63.56 1.29 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -86.12 171.52 11.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 63.35 126.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.916 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -122.11 137.37 54.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.43 138.59 43.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 61.68 54.59 2.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.827 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -27.88 14.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.023 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -105.49 86.48 1.75 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.1 -26.76 30.39 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.61 2.207 . . . . 0.0 112.276 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.826 0.261 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.3 104.19 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -143.56 -48.9 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -142.27 118.49 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.5 165.35 29.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.54 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -118.41 -47.05 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.8 91.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.482 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.82 107.11 0.73 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.84 40.36 3.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.856 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -140.0 61.96 1.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -71.33 174.51 6.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.02 -57.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.0 99.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.69 154.82 7.76 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.573 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -128.55 60.25 1.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 110.801 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 68.03 12.69 8.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.487 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 46.45 71.11 0.32 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.83 0.347 . . . . 0.0 111.288 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 63.48 141.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.827 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.08 -32.05 6.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m 61.8 84.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 62.82 120.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.16 125.09 2.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -59.2 154.35 16.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.815 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.02 105.35 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.097 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.539 ' CD1' ' HG3' ' A' ' 112' ' ' GLU . 33.4 tp -118.52 119.82 35.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.79 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.52 139.47 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.046 0.451 . . . . 0.0 111.369 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 74.7 m-85 -114.09 170.4 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.862 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -48.6 153.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.941 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -116.09 162.05 17.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.19 125.97 25.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.83 -15.28 63.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.662 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -113.74 148.08 37.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.636 0.255 . . . . 0.0 110.567 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -121.1 156.72 31.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.219 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.8 p90 -84.25 157.58 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.94 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.27 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.52 138.84 53.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.746 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 15.2 t -88.92 144.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -116.38 -46.12 4.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.84 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.3 162.18 37.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.874 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.93 136.26 52.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.401 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -99.53 -32.4 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.91 169.84 17.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.526 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.83 101.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 110.986 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.83 -32.69 2.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.354 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 ptt-85 -151.35 159.61 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.874 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' CD2' ' CD1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.65 152.55 38.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -91.66 121.66 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.43 165.8 24.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 112.181 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.478 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -127.18 113.07 15.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.8 m -59.01 133.86 56.47 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.444 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 1.3 m-85 -48.83 -25.36 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -9.82 58.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.76 42.96 2.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.684 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.4 t -127.41 125.61 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.339 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HB2' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.7 115.46 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.567 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -145.27 165.06 29.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.415 . . . . 0.0 111.276 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -106.36 108.41 19.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 16.4 m -84.16 118.85 24.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.42 ' CD2' ' OH ' ' A' ' 97' ' ' TYR . 1.7 m-70 -81.46 143.18 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.787 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -71.93 129.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.835 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 14.2 tpt180 -69.45 143.84 53.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.733 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 79' ' ' ARG . . . -70.01 -57.34 7.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.362 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -52.71 -30.66 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.69 -28.37 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.421 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -49.34 -27.36 3.88 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.317 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.29 -33.34 67.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.3 45.17 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 79' ' ' ARG . 11.6 p -115.91 116.25 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 111.071 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CH2' ' HE2' ' A' ' 107' ' ' LYS . 44.1 p90 -110.5 110.18 20.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.402 ' CD1' ' CD2' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -83.26 147.11 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.414 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -115.44 152.97 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 52' ' ' ILE . 75.6 m -80.28 -6.35 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 111.886 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 p -148.38 55.07 1.02 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.705 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -140.2 169.09 18.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.174 0.511 . . . . 0.0 111.564 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 45.3 mm -89.24 144.81 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.024 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 106' ' ' LEU . 1.2 mt -150.57 171.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.046 0.451 . . . . 0.0 111.228 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -126.01 121.97 34.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.706 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 104' ' ' VAL . 30.4 m -122.48 155.3 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.156 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 105' ' ' ILE . . . -93.13 140.63 15.16 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.574 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.67 105.52 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 110.834 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.46 -63.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.189 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.14 -28.17 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 73' ' ' HIS . 16.4 m-85 -89.32 1.91 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.768 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 65.71 30.02 10.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 7.0 t0 78.04 162.05 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.963 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 84.53 -19.8 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.411 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.47 150.96 38.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.417 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -137.96 173.18 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 111.256 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -130.1 116.61 18.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.462 ' N ' HG12 ' A' ' 92' ' ' VAL . 70.4 t -52.4 111.54 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 93' ' ' GLY . 2.4 mp -81.81 -39.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.495 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -147.1 168.45 21.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.795 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HA ' HG22 ' A' ' 90' ' ' ILE . 4.5 pttp -111.94 119.9 40.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.631 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 23.0 m-85 -84.23 106.9 16.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.19 173.18 8.01 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -73.46 -51.19 18.03 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.313 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.37 -38.45 87.05 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.539 ' HG3' ' CD1' ' A' ' 39' ' ' LEU . 1.1 tp10 -66.63 -31.67 72.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.396 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.631 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -46.05 -43.25 14.34 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.821 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -48.93 -47.11 43.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.157 0.504 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.6 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -58.69 -20.82 51.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.629 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.695 ' HA ' ' CG ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -50.66 -33.26 21.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.45 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -54.98 -34.34 63.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.38 -21.81 41.96 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.733 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.695 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.4 m-30 -67.01 -9.75 42.33 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.03 25.03 63.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.538 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.452 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 5.3 mm-40 -112.7 -47.41 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -108.75 150.07 40.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.411 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 70.8 Cg_endo -75.18 174.15 13.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.592 2.194 . . . . 0.0 112.242 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.48 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.4 p-80 -87.76 2.79 50.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.578 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.89 130.27 46.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.162 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -82.5 131.35 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.0 mm -94.66 150.86 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.984 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -62.0 156.53 20.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.06 123.35 16.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.95 133.55 55.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.5 t0 63.12 124.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.11 104.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.24 82.44 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -142.66 -154.08 6.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.409 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -51.71 163.05 1.38 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.514 2.143 . . . . 0.0 112.257 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.59 115.1 1.74 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.467 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.15 116.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.338 . . . . 0.0 110.909 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -92.73 122.85 35.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.95 -73.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -126.26 155.32 42.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.9 mm -92.72 82.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -121.0 54.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.02 165.32 12.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.849 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -132.96 164.85 26.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -74.18 -171.31 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 21.6 pt -149.52 42.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.104 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.23 121.73 3.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.526 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -72.04 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -33.05 57.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.68 99.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -118.2 -59.41 1.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -152.94 90.85 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.2 pt -84.46 136.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.168 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -174.49 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -63.35 120.43 11.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.081 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.795 0.331 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -116.34 -65.41 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -145.19 98.81 0.2 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.49 51.65 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -117.68 152.63 34.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -69.37 143.48 53.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -164.78 -52.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -146.76 -68.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -176.59 147.79 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -125.54 -63.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.08 35.52 1.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.1 53.8 1.62 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 170.71 19.69 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.62 2.214 . . . . 0.0 112.369 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.808 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--O 1.23 0.118 0 CA-C-O 120.874 0.281 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -71.35 -62.23 1.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.929 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.83 27.39 8.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.008 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.93 -68.82 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.043 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.92 -170.52 31.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.534 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.97 152.08 48.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.2 -101.54 1.61 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.559 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.51 33.47 81.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.461 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 tttp -170.93 -41.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.788 0.327 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.97 168.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.033 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.31 87.75 7.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.9 179.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -43.13 99.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.84 -94.42 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.441 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -145.66 70.95 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 0.0 110.795 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.75 34.14 14.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.786 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.42 -30.13 71.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 p30 166.02 136.62 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.794 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -142.21 -51.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.749 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -166.45 144.05 5.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.842 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.59 94.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -74.14 114.17 12.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -71.1 156.4 39.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -145.78 128.08 15.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HG ' ' CE1' ' A' ' 41' ' ' PHE . 20.1 tp -71.04 134.59 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.46 140.08 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.884 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 11.8 m-30 -113.7 170.94 7.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.42 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -42.01 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.78 168.12 13.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.169 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -67.72 123.59 20.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.35 62.95 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -115.66 145.3 42.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.395 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -120.26 152.06 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 111.531 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.6 p90 -84.71 158.17 20.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.872 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.37 173.4 14.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 112.376 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -128.61 115.11 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.161 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 14.8 t -65.9 139.99 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 112.077 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 63' ' ' MET . 7.0 mm -116.01 -42.77 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.011 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -140.7 158.57 43.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.875 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.6 tpt -111.74 132.1 54.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.44 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -109.17 -163.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.485 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.75 156.71 4.54 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.64 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -56.76 109.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.03 -19.77 3.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.5 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 73' ' ' HIS . 22.1 ptt180 -146.92 163.57 35.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 111.053 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.44 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -147.68 150.78 34.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -91.89 121.58 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.02 165.64 24.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 0.0 112.342 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.453 ' HB3' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -123.53 107.37 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.938 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.1 m -57.91 130.89 48.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.04 -25.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.705 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -74.42 -13.35 60.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.257 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.27 40.72 2.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.542 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.99 120.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.307 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' CA ' ' CE ' ' A' ' 63' ' ' MET . 0.4 OUTLIER -88.68 114.44 25.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -143.81 165.53 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.27 109.81 21.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.8 m -84.28 118.33 24.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 2.4 m-70 -80.62 130.43 35.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.427 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 2.0 tt -68.59 140.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.475 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER 166.32 -167.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.002 0.43 . . . . 0.0 111.446 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.67 174.66 36.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.04 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -52.41 -23.83 6.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.968 0.413 . . . . 0.0 110.701 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -78.83 -18.61 53.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.205 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -48.09 -28.67 3.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.502 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -58.34 -22.9 55.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.883 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.79 46.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.417 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 78' ' ' LEU . 14.2 p -84.81 128.82 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.36 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -110.72 110.04 20.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.008 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.2 147.34 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.613 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m-20 -122.32 152.3 40.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.7 m -80.18 -6.81 58.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 0.0 111.769 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.2 p -143.95 56.53 1.33 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.595 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 85' ' ' ASN . 0.4 OUTLIER -146.93 164.77 31.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.281 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 38.1 mm -87.28 146.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.233 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 90' ' ' ILE . 1.1 mt -150.15 170.99 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 111.184 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.513 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -129.18 121.84 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.753 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 104' ' ' VAL . 16.0 m -116.16 150.38 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.75 131.41 10.72 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.401 HD23 ' CB ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -117.86 133.19 56.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.62 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -178.06 -75.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.28 -12.65 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.322 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 34.5 m-85 -83.11 2.93 32.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.678 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 65.81 25.64 11.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.658 0.266 . . . . 0.0 111.219 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.22 -54.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.758 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -39.7 -35.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 97' ' ' TYR . 8.3 mmmm -127.27 162.76 25.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.808 0.337 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -158.61 162.65 37.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -113.1 126.7 55.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.442 ' N ' HG12 ' A' ' 92' ' ' VAL . 61.5 t -55.02 112.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.99 -58.95 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.106 0.479 . . . . 0.0 110.023 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.517 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 1.3 pp -127.71 160.11 32.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.376 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.404 ' N ' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -107.04 117.47 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.633 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 25.0 m-85 -81.73 106.11 13.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -68.17 168.76 11.56 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.435 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -70.8 -40.77 72.33 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.477 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.26 -40.35 95.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.727 ' O ' HD23 ' A' ' 116' ' ' LEU . 26.3 mt-10 -66.79 -28.54 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.49 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.673 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.43 -48.97 7.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.78 -178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -56.11 -30.67 62.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.573 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -73.93 -22.12 59.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.727 HD23 ' O ' ' A' ' 112' ' ' GLU . 0.1 OUTLIER -50.32 -34.94 25.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.379 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -54.6 -34.76 62.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -20.9 42.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.97 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.0 m-30 -66.56 -6.18 14.17 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.829 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.52 64.59 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.593 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.576 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 48.0 mt-10 -113.87 -64.55 1.29 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.927 0.394 . . . . 0.0 111.234 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -92.49 149.94 39.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.999 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.7 179.55 4.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.634 2.223 . . . . 0.0 112.432 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.23 -32.17 68.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -75.83 -19.22 59.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.332 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.65 121.91 8.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -108.18 132.21 53.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.001 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.06 153.97 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.129 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -65.09 163.61 14.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.707 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.13 175.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.19 129.98 56.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.844 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 45.56 -163.98 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.342 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.7 m 73.67 96.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -158.0 79.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.736 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -108.5 151.01 17.08 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.53 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.21 134.41 61.57 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.663 2.242 . . . . 0.0 112.233 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.15 37.24 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.516 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.08 178.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.08 179.98 1.38 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -130.71 -51.32 1.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.52 178.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.026 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 22.2 mm -110.7 -40.19 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.054 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -107.13 142.34 36.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -136.06 85.12 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.938 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -168.27 93.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.728 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 63.78 104.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.2 tt -120.15 63.73 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.055 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.46 -128.19 5.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.55 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.14 151.67 26.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.9 87.26 3.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -162.89 173.54 13.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -161.85 141.52 10.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.69 121.17 42.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.26 173.81 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -71.23 150.31 45.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -95.59 94.0 7.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.814 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.807 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.759 0.314 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -64.52 -47.43 78.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 158.27 162.84 12.13 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.615 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m 58.51 91.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.27 136.21 39.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.07 -178.15 4.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -130.37 165.61 22.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -145.6 32.23 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.14 -168.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -49.81 118.94 3.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 43.3 p -58.15 144.49 40.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.023 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -122.91 79.67 50.19 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.823 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.91 -34.06 11.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.587 2.191 . . . . 0.0 112.434 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.958 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.776 0.24 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.71 -58.19 1.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 60.9 96.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.22 -46.19 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.19 -137.52 8.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.24 152.82 48.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.44 45.17 2.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.608 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.99 -68.29 0.76 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.542 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.13 -78.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.778 0.323 . . . . 0.0 110.843 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -104.81 115.82 30.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.804 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.62 119.86 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.51 32.91 21.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.999 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -63.18 -49.51 74.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.73 160.32 10.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 105.44 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.393 . . . . 0.0 110.943 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 57.9 76.66 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -89.91 125.92 35.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 65.11 30.21 11.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.06 135.77 8.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -106.79 -63.72 1.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.1 144.22 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -127.17 160.5 31.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.647 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.13 120.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.846 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.23 78.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.416 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 14.6 tp -84.7 120.82 26.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 t -126.95 141.05 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.694 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 4.3 m-30 -109.19 170.45 8.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.612 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -45.6 141.48 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.902 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -111.46 166.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 111.333 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -58.4 129.71 43.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.43 -15.37 60.24 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.589 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.4 ' HB3' HD12 ' A' ' 91' ' ' LEU . 8.4 mt-30 -118.45 154.62 32.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.624 0.25 . . . . 0.0 110.458 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -130.02 152.63 49.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 111.064 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 2.9 p90 -84.39 157.24 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.986 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.16 173.79 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.251 0.548 . . . . 0.0 112.112 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.2 tp60 -128.89 109.62 11.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.13 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 17.5 t -56.31 139.69 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 111.882 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.408 ' O ' HG21 ' A' ' 86' ' ' THR . 0.0 OUTLIER -116.42 -42.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.935 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.4 ttmm -147.71 157.58 43.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.319 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.1 ttt -108.2 143.35 37.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.789 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.89 -25.61 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.118 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.69 -174.63 29.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.61 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -75.37 102.87 5.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.28 -26.28 3.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.407 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 73' ' ' HIS . 0.7 OUTLIER -151.47 155.41 38.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.337 . . . . 0.0 110.927 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.74 150.91 35.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 53' ' ' LYS . 4.4 tp10 -91.74 121.42 33.36 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.79 165.74 23.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.203 0.525 . . . . 0.0 112.145 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.16 107.07 9.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.419 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.5 133.25 55.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.063 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 3.5 m-85 -49.91 -25.22 3.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.724 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -8.46 56.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.235 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.92 43.1 3.4 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.451 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.03 113.94 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.3 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -84.22 113.51 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.751 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -145.15 165.5 28.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.2 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.34 108.56 20.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.979 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 34.0 m -84.31 118.4 24.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 20.3 m80 -82.56 134.5 35.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.628 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.0 tt -68.65 141.03 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.353 . . . . 0.0 111.01 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 2.3 mmt180 -63.95 155.59 30.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.18 -46.78 6.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.484 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -77.33 -40.53 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.6 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -64.02 -16.69 62.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.007 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.441 ' HA ' ' CG1' ' A' ' 82' ' ' VAL . 12.3 ptm180 -48.72 -26.13 2.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.684 0.278 . . . . 0.0 111.498 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -76.05 -35.03 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.554 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.35 34.93 3.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.652 0.263 . . . . 0.0 111.613 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 79' ' ' ARG . 8.5 p -123.79 111.34 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.159 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.98 110.23 20.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.852 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.95 147.16 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.408 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 13.3 m120 -139.88 157.86 45.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.636 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 52' ' ' ILE . 59.6 m -75.33 -6.45 49.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 111.772 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -143.31 76.12 1.51 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.796 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.46 161.16 16.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 51.3 mm -86.96 146.57 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.501 HG23 HD11 ' A' ' 90' ' ' ILE . 1.1 mt -150.49 171.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.362 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.498 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -130.27 122.43 28.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.866 178.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 104' ' ' VAL . 34.9 m -119.57 146.97 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.83 141.69 15.71 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.862 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.4 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -116.3 142.05 47.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.65 0.262 . . . . 0.0 110.575 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -149.11 -81.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.183 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.57 -12.16 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.328 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.417 ' CG ' ' HB2' ' A' ' 101' ' ' LYS . 35.0 m-85 -71.9 -10.18 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.404 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 4.6 mt-30 65.85 25.4 11.24 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.205 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 2.8 t0 83.36 -21.88 0.26 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.36 -29.51 68.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 0.0 110.699 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HB2' ' CG ' ' A' ' 97' ' ' TYR . 10.1 mtpt -144.27 164.85 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.688 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -163.3 171.66 15.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.106 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.34 125.65 50.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.432 ' N ' HG12 ' A' ' 92' ' ' VAL . 99.3 t -49.96 111.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.47 -46.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.196 0.522 . . . . 0.0 109.737 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.502 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -142.06 166.93 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.31 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.421 ' N ' HD13 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -110.44 120.56 42.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.628 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 22.7 m-85 -84.23 105.94 15.47 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -71.78 177.19 4.34 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -77.1 -40.03 47.38 Favored 'General case' 0 CA--C 1.524 -0.045 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.055 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -62.62 -40.99 98.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.717 ' O ' HD21 ' A' ' 116' ' ' LEU . 14.0 mt-10 -65.93 -27.93 68.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.345 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.795 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.26 -50.28 6.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.23 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -56.42 -26.8 54.66 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.246 -0.581 . . . . 0.0 109.714 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -80.17 -22.29 42.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.14 178.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.795 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -49.92 -33.98 19.06 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 121.22 -0.192 . . . . 0.0 111.002 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -54.75 -34.37 62.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.12 -20.39 45.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.059 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.6 m-30 -66.42 -4.37 8.07 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.927 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.55 21.08 53.8 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.735 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 58.5 mm-40 -111.45 -60.42 1.84 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.457 ' CD2' ' CE2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -95.02 144.79 28.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.834 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.442 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 72.6 Cg_endo -76.08 179.8 5.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.631 2.221 . . . . 0.0 112.353 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.77 -29.31 67.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.442 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 25.6 p-80 -81.43 -0.49 41.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.473 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.28 145.15 56.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.836 0.35 . . . . 0.0 110.976 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -124.78 120.82 32.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.992 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mt -90.96 148.3 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -64.5 86.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.169 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 56.21 -179.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.051 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.6 m -90.19 -22.14 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.42 106.6 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.768 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.9 101.2 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.89 85.18 3.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.784 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -113.95 177.12 17.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.33 94.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.715 2.277 . . . . 0.0 112.428 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -151.34 101.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.495 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 63.74 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.817 0.342 . . . . 0.0 111.102 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -160.47 144.73 14.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.967 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -77.0 80.58 3.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.973 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 59.98 162.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.15 -31.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 62.56 -83.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 25.6 t80 178.08 97.05 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.715 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -168.82 113.43 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.77 160.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 tt -156.23 42.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 56.62 -124.86 36.54 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.566 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 p30 -163.62 143.22 8.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -173.98 -46.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -130.28 175.83 8.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 58.55 52.46 6.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.07 88.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.851 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.9 tp -90.26 71.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.049 0.452 . . . . 0.0 111.009 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -83.49 60.5 5.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.762 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -139.38 112.22 7.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.13 -179.942 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtm . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 42.6 tpt85 61.04 109.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.21 -68.8 0.29 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.543 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -93.77 135.34 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -102.71 -161.65 0.86 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.725 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.73 136.54 27.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.857 0.36 . . . . 0.0 111.035 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -105.2 -178.16 3.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -59.62 131.44 50.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.947 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -167.73 77.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.31 120.03 18.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.16 87.52 2.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.19 100.5 9.05 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.837 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.43 175.68 5.71 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.382 2.055 . . . . 0.0 112.342 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.832 0.263 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -133.83 46.37 2.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -165.9 32.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -135.54 74.55 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.93 152.84 7.96 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.387 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.87 -69.04 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.749 0.309 . . . . 0.0 111.016 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.34 -159.71 43.2 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.57 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.66 159.15 22.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.546 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt 60.76 -179.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.811 0.339 . . . . 0.0 110.942 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -116.88 -71.82 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -53.53 8.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 62.25 40.15 11.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.805 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.38 54.64 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.27 159.36 26.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.349 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.34 -64.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.649 0.262 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -43.17 138.53 2.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.695 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -166.21 61.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.826 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.3 99.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -152.87 37.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -71.68 -170.63 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -146.45 159.34 43.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -94.92 -41.65 9.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.97 79.38 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.674 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -82.81 67.08 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.142 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.468 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 16.0 tp -83.14 109.59 17.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.478 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.78 139.66 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.701 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 79.6 m-85 -113.45 170.5 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.714 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -47.68 163.41 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -132.51 156.38 46.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 111.294 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -59.04 129.16 40.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.697 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.45 61.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.558 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' HB3' HD13 ' A' ' 91' ' ' LEU . 26.3 mt-30 -116.43 148.17 40.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.585 0.231 . . . . 0.0 110.439 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.09 152.56 38.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 111.613 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 11.9 p90 -84.5 157.71 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.899 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.3 173.28 15.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 112.42 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -126.5 125.5 42.17 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.082 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 86' ' ' THR . 12.2 t -79.32 138.3 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 63' ' ' MET . 1.1 mt -116.1 -45.75 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.169 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -137.76 157.15 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 7.8 ttm -111.41 143.53 42.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -37.62 6.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.816 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.38 171.66 27.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -60.07 103.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.32 -22.57 3.95 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.616 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -154.5 157.76 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.8 pp -147.95 160.27 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.298 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -102.18 121.47 42.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.98 166.18 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.352 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.451 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 4.3 tpp -126.89 111.61 14.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.056 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 46.6 t -58.67 134.76 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -25.28 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.581 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -74.31 -14.17 60.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.233 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.72 41.19 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.583 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.3 t -127.23 125.79 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.99 115.25 29.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -144.19 160.8 40.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.81 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.32 105.68 17.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.801 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.2 m -85.16 118.75 24.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.673 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -81.39 127.77 33.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 tt -68.43 140.58 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.44 -165.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 0.0 111.514 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.23 169.91 46.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.179 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -48.58 -27.18 2.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.432 . . . . 0.0 110.763 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 1.0 OUTLIER -66.41 -32.86 74.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -48.83 -28.18 3.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.248 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.84 -26.53 58.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 46.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.251 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 9.3 p -124.34 123.07 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.705 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -111.21 109.97 20.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.538 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.457 ' CG2' HD11 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -65.06 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -102.06 151.48 22.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.462 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.449 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 86.2 m -80.25 -6.55 58.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.62 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.95 72.06 1.34 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.639 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -165.65 167.39 17.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 26.5 mm -86.9 146.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.192 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 90' ' ' ILE . 1.1 mt -150.3 171.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.383 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.521 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -129.57 122.31 28.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.785 178.678 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 104' ' ' VAL . 26.9 m -117.83 146.68 21.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.155 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.97 140.08 14.91 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.911 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.51 132.6 53.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.648 0.261 . . . . 0.0 110.616 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.55 -80.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.01 -15.95 63.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.449 ' CE2' ' HB2' ' A' ' 103' ' ' ASP . 48.5 m-85 -72.44 -8.8 56.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.547 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 67.29 29.94 7.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.34 -175.94 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.57 -61.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.836 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.15 156.66 17.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.967 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.408 ' CB ' ' CG2' ' A' ' 92' ' ' VAL . . . -141.28 -177.71 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.829 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.449 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 10.5 t70 -133.96 120.31 20.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.459 ' N ' HG11 ' A' ' 92' ' ' VAL . 59.8 t -52.87 112.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.845 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.75 -62.16 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.077 0.465 . . . . 0.0 110.057 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.553 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 1.5 pp -124.8 159.62 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.46 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.92 118.73 37.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.644 ' CG ' ' HE2' ' A' ' 119' ' ' TYR . 22.8 m-85 -82.24 106.28 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.09 173.39 5.58 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -74.48 -40.23 61.97 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.693 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.06 -40.48 95.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.729 ' O ' HD21 ' A' ' 116' ' ' LEU . 19.4 mt-10 -66.99 -28.37 68.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.505 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.754 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.63 -48.94 7.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.909 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -55.9 -30.26 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.386 0.612 . . . . 0.0 109.528 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.607 ' O ' ' N ' ' A' ' 118' ' ' ALA . 1.4 m -76.14 -22.46 55.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.173 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.754 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.22 -32.95 17.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.067 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.51 -34.3 61.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.74 42.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.778 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.644 ' HE2' ' CG ' ' A' ' 108' ' ' TYR . 4.2 m-30 -66.97 -11.64 57.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.86 23.27 65.39 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.633 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.54 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 50.8 mt-10 -109.54 -52.05 2.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.933 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.466 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -100.1 148.09 34.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.723 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.401 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 60.0 Cg_endo -72.52 178.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 0.0 112.339 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -30.8 69.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.401 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 56.7 p-80 -84.2 -3.49 58.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.405 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.35 147.64 30.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.887 0.375 . . . . 0.0 111.164 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -115.07 148.39 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.73 158.35 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.011 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -88.7 63.37 6.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.04 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 58.77 110.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.01 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.36 -29.21 66.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 64.03 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.4 m 56.06 96.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.22 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.81 67.96 1.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.711 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.62 -174.82 31.41 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.555 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -52.19 135.81 53.3 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.592 2.195 . . . . 0.0 112.362 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -127.26 73.02 0.45 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.513 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.4 172.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -146.89 35.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -134.22 77.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -138.74 31.65 2.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.2 mt -121.35 147.04 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.089 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -66.62 93.43 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -88.21 120.0 29.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -123.73 140.62 52.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.41 136.84 32.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 30.2 mm -106.62 81.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.025 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 162.43 79.11 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -123.85 115.01 20.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.58 -51.31 65.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.58 128.99 34.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 60.35 78.42 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.31 94.74 7.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 15.3 tt -64.52 146.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.12 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -113.63 -42.03 3.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.6 p30 -102.83 140.33 37.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 157' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.159 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptp . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -129.51 115.31 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.06 28.32 9.92 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.23 73.67 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.916 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -60.65 178.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -120.5 71.24 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -60.52 119.69 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.86 122.59 14.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.872 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.28 30.8 6.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -122.15 82.64 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 30.2 p -99.18 123.64 43.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.984 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t0 59.57 79.31 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.71 84.6 1.22 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.479 2.119 . . . . 0.0 112.386 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.921 0.3 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -105.17 60.28 0.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.853 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 63.1 -79.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.031 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt 61.78 -179.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.98 143.1 0.91 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 mttt 59.26 -178.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.28 -147.56 8.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.556 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.98 99.83 0.36 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -149.27 32.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -107.07 128.19 54.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.23 106.37 18.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.79 35.02 2.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.62 -68.95 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.52 -39.53 2.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.448 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -60.26 110.77 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.22 62.05 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.795 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -78.92 104.2 9.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 63.26 120.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -143.91 130.03 19.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.88 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.99 -171.0 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -132.6 167.74 19.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.9 ptpm? -148.85 -43.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.68 140.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -70.0 152.66 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.993 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 41' ' ' PHE . 30.1 tp -68.31 130.63 43.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.71 140.34 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.804 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.767 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.4 m-30 -112.51 170.95 7.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -45.24 148.61 0.6 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.952 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.75 162.43 20.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.39 . . . . 0.0 111.347 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -57.04 130.44 46.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.72 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.65 -15.36 61.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.369 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.41 ' HB3' HD12 ' A' ' 91' ' ' LEU . 2.0 mt-30 -123.62 144.49 49.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -118.85 153.64 34.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 111.383 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 10.1 p90 -84.22 157.71 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.698 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.31 173.52 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.362 0.601 . . . . 0.0 112.389 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -128.19 120.83 28.05 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.189 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 29.6 t -70.8 134.91 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.985 0.421 . . . . 0.0 111.664 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -116.45 -38.58 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -140.68 159.82 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.74 143.07 45.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.66 -58.74 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.944 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.77 -168.1 16.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.647 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -83.72 0.89 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.517 0.199 . . . . 0.0 111.49 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.58 -8.39 7.62 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.883 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -153.36 160.17 42.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 110.779 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.411 HD21 HG22 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -147.94 149.77 32.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -91.84 121.41 33.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.97 165.62 25.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 112.141 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.43 ' CE ' ' CB ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -126.1 111.84 15.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.169 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.48 135.96 57.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.3 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.0 m-85 -49.73 -25.39 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.34 -7.17 51.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.289 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.84 44.42 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.446 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.21 130.64 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 111.303 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' CB ' ' CE ' ' A' ' 63' ' ' MET . 8.6 tttt -95.7 113.73 25.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -145.04 165.59 27.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 111.125 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.7 mm? -103.12 109.23 20.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.406 ' HB3' ' CG1' ' A' ' 92' ' ' VAL . 25.7 m -84.41 119.8 25.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.99 136.53 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.0 tt -68.73 140.73 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -73.75 145.11 45.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.108 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -48.26 34.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.311 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -29.13 70.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.363 . . . . 0.0 110.628 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 3.8 mm? -84.67 -29.14 25.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.805 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HA ' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -48.97 -27.2 2.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -59.05 -42.16 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.266 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.83 46.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 111.434 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 9.8 p -123.95 117.9 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -110.93 110.06 20.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.066 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.411 HG22 HD21 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -83.1 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.251 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.444 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 t30 -108.33 159.35 16.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.106 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.6 m -80.12 -5.72 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 p -147.67 55.41 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.629 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.6 162.19 35.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.205 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.507 ' CG2' HD13 ' A' ' 116' ' ' LEU . 30.4 mm -87.03 146.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.288 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.496 HD12 HG23 ' A' ' 90' ' ' ILE . 1.2 mt -150.58 171.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.152 0.501 . . . . 0.0 111.327 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.496 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -129.56 122.39 29.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.448 178.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 72' ' ' CYS . 27.2 m -121.94 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.406 ' HA2' ' CB ' ' A' ' 46' ' ' GLN . . . -90.78 143.79 16.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mt -113.73 26.31 10.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.956 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.02 19.41 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.2 -49.2 6.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.682 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -105.46 -11.19 16.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.221 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 65.48 29.61 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -135.48 178.45 7.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -57.38 -18.26 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.856 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 132.37 34.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.816 0.341 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.72 158.14 23.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.472 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -115.45 120.48 39.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.032 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.406 ' O ' ' CG ' ' A' ' 75' ' ' ARG . 94.5 t -50.33 111.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.738 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.1 mm -77.94 -36.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 109.679 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.518 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -154.13 167.45 29.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.452 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.417 ' N ' HD13 ' A' ' 106' ' ' LEU . 14.6 pttt -110.28 121.64 45.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.15 0.5 . . . . 0.0 112.274 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.636 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 23.2 m-85 -86.4 106.6 17.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -73.86 178.29 4.98 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -76.54 -41.76 45.45 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.071 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -61.65 -40.05 93.52 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.699 ' O ' HD22 ' A' ' 116' ' ' LEU . 9.6 mt-10 -68.63 -28.0 66.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.351 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.721 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.54 -51.63 6.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.955 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -55.72 -27.22 49.36 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.662 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.584 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -76.58 -22.11 54.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.001 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.721 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.0 -34.43 21.13 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -54.85 -34.55 63.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.35 -20.92 43.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.921 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.767 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.9 m-30 -66.77 -7.28 20.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.827 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.22 24.53 65.46 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.566 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.567 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.8 mt-10 -114.05 -63.5 1.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.876 0.369 . . . . 0.0 111.191 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.42 144.59 29.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.957 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.448 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.7 Cg_endo -71.38 179.78 4.28 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.657 2.238 . . . . 0.0 112.401 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -70.89 -34.61 71.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.448 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 20.7 p-80 -72.44 -17.98 61.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -56.84 133.66 54.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.732 0.301 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -114.36 134.35 55.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.5 mt -99.11 141.7 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.097 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -67.82 157.82 33.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.02 162.28 7.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.716 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.43 141.57 54.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -39.23 136.31 0.88 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.857 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.8 p -95.74 -168.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 61.02 84.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.2 154.91 8.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.531 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.8 -166.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.52 2.146 . . . . 0.0 112.278 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -117.63 106.68 1.42 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.477 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.34 -78.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 110.985 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -170.31 -43.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.9 t70 61.74 71.53 0.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.74 81.64 1.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.781 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.0 mm -107.68 128.42 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 172.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.62 -169.54 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -176.16 -43.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -109.98 165.51 11.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.7 tt -170.76 55.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.058 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.56 176.5 27.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.13 31.59 4.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.318 . . . . 0.0 110.821 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -98.27 36.41 1.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 t70 60.68 56.97 2.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -55.0 18.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 44.2 t0 63.57 141.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.1 pt -123.48 141.35 44.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.098 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.52 -23.59 23.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 t0 64.65 164.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.8 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.037 179.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.761 0.315 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -35.22 73.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.58 -82.68 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.512 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 18.1 t -148.45 -74.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.729 0.299 . . . . 0.0 110.989 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 40.43 0.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 11.7 m170 69.07 -67.19 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.022 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -105.68 138.66 41.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.013 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -110.76 -36.78 5.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.733 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.62 82.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 6.9 m170 53.96 -168.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.57 -80.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.748 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 55.78 75.62 0.57 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.062 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.69 -40.67 77.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.62 2.213 . . . . 0.0 112.253 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.969 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 C--O 1.231 0.137 0 CA-C-O 120.834 0.264 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 51.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -60.81 -75.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.01 -53.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.92 -151.76 6.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt 66.09 -72.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.697 0.284 . . . . 0.0 111.068 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.45 86.74 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.13 66.04 0.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -115.92 -66.64 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.863 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -75.37 110.95 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 120.46 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -115.15 33.94 5.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -116.42 -36.27 4.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.13 -113.33 5.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.483 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -149.38 112.77 4.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -41.73 -66.7 0.32 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.703 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -176.79 -178.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.933 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 59.09 -179.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.01 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -95.45 175.11 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -89.53 -64.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 58.83 77.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.15 95.68 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.78 146.27 37.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -109.37 102.77 11.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.437 ' CD1' ' HB2' ' A' ' 112' ' ' GLU . 13.5 tp -68.81 99.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.704 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.4 ' CG1' HD22 ' A' ' 106' ' ' LEU . 18.9 t -88.35 139.15 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.624 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 86.5 m-85 -110.69 170.27 8.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -52.79 148.43 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.887 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -116.85 160.52 20.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.402 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.63 130.07 45.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.48 61.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.541 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.412 ' HB3' HD11 ' A' ' 91' ' ' LEU . 1.5 mt-30 -117.53 140.97 48.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.53 0.205 . . . . 0.0 110.559 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -115.66 154.36 29.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 111.408 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 5.3 p90 -84.55 157.78 21.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.21 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.01 173.18 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.225 0.536 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.04 109.05 11.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.273 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 20.6 t -57.2 135.47 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.769 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.07 -40.48 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.697 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.63 158.82 43.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.735 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -115.7 139.02 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.63 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -110.72 -48.79 3.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.773 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.88 -179.27 30.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.54 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 67.65 19.53 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.304 . . . . 0.0 111.239 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.47 28.79 9.33 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.839 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -154.82 155.88 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 1.2 pp -147.6 152.5 38.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.156 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -91.75 121.39 33.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . . . -124.25 165.06 18.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 112.331 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.407 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 1.2 tpt -125.8 100.24 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.86 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.37 132.17 50.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.637 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.2 m-85 -49.93 -27.0 4.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.453 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -8.09 55.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.434 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.72 40.71 3.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.531 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.13 123.06 61.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.262 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 1.9 tppp? -94.14 117.19 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -145.08 164.71 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.037 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.21 106.52 18.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.729 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 36.8 m -84.07 118.77 24.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 137.71 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -68.66 139.18 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.704 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.11 143.9 56.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.143 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.58 -38.28 57.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.51 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -75.87 -29.4 58.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.659 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 2.7 mm? -82.7 -28.65 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HA ' HG11 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -49.63 -27.62 4.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.248 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -35.56 69.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.304 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.24 48.74 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 10.7 p -120.95 119.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.143 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -110.81 110.27 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.419 ' CD1' ' CD2' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -87.11 147.14 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.435 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -118.84 156.32 29.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.3 m -80.15 -6.45 57.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.168 0.509 . . . . 0.0 111.377 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -145.34 71.24 1.28 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.43 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.73 165.18 33.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.085 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.533 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 38.4 mm -86.78 144.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.488 HD11 HG21 ' A' ' 90' ' ' ILE . 1.1 mt -150.52 172.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 111.063 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -129.01 127.11 40.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.795 178.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 104' ' ' VAL . 31.6 m -122.2 149.51 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.92 135.85 12.96 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.87 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 123.78 42.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.6 0.238 . . . . 0.0 110.72 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.57 -80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -61.12 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -73.52 -8.03 54.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.433 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 66.71 30.2 8.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.823 0.344 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.73 -169.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.14 -62.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.775 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -108.59 168.68 9.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.761 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 92' ' ' VAL . . . -152.68 177.2 10.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.98 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.33 119.1 21.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.833 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.444 ' N ' HG12 ' A' ' 92' ' ' VAL . 70.9 t -49.89 111.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.906 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -82.5 -47.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.13 0.491 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.453 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.4 pp -141.52 169.16 18.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.59 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.407 ' HA ' HG22 ' A' ' 90' ' ' ILE . 12.0 pttp -110.28 122.51 47.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 111.96 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.651 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 20.1 m-85 -85.44 107.0 17.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -64.27 168.08 5.98 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.82 -51.06 11.08 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.4 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.457 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 46.2 t0 -62.02 -38.2 87.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.477 ' OE2' ' HA ' ' A' ' 108' ' ' TYR . 0.7 OUTLIER -75.28 -26.16 58.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.018 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.589 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . . . -45.44 -41.89 9.83 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.765 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.457 ' CG ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -53.11 -36.71 61.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.318 0.58 . . . . 0.0 109.488 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.596 ' O ' ' N ' ' A' ' 118' ' ' ALA . 1.0 OUTLIER -61.61 -21.04 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.971 177.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.681 ' HA ' ' CG ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -50.32 -32.93 18.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.354 -178.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -34.48 65.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.1 -21.64 43.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.639 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.681 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -67.24 -10.5 51.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.077 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.72 64.83 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.619 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.473 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 65.4 mm-40 -111.3 -53.53 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.772 0.32 . . . . 0.0 111.013 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -98.04 147.2 32.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.78 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.414 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.1 Cg_endo -70.91 175.1 9.52 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.56 2.173 . . . . 0.0 112.193 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.29 -27.12 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.414 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 21.3 p-80 -81.62 -10.84 59.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.429 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.91 164.51 0.58 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -129.77 144.74 51.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mm -84.06 139.72 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -85.97 98.55 10.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 57.87 85.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.7 m -64.09 -39.24 93.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.832 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.3 t0 59.98 176.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.8 t -152.5 157.25 40.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.06 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -113.95 46.92 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.99 117.95 5.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.454 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.85 -33.0 59.15 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.398 2.065 . . . . 0.0 112.295 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 167.66 79.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.514 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 62.29 106.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -63.65 -31.76 73.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -84.66 -163.7 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.41 -165.46 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 10.8 tt -53.5 150.86 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.311 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -106.8 141.59 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 62.54 143.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.915 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 60.44 110.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.63 42.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.38 -148.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.226 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.06 122.42 0.6 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.7 t70 61.9 63.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.931 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -124.39 -46.49 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -174.22 137.53 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.42 -62.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.68 138.92 30.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.835 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.0 pt -78.42 138.88 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 41.0 t0 60.08 66.83 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -108.05 -31.02 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.144 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.763 0.316 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 62.86 40.44 9.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 154.73 175.9 26.37 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.525 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.09 51.55 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.82 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.83 38.24 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.21 164.31 30.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -126.09 151.16 47.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -110.3 111.25 22.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.12 -177.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.83 168.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 20.3 m -118.88 73.31 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.64 67.53 1.15 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.809 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.12 151.62 34.11 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.523 2.148 . . . . 0.0 112.16 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.069 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 CA-C-O 120.869 0.279 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -102.52 143.23 32.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.048 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t30 62.81 141.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.007 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.93 121.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.97 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.28 62.93 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.468 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -100.2 115.92 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.77 -168.9 0.69 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.461 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.58 31.13 3.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.524 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 73.52 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 0.0 110.845 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -161.04 94.84 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.4 -64.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.1 88.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.71 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 63.48 53.03 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.742 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.66 173.27 4.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.575 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -105.77 -73.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 62.0 72.74 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -144.55 159.09 43.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.7 p30 43.6 39.8 2.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -62.88 131.44 48.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -162.37 -60.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -66.19 120.23 12.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.15 60.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.963 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.47 80.75 6.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -74.67 150.84 39.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.018 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.414 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 19.7 tp -127.59 124.47 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.8 t -126.47 140.5 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.93 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.754 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 5.3 m-30 -110.6 170.64 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.442 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -46.45 147.62 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.039 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -128.1 165.05 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.283 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.47 130.51 46.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.739 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.44 -15.26 61.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.386 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -127.31 146.52 50.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -125.29 153.88 42.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.022 0.439 . . . . 0.0 111.492 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 7.8 p90 -84.32 157.88 21.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.84 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.81 173.55 15.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 112.388 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.406 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 tm0? -128.75 124.27 35.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 21.7 t -76.58 140.94 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 111.95 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 63' ' ' MET . 0.8 OUTLIER -115.95 -41.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.072 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -147.66 161.25 41.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -110.15 142.04 42.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.441 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 1.8 mt -97.04 -30.28 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.29 61.03 3.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.704 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -177.73 51.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.568 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.59 11.07 64.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.424 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 73' ' ' HIS . 24.8 ptt180 -147.25 164.17 34.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -147.19 155.61 42.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -91.71 122.09 33.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.01 165.76 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.174 0.512 . . . . 0.0 111.941 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.456 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 4.6 tpp -131.28 111.79 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.116 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -59.27 131.76 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.361 . . . . 0.0 110.463 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.64 -26.3 2.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.789 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.33 -14.22 60.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.84 1.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.58 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -126.92 126.28 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 111.038 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.01 113.23 24.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.29 163.52 34.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.5 mm? -102.82 114.25 28.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.706 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.2 m -83.99 118.71 24.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 4.9 m80 -83.99 146.32 28.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.7 mm -68.6 120.12 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.31 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 28.5 tpt180 -64.79 137.98 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.19 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.96 -65.96 2.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.656 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.34 9.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.48 -17.78 33.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.5 ptt85 -48.73 -29.73 4.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.238 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -55.32 -27.07 44.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.98 38.78 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.058 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.2 p -81.74 111.15 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.398 . . . . 0.0 110.758 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -111.15 110.52 21.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.482 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.447 HG23 HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -115.05 147.47 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -132.27 160.77 35.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.686 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.43 HG21 ' O ' ' A' ' 52' ' ' ILE . 74.7 m -80.59 -6.73 58.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.153 0.501 . . . . 0.0 111.805 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -147.51 69.86 1.16 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.746 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.96 161.98 36.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.133 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.531 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 1.5 mp -86.76 147.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.5 HD13 HG21 ' A' ' 90' ' ' ILE . 1.6 mt -150.42 172.37 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 111.58 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.504 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -128.2 122.0 30.79 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.48 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 104' ' ' VAL . 13.6 m -117.86 157.01 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.55 123.23 7.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.539 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.39 111.79 21.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.764 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -176.98 -71.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.44 -12.48 61.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.52 10.74 16.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.62 29.75 10.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.977 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.7 t0 68.45 -178.9 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.29 -61.06 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -96.36 163.6 13.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.676 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -163.74 139.82 6.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.96 129.4 36.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 96.2 t -55.01 111.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.808 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 mm -77.53 -48.76 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.135 0.493 . . . . 0.0 109.853 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.521 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -140.94 167.3 22.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.255 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.439 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -111.82 119.59 39.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 112.305 -178.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.631 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 24.2 m-85 -83.86 106.08 15.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -72.2 177.86 4.21 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -77.13 -40.54 45.33 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.175 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -61.41 -40.49 94.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.711 ' O ' HD23 ' A' ' 116' ' ' LEU . 11.5 mt-10 -67.03 -27.91 67.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.508 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.847 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.31 -49.47 6.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.984 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -28.15 56.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.348 0.594 . . . . 0.0 109.5 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.98 -22.79 42.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.167 178.414 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.847 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.89 -33.75 25.43 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.064 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -55.2 -34.18 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.02 -20.32 45.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.932 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.754 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.4 -6.14 13.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.83 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.46 24.8 53.55 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.791 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.454 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 49.2 mm-40 -114.27 -56.28 2.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -90.85 153.29 45.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 73.5 Cg_endo -75.81 -179.79 5.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.723 2.282 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.0 -31.28 67.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.088 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 29.4 p-80 -84.17 2.71 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.532 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.1 122.28 14.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.158 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -108.82 121.53 45.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.77 158.69 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -67.83 172.95 4.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.14 162.48 19.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.5 m -63.42 -48.97 75.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.0 t0 63.05 44.09 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.8 m -129.33 99.38 5.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -173.01 127.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 123.79 80.86 0.49 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.521 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.03 -49.65 16.85 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.617 2.211 . . . . 0.0 112.308 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -162.55 42.92 0.36 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.552 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.29 113.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.98 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 43.32 80.99 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.438 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.24 125.96 4.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.846 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -87.91 97.88 11.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.1 tt -112.79 23.5 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.146 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -134.9 121.14 20.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -84.6 -45.76 12.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.033 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -67.74 132.56 47.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.31 -170.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 29.7 mt -101.31 34.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -125.91 -160.5 10.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.59 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -98.19 116.07 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.769 0.319 . . . . 0.0 110.823 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -87.72 172.72 9.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.952 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -106.17 36.09 2.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -140.09 76.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -106.98 -174.01 2.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.783 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.33 48.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -68.23 157.87 34.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.37 169.4 17.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.106 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.83 0.348 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -101.05 -74.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.85 83.29 0.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.51 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -129.91 136.12 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.781 0.324 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -111.33 116.17 30.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -134.41 -48.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -144.6 85.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -93.53 131.46 38.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -136.35 172.33 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -134.67 150.96 50.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.61 51.74 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -146.93 89.9 5.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -51.98 -28.28 31.47 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.565 2.177 . . . . 0.0 112.327 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 2.0 ttp . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.893 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.767 0.236 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt 64.78 91.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -58.61 -78.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.1 mptt 55.36 45.07 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.881 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.43 -25.95 43.16 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.616 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -129.86 169.08 15.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.59 88.61 0.11 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.557 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.11 152.66 21.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.27 -52.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 0.0 110.945 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 61.71 30.22 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.97 163.58 14.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 tpt85 -129.26 85.32 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.927 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -72.01 -174.37 1.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.23 -122.42 2.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.38 178.11 5.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 59.23 170.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.968 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.99 69.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.73 56.44 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 63.53 144.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.73 96.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 60.59 160.36 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -123.7 123.91 41.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.849 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 61.4 111.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.825 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -174.47 100.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.01 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.417 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 22.9 tp -68.09 122.73 18.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 15.4 t -114.69 139.88 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.617 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 24.5 m-85 -116.9 170.07 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.582 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 158.19 19.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.792 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -144.46 178.04 8.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.361 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -44.52 137.02 3.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.27 61.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.425 ' HB3' HD13 ' A' ' 91' ' ' LEU . 2.5 mt-30 -141.73 139.2 32.82 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -123.4 157.63 32.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.007 0.432 . . . . 0.0 111.535 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 4.9 p90 -84.5 158.05 21.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.93 173.86 14.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.248 0.547 . . . . 0.0 112.2 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.78 120.6 26.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.019 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.419 ' CG2' HD11 ' A' ' 60' ' ' LEU . 23.4 t -70.89 135.46 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 112.039 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.433 HD11 ' HB2' ' A' ' 63' ' ' MET . 14.0 mt -116.29 -40.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 157.62 46.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.12 131.6 56.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.747 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -105.89 -32.68 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.8 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.42 -171.67 48.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.57 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 m120 61.9 26.49 16.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.718 0.294 . . . . 0.0 111.049 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.85 32.19 24.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.616 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -155.4 157.27 36.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.605 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.432 ' HA ' ' HG ' ' A' ' 55' ' ' LEU . 2.6 pp -148.04 160.91 42.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 111.611 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -104.41 120.83 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.51 164.68 27.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.23 0.538 . . . . 0.0 112.033 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.433 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -120.08 114.8 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.191 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.2 m -59.45 133.47 56.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.502 ' CG ' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -48.2 -25.54 1.54 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.622 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.0 -14.07 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.339 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.89 39.75 2.45 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.664 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.34 129.6 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 111.428 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' CB ' ' CE ' ' A' ' 63' ' ' MET . 1.7 ttmp? -91.66 117.94 30.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' NH2' ' CG2' ' A' ' 92' ' ' VAL . 33.2 ptt180 -142.7 165.57 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.981 0.42 . . . . 0.0 111.165 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.4 mm? -104.29 108.08 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.5 m -84.87 118.75 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.416 ' CD2' ' CE2' ' A' ' 97' ' ' TYR . 2.2 m-70 -85.01 130.32 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.0 tt -68.64 140.91 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.047 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 14.2 tpt180 -76.6 148.51 36.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.087 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.22 -79.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.984 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.39 -26.1 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.722 0.296 . . . . 0.0 111.544 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -79.93 -45.33 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.186 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -58.46 -24.12 59.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -58.64 -33.43 70.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 8.44 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.585 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.451 ' O ' ' CG1' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -124.18 119.69 57.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.132 0.491 . . . . 0.0 111.167 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -111.07 110.32 20.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.766 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.408 HG23 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.49 147.59 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.3 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -118.97 159.33 24.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 40.2 m -76.12 -6.09 49.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.697 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.1 p -145.83 71.57 1.27 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.702 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.59 160.52 39.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.079 0.466 . . . . 0.0 111.208 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 38.3 mm -86.94 146.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.489 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.506 HG22 HD12 ' A' ' 90' ' ' ILE . 1.4 mt -150.41 171.14 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.241 0.543 . . . . 0.0 111.631 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.498 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -129.07 124.37 34.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.429 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 102' ' ' ALA . 16.9 m -122.69 160.26 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.351 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.93 135.77 12.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -100.45 159.1 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 60.87 22.82 12.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.178 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.04 -47.37 7.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.674 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.416 ' CE2' ' CD2' ' A' ' 73' ' ' HIS . 46.2 m-85 -96.95 4.15 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.136 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 65.82 29.71 10.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.722 0.296 . . . . 0.0 110.796 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.61 175.32 13.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.438 . . . . 0.0 111.109 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -17.58 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.109 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -77.67 124.79 28.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 111.369 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB2' ' CG2' ' A' ' 92' ' ' VAL . . . -111.5 156.16 22.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.053 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 13.1 p30 -102.82 120.67 41.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.881 0.372 . . . . 0.0 111.426 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 80.3 t -52.62 111.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.325 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.6 mm -79.02 -33.25 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.266 0.555 . . . . 0.0 109.81 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.479 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 2.6 pp -159.1 166.83 30.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.442 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HA ' HG23 ' A' ' 90' ' ' ILE . 1.6 tttt -109.9 116.94 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.061 0.457 . . . . 0.0 112.145 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.654 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 22.3 m-85 -79.23 106.12 11.04 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -73.44 177.15 5.45 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -76.03 -40.16 54.03 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.001 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.07 -40.81 97.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.696 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.9 mt-10 -67.76 -28.1 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.381 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.838 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.44 -49.13 7.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.829 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.39 -29.21 61.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.31 0.576 . . . . 0.0 109.489 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -78.32 -22.56 47.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.181 178.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.838 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.08 -33.86 27.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.024 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -33.76 61.54 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -21.01 43.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.729 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.654 ' HE2' ' CD1' ' A' ' 108' ' ' TYR . 4.0 m-30 -66.73 -8.44 28.08 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.89 23.46 51.18 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.418 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 2.9 mm-40 -109.93 -51.55 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.421 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.99 125.21 44.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.426 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 35.6 Cg_exo -57.27 179.0 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.327 2.018 . . . . 0.0 112.15 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.59 -28.63 67.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.426 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 10.3 p-80 -80.78 -23.28 39.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.222 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -55.39 141.21 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.284 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -124.14 146.51 48.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 mt -99.98 152.51 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -67.1 164.69 17.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.76 127.15 30.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.7 m -58.5 -22.0 53.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.195 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.7 t0 65.04 42.22 4.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.922 0.391 . . . . 0.0 110.81 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.4 m -83.11 97.34 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.59 114.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.18 99.14 2.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.481 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.74 101.86 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.471 2.114 . . . . 0.0 112.213 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.21 -28.28 64.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t70 62.15 97.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.22 145.25 28.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.13 -178.82 3.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.47 -63.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.47 67.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.57 117.11 29.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -104.64 126.83 52.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.767 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.93 111.93 1.67 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -144.19 128.66 17.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 147' ' ' ILE . 6.4 tp -100.44 82.91 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.151 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -95.74 171.19 28.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.43 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -110.83 -37.19 5.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.783 0.325 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -65.75 114.04 4.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.34 101.7 11.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.45 31.54 5.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -111.75 -69.49 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.6 tp -145.17 144.55 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -159.76 83.64 0.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 66.66 -71.25 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.078 -179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.923 0.392 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -74.58 100.37 3.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.844 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.39 43.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.459 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.18 152.11 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.33 120.0 4.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.973 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.72 57.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.762 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -87.88 -31.14 19.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.54 -167.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 m80 63.04 -79.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -120.83 58.24 0.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.6 156.52 19.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -151.36 63.16 5.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.42 97.45 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.561 2.174 . . . . 0.0 112.167 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 120.786 0.244 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.95 56.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.04 -39.27 42.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.2 153.2 34.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.51 72.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.574 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -80.14 119.18 22.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.16 101.57 2.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.46 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.96 134.0 14.28 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -107.68 -29.1 9.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.76 0.315 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.27 175.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.3 mmt-85 -63.03 99.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -117.81 121.94 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -115.58 91.14 3.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.85 27.44 19.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.539 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -109.72 -172.17 1.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.845 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 m120 61.97 105.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -127.65 42.21 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.8 m120 60.65 -174.63 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -167.49 58.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 t -97.38 113.32 24.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.806 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 62.09 -161.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.594 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.4 tttt 73.9 60.38 0.09 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.937 0.399 . . . . 0.0 110.88 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 59.98 101.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.39 88.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.44 ' CD1' ' HG2' ' A' ' 112' ' ' GLU . 13.7 tp -118.9 130.51 55.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.439 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 17.7 t -121.84 139.58 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.097 0.475 . . . . 0.0 111.402 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 119' ' ' TYR . 53.8 m-85 -115.22 171.7 7.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -39.44 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -133.81 158.49 43.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 126.78 28.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.74 78.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.97 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -115.12 143.77 44.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.824 0.312 . . . . 0.0 110.658 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -119.22 166.21 13.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.129 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.597 ' CZ ' ' CE2' ' A' ' 108' ' ' TYR . 3.8 m-85 -84.78 156.82 21.21 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.706 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 64' ' ' CYS . . . -149.5 142.75 25.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.681 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.29 108.43 16.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.946 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 21.5 t -55.42 137.56 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 86' ' ' THR . 0.3 OUTLIER -116.13 -42.62 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.15 151.95 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.47 134.04 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.679 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 61' ' ' GLU . 1.2 mt -93.72 -35.63 12.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.825 0.345 . . . . 0.0 110.772 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.25 -132.35 3.2 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -112.6 89.52 3.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.324 . . . . 0.0 110.976 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 147.75 -24.21 1.48 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -152.87 160.25 43.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.634 0.254 . . . . 0.0 110.534 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.451 ' CD2' ' CD1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.21 150.05 34.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 111.367 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.3 tt0 -91.72 121.64 33.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.56 166.11 24.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.237 0.541 . . . . 0.0 112.318 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.415 ' HE1' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -115.17 95.92 5.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.095 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 18.7 t -45.8 125.91 6.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' CZ ' HD23 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -48.46 -23.35 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.91 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -13.2 60.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.599 0.238 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.43 34.36 4.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.687 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.19 124.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 0.0 OUTLIER -85.86 112.47 21.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.58 165.77 27.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.907 0.385 . . . . 0.0 111.304 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -97.12 108.01 20.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.6 m -84.24 125.76 32.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.614 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.75 137.08 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.1 tt -68.87 140.3 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.821 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -74.31 145.69 43.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.913 0.387 . . . . 0.0 111.348 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.89 -51.23 15.61 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.272 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -31.56 64.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.986 0.422 . . . . 0.0 110.501 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 4.5 mm? -85.9 -31.71 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.453 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -49.01 -28.84 4.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.314 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -56.9 -27.48 60.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -169.37 49.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.36 . . . . 0.0 111.165 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 78' ' ' LEU . 9.4 p -123.0 122.94 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.644 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -111.03 109.58 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.673 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.451 ' CD1' ' CD2' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -81.12 123.77 38.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 179.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.489 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -84.72 152.82 23.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 52' ' ' ILE . 63.0 m -79.92 -5.92 56.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.512 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 p -146.54 51.77 1.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -133.71 165.0 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 111.57 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.558 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 1.5 mp -87.72 146.58 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.875 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 106' ' ' LEU . 1.3 mt -150.42 170.5 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.054 0.454 . . . . 0.0 111.195 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.538 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -123.27 122.4 38.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.93 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.449 HG13 ' N ' ' A' ' 104' ' ' VAL . 19.4 m -120.55 154.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.04 153.81 20.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.851 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.409 ' CD2' ' CB ' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -137.17 131.25 32.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 179.55 -68.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.094 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.28 -15.02 60.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -72.58 -11.4 60.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.582 0.229 . . . . 0.0 111.556 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 64.87 29.72 12.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.857 0.36 . . . . 0.0 110.807 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.9 OUTLIER 62.85 97.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 99' ' ' ASP . 4.3 t-20 165.12 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -141.94 162.39 35.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.474 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.419 ' CB ' ' CG2' ' A' ' 92' ' ' VAL . . . -139.29 170.99 14.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -128.79 111.33 13.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.449 ' N ' HG13 ' A' ' 92' ' ' VAL . 68.5 t -49.94 112.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.3 mm -83.94 -43.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.175 0.512 . . . . 0.0 109.764 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 90' ' ' ILE . 2.0 pp -144.46 165.82 26.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.421 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.491 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -111.87 120.7 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.923 -179.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.668 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 27.3 m-85 -83.11 105.91 14.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.97 166.77 4.31 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -73.12 -35.96 66.63 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.402 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.96 -40.22 97.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.742 ' O ' HD23 ' A' ' 116' ' ' LEU . 51.7 mt-10 -64.18 -28.19 69.58 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.561 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.912 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.58 -38.43 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.675 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -33.98 77.16 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 112' ' ' GLU . 5.1 p -77.58 -23.09 50.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.867 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.912 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -52.54 -31.36 35.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.18 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -33.11 62.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.31 -21.79 42.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.731 177.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.68 ' CG ' HD21 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.44 -7.55 26.23 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.858 0.361 . . . . 0.0 110.218 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.11 84.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.003 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.458 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 38.2 mm-40 -125.83 -56.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.505 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.62 118.64 67.51 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.442 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 51.2 Cg_exo -54.3 178.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.206 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.442 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 10.0 p-80 -77.23 -17.85 58.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.246 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -52.62 128.73 27.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.363 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -106.76 133.03 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.465 HG22 ' CB ' ' A' ' 113' ' ' ALA . 5.4 mt -101.77 155.74 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.437 ' N ' HG21 ' A' ' 128' ' ' ILE . 12.0 p-10 -72.39 63.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 54.34 -174.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.128 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.7 m -117.73 -64.41 1.3 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.98 88.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.5 p -99.13 174.4 6.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.965 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 134' ' ' PHE . 16.0 p90 -124.42 100.37 6.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 178.79 98.18 0.11 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.473 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.42 179.23 2.61 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.507 2.138 . . . . 0.0 112.335 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.87 -144.63 22.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.482 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.77 131.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.765 0.317 . . . . 0.0 110.993 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.63 117.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.024 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -60.16 103.36 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.98 -46.41 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 22.8 mt -140.67 118.88 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.223 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -100.14 -15.76 18.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.203 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -53.79 -43.92 69.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.802 0.334 . . . . 0.0 111.016 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.28 42.04 15.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.53 76.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.42 109.81 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.078 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.17 -179.25 51.7 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 61.54 155.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.861 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.94 131.97 38.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -136.35 43.33 2.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.71 106.48 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -103.28 -24.03 13.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 154' ' ' ILE . 0.1 OUTLIER -132.79 68.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.919 0.39 . . . . 0.0 111.072 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -144.09 121.14 11.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.845 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -139.89 125.23 18.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.3 mm . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.141 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.79 0.328 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 62.29 159.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.797 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.08 42.6 0.19 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.529 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.82 70.66 1.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.893 0.378 . . . . 0.0 110.869 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -119.42 32.35 6.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -133.19 174.6 10.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -164.01 107.48 0.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.96 145.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 33.7 m170 60.72 -178.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 62.08 29.59 17.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.002 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 51.2 m -87.05 70.09 10.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.786 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.45 76.36 0.51 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 172.82 11.84 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.54 2.16 . . . . 0.0 112.327 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 C--O 1.231 0.151 0 CA-C-O 120.739 0.224 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.9 -64.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 64.37 73.69 0.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -110.5 -23.24 11.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.135 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.42 122.73 16.3 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.716 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -82.45 -59.47 2.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.36 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.44 -56.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.45 -102.83 0.65 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.453 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? 61.09 29.21 18.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.708 0.289 . . . . 0.0 110.929 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -176.39 37.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.753 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.24 50.06 4.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.99 89.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 28.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.014 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.95 -29.38 3.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.424 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 67.66 -70.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.752 0.31 . . . . 0.0 111.061 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.94 86.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.39 -57.57 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 m120 64.97 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.821 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -92.61 -11.67 33.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.283 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 p 64.93 110.92 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.845 0.355 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.38 43.77 1.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -59.63 -32.8 70.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.23 102.84 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.41 137.23 53.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.534 ' CD1' ' CG ' ' A' ' 112' ' ' GLU . 16.4 tp -127.21 123.73 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.4 140.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.6 m-85 -111.04 170.06 8.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.085 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.48 149.13 48.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.685 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.25 176.41 7.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.346 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -49.64 134.1 20.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.081 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.45 -15.09 60.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.12 139.42 45.9 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -125.06 157.2 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.07 0.462 . . . . 0.0 111.496 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CE2' ' CD1' ' A' ' 65' ' ' PHE . 2.9 p90 -84.6 158.12 20.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.034 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.37 173.65 13.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.233 0.539 . . . . 0.0 111.997 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 38.4 tp60 -128.64 108.94 10.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.92 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 12.0 t -60.98 136.14 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.047 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 mp -116.2 -40.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.703 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 157.95 44.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 1.5 ttt -116.9 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.66 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -117.35 -167.62 1.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.729 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.37 -178.53 19.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.441 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.36 39.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.73 52.15 53.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.76 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' HIS . 8.2 ptt180 -154.81 162.66 41.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.311 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' CD2' ' CD1' ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.06 152.26 38.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.291 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -94.02 121.82 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.907 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.29 161.36 30.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.235 0.54 . . . . 0.0 112.093 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -119.97 101.65 8.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.146 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.05 129.22 40.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.37 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 3.4 m-85 -50.63 -24.54 3.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.468 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -8.42 56.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 35.63 5.0 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.685 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.23 124.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.377 . . . . 0.0 111.087 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.8 tptm -96.36 115.21 27.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -141.48 160.99 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 2.4 mm? -95.67 110.79 22.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.5 m -84.25 119.02 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -79.85 141.49 36.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.373 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.435 HD13 ' CD1' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -68.63 126.76 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -179.23 -168.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.645 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.47 171.16 40.97 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.298 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -21.6 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.848 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -68.71 -10.81 58.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.412 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -47.6 -28.52 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.611 0.243 . . . . 0.0 111.48 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -61.96 -26.28 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.426 ' HE3' ' CZ2' ' A' ' 83' ' ' TRP . 10.2 mtpt -170.31 52.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 78' ' ' LEU . 14.3 p -81.97 111.07 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.426 ' CZ2' ' HE3' ' A' ' 81' ' ' LYS . 10.3 m0 -111.62 109.62 19.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.606 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.435 ' CD1' HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -97.06 147.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.63 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.458 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.4 m-80 -119.58 153.38 35.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.927 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.9 m -80.25 -6.4 57.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 111.675 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.7 62.37 1.32 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.98 165.73 34.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.261 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.522 ' C ' ' HB2' ' A' ' 108' ' ' TYR . 37.2 mm -86.93 145.7 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.29 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.529 HG22 HD11 ' A' ' 90' ' ' ILE . 1.1 mt -150.84 171.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.508 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -129.01 122.24 29.62 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.536 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 104' ' ' VAL . 10.1 m -115.18 164.14 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.92 123.21 6.86 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.532 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.418 ' N ' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -109.98 119.76 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.755 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -163.96 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -12.16 60.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -84.81 10.99 10.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.685 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 66.79 26.79 9.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 72.8 -57.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.462 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -40.71 -32.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.717 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -123.61 158.96 30.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -153.07 156.34 38.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -107.23 126.5 52.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.424 ' N ' HG12 ' A' ' 92' ' ' VAL . 87.2 t -52.5 111.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.686 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 12.7 mm -80.93 -58.4 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.867 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.509 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -129.67 167.22 18.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.358 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' N ' HD13 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -110.84 119.31 38.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.644 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 23.3 m-85 -84.01 106.38 15.62 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -70.46 172.84 7.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 113' ' ' ALA . . . -75.61 -51.05 13.71 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.636 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -61.32 -39.14 89.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.534 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 23.6 tt0 -67.1 -29.94 69.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.607 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.617 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -45.84 -42.87 12.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.543 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -41.89 58.65 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 110.149 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.577 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -61.87 -21.32 64.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.516 178.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.704 ' HA ' ' CG ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -50.7 -33.35 22.43 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.049 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -55.24 -34.74 64.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.3 -20.58 44.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.009 177.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.2 m-30 -66.58 -8.28 25.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.876 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 22.93 56.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.493 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 66.6 mm-40 -109.77 -61.0 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.912 0.387 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.474 ' CD2' ' CE2' ' A' ' 48' ' ' TYR . 0.1 OUTLIER -82.18 139.45 45.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.745 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.441 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 64.3 Cg_endo -73.78 178.03 7.32 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.45 -29.8 70.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 27.3 p-80 -84.19 2.48 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.5 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.15 126.37 30.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 110.994 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -123.59 127.58 48.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.7 mt -91.95 156.38 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -78.81 151.03 32.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.98 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.08 139.12 58.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.26 -45.29 2.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.842 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.81 -175.97 4.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.952 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -162.27 93.72 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.974 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 116.46 -93.9 0.62 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.633 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.6 -178.66 3.16 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.542 2.161 . . . . 0.0 112.52 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.25 -95.54 0.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 59.03 77.85 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -160.5 52.02 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.5 -28.82 68.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.3 160.53 18.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.94 -31.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.466 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.35 94.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 111.26 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 62.51 122.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -137.26 142.18 41.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -164.52 47.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.18 38.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.112 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.12 -175.57 13.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.517 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.35 136.38 54.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 110.949 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.62 169.97 9.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 t0 62.11 39.09 13.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -85.92 129.45 34.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.14 147.98 37.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.6 pp -113.83 171.49 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.102 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.1 t0 61.69 97.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.0 t0 62.9 -168.04 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.11 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.731 0.3 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -37.5 79.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.827 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 109.78 113.75 3.57 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -146.57 105.85 3.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.33 . . . . 0.0 110.908 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -170.9 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.949 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -137.9 161.81 35.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -113.85 86.09 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -63.03 -179.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -104.8 116.23 31.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -153.17 111.78 3.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 35.0 m -95.75 127.91 42.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.854 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -143.06 83.37 11.23 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.18 -177.87 1.87 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.217 . . . . 0.0 112.261 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.797 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.816 0.257 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -84.4 81.34 8.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -87.42 153.32 21.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -87.5 -24.43 24.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.02 125.99 34.7 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.644 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.96 -172.18 2.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 0.0 110.9 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.74 34.62 78.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.557 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.0 85.59 0.11 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -156.03 66.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -173.63 121.05 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.797 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -100.31 170.07 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 mpp_? -70.22 110.42 5.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 106.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.899 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.9 43.39 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -70.56 -20.18 62.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.697 0.284 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 65.03 133.0 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 59.4 101.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.83 112.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -111.32 71.67 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.849 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -115.0 153.34 30.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.98 71.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.924 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -157.21 -72.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -176.8 147.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -100.04 98.5 9.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.047 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' HG2' ' A' ' 112' ' ' GLU . 23.3 tp -103.29 118.38 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.404 ' CG1' HD23 ' A' ' 106' ' ' LEU . 19.1 t -108.08 139.11 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.628 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 66.9 m-85 -112.75 170.43 8.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.711 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -48.28 143.42 4.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.47 156.17 19.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -56.1 129.85 41.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.838 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.23 -15.35 62.31 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.391 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -116.38 152.95 32.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.636 0.255 . . . . 0.0 110.401 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -125.93 154.48 42.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 111.335 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 10.0 p90 -84.34 157.87 21.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.76 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.83 173.42 15.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.327 0.584 . . . . 0.0 112.204 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -123.77 142.43 51.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.813 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 22.7 t -92.16 139.02 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 111.799 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 63' ' ' MET . 1.0 OUTLIER -115.85 -48.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.274 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -141.77 162.2 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.0 mmm -113.96 137.09 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -106.19 -69.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.896 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.23 179.65 16.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.565 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -72.37 -13.99 61.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.565 0.221 . . . . 0.0 111.259 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 74' ' ' ILE . . . -118.78 8.85 12.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.4 155.98 34.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.752 0.311 . . . . 0.0 111.0 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.401 HD21 ' CD1' ' A' ' 84' ' ' ILE . 1.6 pp -147.89 164.1 34.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.379 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -104.23 121.42 43.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.05 165.96 23.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.274 0.559 . . . . 0.0 112.262 -178.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.454 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 3.7 tpp -130.14 110.92 11.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.078 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.25 133.5 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -27.27 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.502 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.37 -13.24 60.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.58 43.04 1.9 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.497 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.05 117.8 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.64 112.99 24.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.1 156.84 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -92.66 107.89 19.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.856 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 32.3 m -84.17 118.42 24.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.376 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -82.84 123.7 29.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.765 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.409 ' CG2' ' HA2' ' A' ' 58' ' ' GLY . 5.5 tt -68.73 140.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 176.73 -161.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.793 0.33 . . . . 0.0 111.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.3 168.93 39.01 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.028 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.72 2.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.575 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 1.2 mm? -64.47 -34.57 78.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.784 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -27.16 3.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.292 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -56.76 -37.66 71.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -157.64 48.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.196 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 p -123.51 121.19 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.261 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.55 109.86 20.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.401 ' CD1' HD21 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.38 147.17 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.086 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.412 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -108.75 152.84 24.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.957 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 52' ' ' ILE . 70.3 m -80.17 -6.36 57.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 111.69 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 p -146.2 61.69 1.24 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.687 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.96 168.52 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.186 0.517 . . . . 0.0 111.45 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.502 ' C ' ' HB2' ' A' ' 108' ' ' TYR . 47.6 mm -91.81 146.78 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.213 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.491 HG22 HD12 ' A' ' 90' ' ' ILE . 1.2 mt -150.9 170.7 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 111.449 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.483 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 0.1 OUTLIER -128.68 121.66 29.05 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.519 178.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 104' ' ' VAL . 15.3 m -118.66 148.4 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.13 128.4 8.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 111.54 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.735 0.302 . . . . 0.0 110.73 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.33 -75.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -55.35 -23.22 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.335 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -85.28 4.88 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.633 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 65.78 30.02 10.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 76.36 178.86 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 73.28 -60.67 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.809 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.26 151.05 22.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.674 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.406 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -148.83 151.22 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.991 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -99.44 127.96 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.431 ' N ' HG13 ' A' ' 92' ' ' VAL . 62.0 t -54.86 111.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.471 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -82.73 -56.74 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 109.923 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.526 ' CD1' ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -130.91 166.08 21.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.48 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.425 ' N ' HD11 ' A' ' 106' ' ' LEU . 10.4 tttt -111.74 117.93 34.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.702 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 23.2 m-85 -84.15 106.55 15.88 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -87.48 -178.94 6.26 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.466 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . . . -68.38 -45.35 72.99 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.363 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.86 -39.48 77.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.742 ' O ' HD22 ' A' ' 116' ' ' LEU . 54.2 mt-10 -71.15 -28.7 64.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.593 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.863 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.81 -47.46 8.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.637 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.85 -28.98 64.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 109.399 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -79.7 -22.86 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.253 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.863 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.74 -34.07 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.095 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -55.18 -33.22 62.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.27 -21.1 43.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.806 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.702 ' HE2' ' CD1' ' A' ' 108' ' ' TYR . 4.0 m-30 -66.57 -9.95 40.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.11 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.55 56.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.595 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 3.0 mm-40 -108.95 -52.74 2.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.055 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -93.06 130.65 35.4 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.825 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 178.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.346 2.031 . . . . 0.0 112.138 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -73.42 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -84.04 1.39 44.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.57 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.94 138.12 55.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.878 0.371 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.71 125.32 44.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.75 142.94 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.44 162.37 23.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.829 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.13 -170.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 m -61.55 -59.34 5.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.67 91.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.81 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.0 m -143.9 62.11 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.8 41.05 2.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.825 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -52.5 107.28 0.49 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.733 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.12 88.91 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.438 2.092 . . . . 0.0 112.239 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.13 -97.17 1.02 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.527 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 62.0 116.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -173.72 160.48 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -168.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -152.77 42.97 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.2 tt -56.56 -38.99 59.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.257 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -86.01 145.94 26.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.916 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -65.56 130.81 44.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.11 38.29 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.32 106.04 6.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -125.15 79.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.43 162.81 36.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.368 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -168.67 133.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -76.66 -42.31 42.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -79.48 179.07 7.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.8 134.47 47.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -81.77 149.77 28.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.9 mt 63.56 81.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -110.63 56.1 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -108.19 68.35 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.147 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.84 0.352 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.12 179.07 6.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 125.83 135.51 4.3 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.87 112.0 14.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -119.37 60.58 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 61.2 99.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -170.33 131.68 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -162.84 44.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 56.5 m170 60.64 83.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -115.04 -44.49 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -162.64 36.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -135.85 110.44 10.17 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.68 -11.36 31.86 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.437 2.092 . . . . 0.0 112.544 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 24.5 tpp . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.922 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.807 0.253 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -74.75 78.9 2.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -81.63 78.45 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mttp 64.12 -77.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.098 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.59 -120.52 15.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.46 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -109.93 65.92 0.62 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.5 92.91 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.519 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.1 -123.25 7.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.517 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.44 -68.54 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 111.002 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -57.86 89.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -156.42 138.83 14.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -131.98 91.08 2.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.5 89.67 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.88 -97.46 2.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.91 -78.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.762 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 57.5 -165.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 65.36 52.9 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.06 179.57 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.057 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.58 -168.44 1.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 p -138.58 137.83 37.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -170.96 48.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.82 31.86 18.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -104.08 73.26 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.878 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -129.04 81.44 2.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.45 ' CD1' ' HB2' ' A' ' 112' ' ' GLU . 13.0 tp -68.56 105.74 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 106' ' ' LEU . 17.8 t -97.78 139.35 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.204 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 78.6 m-85 -108.58 170.72 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.995 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -44.31 158.28 0.05 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.43 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.0 156.17 35.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.087 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.86 126.2 26.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.85 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.94 -15.35 62.02 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.604 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -111.21 152.61 26.91 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -122.89 150.6 42.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 4.4 p90 -84.79 157.86 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.295 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.82 174.0 12.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.335 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.423 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 tm0? -127.58 114.4 17.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.298 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.431 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 38.4 t -68.64 131.06 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.907 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 63' ' ' MET . 30.4 mt -116.04 -37.14 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.875 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -141.14 155.86 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 2.7 mtp -117.16 146.94 42.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.529 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -110.68 -46.13 3.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 110.802 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.7 -137.51 2.49 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.73 -26.8 9.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.666 0.269 . . . . 0.0 110.982 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 74' ' ' ILE . . . -103.57 3.72 46.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.075 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -155.28 156.37 35.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.905 0.353 . . . . 0.0 111.036 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' CD2' HG21 ' A' ' 84' ' ' ILE . 2.3 pp -148.08 167.19 25.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.505 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -112.9 121.25 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.161 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -135.85 164.91 26.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.213 0.53 . . . . 0.0 112.293 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.414 ' HB3' ' CD1' ' A' ' 52' ' ' ILE . 8.0 tpp -118.24 110.3 17.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.165 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -59.14 133.25 55.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.8 m-85 -48.04 -24.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.07 -11.31 60.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.367 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.24 42.21 2.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.729 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.11 133.01 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.313 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.86 112.5 25.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -145.54 164.81 30.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.003 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' CD1' HD13 ' A' ' 55' ' ' LEU . 2.9 mm? -98.35 108.9 21.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 37.4 m -89.92 118.8 29.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.922 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.43 132.67 36.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.67 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.432 ' CG2' ' HA2' ' A' ' 58' ' ' GLY . 10.8 tt -68.93 140.99 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -56.24 174.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.074 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.15 -49.82 2.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.229 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -33.52 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -71.18 -45.98 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.639 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.497 ' HA ' HG12 ' A' ' 82' ' ' VAL . 11.4 ptm180 -56.59 -25.7 53.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -28.41 64.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm -137.35 8.24 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.851 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -124.35 124.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.956 0.407 . . . . 0.0 111.487 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -110.79 110.41 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.405 HG21 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.32 147.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 111.416 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -117.51 157.76 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.04 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 46.1 m -76.06 -6.36 50.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.751 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -144.45 73.55 1.38 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.649 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.79 162.28 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 108' ' ' TYR . 33.5 mm -86.94 147.31 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.603 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.522 HD12 HG22 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -150.7 171.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.43 . . . . 0.0 111.438 179.703 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -130.12 122.92 29.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.9 178.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 104' ' ' VAL . 31.0 m -121.6 157.34 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.994 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.62 136.14 12.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.862 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.41 ' CD2' ' HB3' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -118.27 110.27 17.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.0 110.743 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.67 -68.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 111.108 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.2 -27.77 23.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.245 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -85.71 -0.24 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.65 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 65.8 30.27 10.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 5.6 m-20 77.88 162.55 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 85.56 -23.34 0.16 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.36 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -141.22 157.01 45.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.662 0.268 . . . . 0.0 110.449 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' A' ' 94' ' ' LEU . . . -148.54 174.28 12.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 0.0 111.141 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -128.64 124.22 35.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.589 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.46 ' N ' HG12 ' A' ' 92' ' ' VAL . 49.8 t -52.55 111.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.667 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -83.41 -37.44 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 109.819 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 90' ' ' ILE . 2.4 pp -152.48 164.08 38.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.419 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' CB ' ' CG2' ' A' ' 82' ' ' VAL . 4.8 tmtt? -109.32 118.21 36.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 111.911 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.66 ' CD1' ' HE2' ' A' ' 119' ' ' TYR . 22.4 m-85 -79.83 106.6 11.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 112' ' ' GLU . 9.8 m-20 -60.17 166.91 2.62 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 113' ' ' ALA . . . -78.0 -50.66 11.69 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.62 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.31 -42.91 99.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.45 ' HB2' ' CD1' ' A' ' 39' ' ' LEU . 0.6 OUTLIER -68.85 -26.6 65.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.01 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.621 ' HA ' ' CD2' ' A' ' 116' ' ' LEU . . . -45.68 -34.06 3.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.305 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -55.82 -39.56 71.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.421 0.629 . . . . 0.0 109.396 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.609 ' O ' ' N ' ' A' ' 118' ' ' ALA . 12.0 m -61.01 -20.85 62.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.089 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.685 ' HA ' ' CG ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -49.55 -34.89 18.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.38 -178.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.03 -34.96 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.39 42.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.78 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.685 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -66.82 -10.53 48.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 27.55 66.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 7.8 mm-40 -114.02 -51.87 2.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.685 0.279 . . . . 0.0 111.035 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -97.89 139.86 21.57 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.44 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 35.1 Cg_exo -59.21 179.41 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.415 2.077 . . . . 0.0 112.103 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -72.76 -27.74 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.44 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 9.2 p-80 -79.1 -18.83 52.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.379 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.57 135.86 39.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.827 0.346 . . . . 0.0 111.411 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.46 131.1 45.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 mt -102.38 158.72 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.271 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.47 171.45 7.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.94 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 59.74 45.8 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.975 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -81.35 165.7 21.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.68 139.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.7 m -67.54 156.61 36.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.04 88.19 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.32 -91.03 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.05 98.48 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.538 2.159 . . . . 0.0 112.346 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.51 -140.3 16.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.478 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.0 t0 60.1 71.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.83 32.33 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.28 67.14 4.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.41 175.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.6 tt -91.03 146.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.25 -179.66 4.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.04 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 59.17 177.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -142.03 -175.82 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.956 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.2 t0 62.61 48.31 4.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 tt -148.83 111.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.082 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.64 -130.56 1.4 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.448 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.02 137.67 53.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.832 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -177.22 -172.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.4 t0 65.01 122.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -123.63 161.66 24.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.46 88.17 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.82 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 16.8 tt -173.52 116.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.034 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t0 60.87 77.9 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -155.38 142.41 19.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.507 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.817 0.341 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.631 HD21 ' HE1' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -81.58 142.78 32.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.455 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' HB ' HD22 ' A' ' 106' ' ' LEU . 21.8 t -116.11 138.5 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.07 0.462 . . . . 0.0 111.626 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.607 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.8 m-85 -107.48 170.49 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.364 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 2.6 ttpt -52.86 145.39 12.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 0.0 110.738 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -111.73 156.58 21.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.4 130.1 45.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.92 -15.47 61.72 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.423 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' OE1' HD11 ' A' ' 91' ' ' LEU . 17.6 mt-30 -116.32 144.91 43.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.639 0.257 . . . . 0.0 110.326 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -118.1 155.3 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.468 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.3 p90 -84.45 157.71 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.88 173.25 13.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.193 0.521 . . . . 0.0 112.328 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.483 ' HG2' HD13 ' A' ' 89' ' ' ILE . 1.2 tm0? -129.27 130.77 46.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.915 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 43.9 t -82.08 139.92 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.084 0.469 . . . . 0.0 112.051 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.493 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.0 -39.74 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -141.65 157.81 44.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.463 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.561 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -111.53 142.62 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.813 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.929 HD21 ' HB2' ' A' ' 61' ' ' GLU . 3.3 mt -103.79 -155.83 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -44.55 -84.57 0.01 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.194 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -159.76 -43.81 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.42 -0.22 71.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.007 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.694 ' HG3' HD12 ' A' ' 55' ' ' LEU . 26.3 ptt180 -151.76 167.2 28.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.094 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.734 ' CD2' HG21 ' A' ' 84' ' ' ILE . 2.0 pp -147.66 154.54 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.04 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.929 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.5 tt0 -91.78 121.75 33.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.042 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -149.78 164.82 34.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.493 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -138.75 133.27 31.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.536 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.438 ' O ' ' HE3' ' A' ' 63' ' ' MET . 49.2 t -64.41 141.6 58.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.974 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.3 m-85 -48.66 -23.19 0.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.782 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -13.78 61.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.331 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.02 34.64 3.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.76 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 110.74 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 111.037 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 63' ' ' MET . 5.5 mmtm -85.69 118.34 25.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -145.12 156.61 43.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.003 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -91.99 105.77 17.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.493 ' SG ' HG11 ' A' ' 92' ' ' VAL . 12.1 m -85.41 118.77 25.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.732 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.45 141.25 36.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.697 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.883 HD12 ' CD1' ' A' ' 84' ' ' ILE . 2.1 tt -68.6 140.28 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 26.6 tpt180 -67.27 155.33 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.352 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.08 -61.53 2.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.269 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.42 -39.75 91.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.501 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -69.15 -17.88 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.987 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.499 ' HA ' HG12 ' A' ' 82' ' ' VAL . 1.2 ptt180 -48.67 -28.72 3.73 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.292 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -75.01 -29.38 60.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.344 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.67 44.6 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 82' ' ' VAL . 11.0 p -117.45 115.7 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 110.955 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -110.74 110.27 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.883 ' CD1' HD12 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -106.1 147.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.758 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.2 m-20 -137.57 165.51 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.904 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.7 m -80.28 -6.16 57.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.596 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.08 68.62 0.94 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.579 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -150.8 164.27 36.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.929 HG21 ' CD1' ' A' ' 116' ' ' LEU . 32.0 mm -87.63 144.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.229 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.3 mt -150.68 171.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 111.241 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.741 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -127.2 122.34 33.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.706 HG12 ' HA ' ' A' ' 104' ' ' VAL . 17.0 m -120.4 139.18 48.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.432 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.456 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -80.5 146.17 27.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.293 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 93' ' ' GLY . 1.4 mt -114.64 167.3 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' CB ' ' O ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER 82.03 -8.08 1.31 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.835 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -35.7 27.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.642 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -105.66 22.83 14.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.435 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 55.5 mm-40 68.92 30.53 4.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.766 0.317 . . . . 0.0 110.77 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 100' ' ' ASN . 1.3 t0 82.99 -175.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 99' ' ' ASP . 8.5 t-20 69.62 -60.93 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.777 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -98.77 155.73 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -145.84 131.08 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -88.99 123.93 33.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.276 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.706 ' HA ' HG12 ' A' ' 92' ' ' VAL . 80.6 t -52.09 112.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.653 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -78.84 -39.46 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 109.971 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.032 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -150.56 166.61 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.372 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.595 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -108.31 123.27 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 111.813 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.032 ' CE1' HD11 ' A' ' 106' ' ' LEU . 20.3 m-85 -87.45 106.73 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.56 166.69 6.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.58 -38.61 62.6 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.515 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.36 -40.14 95.44 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.703 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.3 mm-40 -62.25 -27.47 69.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.76 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.929 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.55 -36.61 2.14 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.846 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -63.82 -33.05 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -78.48 -22.8 46.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.902 177.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.929 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.75 -31.75 27.89 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.165 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -33.33 62.82 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.47 -22.05 41.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.748 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.653 ' CG ' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.2 -11.65 57.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.07 29.28 74.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.497 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.505 ' HB2' HD23 ' A' ' 122' ' ' LEU . 34.2 mt-10 -117.09 -52.42 2.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.206 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.522 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -102.89 141.4 22.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 -179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.667 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 71.4 Cg_endo -74.54 179.11 6.24 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.51 2.14 . . . . 0.0 112.206 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -71.03 -17.22 62.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.246 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 11.9 p-80 -97.72 -1.91 42.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.638 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.667 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -59.66 154.31 18.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 111.178 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -115.37 125.87 53.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.851 HD13 ' HB1' ' A' ' 113' ' ' ALA . 13.3 mt . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.011 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.799 0.333 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.709 HD11 ' CE1' ' A' ' 119' ' ' TYR . 21.6 tp -89.96 125.91 35.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.705 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.73 140.65 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.688 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.758 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -110.75 170.41 8.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.347 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -47.78 144.13 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.709 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -119.51 164.6 15.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.405 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -56.53 131.49 48.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.726 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.03 -15.41 61.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.379 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -124.95 148.34 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.714 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.2 tt0 -124.21 154.41 40.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.231 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.0 p90 -84.18 157.89 21.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.788 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.72 14.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.27 0.557 . . . . 0.0 112.5 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.579 ' OE1' HD13 ' A' ' 89' ' ' ILE . 33.4 tp60 -129.94 109.14 10.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.12 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.511 ' CG2' HD11 ' A' ' 90' ' ' ILE . 26.7 t -56.32 141.18 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -115.67 -43.04 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.833 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 160.59 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -108.83 131.87 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.454 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -93.45 -29.19 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.991 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.15 -175.37 32.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -73.33 95.28 2.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.01 -28.16 2.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.783 ' CD ' HD12 ' A' ' 55' ' ' LEU . 26.2 ptt180 -150.27 160.22 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.989 HD22 HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.66 154.77 41.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.905 ' HB2' HD21 ' A' ' 55' ' ' LEU . 17.1 tt0 -99.72 121.6 41.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.771 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.509 ' C ' HD11 ' A' ' 52' ' ' ILE . . . -130.11 157.41 42.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.084 0.469 . . . . 0.0 111.879 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.416 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -114.9 105.36 12.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.31 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.1 m -56.98 127.55 32.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.47 -25.45 1.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.672 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 -9.94 59.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.265 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.02 37.23 4.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 70' ' ' ARG . 21.2 t -127.01 118.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 111.342 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' CA ' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.41 118.01 25.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.622 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' HG3' HG12 ' A' ' 68' ' ' VAL . 7.4 mtm180 -145.09 161.99 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.247 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.866 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -102.34 117.75 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.795 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.6 ' SG ' HG11 ' A' ' 92' ' ' VAL . 9.3 m -99.71 119.44 38.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -77.05 149.22 35.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.573 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.494 HD12 ' CD1' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -68.83 129.51 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.767 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -53.08 159.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.316 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.03 -52.21 2.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -74.31 -33.94 63.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 110.399 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.613 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -74.71 -19.79 60.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.784 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.774 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -50.36 -27.26 5.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.04 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -60.31 -30.46 69.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -153.97 36.53 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 79' ' ' ARG . 7.7 p -105.08 111.0 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.083 0.468 . . . . 0.0 110.957 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -111.23 110.21 20.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.789 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.989 HD13 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.06 147.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.896 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -129.5 161.52 30.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 52' ' ' ILE . 88.2 m -80.0 -6.63 57.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.049 0.452 . . . . 0.0 111.73 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 p -144.61 71.74 1.32 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.7 159.55 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.141 0.496 . . . . 0.0 111.537 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.889 HG21 ' CD1' ' A' ' 116' ' ' LEU . 30.1 mm -86.88 147.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.2 mt -150.54 171.23 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.399 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.75 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -127.81 122.28 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.596 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 104' ' ' VAL . 33.2 m -121.73 153.69 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.443 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.77 140.51 15.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.37 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.714 HD11 ' HB2' ' A' ' 47' ' ' GLU . 4.0 mt -113.86 177.12 4.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 0.0 111.003 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.81 8.7 6.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.454 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -93.44 -38.84 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.845 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -105.63 22.86 14.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 69.1 30.54 4.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 11.1 t0 81.07 162.79 0.16 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 9.0 t-20 84.86 -18.69 0.38 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.448 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HE2' HD23 ' A' ' 71' ' ' LEU . 15.6 mmtp -142.0 151.43 42.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -139.67 -177.06 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.9 116.04 10.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.785 ' HA ' HG12 ' A' ' 92' ' ' VAL . 91.4 t -51.22 111.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.979 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -83.18 -50.37 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 0.0 109.813 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.053 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -136.19 168.95 18.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.653 ' N ' HD12 ' A' ' 106' ' ' LEU . 11.1 ttpt -111.37 121.74 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.053 ' CE1' HD11 ' A' ' 106' ' ' LEU . 21.6 m-85 -86.77 106.47 17.71 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.93 175.4 5.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -75.68 -41.79 52.9 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.768 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -61.5 -40.22 93.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.67 ' O ' HD23 ' A' ' 116' ' ' LEU . 18.4 mt-10 -67.12 -28.23 67.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.544 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.957 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.56 -47.83 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.876 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -56.52 -29.49 61.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.396 0.617 . . . . 0.0 109.503 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.695 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -75.89 -22.18 56.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.246 178.46 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.34 -35.68 28.89 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.287 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -54.55 -34.78 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.17 -20.46 44.78 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.932 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.758 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.8 m-30 -66.35 -5.49 10.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.781 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 24.9 57.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.582 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 57.0 mm-40 -114.11 -60.37 1.89 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.278 . . . . 0.0 111.318 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.76 139.16 24.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.083 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 24.2 Cg_exo -63.13 -178.99 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.531 2.154 . . . . 0.0 112.129 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.66 -26.86 62.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.064 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 15.6 p-80 -82.98 -9.67 59.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.503 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -55.96 135.25 52.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.333 . . . . 0.0 111.182 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -121.99 127.6 50.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.957 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.0 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.34 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.644 HD11 ' HE1' ' A' ' 119' ' ' TYR . 25.4 tp -77.17 117.27 18.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.462 ' CG1' HD22 ' A' ' 106' ' ' LEU . 21.4 t -105.34 139.15 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.609 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 81.0 m-85 -114.28 170.42 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.672 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HA ' HD22 ' A' ' 91' ' ' LEU . 5.9 ttpm? -47.09 152.64 0.53 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.14 159.52 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.933 0.397 . . . . 0.0 111.155 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.35 127.66 33.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.853 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.24 61.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.618 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.518 ' CB ' HD11 ' A' ' 91' ' ' LEU . 12.8 mt-30 -115.84 146.38 42.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.586 ' CB ' HD11 ' A' ' 94' ' ' LEU . 47.3 tp10 -120.6 156.05 32.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 111.405 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 65' ' ' PHE . 1.9 p90 -84.48 157.79 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.985 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.62 173.3 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 112.141 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 62.8 tp60 -128.68 109.59 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.678 ' CG2' HD11 ' A' ' 90' ' ' ILE . 2.7 t -54.25 135.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.975 0.417 . . . . 0.0 111.853 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.932 HD13 ' HB3' ' A' ' 63' ' ' MET . 1.0 OUTLIER -115.67 -44.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.842 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -141.51 162.25 35.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.693 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.3 ttt -116.22 143.14 45.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -111.24 -57.74 2.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.705 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 149.02 9.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.607 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.89 74.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.045 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.917 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 55.1 34.04 58.1 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.705 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.892 ' HB3' HD12 ' A' ' 55' ' ' LEU . 14.7 mmt180 -144.94 129.73 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.411 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.858 HD22 HG12 ' A' ' 84' ' ' ILE . 1.1 pp -147.03 138.92 24.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.692 ' HB2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -90.95 121.25 32.62 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . . . -122.37 164.62 17.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 112.026 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.932 ' HB3' HD13 ' A' ' 52' ' ' ILE . 4.9 tpt -130.6 95.29 3.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.27 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.3 130.66 43.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.301 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 8.5 m-85 -49.57 -24.59 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.765 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.31 -9.19 58.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.258 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.5 5.34 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.65 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.18 110.98 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.197 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.25 122.27 35.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -145.23 165.67 27.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.075 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.022 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -93.5 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.548 ' SG ' HG11 ' A' ' 92' ' ' VAL . 32.8 m -90.92 134.28 34.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.572 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.39 131.29 34.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.917 HG22 ' HA2' ' A' ' 58' ' ' GLY . 17.4 tt -68.52 140.77 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.941 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.434 ' CB ' ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -62.72 151.95 37.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.82 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.36 -43.0 26.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.667 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -76.03 -31.38 58.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 75' ' ' ARG . 3.1 mm? -75.73 -50.61 14.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.6 -25.33 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -51.36 -39.76 57.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.014 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -141.52 13.0 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.452 HG22 ' HD3' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -124.32 120.69 59.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.982 0.42 . . . . 0.0 111.092 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -110.96 115.04 28.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.655 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.858 HG12 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -64.06 131.83 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 110.597 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.565 ' O ' HG21 ' A' ' 51' ' ' VAL . 5.6 m-80 -98.18 156.46 16.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.172 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 86' ' ' THR . 77.0 m -76.28 -6.45 51.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.887 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.58 80.71 1.77 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.86 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 162.85 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.967 0.413 . . . . 0.0 111.302 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 116' ' ' LEU . 29.8 mm -86.84 146.78 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.328 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.801 HD13 HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.68 171.22 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.679 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.722 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.61 121.81 29.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.661 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.78 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.3 m -118.63 148.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.115 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.79 139.19 15.68 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.795 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -125.43 137.11 53.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.726 0.298 . . . . 0.0 110.623 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -177.23 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.109 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.71 -20.61 61.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.254 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -72.3 -10.58 59.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.309 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 9.2 mt-30 68.57 28.35 5.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.367 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 8.8 t0 79.17 -47.25 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.668 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -43.0 -30.3 0.41 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.33 164.09 29.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -146.77 -177.31 5.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -137.9 112.92 9.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.78 ' HA ' HG12 ' A' ' 92' ' ' VAL . 60.3 t -50.36 111.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.9 mm -87.9 -55.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.157 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.034 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -131.28 163.79 27.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.503 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.586 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -109.41 115.63 30.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.034 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.7 m-85 -79.02 106.29 10.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -69.52 175.72 3.92 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.625 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.72 -40.2 49.4 Favored 'General case' 0 C--O 1.229 0.023 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.796 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.43 -40.11 93.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.71 ' O ' HD23 ' A' ' 116' ' ' LEU . 17.4 mt-10 -66.94 -28.35 68.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.882 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.55 -46.31 7.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.871 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -30.26 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -77.91 -22.29 49.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.153 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.914 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.16 -32.65 23.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.147 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -54.93 -33.85 62.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -21.91 41.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.76 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.675 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -66.93 -13.16 61.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.75 28.23 69.67 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.635 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.531 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.4 mt-10 -113.2 -53.74 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 111.255 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.595 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -87.58 140.51 31.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.721 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 65.3 Cg_endo -73.66 179.41 5.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -28.05 66.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.987 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 47.0 p-80 -87.07 2.45 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.535 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.721 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -81.09 127.75 32.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.883 0.373 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.22 137.22 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.882 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.5 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.765 0.317 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.616 HD12 ' HG2' ' A' ' 112' ' ' GLU . 11.2 tp -119.54 116.19 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' O ' ' HE1' ' A' ' 108' ' ' TYR . 18.3 t -129.22 141.04 47.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.802 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.745 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 1.7 m-85 -108.24 170.3 8.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.117 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 159.66 25.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.719 0.295 . . . . 0.0 110.697 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.12 175.44 10.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.128 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -47.15 130.87 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.18 -15.33 62.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.435 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.549 ' HB3' HD11 ' A' ' 91' ' ' LEU . 5.8 mt-30 -136.67 146.61 46.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.316 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.72 158.72 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.51 157.98 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.212 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 173.88 12.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.205 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.445 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -129.78 110.99 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.303 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 41.7 t -62.66 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.008 0.432 . . . . 0.0 111.799 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 86' ' ' THR . 25.0 mt -116.11 -39.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.917 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 151.06 42.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.977 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.56 ' CE ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -110.73 125.85 53.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.912 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -89.14 -166.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.611 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.81 69.85 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.77 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 3.8 p-10 178.41 55.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 110.965 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.63 28.05 62.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.835 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.878 ' CD ' HD12 ' A' ' 55' ' ' LEU . 12.9 ptp180 -144.81 167.27 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.734 0.302 . . . . 0.0 110.912 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.97 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.22 146.48 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.108 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.912 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.2 tt0 -91.83 122.61 34.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.188 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -137.39 163.23 31.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.263 0.554 . . . . 0.0 112.315 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 8.2 tpp -123.35 110.81 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -60.32 134.26 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.9 m-85 -47.8 -26.3 1.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.804 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.39 -8.04 54.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.427 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.08 44.17 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 t -127.12 118.35 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 0.0 111.288 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 2.8 ttmt -87.61 114.89 24.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.75 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -144.07 163.53 33.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -105.42 108.27 19.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 4.4 m -84.19 119.14 24.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.303 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -76.6 155.7 33.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.34 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 1.069 HD11 HD11 ' A' ' 84' ' ' ILE . 5.3 mm -68.36 123.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.416 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.515 ' NH2' HD12 ' A' ' 105' ' ' ILE . 13.5 tpt180 -53.93 162.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.434 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.01 -53.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.272 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -35.15 76.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 3.2 mm? -78.64 -11.28 59.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.181 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -48.79 -33.88 11.25 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.847 0.356 . . . . 0.0 111.334 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -56.31 -23.25 35.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -162.27 40.9 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.252 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 82' ' ' VAL . 14.6 p -82.7 110.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 110.742 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -112.21 110.14 20.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.626 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.069 HD11 HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -112.3 145.53 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.255 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.481 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m120 -132.05 163.65 27.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 52' ' ' ILE . 39.4 m -76.47 -6.63 52.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 111.653 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 m -148.36 72.34 1.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.658 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 159.79 39.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.167 0.508 . . . . 0.0 111.364 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.878 HG21 ' CD1' ' A' ' 116' ' ' LEU . 39.9 mm -87.11 145.99 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.183 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.688 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.3 mt -150.93 171.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.119 0.485 . . . . 0.0 111.392 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.732 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.4 125.83 39.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.53 178.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.681 ' N ' HD12 ' A' ' 91' ' ' LEU . 15.9 m -122.23 155.61 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.27 126.27 8.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.706 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -109.89 126.74 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 110.76 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 -177.94 -72.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.056 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.94 -12.08 60.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.371 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 103' ' ' ASP . 39.5 m-85 -90.49 17.51 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.686 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 65.81 23.54 11.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.563 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 t0 73.42 -58.12 0.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.544 0.211 . . . . 0.0 111.556 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -41.73 -33.44 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.41 ' CB ' ' HB3' ' A' ' 97' ' ' TYR . 3.7 mptt -113.91 161.94 17.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -157.67 131.59 8.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 31.9 t70 -90.7 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.643 ' CA ' HG12 ' A' ' 92' ' ' VAL . 91.5 t -51.56 111.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.515 HD12 ' NH2' ' A' ' 75' ' ' ARG . 41.2 mm -77.53 -36.52 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.559 . . . . 0.0 109.86 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.084 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.3 pp -155.11 170.75 21.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.358 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.657 ' N ' HD12 ' A' ' 106' ' ' LEU . 15.1 pttm -112.12 126.17 54.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.084 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.1 m-85 -92.98 106.71 18.63 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.411 ' OD1' ' CG ' ' A' ' 112' ' ' GLU . 47.0 p30 -85.55 -174.35 5.13 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.654 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.71 -41.31 60.42 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.199 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.27 -40.67 91.19 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.718 ' O ' HD23 ' A' ' 116' ' ' LEU . 18.0 mt-10 -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.305 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 1.087 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.51 -48.31 7.37 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.021 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -57.23 -28.85 63.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.413 0.625 . . . . 0.0 109.498 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -80.19 -22.96 41.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.296 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.906 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.34 -34.74 24.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.09 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -54.86 -33.95 62.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -20.05 45.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.142 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.745 ' CD1' ' CD1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.08 -6.8 14.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.759 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.33 66.68 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.377 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 55.3 mm-40 -119.95 -60.02 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.419 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.748 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -90.9 128.82 46.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 38.4 Cg_exo -59.8 -179.19 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.384 2.056 . . . . 0.0 111.914 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.72 -21.92 63.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.48 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.5 p-80 -88.08 -0.94 57.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.614 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.17 158.33 11.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -117.4 147.57 42.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.087 HD12 ' HB1' ' A' ' 113' ' ' ALA . 42.7 mm . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.856 0.36 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.699 HD12 ' HG2' ' A' ' 112' ' ' GLU . 20.3 tp -72.99 101.57 3.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.499 ' CG1' HD22 ' A' ' 106' ' ' LEU . 14.4 t -91.38 139.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 111.377 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.2 m-85 -110.88 170.44 8.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.881 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.5 ttpp -52.98 152.5 3.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' ' NE2' ' A' ' 46' ' ' GLN . 34.4 mt-10 -123.8 157.61 33.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.44 . . . . 0.0 111.45 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.95 132.47 49.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.93 -15.55 60.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.514 ' CB ' HD11 ' A' ' 91' ' ' LEU . 6.4 mt-30 -116.8 151.46 36.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.704 0.288 . . . . 0.0 110.521 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.773 ' HB3' HD11 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -124.42 149.45 46.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.18 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 3.2 p90 -84.21 157.58 21.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.703 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.82 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.287 0.565 . . . . 0.0 112.502 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.419 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 34.1 tp60 -130.31 119.79 23.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.808 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 85' ' ' ASN . 10.7 t -70.24 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -115.7 -43.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.867 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 162.04 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.755 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.35 143.64 34.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.652 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 71' ' ' LEU . 6.2 mt -108.09 -30.4 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.34 -166.25 31.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.38 99.18 8.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 136.67 -24.84 3.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.616 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.74 ' HG3' HD12 ' A' ' 55' ' ' LEU . 8.7 ptp180 -152.88 159.78 43.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.643 HD22 HG21 ' A' ' 84' ' ' ILE . 1.1 pp -147.41 158.25 43.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.636 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -91.94 121.56 33.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.535 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.29 165.93 24.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.274 0.559 . . . . 0.0 112.276 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.876 ' HB2' HD11 ' A' ' 52' ' ' ILE . 2.1 tpp -134.84 111.97 10.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.186 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.08 132.91 55.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.21 -26.3 1.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.876 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -74.47 -14.22 60.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.402 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.97 42.9 1.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.39 112.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.187 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 23.5 tttt -84.27 112.76 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.624 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 101' ' ' LYS . 11.4 ptp180 -145.28 161.72 38.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -102.57 108.32 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.486 ' HB3' HG11 ' A' ' 92' ' ' VAL . 9.7 m -83.74 118.38 23.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.629 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 3.7 m-70 -79.52 131.89 36.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.768 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 82' ' ' VAL . 1.4 tt -68.5 137.12 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 171.59 -161.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.315 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.54 171.45 47.12 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.232 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.85 -25.74 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.646 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.659 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -75.62 -19.82 58.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.127 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -28.22 2.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 111.231 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -26.41 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -169.18 46.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.822 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 74' ' ' ILE . 14.9 p -87.23 126.64 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -106.92 110.22 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.643 HG21 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -94.72 147.31 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.571 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.441 ' O ' HG21 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -128.2 153.54 46.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.43 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 91.7 m -80.28 -7.01 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.715 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.7 m -142.98 53.49 1.37 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.526 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.2 167.02 23.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.488 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.893 HG21 ' CD1' ' A' ' 116' ' ' LEU . 27.9 mm -90.67 146.02 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.233 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -150.12 171.2 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.095 0.474 . . . . 0.0 111.237 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.729 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -130.18 122.43 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.866 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.739 HG12 ' HA ' ' A' ' 104' ' ' VAL . 27.0 m -117.51 147.85 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.88 132.05 11.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.784 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -118.92 107.9 14.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -162.6 -79.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.939 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.6 -15.99 63.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.115 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.476 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 4.7 m-85 -72.22 -8.37 54.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.648 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 68.16 29.41 6.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.263 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 72.24 -174.42 0.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.69 -61.59 0.5 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.82 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -111.98 171.09 7.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -156.85 170.91 21.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.872 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -119.73 124.98 47.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.739 ' HA ' HG12 ' A' ' 92' ' ' VAL . 86.9 t -53.08 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.03 -54.99 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.046 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -133.19 166.62 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.414 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.596 ' N ' HD12 ' A' ' 106' ' ' LEU . 14.7 pttm -110.56 118.62 36.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.072 0.463 . . . . 0.0 112.185 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.046 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.0 m-85 -82.82 106.54 14.74 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.63 176.69 7.41 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.07 -44.41 60.6 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.105 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.25 -39.98 88.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.699 ' HG2' HD12 ' A' ' 39' ' ' LEU . 8.5 mt-10 -69.16 -29.31 67.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.586 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 1.101 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.96 -48.33 8.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.902 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 109.599 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.626 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -75.13 -22.07 58.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.147 178.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.893 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.24 -34.03 21.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 121.124 -0.231 . . . . 0.0 111.118 -179.267 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -34.63 63.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.44 42.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.612 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.68 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.2 m-30 -66.55 -11.98 55.5 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.13 29.21 67.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.521 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 25.3 mm-40 -115.69 -50.24 2.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.738 0.304 . . . . 0.0 111.243 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.602 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -94.92 140.65 22.57 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.09 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.465 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 24.4 Cg_exo -63.09 -178.86 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.477 2.118 . . . . 0.0 112.05 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.26 -28.03 63.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.002 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 13.7 p-80 -78.92 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.24 130.89 36.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 111.272 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.63 148.55 33.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.101 HD12 ' HB1' ' A' ' 113' ' ' ALA . 26.7 mm . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.816 0.341 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.591 HD21 ' CB ' ' A' ' 115' ' ' SER . 14.2 tp -84.32 113.5 21.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.549 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.01 140.9 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.745 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.7 m-85 -107.75 169.84 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.089 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 137.83 58.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.506 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' NE2' ' A' ' 46' ' ' GLN . 11.8 pt-20 -112.87 175.27 5.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.063 0.458 . . . . 0.0 111.478 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -50.71 133.92 25.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.129 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.27 -15.36 60.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.463 ' NE2' ' HG3' ' A' ' 43' ' ' GLU . 2.3 mt-30 -130.94 148.31 52.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 110.573 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.554 ' H ' HD21 ' A' ' 94' ' ' LEU . 2.2 tt0 -130.22 159.89 35.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.086 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.31 158.16 21.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.007 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.99 173.56 14.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.246 0.546 . . . . 0.0 112.189 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -129.71 129.73 44.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.029 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 60' ' ' LEU . 47.4 t -81.82 140.77 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 0.0 112.019 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.467 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -116.42 -41.45 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.1 160.39 40.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.698 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.622 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -117.04 146.67 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -110.21 -29.79 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.913 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.94 176.77 18.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.62 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.08 107.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.821 0.344 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 132.61 -33.9 2.57 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.527 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.7 ' HD2' HD12 ' A' ' 55' ' ' LEU . 18.4 ptt180 -153.31 159.52 42.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.995 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.685 ' CD2' HG21 ' A' ' 84' ' ' ILE . 1.6 pp -147.59 155.81 42.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.048 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.866 ' HB2' HD21 ' A' ' 55' ' ' LEU . 15.6 tt0 -92.1 121.71 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.081 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.21 165.6 32.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.53 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.467 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.47 134.6 39.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.324 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.8 m -63.92 142.6 58.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.608 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 1.6 m-85 -51.17 -23.98 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.346 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.13 -11.1 60.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.35 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.98 41.13 2.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.783 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.615 HG11 HH21 ' A' ' 70' ' ' ARG . 21.2 t -127.02 110.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.007 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -82.2 116.41 21.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.051 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.615 HH21 HG11 ' A' ' 68' ' ' VAL . 8.9 ptp180 -145.05 155.77 43.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.73 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -89.68 106.93 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.579 ' HB3' HG11 ' A' ' 92' ' ' VAL . 13.6 m -84.27 118.66 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.676 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -81.92 137.9 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 82' ' ' VAL . 5.1 tt -68.68 140.13 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.782 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.31 143.45 44.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.25 38.87 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -62.88 -32.69 73.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HB ' ' A' ' 82' ' ' VAL . 1.1 mm? -82.91 -29.4 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.636 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.631 ' HA ' HG12 ' A' ' 82' ' ' VAL . 3.0 mtp180 -49.25 -27.74 4.03 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.267 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -64.32 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.0 45.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 74' ' ' ILE . 9.3 p -121.33 120.99 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.974 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 110.19 20.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.685 HG21 ' CD2' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -89.69 147.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.463 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -123.12 159.28 28.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.247 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 86' ' ' THR . 63.3 m -80.32 -5.91 57.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.442 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 70.05 0.95 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.636 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.14 165.73 35.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.224 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.894 HG21 ' CD1' ' A' ' 116' ' ' LEU . 45.9 mm -87.22 143.97 10.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.236 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.64 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.3 mt -150.35 171.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.046 0.45 . . . . 0.0 111.213 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.731 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -126.54 122.26 34.62 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.587 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.642 HG12 ' CA ' ' A' ' 104' ' ' VAL . 12.8 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.049 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.45 120.21 6.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.671 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.86 117.28 33.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.896 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -73.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.29 -25.97 62.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.424 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -91.62 14.25 15.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.547 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 20.2 mt-30 65.79 24.57 11.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.32 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 5.5 m-20 81.6 -45.65 0.2 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -42.29 -38.3 1.77 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.553 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.56 165.25 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.365 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -158.91 132.05 7.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.18 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -88.96 128.02 35.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.642 ' CA ' HG12 ' A' ' 92' ' ' VAL . 94.1 t -53.24 111.85 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.849 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.1 mm -78.21 -45.65 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -144.29 169.93 16.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.401 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.662 ' N ' HD12 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -111.79 123.77 50.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.063 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.6 m-85 -88.5 106.41 18.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -75.4 179.86 4.96 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.644 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.0 -42.21 39.6 Favored 'General case' 0 C--O 1.228 -0.068 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.431 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -61.15 -40.03 92.32 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.684 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.5 mt-10 -67.54 -27.85 67.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.461 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.4 -49.31 7.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.032 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -56.3 -27.4 55.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 109.577 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.09 -22.7 41.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.136 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.894 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.46 -34.36 24.54 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.028 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -55.0 -34.12 63.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.11 -20.59 44.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.849 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.56 -5.98 13.39 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.802 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.41 26.29 61.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.448 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 56.2 mm-40 -115.91 -60.76 1.83 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.87 124.89 59.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.539 ' HB2' ' CD2' ' A' ' 125' ' ' HIS . 40.6 Cg_exo -56.88 179.75 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.431 2.088 . . . . 0.0 112.257 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -25.06 65.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.095 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.539 ' CD2' ' HB2' ' A' ' 123' ' ' PRO . 32.6 p80 -85.89 -17.13 36.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.39 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -52.86 139.4 27.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.808 0.337 . . . . 0.0 111.24 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -117.76 137.89 52.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 113' ' ' ALA . 4.4 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.8 0.333 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.561 HD11 ' HE1' ' A' ' 119' ' ' TYR . 24.8 tp -86.81 128.63 35.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.793 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 t -127.31 140.68 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.832 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.749 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -112.72 170.39 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.346 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -52.68 149.58 5.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.729 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.82 164.61 27.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 111.5 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.89 132.99 37.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.76 -15.34 60.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.469 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.527 ' HB3' HD11 ' A' ' 91' ' ' LEU . 17.0 mt-30 -134.73 137.21 43.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.858 ' HB2' HD11 ' A' ' 94' ' ' LEU . 3.7 tt0 -117.23 155.22 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 111.276 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 5.3 p90 -84.02 157.65 21.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.622 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.76 173.89 12.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.593 . . . . 0.0 112.521 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.528 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -131.01 117.13 18.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.037 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 60' ' ' LEU . 41.5 t -67.46 138.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 112.065 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.09 -41.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.556 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 161.33 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.745 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.573 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -116.4 144.2 44.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.722 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.805 HD11 HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -105.54 -27.98 11.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.026 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.04 59.14 10.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -177.61 63.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.1 20.73 50.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.637 ' HB2' HD12 ' A' ' 55' ' ' LEU . 1.3 mtm105 -152.36 163.53 39.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.851 HD22 HG21 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -147.85 145.23 28.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.609 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.746 ' HB2' HD21 ' A' ' 55' ' ' LEU . 6.7 tt0 -91.09 120.77 32.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.44 165.62 32.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 111.665 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 9.8 ptp -138.98 128.0 23.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.59 146.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.286 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.462 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.9 m-85 -50.33 -20.68 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.811 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 68' ' ' VAL . 29.1 p30 -73.62 -8.18 54.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.61 0.243 . . . . 0.0 111.324 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 41.03 4.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 63' ' ' MET . 20.1 t -127.15 110.27 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.659 0.266 . . . . 0.0 111.1 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -83.59 120.14 25.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 165.7 27.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.303 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.805 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -95.68 105.69 17.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.682 ' HB3' HG11 ' A' ' 92' ' ' VAL . 11.8 m -89.14 118.47 28.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -76.6 139.15 40.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.699 HD11 HG13 ' A' ' 82' ' ' VAL . 5.6 tt -68.52 138.49 22.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.86 151.92 24.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.073 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.66 -39.28 18.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.46 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -78.52 -30.75 47.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.516 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.3 mm? -77.86 -29.56 50.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.498 ' HA ' HG12 ' A' ' 82' ' ' VAL . 21.4 ptt180 -48.97 -26.9 2.77 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.34 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -38.91 74.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.313 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 48.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.363 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.699 HG13 HD11 ' A' ' 74' ' ' ILE . 8.5 p -124.18 119.74 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -110.75 109.96 20.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.991 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.851 HG21 HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -80.95 139.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.2 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 14.6 m-80 -110.57 160.51 16.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 0.0 111.529 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.433 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 66.1 m -80.3 -6.2 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.525 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -147.79 70.33 1.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 85' ' ' ASN . 0.5 OUTLIER -154.19 164.63 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.223 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.862 HG21 ' CD1' ' A' ' 116' ' ' LEU . 46.7 mm -89.4 144.39 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.341 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.676 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.22 171.13 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.047 0.451 . . . . 0.0 111.101 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 92' ' ' VAL . 0.2 OUTLIER -126.94 125.75 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.638 178.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.4 m -125.62 156.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.259 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.25 127.88 9.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.54 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -105.24 177.45 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.76 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.27 -51.12 0.43 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.522 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -41.07 12.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 111.452 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.53 23.08 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 69.17 30.24 4.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.801 0.334 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.6 175.94 0.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.618 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.34 -57.19 0.56 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.063 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.83 149.24 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.467 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -139.24 -179.37 5.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.962 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.79 121.37 19.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.764 ' HA ' HG12 ' A' ' 92' ' ' VAL . 85.5 t -51.07 111.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.683 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.27 -37.44 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 0.0 109.768 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.057 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -150.93 168.54 24.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.36 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.65 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -112.32 121.2 44.22 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.057 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.3 m-85 -86.34 106.29 17.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.42 176.6 5.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.9 -39.75 49.78 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.967 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -40.95 98.52 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.652 ' O ' HD23 ' A' ' 116' ' ' LEU . 10.4 mt-10 -66.27 -27.78 68.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.417 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.819 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.38 -48.26 6.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.055 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -27.66 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.425 0.631 . . . . 0.0 109.492 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.63 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -79.17 -22.71 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.202 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.862 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.37 -35.28 27.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.221 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -34.42 62.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.23 -20.3 44.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.013 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.749 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.51 -4.36 8.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.808 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 24.77 58.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.597 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 42.3 mm-40 -115.35 -60.93 1.82 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.808 0.337 . . . . 0.0 111.266 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.32 126.36 46.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 36.7 Cg_exo -57.41 179.82 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.417 2.078 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.39 -23.36 64.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.449 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 37.2 p-80 -90.67 2.48 55.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.582 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.24 147.71 50.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -115.61 136.68 52.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.048 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.797 HD13 ' HB1' ' A' ' 113' ' ' ALA . 7.3 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.836 0.35 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.793 HD11 ' HE1' ' A' ' 119' ' ' TYR . 39.4 tp -96.48 125.38 40.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.558 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.57 140.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.944 0.402 . . . . 0.0 111.897 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.77 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.3 m-30 -112.34 170.44 8.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.466 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.42 150.74 4.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -127.76 165.12 20.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.701 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.35 133.05 49.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.97 -15.5 60.72 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.447 ' CB ' HD11 ' A' ' 91' ' ' LEU . 14.3 mt-30 -126.43 140.04 52.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.9 150.32 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.147 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 6.4 p90 -84.35 156.32 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.887 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.76 173.26 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.19 0.519 . . . . 0.0 112.219 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.735 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -119.08 153.9 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.362 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 90' ' ' ILE . 12.9 t -97.29 141.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.022 0.439 . . . . 0.0 112.142 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.794 ' O ' HG23 ' A' ' 86' ' ' THR . 0.7 OUTLIER -114.13 -52.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.44 162.22 36.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.588 ' HE3' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -114.66 126.48 54.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.124 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -96.59 -29.78 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.63 178.18 21.8 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -56.39 112.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.77 0.319 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.838 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 101.5 -13.68 58.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.727 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.755 ' HB3' HD12 ' A' ' 55' ' ' LEU . 9.0 mmt180 -138.78 121.88 16.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.242 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.729 HD22 HD13 ' A' ' 84' ' ' ILE . 1.3 pp -142.36 142.23 32.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.539 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.583 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.0 tt0 -90.7 121.67 32.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -127.2 162.12 26.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -123.08 101.62 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.216 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.17 133.32 49.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.402 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -49.34 -25.94 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.523 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -13.7 60.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.177 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.39 36.02 3.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.49 122.66 59.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 111.453 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 63' ' ' MET . 11.6 ptmt -95.12 121.72 37.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.603 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -144.12 165.59 27.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.17 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.124 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -94.02 105.68 17.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.437 ' SG ' HG11 ' A' ' 92' ' ' VAL . 29.8 m -88.82 125.05 34.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -83.27 142.02 31.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.619 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.838 HG22 ' HA2' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -68.79 138.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.94 155.23 20.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 0.0 111.001 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.17 -46.08 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.548 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -76.71 -42.22 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 0.0 110.783 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.658 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -67.03 -19.72 65.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.678 ' HA ' HG12 ' A' ' 82' ' ' VAL . 1.4 ptm180 -50.64 -28.11 8.22 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.827 0.346 . . . . 0.0 111.322 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -64.86 -29.54 70.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.618 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.99 40.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 79' ' ' ARG . 7.6 p -120.87 110.88 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 110.983 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 32.2 m0 -111.39 110.36 20.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.157 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.729 HD13 HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -86.45 145.47 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.454 ' O ' HG11 ' A' ' 51' ' ' VAL . 52.4 m-20 -132.11 164.93 25.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 52' ' ' ILE . 93.8 m -78.08 -6.5 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.761 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.4 73.99 1.45 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -165.34 161.24 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.261 0.553 . . . . 0.0 111.481 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.85 HG21 ' CD1' ' A' ' 116' ' ' LEU . 32.8 mm -92.28 149.12 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.011 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.728 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.19 173.56 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.638 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -130.11 126.88 38.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.566 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.688 ' N ' HD12 ' A' ' 91' ' ' LEU . 21.0 m -121.73 156.51 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.391 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.561 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -99.44 149.79 19.02 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.648 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.568 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -125.46 135.66 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.705 0.288 . . . . 0.0 110.799 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 -177.57 -76.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.188 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.9 -18.09 38.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.407 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 101' ' ' LYS . 42.9 m-85 -72.38 -9.26 58.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.551 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 72.16 29.39 2.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.746 0.307 . . . . 0.0 111.304 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.1 -55.75 0.64 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.42 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -42.03 -31.95 0.4 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 97' ' ' TYR . 24.5 mttt -128.22 164.45 22.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.673 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -151.41 177.28 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.19 116.95 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.658 ' CA ' HG12 ' A' ' 92' ' ' VAL . 80.5 t -49.93 111.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.972 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mm -82.26 -45.56 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.191 0.52 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.007 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.6 pp -142.41 161.15 38.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.779 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.614 ' HB3' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -104.53 118.1 35.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.999 0.428 . . . . 0.0 111.792 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.007 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.0 m-85 -81.11 106.47 13.13 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 167.15 4.78 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.73 -39.52 51.56 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.422 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.57 -40.06 95.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.639 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.4 mm-40 -68.09 -26.52 65.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.275 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 1.038 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -42.75 -48.98 5.72 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.835 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -29.76 63.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.399 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.613 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -73.39 -22.03 60.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.013 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.85 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -48.95 -35.52 15.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.236 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -54.53 -35.06 62.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.14 -20.31 45.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.927 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.793 ' HE1' HD11 ' A' ' 39' ' ' LEU . 3.6 m-30 -65.98 -7.69 18.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.559 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.49 27.31 67.72 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.511 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.46 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 50.4 mm-40 -118.49 -59.79 1.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.321 . . . . 0.0 111.289 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.0 142.17 24.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.061 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 31.5 Cg_exo -61.06 -179.75 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.583 2.189 . . . . 0.0 112.146 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.94 -25.88 59.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.993 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -82.56 1.46 37.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.534 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.41 138.35 55.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.375 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 148.2 32.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.038 HD12 ' HB1' ' A' ' 113' ' ' ALA . 21.7 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.431 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.564 HD12 ' CD ' ' A' ' 112' ' ' GLU . 33.4 tp -118.52 119.82 35.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.79 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 106' ' ' LEU . 14.9 t -104.52 139.47 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.046 0.451 . . . . 0.0 111.369 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 74.7 m-85 -114.09 170.4 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.862 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HA ' HD22 ' A' ' 91' ' ' LEU . 10.3 ttpt -48.6 153.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.941 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -116.09 162.05 17.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.19 125.97 25.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.83 -15.28 63.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.662 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.558 ' OE1' HD11 ' A' ' 91' ' ' LEU . 23.2 mt-30 -113.74 148.08 37.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.636 0.255 . . . . 0.0 110.567 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.833 ' HB2' HD11 ' A' ' 94' ' ' LEU . 32.2 tt0 -121.1 156.72 31.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.219 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 3.8 p90 -84.25 157.58 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.94 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.27 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.491 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -126.52 138.84 53.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.746 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 85' ' ' ASN . 15.2 t -88.92 144.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.905 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -116.38 -46.12 4.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.84 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.3 162.18 37.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.874 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.408 ' HE3' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -112.93 136.26 52.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.848 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -99.53 -32.4 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.91 169.84 17.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.526 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.83 101.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 110.986 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 139.83 -32.69 2.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.354 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.753 ' HD2' HD12 ' A' ' 55' ' ' LEU . 16.3 ptt-85 -151.35 159.61 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.874 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.88 HD22 HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.65 152.55 38.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.848 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.4 tt0 -91.66 121.66 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -136.43 165.8 24.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 112.181 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.905 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -127.18 113.07 15.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.8 m -59.01 133.86 56.47 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.444 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 1.3 m-85 -48.83 -25.36 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -9.82 58.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.76 42.96 2.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.684 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.405 HG11 ' NE ' ' A' ' 70' ' ' ARG . 15.4 t -127.41 125.61 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.339 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HB2' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.7 115.46 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.567 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' NE ' HG11 ' A' ' 68' ' ' VAL . 62.2 mtt180 -145.27 165.06 29.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.415 . . . . 0.0 111.276 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.718 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -106.36 108.41 19.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.472 ' HB3' HG11 ' A' ' 92' ' ' VAL . 16.4 m -84.16 118.85 24.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -81.46 143.18 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.787 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.491 HG22 ' HA2' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -71.93 129.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.835 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 14.2 tpt180 -69.45 143.84 53.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.733 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 79' ' ' ARG . . . -70.01 -57.34 7.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.362 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -52.71 -30.66 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.555 HD12 ' HB ' ' A' ' 82' ' ' VAL . 1.1 mm? -86.69 -28.37 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.834 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.659 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -49.34 -27.36 3.88 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.317 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.29 -33.34 67.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.3 45.17 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 79' ' ' ARG . 11.6 p -115.91 116.25 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 111.071 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.408 ' CH2' ' HE2' ' A' ' 107' ' ' LYS . 44.1 p90 -110.5 110.18 20.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.88 HD13 HD22 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -83.26 147.11 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.457 ' O ' HG21 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -115.44 152.97 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 86' ' ' THR . 75.6 m -80.28 -6.35 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 111.886 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 p -148.38 55.07 1.02 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.705 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -140.2 169.09 18.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.174 0.511 . . . . 0.0 111.564 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.919 HG21 ' CD1' ' A' ' 116' ' ' LEU . 45.3 mm -89.24 144.81 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.024 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.2 mt -150.57 171.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.046 0.451 . . . . 0.0 111.228 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.73 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -126.01 121.97 34.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.706 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.721 HG12 ' CA ' ' A' ' 104' ' ' VAL . 30.4 m -122.48 155.3 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.156 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 105' ' ' ILE . . . -93.13 140.63 15.16 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.574 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -121.67 105.52 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 110.834 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.46 -63.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.189 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.14 -28.17 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -89.32 1.91 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.768 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 65.71 30.02 10.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 7.0 t0 78.04 162.05 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.963 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 84.53 -19.8 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.411 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.47 150.96 38.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -137.96 173.18 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 111.256 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.849 ' O ' HD12 ' A' ' 105' ' ' ILE . 37.4 t70 -130.1 116.61 18.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.721 ' CA ' HG12 ' A' ' 92' ' ' VAL . 70.4 t -52.4 111.54 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 103' ' ' ASP . 2.4 mp -81.81 -39.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.053 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -147.1 168.45 21.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.795 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 106' ' ' LEU . 4.5 pttp -111.94 119.9 40.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.053 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.0 m-85 -84.23 106.9 16.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.19 173.18 8.01 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.684 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.46 -51.19 18.03 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.313 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.37 -38.45 87.05 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.564 ' CD ' HD12 ' A' ' 39' ' ' LEU . 1.1 tp10 -66.63 -31.67 72.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.396 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.934 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -46.05 -43.25 14.34 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.821 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -48.93 -47.11 43.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.157 0.504 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -58.69 -20.82 51.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.629 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.919 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.66 -33.26 21.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.45 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -54.98 -34.34 63.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.38 -21.81 41.96 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.733 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.714 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.4 m-30 -67.01 -9.75 42.33 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.03 25.03 63.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.538 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 5.3 mm-40 -112.7 -47.41 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -108.75 150.07 40.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 70.8 Cg_endo -75.18 174.15 13.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.592 2.194 . . . . 0.0 112.242 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.48 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.4 p-80 -87.76 2.79 50.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.578 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -58.89 130.27 46.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.162 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -82.5 131.35 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.934 HD12 ' HB1' ' A' ' 113' ' ' ALA . 38.0 mm . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.984 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.841 0.353 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.693 HD11 ' CE1' ' A' ' 119' ' ' TYR . 20.1 tp -71.04 134.59 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.46 140.08 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.884 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 11.8 m-30 -113.7 170.94 7.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.42 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -42.01 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.78 168.12 13.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.169 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -67.72 123.59 20.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.35 62.95 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.531 ' CB ' HD11 ' A' ' 91' ' ' LEU . 12.9 mt-30 -115.66 145.3 42.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.395 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.735 ' HB2' HD11 ' A' ' 94' ' ' LEU . 15.4 tt0 -120.26 152.06 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 111.531 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.6 p90 -84.71 158.17 20.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.872 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.37 173.4 14.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 112.376 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.43 ' HG2' HD13 ' A' ' 89' ' ' ILE . 4.5 tm0? -128.61 115.11 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.161 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 14.8 t -65.9 139.99 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 112.077 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.918 HD11 ' HB3' ' A' ' 63' ' ' MET . 7.0 mm -116.01 -42.77 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.011 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -140.7 158.57 43.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.875 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.567 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.6 tpt -111.74 132.1 54.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.95 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -109.17 -163.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.485 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.75 156.71 4.54 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.64 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -56.76 109.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 135.03 -19.77 3.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.5 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.655 ' HD2' HD12 ' A' ' 55' ' ' LEU . 22.1 ptt180 -146.92 163.57 35.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 111.053 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.792 HD22 ' CD1' ' A' ' 84' ' ' ILE . 0.5 OUTLIER -147.68 150.78 34.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.885 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.2 tt0 -91.89 121.58 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.02 165.64 24.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 0.0 112.342 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.918 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -123.53 107.37 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.938 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.1 m -57.91 130.89 48.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.04 -25.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.705 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -74.42 -13.35 60.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.257 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.27 40.72 2.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.542 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.99 120.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.307 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 0.4 OUTLIER -88.68 114.44 25.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -143.81 165.53 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.95 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -103.27 109.81 21.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.8 m -84.28 118.33 24.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 2.4 m-70 -80.62 130.43 35.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.669 HD12 HD11 ' A' ' 84' ' ' ILE . 2.0 tt -68.59 140.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.475 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER 166.32 -167.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.002 0.43 . . . . 0.0 111.446 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.67 174.66 36.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.04 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -52.41 -23.83 6.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.968 0.413 . . . . 0.0 110.701 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -78.83 -18.61 53.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.205 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -48.09 -28.67 3.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.502 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -58.34 -22.9 55.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.883 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.79 46.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.417 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.589 HG13 HD11 ' A' ' 74' ' ' ILE . 14.2 p -84.81 128.82 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.36 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -110.72 110.04 20.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.008 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.792 ' CD1' HD22 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -95.2 147.34 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.613 179.291 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m-20 -122.32 152.3 40.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.407 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 32.7 m -80.18 -6.81 58.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 0.0 111.769 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.2 p -143.95 56.53 1.33 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.595 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 85' ' ' ASN . 0.4 OUTLIER -146.93 164.77 31.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.281 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.901 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.1 mm -87.28 146.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.233 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.664 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.1 mt -150.15 170.99 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 111.184 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.675 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -129.18 121.84 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.753 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 104' ' ' VAL . 16.0 m -116.16 150.38 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.75 131.41 10.72 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.735 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -117.86 133.19 56.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.62 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -178.06 -75.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.28 -12.65 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.322 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 34.5 m-85 -83.11 2.93 32.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.678 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 65.81 25.64 11.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.658 0.266 . . . . 0.0 111.219 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.22 -54.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.758 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -39.7 -35.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 97' ' ' TYR . 8.3 mmmm -127.27 162.76 25.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.808 0.337 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -158.61 162.65 37.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -113.1 126.7 55.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.723 ' HA ' HG12 ' A' ' 92' ' ' VAL . 61.5 t -55.02 112.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.99 -58.95 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.106 0.479 . . . . 0.0 110.023 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.055 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.3 pp -127.71 160.11 32.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.376 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.571 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -107.04 117.47 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.055 ' CE1' HD11 ' A' ' 106' ' ' LEU . 25.0 m-85 -81.73 106.11 13.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -68.17 168.76 11.56 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -70.8 -40.77 72.33 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.477 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.26 -40.35 95.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.716 ' O ' HD23 ' A' ' 116' ' ' LEU . 26.3 mt-10 -66.79 -28.54 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.49 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.906 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.43 -48.97 7.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.78 -178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -56.11 -30.67 62.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -73.93 -22.12 59.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.901 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.32 -34.94 25.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.379 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -54.6 -34.76 62.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -20.9 42.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.97 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.0 m-30 -66.56 -6.18 14.17 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.829 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.52 64.59 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.593 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.595 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 48.0 mt-10 -113.87 -64.55 1.29 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.927 0.394 . . . . 0.0 111.234 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -92.49 149.94 39.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.999 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 58.2 Cg_endo -71.7 179.55 4.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.634 2.223 . . . . 0.0 112.432 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.23 -32.17 68.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -75.83 -19.22 59.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.332 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.459 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -53.65 121.91 8.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -108.18 132.21 53.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.001 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.906 HD13 ' HB1' ' A' ' 113' ' ' ALA . 2.7 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.129 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD11 ' HE1' ' A' ' 119' ' ' TYR . 14.6 tp -84.7 120.82 26.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 t -126.95 141.05 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.694 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 4.3 m-30 -109.19 170.45 8.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.612 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.1 ttpp -45.6 141.48 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.902 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -111.46 166.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 111.333 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -58.4 129.71 43.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.43 -15.37 60.24 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.589 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.487 ' CB ' HD11 ' A' ' 91' ' ' LEU . 8.4 mt-30 -118.45 154.62 32.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.624 0.25 . . . . 0.0 110.458 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -130.02 152.63 49.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 111.064 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 2.9 p90 -84.39 157.24 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.986 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.16 173.79 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.251 0.548 . . . . 0.0 112.112 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.519 ' OE1' HD13 ' A' ' 89' ' ' ILE . 38.2 tp60 -128.89 109.62 11.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.13 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.525 ' CG2' HD11 ' A' ' 90' ' ' ILE . 17.5 t -56.31 139.69 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 111.882 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 63' ' ' MET . 0.0 OUTLIER -116.42 -42.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.935 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.4 ttmm -147.71 157.58 43.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.319 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.647 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.1 ttt -108.2 143.35 37.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.789 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.863 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -111.89 -25.61 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.118 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.69 -174.63 29.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.61 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -75.37 102.87 5.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 135.28 -26.28 3.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.407 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.678 ' HD2' HD12 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -151.47 155.41 38.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.337 . . . . 0.0 110.927 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.74 150.91 35.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.863 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.4 tp10 -91.74 121.42 33.36 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.79 165.74 23.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.203 0.525 . . . . 0.0 112.145 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.535 ' HB2' HD13 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -127.16 107.07 9.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.419 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.5 133.25 55.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.063 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 3.5 m-85 -49.91 -25.22 3.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.724 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -8.46 56.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.235 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.92 43.1 3.4 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.451 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.03 113.94 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.3 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 24.8 tttt -84.22 113.51 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.751 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -145.15 165.5 28.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.2 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.854 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -100.34 108.56 20.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.979 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.721 ' HB3' HG11 ' A' ' 92' ' ' VAL . 34.0 m -84.31 118.4 24.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 20.3 m80 -82.56 134.5 35.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.628 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.626 HG22 ' HA2' ' A' ' 58' ' ' GLY . 10.0 tt -68.65 141.03 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.353 . . . . 0.0 111.01 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 2.3 mmt180 -63.95 155.59 30.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.18 -46.78 6.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.484 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -77.33 -40.53 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.6 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.727 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -64.02 -16.69 62.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.007 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.636 ' HA ' HG12 ' A' ' 82' ' ' VAL . 12.3 ptm180 -48.72 -26.13 2.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.684 0.278 . . . . 0.0 111.498 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -76.05 -35.03 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.554 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.35 34.93 3.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.652 0.263 . . . . 0.0 111.613 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.727 ' HB ' HD12 ' A' ' 78' ' ' LEU . 8.5 p -123.79 111.34 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.159 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.98 110.23 20.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.852 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.946 HG21 HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -91.95 147.16 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.415 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 13.3 m120 -139.88 157.86 45.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.636 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 52' ' ' ILE . 59.6 m -75.33 -6.45 49.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 111.772 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -143.31 76.12 1.51 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.796 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.46 161.16 16.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.847 HG21 ' CD1' ' A' ' 116' ' ' LEU . 51.3 mm -86.96 146.57 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.633 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.1 mt -150.49 171.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.362 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -130.27 122.43 28.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.866 178.544 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.791 HG12 ' HA ' ' A' ' 104' ' ' VAL . 34.9 m -119.57 146.97 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.529 ' O ' ' HB1' ' A' ' 102' ' ' ALA . . . -95.83 141.69 15.71 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.862 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 142.05 47.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.65 0.262 . . . . 0.0 110.575 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -149.11 -81.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.183 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.57 -12.16 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.328 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 101' ' ' LYS . 35.0 m-85 -71.9 -10.18 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.404 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 4.6 mt-30 65.85 25.4 11.24 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.205 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 2.8 t0 83.36 -21.88 0.26 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.36 -29.51 68.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 0.0 110.699 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.427 ' HB2' ' CG ' ' A' ' 97' ' ' TYR . 10.1 mtpt -144.27 164.85 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.688 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.542 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -163.3 171.66 15.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.106 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.34 125.65 50.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.791 ' HA ' HG12 ' A' ' 92' ' ' VAL . 99.3 t -49.96 111.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.47 -46.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.196 0.522 . . . . 0.0 109.737 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.062 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -142.06 166.93 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.31 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.601 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -110.44 120.56 42.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.114 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.062 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.7 m-85 -84.23 105.94 15.47 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -71.78 177.19 4.34 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.1 -40.03 47.38 Favored 'General case' 0 CA--C 1.524 -0.045 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.055 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -62.62 -40.99 98.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.701 ' O ' HD23 ' A' ' 116' ' ' LEU . 14.0 mt-10 -65.93 -27.93 68.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.345 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.26 -50.28 6.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.23 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -56.42 -26.8 54.66 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.246 -0.581 . . . . 0.0 109.714 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -80.17 -22.29 42.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.14 178.307 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.847 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -49.92 -33.98 19.06 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 121.22 -0.192 . . . . 0.0 111.002 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -54.75 -34.37 62.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.12 -20.39 45.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.059 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.6 m-30 -66.42 -4.37 8.07 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.927 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.55 21.08 53.8 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.735 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.473 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 58.5 mm-40 -111.45 -60.42 1.84 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.649 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.02 144.79 28.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.834 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 72.6 Cg_endo -76.08 179.8 5.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.631 2.221 . . . . 0.0 112.353 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.77 -29.31 67.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.442 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 25.6 p-80 -81.43 -0.49 41.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.473 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.484 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -66.28 145.15 56.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.836 0.35 . . . . 0.0 110.976 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -124.78 120.82 32.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.992 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.3 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.946 0.403 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.644 HD23 ' CZ ' ' A' ' 41' ' ' PHE . 16.0 tp -83.14 109.59 17.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.478 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' CG1' HD22 ' A' ' 106' ' ' LEU . 15.1 t -91.78 139.66 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.701 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.644 ' CZ ' HD23 ' A' ' 39' ' ' LEU . 79.6 m-85 -113.45 170.5 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.714 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.518 ' HA ' HD22 ' A' ' 91' ' ' LEU . 7.9 tttt -47.68 163.41 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -132.51 156.38 46.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 111.294 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -59.04 129.16 40.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.697 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.45 61.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.558 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.513 ' OE1' HD11 ' A' ' 91' ' ' LEU . 26.3 mt-30 -116.43 148.17 40.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.585 0.231 . . . . 0.0 110.439 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.09 152.56 38.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 111.613 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 11.9 p90 -84.5 157.71 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.899 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.3 173.28 15.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 112.42 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.404 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -126.5 125.5 42.17 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.082 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.689 HG13 HD13 ' A' ' 60' ' ' LEU . 12.2 t -79.32 138.3 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.942 HD11 ' HB2' ' A' ' 63' ' ' MET . 1.1 mt -116.1 -45.75 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.169 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -137.76 157.15 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.531 ' C ' HD23 ' A' ' 55' ' ' LEU . 7.8 ttm -111.41 143.53 42.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.852 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -106.49 -37.62 6.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.38 171.66 27.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -60.07 103.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 133.32 -22.57 3.95 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.616 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.728 ' CD ' HD12 ' A' ' 55' ' ' LEU . 13.3 ptp180 -154.5 157.76 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.689 HD13 HG13 ' A' ' 51' ' ' VAL . 2.8 pp -147.95 160.27 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.298 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.782 ' HB2' HD21 ' A' ' 55' ' ' LEU . 10.0 tp10 -102.18 121.47 42.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -135.98 166.18 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.352 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.942 ' HB2' HD11 ' A' ' 52' ' ' ILE . 4.3 tpp -126.89 111.61 14.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.056 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 46.6 t -58.67 134.76 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -25.28 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.581 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -74.31 -14.17 60.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.233 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.72 41.19 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.583 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.3 t -127.23 125.79 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.548 ' CA ' ' HE2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -99.99 115.25 29.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -144.19 160.8 40.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.81 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.852 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -96.32 105.68 17.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.801 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.52 ' HB3' HG11 ' A' ' 92' ' ' VAL . 14.2 m -85.16 118.75 24.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.673 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -81.39 127.77 33.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.656 HG22 ' HA2' ' A' ' 58' ' ' GLY . 6.0 tt -68.43 140.58 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.44 -165.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 0.0 111.514 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.23 169.91 46.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.179 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -48.58 -27.18 2.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.432 . . . . 0.0 110.763 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 1.0 OUTLIER -66.41 -32.86 74.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.483 ' HA ' HG12 ' A' ' 82' ' ' VAL . 23.3 ptt180 -48.83 -28.18 3.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.248 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.84 -26.53 58.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 46.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.251 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.529 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.3 p -124.34 123.07 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.705 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -111.21 109.97 20.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.538 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.881 HG22 HD13 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -65.06 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -102.06 151.48 22.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.462 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.471 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 86.2 m -80.25 -6.55 58.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.62 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.95 72.06 1.34 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.639 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -165.65 167.39 17.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.906 HG21 ' CD1' ' A' ' 116' ' ' LEU . 26.5 mm -86.9 146.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.192 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.881 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.3 171.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.383 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.681 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.57 122.31 28.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.785 178.678 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.9 m -117.83 146.68 21.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.155 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.97 140.08 14.91 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.911 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -123.51 132.6 53.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.648 0.261 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.55 -80.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.01 -15.95 63.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 103' ' ' ASP . 48.5 m-85 -72.44 -8.8 56.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.547 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 67.29 29.94 7.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.34 -175.94 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.57 -61.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.836 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.15 156.66 17.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.967 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.545 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -141.28 -177.71 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.829 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.473 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 10.5 t70 -133.96 120.31 20.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.888 ' HA ' HG12 ' A' ' 92' ' ' VAL . 59.8 t -52.87 112.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.845 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.75 -62.16 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.077 0.465 . . . . 0.0 110.057 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.5 pp -124.8 159.62 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.46 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -105.92 118.73 37.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.063 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.8 m-85 -82.24 106.28 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.09 173.39 5.58 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.643 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.48 -40.23 61.97 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.693 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.06 -40.48 95.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.716 ' O ' HD23 ' A' ' 116' ' ' LEU . 19.4 mt-10 -66.99 -28.37 68.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.505 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.987 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.63 -48.94 7.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.909 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -55.9 -30.26 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.386 0.612 . . . . 0.0 109.528 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 1.4 m -76.14 -22.46 55.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.173 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.906 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.22 -32.95 17.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.067 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.51 -34.3 61.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.74 42.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.778 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.675 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.2 m-30 -66.97 -11.64 57.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.86 23.27 65.39 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.633 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 50.8 mt-10 -109.54 -52.05 2.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.933 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.541 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.1 148.09 34.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.723 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 60.0 Cg_endo -72.52 178.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 0.0 112.339 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -30.8 69.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.401 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 56.7 p-80 -84.2 -3.49 58.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.405 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -58.35 147.64 30.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.887 0.375 . . . . 0.0 111.164 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -115.07 148.39 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.987 HD12 ' HB1' ' A' ' 113' ' ' ALA . 28.2 mm . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.011 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.85 0.357 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.693 HD11 ' HE1' ' A' ' 119' ' ' TYR . 30.1 tp -68.31 130.63 43.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.71 140.34 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.804 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.767 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.4 m-30 -112.51 170.95 7.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -45.24 148.61 0.6 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.952 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.75 162.43 20.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.39 . . . . 0.0 111.347 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -57.04 130.44 46.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.72 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.65 -15.36 61.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.369 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.419 ' CB ' ' HA2' ' A' ' 93' ' ' GLY . 2.0 mt-30 -123.62 144.49 49.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -118.85 153.64 34.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 111.383 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 10.1 p90 -84.22 157.71 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.698 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.31 173.52 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.362 0.601 . . . . 0.0 112.389 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.607 ' HG2' HD13 ' A' ' 89' ' ' ILE . 1.8 tm0? -128.19 120.83 28.05 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.189 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.61 HG22 ' CD1' ' A' ' 60' ' ' LEU . 29.6 t -70.8 134.91 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.985 0.421 . . . . 0.0 111.664 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.71 HD12 ' CB ' ' A' ' 63' ' ' MET . 0.5 OUTLIER -116.45 -38.58 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -140.68 159.82 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.626 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -115.74 143.07 45.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.926 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -111.66 -58.74 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.944 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.77 -168.1 16.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.647 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -83.72 0.89 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.517 0.199 . . . . 0.0 111.49 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -121.58 -8.39 7.62 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.883 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.681 ' CD ' HD12 ' A' ' 55' ' ' LEU . 22.8 ptt180 -153.36 160.17 42.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 110.779 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.892 HD22 HD13 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -147.94 149.77 32.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.894 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.2 tt0 -91.84 121.41 33.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.97 165.62 25.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 112.141 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.71 ' CB ' HD12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.1 111.84 15.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.169 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.48 135.96 57.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.3 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.0 m-85 -49.73 -25.39 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.34 -7.17 51.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.289 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.84 44.42 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.446 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.21 130.64 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 111.303 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.576 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 8.6 tttt -95.7 113.73 25.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.507 ' NH1' HD22 ' A' ' 94' ' ' LEU . 12.5 ptp180 -145.04 165.59 27.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.926 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -103.12 109.23 20.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.734 ' HB3' HG11 ' A' ' 92' ' ' VAL . 25.7 m -84.41 119.8 25.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.99 136.53 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.667 HD11 HG13 ' A' ' 82' ' ' VAL . 7.0 tt -68.73 140.73 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.928 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.437 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -73.75 145.11 45.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.108 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -48.26 34.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.311 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -29.13 70.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.363 . . . . 0.0 110.628 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.5 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.8 mm? -84.67 -29.14 25.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.805 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -48.97 -27.2 2.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -59.05 -42.16 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.266 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.83 46.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 111.434 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.667 HG13 HD11 ' A' ' 74' ' ' ILE . 9.8 p -123.95 117.9 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -110.93 110.06 20.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.066 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.892 HD13 HD22 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -83.1 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.251 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.452 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 t30 -108.33 159.35 16.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.106 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 86' ' ' THR . 58.6 m -80.12 -5.72 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 p -147.67 55.41 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.629 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.6 162.19 35.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.205 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.894 HG21 ' CD1' ' A' ' 116' ' ' LEU . 30.4 mm -87.03 146.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.288 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.2 mt -150.58 171.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.152 0.501 . . . . 0.0 111.327 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.707 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.56 122.39 29.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.448 178.443 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.734 HG11 ' HB3' ' A' ' 72' ' ' CYS . 27.2 m -121.94 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 46' ' ' GLN . . . -90.78 143.79 16.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.507 HD22 ' NH1' ' A' ' 70' ' ' ARG . 4.6 mt -113.73 26.31 10.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.956 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.02 19.41 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.2 -49.2 6.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.682 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -105.46 -11.19 16.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.221 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 65.48 29.61 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -135.48 178.45 7.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -57.38 -18.26 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.856 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 132.37 34.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.816 0.341 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -115.72 158.14 23.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.472 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -115.45 120.48 39.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.032 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.694 ' CA ' HG12 ' A' ' 92' ' ' VAL . 94.5 t -50.33 111.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.738 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.1 mm -77.94 -36.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 109.679 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.07 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -154.13 167.45 29.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.452 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 82' ' ' VAL . 14.6 pttt -110.28 121.64 45.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.15 0.5 . . . . 0.0 112.274 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.07 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.2 m-85 -86.4 106.6 17.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -73.86 178.29 4.98 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.54 -41.76 45.45 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.071 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -61.65 -40.05 93.52 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.683 ' O ' HD23 ' A' ' 116' ' ' LEU . 9.6 mt-10 -68.63 -28.0 66.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.351 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.741 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.54 -51.63 6.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.955 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -55.72 -27.22 49.36 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.662 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -76.58 -22.11 54.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.001 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.894 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.0 -34.43 21.13 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -54.85 -34.55 63.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.35 -20.92 43.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.921 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.767 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.9 m-30 -66.77 -7.28 20.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.827 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.22 24.53 65.46 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.566 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.578 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.8 mt-10 -114.05 -63.5 1.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.876 0.369 . . . . 0.0 111.191 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.42 144.59 29.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.957 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.448 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.7 Cg_endo -71.38 179.78 4.28 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.657 2.238 . . . . 0.0 112.401 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -70.89 -34.61 71.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.448 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 20.7 p-80 -72.44 -17.98 61.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -56.84 133.66 54.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.732 0.301 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -114.36 134.35 55.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.652 HD13 ' HB1' ' A' ' 113' ' ' ALA . 4.5 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.097 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.632 HD23 ' CZ ' ' A' ' 41' ' ' PHE . 13.5 tp -68.81 99.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.704 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.497 ' CG1' HD22 ' A' ' 106' ' ' LEU . 18.9 t -88.35 139.15 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CZ ' HD23 ' A' ' 39' ' ' LEU . 86.5 m-85 -110.69 170.27 8.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.569 ' HA ' HD22 ' A' ' 91' ' ' LEU . 7.0 ttpt -52.79 148.43 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.887 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -116.85 160.52 20.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.402 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.63 130.07 45.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.48 61.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.541 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.498 ' CB ' HD11 ' A' ' 91' ' ' LEU . 4.7 mt-30 -117.53 140.97 48.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.53 0.205 . . . . 0.0 110.559 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' HD11 ' A' ' 94' ' ' LEU . 7.9 tp10 -115.66 154.36 29.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 111.408 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 5.3 p90 -84.55 157.78 21.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.21 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.01 173.18 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.225 0.536 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.04 109.05 11.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.273 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 90' ' ' ILE . 20.6 t -57.2 135.47 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.769 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.869 HD13 ' CB ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -116.07 -40.48 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.697 179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.63 158.82 43.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.735 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.638 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -115.7 139.02 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.63 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.049 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -110.72 -48.79 3.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.773 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.88 -179.27 30.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.54 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 67.65 19.53 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.304 . . . . 0.0 111.239 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.47 28.79 9.33 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.839 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HG3' HD12 ' A' ' 55' ' ' LEU . 6.2 ptt180 -154.82 155.88 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.598 HD22 ' CD1' ' A' ' 84' ' ' ILE . 1.2 pp -147.6 152.5 38.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.156 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.903 ' HB2' HD21 ' A' ' 55' ' ' LEU . 36.6 tt0 -91.75 121.39 33.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 72' ' ' CYS . . . -124.25 165.06 18.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 112.331 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.869 ' CB ' HD13 ' A' ' 52' ' ' ILE . 1.2 tpt -125.8 100.24 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.86 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.37 132.17 50.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.637 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.2 m-85 -49.93 -27.0 4.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.453 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -8.09 55.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.434 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.72 40.71 3.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.531 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.13 123.06 61.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.262 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' HE3' ' A' ' 63' ' ' MET . 1.9 tppp? -94.14 117.19 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -145.08 164.71 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.037 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.049 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -98.21 106.52 18.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.729 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.451 ' HB3' HG11 ' A' ' 92' ' ' VAL . 36.8 m -84.07 118.77 24.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 137.71 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.696 HD11 HG13 ' A' ' 82' ' ' VAL . 2.9 tt -68.66 139.18 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.704 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.11 143.9 56.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.143 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.58 -38.28 57.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.51 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -75.87 -29.4 58.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.659 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.484 ' O ' HG12 ' A' ' 82' ' ' VAL . 2.7 mm? -82.7 -28.65 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -49.63 -27.62 4.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.248 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -35.56 69.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.304 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.24 48.74 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.696 HG13 HD11 ' A' ' 74' ' ' ILE . 10.7 p -120.95 119.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.143 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -110.81 110.27 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.679 HG22 HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -87.11 147.14 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.443 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -118.84 156.32 29.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 33.3 m -80.15 -6.45 57.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.168 0.509 . . . . 0.0 111.377 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -145.34 71.24 1.28 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.43 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.73 165.18 33.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.085 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.947 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.4 mm -86.78 144.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.679 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.52 172.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 111.063 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.726 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.01 127.11 40.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.795 178.525 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.724 ' N ' HD12 ' A' ' 91' ' ' LEU . 31.6 m -122.2 149.51 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 46' ' ' GLN . . . -91.92 135.85 12.96 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.87 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -122.46 123.78 42.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.6 0.238 . . . . 0.0 110.72 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.57 -80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -61.12 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -73.52 -8.03 54.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.433 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 66.71 30.2 8.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.823 0.344 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.73 -169.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.14 -62.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.775 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -108.59 168.68 9.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.761 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 92' ' ' VAL . . . -152.68 177.2 10.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.98 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.33 119.1 21.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.833 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.713 ' HA ' HG12 ' A' ' 92' ' ' VAL . 70.9 t -49.89 111.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.906 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -82.5 -47.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.13 0.491 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.018 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.4 pp -141.52 169.16 18.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.59 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.605 ' N ' HD12 ' A' ' 106' ' ' LEU . 12.0 pttp -110.28 122.51 47.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 111.96 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.018 ' CE1' HD11 ' A' ' 106' ' ' LEU . 20.1 m-85 -85.44 107.0 17.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -64.27 168.08 5.98 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.82 -51.06 11.08 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.4 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.457 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 46.2 t0 -62.02 -38.2 87.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.506 ' OE2' ' HA ' ' A' ' 108' ' ' TYR . 0.7 OUTLIER -75.28 -26.16 58.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.018 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -45.44 -41.89 9.83 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.765 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.457 ' CG ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -53.11 -36.71 61.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.318 0.58 . . . . 0.0 109.488 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.645 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 1.0 OUTLIER -61.61 -21.04 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.971 177.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.947 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.32 -32.93 18.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.354 -178.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -34.48 65.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.1 -21.64 43.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.639 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.698 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -67.24 -10.5 51.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.077 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.72 64.83 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.619 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 65.4 mm-40 -111.3 -53.53 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.772 0.32 . . . . 0.0 111.013 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.579 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -98.04 147.2 32.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.78 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.414 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.1 Cg_endo -70.91 175.1 9.52 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.56 2.173 . . . . 0.0 112.193 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.29 -27.12 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.414 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 21.3 p-80 -81.62 -10.84 59.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.429 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.91 164.51 0.58 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -129.77 144.74 51.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.569 HD12 ' CB ' ' A' ' 113' ' ' ALA . 26.4 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.871 0.367 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.524 HD11 ' HE1' ' A' ' 119' ' ' TYR . 19.7 tp -127.59 124.47 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.8 t -126.47 140.5 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.93 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.754 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 5.3 m-30 -110.6 170.64 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.442 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -46.45 147.62 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.039 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -128.1 165.05 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.283 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.47 130.51 46.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.739 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.44 -15.26 61.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.386 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.533 ' HB3' HD11 ' A' ' 91' ' ' LEU . 30.3 mt-30 -127.31 146.52 50.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.2 tt0 -125.29 153.88 42.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.022 0.439 . . . . 0.0 111.492 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 7.8 p90 -84.32 157.88 21.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.84 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.81 173.55 15.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 112.388 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 tm0? -128.75 124.27 35.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 21.7 t -76.58 140.94 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 111.95 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.935 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.8 OUTLIER -115.95 -41.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.072 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -147.66 161.25 41.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.506 ' HE2' HD12 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -110.15 142.04 42.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.441 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 61' ' ' GLU . 1.8 mt -97.04 -30.28 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.29 61.03 3.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.704 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -177.73 51.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.568 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.59 11.07 64.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.424 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.708 ' HD2' HD12 ' A' ' 55' ' ' LEU . 24.8 ptt180 -147.25 164.17 34.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.833 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.19 155.61 42.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.789 ' HB2' HD21 ' A' ' 55' ' ' LEU . 22.7 tt0 -91.71 122.09 33.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.01 165.76 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.174 0.512 . . . . 0.0 111.941 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.935 ' HB2' HD11 ' A' ' 52' ' ' ILE . 4.6 tpp -131.28 111.79 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.116 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -59.27 131.76 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.361 . . . . 0.0 110.463 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.64 -26.3 2.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.789 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.33 -14.22 60.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.84 1.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.58 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -126.92 126.28 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 111.038 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.557 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -95.01 113.23 24.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.29 163.52 34.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.627 HD22 ' N ' ' A' ' 71' ' ' LEU . 2.5 mm? -102.82 114.25 28.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.706 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.2 m -83.99 118.71 24.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 4.9 m80 -83.99 146.32 28.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.837 HD11 ' CD1' ' A' ' 84' ' ' ILE . 23.7 mm -68.6 120.12 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.31 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 28.5 tpt180 -64.79 137.98 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.19 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.96 -65.96 2.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.656 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.34 9.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -86.48 -17.78 33.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.477 ' HA ' HG12 ' A' ' 82' ' ' VAL . 11.5 ptt85 -48.73 -29.73 4.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.238 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -55.32 -27.07 44.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.98 38.78 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.058 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 82' ' ' VAL . 13.2 p -81.74 111.15 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.398 . . . . 0.0 110.758 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -111.15 110.52 21.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.482 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -115.05 147.47 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.489 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -132.27 160.77 35.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.686 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 86' ' ' THR . 74.7 m -80.59 -6.73 58.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.153 0.501 . . . . 0.0 111.805 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -147.51 69.86 1.16 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.746 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.96 161.98 36.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.133 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.82 HG21 ' CD1' ' A' ' 116' ' ' LEU . 1.5 mp -86.76 147.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.643 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.6 mt -150.42 172.37 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 111.58 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.64 ' H ' HG22 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -128.2 122.0 30.79 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.48 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 104' ' ' VAL . 13.6 m -117.86 157.01 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.55 123.23 7.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.539 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -115.39 111.79 21.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.764 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -176.98 -71.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.44 -12.48 61.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.52 10.74 16.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.62 29.75 10.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.977 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.7 t0 68.45 -178.9 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.29 -61.06 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -96.36 163.6 13.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.676 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -163.74 139.82 6.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.96 129.4 36.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.69 ' HA ' HG12 ' A' ' 92' ' ' VAL . 96.2 t -55.01 111.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.808 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 mm -77.53 -48.76 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.135 0.493 . . . . 0.0 109.853 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.071 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -140.94 167.3 22.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.255 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -111.82 119.59 39.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 112.305 -178.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.071 ' CE1' HD11 ' A' ' 106' ' ' LEU . 24.2 m-85 -83.86 106.08 15.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -72.2 177.86 4.21 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.13 -40.54 45.33 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.175 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -61.41 -40.49 94.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.694 ' O ' HD23 ' A' ' 116' ' ' LEU . 11.5 mt-10 -67.03 -27.91 67.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.508 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.872 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.31 -49.47 6.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.984 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -28.15 56.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.348 0.594 . . . . 0.0 109.5 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.98 -22.79 42.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.167 178.414 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.872 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.89 -33.75 25.43 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.064 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -55.2 -34.18 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.02 -20.32 45.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.932 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.754 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.4 -6.14 13.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.83 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.46 24.8 53.55 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.791 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 49.2 mm-40 -114.27 -56.28 2.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.737 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -90.85 153.29 45.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 73.5 Cg_endo -75.81 -179.79 5.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.723 2.282 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.0 -31.28 67.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.088 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.447 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 29.4 p-80 -84.17 2.71 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.532 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.533 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -61.1 122.28 14.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.158 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -108.82 121.53 45.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.815 HD13 ' HB1' ' A' ' 113' ' ' ALA . 2.9 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.809 0.337 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.526 HD11 ' HE1' ' A' ' 119' ' ' TYR . 22.9 tp -68.09 122.73 18.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 15.4 t -114.69 139.88 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.617 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 24.5 m-85 -116.9 170.07 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.582 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -86.44 158.19 19.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.792 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -144.46 178.04 8.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.361 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -44.52 137.02 3.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.27 61.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.474 ' CB ' HD11 ' A' ' 91' ' ' LEU . 2.5 mt-30 -141.73 139.2 32.82 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.2 tt0 -123.4 157.63 32.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.007 0.432 . . . . 0.0 111.535 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 4.9 p90 -84.5 158.05 21.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.521 ' HB2' HH21 ' A' ' 70' ' ' ARG . . . -151.93 173.86 14.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.248 0.547 . . . . 0.0 112.2 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.412 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -128.78 120.6 26.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.019 179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.606 HG13 HD13 ' A' ' 60' ' ' LEU . 23.4 t -70.89 135.46 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 112.039 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 63' ' ' MET . 14.0 mt -116.29 -40.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 157.62 46.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.543 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -117.12 131.6 56.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.747 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.996 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -105.89 -32.68 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.8 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.42 -171.67 48.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.57 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 m120 61.9 26.49 16.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.718 0.294 . . . . 0.0 111.049 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 83.85 32.19 24.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.616 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.578 ' HG3' HD12 ' A' ' 55' ' ' LEU . 12.1 ptt180 -155.4 157.27 36.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.605 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 84' ' ' ILE . 2.6 pp -148.04 160.91 42.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 111.611 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.901 ' HB2' HD21 ' A' ' 55' ' ' LEU . 34.4 tt0 -104.41 120.83 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -136.51 164.68 27.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.23 0.538 . . . . 0.0 112.033 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.648 ' HE3' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -120.08 114.8 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.191 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.2 m -59.45 133.47 56.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.502 ' CG ' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -48.2 -25.54 1.54 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.622 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.0 -14.07 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.339 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.89 39.75 2.45 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.664 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.34 129.6 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 111.428 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.648 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 1.7 ttmp? -91.66 117.94 30.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.521 HH21 ' HB2' ' A' ' 49' ' ' ALA . 33.2 ptt180 -142.7 165.57 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.981 0.42 . . . . 0.0 111.165 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.996 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -104.29 108.08 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.632 ' HB3' HG11 ' A' ' 92' ' ' VAL . 12.5 m -84.87 118.75 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.498 ' N ' ' CD2' ' A' ' 73' ' ' HIS . 19.5 m170 -85.01 130.32 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 84' ' ' ILE . 12.0 tt -68.64 140.91 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.047 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 14.2 tpt180 -76.6 148.51 36.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.087 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.22 -79.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.984 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.39 -26.1 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.722 0.296 . . . . 0.0 111.544 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -79.93 -45.33 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.186 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HA ' HG12 ' A' ' 82' ' ' VAL . 3.5 ptt180 -58.46 -24.12 59.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -58.64 -33.43 70.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 8.44 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.585 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.495 ' CB ' HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -124.18 119.69 57.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.132 0.491 . . . . 0.0 111.167 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -111.07 110.32 20.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.766 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.843 HD13 HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.49 147.59 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.3 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -118.97 159.33 24.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 86' ' ' THR . 40.2 m -76.12 -6.09 49.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.697 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.1 p -145.83 71.57 1.27 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.702 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.59 160.52 39.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.079 0.466 . . . . 0.0 111.208 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.857 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.3 mm -86.94 146.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.489 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.643 HD13 HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.41 171.14 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.241 0.543 . . . . 0.0 111.631 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.716 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.07 124.37 34.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.429 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG12 ' CA ' ' A' ' 104' ' ' VAL . 16.9 m -122.69 160.26 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.351 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.93 135.77 12.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 47' ' ' GLU . 2.8 mt -100.45 159.1 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 60.87 22.82 12.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.178 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.04 -47.37 7.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.674 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 103' ' ' ASP . 46.2 m-85 -96.95 4.15 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.136 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 65.82 29.71 10.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.722 0.296 . . . . 0.0 110.796 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.61 175.32 13.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.438 . . . . 0.0 111.109 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -17.58 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.109 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -77.67 124.79 28.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 111.369 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.478 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -111.5 156.16 22.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.053 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.409 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 13.1 p30 -102.82 120.67 41.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.881 0.372 . . . . 0.0 111.426 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.67 ' CA ' HG12 ' A' ' 92' ' ' VAL . 80.3 t -52.62 111.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.325 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.408 ' HB ' ' HG ' ' A' ' 91' ' ' LEU . 32.6 mm -79.02 -33.25 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.266 0.555 . . . . 0.0 109.81 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.04 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.6 pp -159.1 166.83 30.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.442 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.54 ' N ' HD12 ' A' ' 106' ' ' LEU . 1.6 tttt -109.9 116.94 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.061 0.457 . . . . 0.0 112.145 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.04 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.3 m-85 -79.23 106.12 11.04 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -73.44 177.15 5.45 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.671 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.03 -40.16 54.03 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.001 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.07 -40.81 97.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.678 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.9 mt-10 -67.76 -28.1 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.381 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.44 -49.13 7.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.829 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.39 -29.21 61.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.31 0.576 . . . . 0.0 109.489 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -78.32 -22.56 47.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.181 178.306 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.857 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.08 -33.86 27.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.024 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -33.76 61.54 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -21.01 43.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.729 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.702 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.0 m-30 -66.73 -8.44 28.08 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.89 23.46 51.18 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.418 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 2.9 mm-40 -109.93 -51.55 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.724 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -97.99 125.21 44.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 35.6 Cg_exo -57.27 179.0 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.327 2.018 . . . . 0.0 112.15 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.59 -28.63 67.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 10.3 p-80 -80.78 -23.28 39.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.222 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.545 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -55.39 141.21 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.284 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -124.14 146.51 48.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.863 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.6 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.477 HD21 ' CB ' ' A' ' 115' ' ' SER . 13.7 tp -118.9 130.51 55.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.549 HG11 ' CD2' ' A' ' 106' ' ' LEU . 17.7 t -121.84 139.58 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.097 0.475 . . . . 0.0 111.402 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 119' ' ' TYR . 53.8 m-85 -115.22 171.7 7.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -39.44 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -133.81 158.49 43.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 126.78 28.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.74 78.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.97 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.656 ' OE1' HD11 ' A' ' 91' ' ' LEU . 3.0 mt-30 -115.12 143.77 44.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.824 0.312 . . . . 0.0 110.658 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.865 ' HB2' HD11 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -119.22 166.21 13.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.129 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.597 ' CZ ' ' CE2' ' A' ' 108' ' ' TYR . 3.8 m-85 -84.78 156.82 21.21 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.706 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 64' ' ' CYS . . . -149.5 142.75 25.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.681 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.29 108.43 16.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.946 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 60' ' ' LEU . 21.5 t -55.42 137.56 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.461 HD11 ' C ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -116.13 -42.62 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.15 151.95 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.462 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -99.47 134.04 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.679 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 ' HD2' ' A' ' 59' ' ' ARG . 1.2 mt -93.72 -35.63 12.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.825 0.345 . . . . 0.0 110.772 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.25 -132.35 3.2 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -112.6 89.52 3.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.324 . . . . 0.0 110.976 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 147.75 -24.21 1.48 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.822 ' HD2' HD12 ' A' ' 55' ' ' LEU . 14.6 ptt180 -152.87 160.25 43.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.634 0.254 . . . . 0.0 110.534 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.838 HD22 ' CD1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.21 150.05 34.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 111.367 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.682 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.3 tt0 -91.72 121.64 33.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.461 ' C ' HD11 ' A' ' 52' ' ' ILE . . . -137.56 166.11 24.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.237 0.541 . . . . 0.0 112.318 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.478 ' HE3' ' CG ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -115.17 95.92 5.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.095 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 18.7 t -45.8 125.91 6.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.88 ' CZ ' HD22 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -48.46 -23.35 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.91 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -13.2 60.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.599 0.238 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.43 34.36 4.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.687 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.19 124.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' CG ' ' HE3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -85.86 112.47 21.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.58 165.77 27.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.907 0.385 . . . . 0.0 111.304 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.705 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -97.12 108.01 20.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.484 ' SG ' HG11 ' A' ' 92' ' ' VAL . 29.6 m -84.24 125.76 32.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.614 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -82.75 137.08 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.697 HD11 HG13 ' A' ' 82' ' ' VAL . 8.1 tt -68.87 140.3 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.821 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.421 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.31 145.69 43.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.913 0.387 . . . . 0.0 111.348 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.89 -51.23 15.61 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.272 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -31.56 64.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.986 0.422 . . . . 0.0 110.501 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.5 mm? -85.9 -31.71 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.453 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.526 ' HA ' HG12 ' A' ' 82' ' ' VAL . 8.1 mtp180 -49.01 -28.84 4.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.314 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -56.9 -27.48 60.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -169.37 49.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.36 . . . . 0.0 111.165 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 107' ' ' LYS . 9.4 p -123.0 122.94 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.644 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -111.03 109.58 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.673 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.838 ' CD1' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -81.12 123.77 38.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 179.598 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -84.72 152.82 23.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 86' ' ' THR . 63.0 m -79.92 -5.92 56.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.512 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 p -146.54 51.77 1.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -133.71 165.0 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 111.57 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.841 HG21 ' CD1' ' A' ' 116' ' ' LEU . 1.5 mp -87.72 146.58 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.875 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.75 HG23 ' HA ' ' A' ' 107' ' ' LYS . 1.3 mt -150.42 170.5 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.054 0.454 . . . . 0.0 111.195 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.667 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -123.27 122.4 38.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.93 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 104' ' ' VAL . 19.4 m -120.55 154.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.676 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -97.04 153.81 20.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.851 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -137.17 131.25 32.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 179.55 -68.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.094 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.28 -15.02 60.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 101' ' ' LYS . 16.8 m-85 -72.58 -11.4 60.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.582 0.229 . . . . 0.0 111.556 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 64.87 29.72 12.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.857 0.36 . . . . 0.0 110.807 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.9 OUTLIER 62.85 97.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 99' ' ' ASP . 18.4 t30 165.12 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . 24.3 mttt -141.94 162.39 35.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.474 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.651 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -139.29 170.99 14.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -128.79 111.33 13.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.71 ' HA ' HG12 ' A' ' 92' ' ' VAL . 68.5 t -49.94 112.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.3 mm -83.94 -43.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.175 0.512 . . . . 0.0 109.764 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.027 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -144.46 165.82 26.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.421 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.816 ' HG2' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.87 120.7 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.923 -179.448 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.027 ' CE1' HD11 ' A' ' 106' ' ' LEU . 27.3 m-85 -83.11 105.91 14.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.97 166.77 4.31 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.12 -35.96 66.63 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.402 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.96 -40.22 97.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.738 ' O ' HD23 ' A' ' 116' ' ' LEU . 51.7 mt-10 -64.18 -28.19 69.58 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.561 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.954 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.58 -38.43 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.675 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -33.98 77.16 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.647 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 5.1 p -77.58 -23.09 50.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.867 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.954 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -52.54 -31.36 35.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.18 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -33.11 62.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.31 -21.79 42.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.731 177.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.736 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.44 -7.55 26.23 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.858 0.361 . . . . 0.0 110.218 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.11 84.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.003 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.479 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 38.2 mm-40 -125.83 -56.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.88 HD22 ' CZ ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -93.62 118.64 67.51 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 51.2 Cg_exo -54.3 178.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.206 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 10.0 p-80 -77.23 -17.85 58.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.246 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -52.62 128.73 27.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.363 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -106.76 133.03 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.853 HD13 ' HB1' ' A' ' 113' ' ' ALA . 5.4 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.826 0.346 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD21 ' CB ' ' A' ' 115' ' ' SER . 16.4 tp -127.21 123.73 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.4 140.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.6 m-85 -111.04 170.06 8.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.085 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -69.48 149.13 48.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.685 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.25 176.41 7.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.346 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -49.64 134.1 20.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.081 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.45 -15.09 60.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.504 HE22 HG21 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -134.12 139.42 45.9 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -125.06 157.2 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.07 0.462 . . . . 0.0 111.496 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 2.9 p90 -84.6 158.12 20.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.034 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.37 173.65 13.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.233 0.539 . . . . 0.0 111.997 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.446 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 38.4 tp60 -128.64 108.94 10.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.92 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.518 HG21 HD11 ' A' ' 90' ' ' ILE . 12.0 t -60.98 136.14 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.047 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 63' ' ' MET . 1.2 mp -116.2 -40.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.703 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 157.95 44.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.644 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.5 ttt -116.9 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.66 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -117.35 -167.62 1.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.729 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.37 -178.53 19.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.441 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.36 39.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.73 52.15 53.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.76 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.544 ' HG3' HD12 ' A' ' 55' ' ' LEU . 8.2 ptt180 -154.81 162.66 41.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.311 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.06 152.26 38.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.291 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.895 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.5 tt0 -94.02 121.82 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.907 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.29 161.36 30.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.235 0.54 . . . . 0.0 112.093 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.654 ' HB3' HD13 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -119.97 101.65 8.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.146 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.05 129.22 40.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.37 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 3.4 m-85 -50.63 -24.54 3.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.468 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -8.42 56.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 35.63 5.0 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.685 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.23 124.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.377 . . . . 0.0 111.087 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 9.8 tptm -96.36 115.21 27.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -141.48 160.99 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.038 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -95.67 110.79 22.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.464 ' HB3' HG11 ' A' ' 92' ' ' VAL . 12.5 m -84.25 119.02 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -79.85 141.49 36.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.373 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -68.63 126.76 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -179.23 -168.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.645 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.47 171.16 40.97 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.298 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -21.6 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.848 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.5 HD12 ' HG2' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -68.71 -10.81 58.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.412 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -47.6 -28.52 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.611 0.243 . . . . 0.0 111.48 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -61.96 -26.28 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.43 ' HE3' ' CZ2' ' A' ' 83' ' ' TRP . 10.2 mtpt -170.31 52.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 82' ' ' VAL . 14.3 p -81.97 111.07 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.43 ' CZ2' ' HE3' ' A' ' 81' ' ' LYS . 10.3 m0 -111.62 109.62 19.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.606 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.033 HD13 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -97.06 147.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.63 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.4 m-80 -119.58 153.38 35.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.927 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 86' ' ' THR . 55.9 m -80.25 -6.4 57.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 111.675 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.7 62.37 1.32 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.98 165.73 34.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.261 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 116' ' ' LEU . 37.2 mm -86.93 145.7 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.29 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.675 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.84 171.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.72 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.01 122.24 29.62 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.536 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.636 HG12 ' CA ' ' A' ' 104' ' ' VAL . 10.1 m -115.18 164.14 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.92 123.21 6.86 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.532 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -109.98 119.76 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.755 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -163.96 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -12.16 60.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -84.81 10.99 10.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.685 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 66.79 26.79 9.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 72.8 -57.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.462 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -40.71 -32.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.717 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -123.61 158.96 30.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -153.07 156.34 38.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -107.23 126.5 52.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.636 ' CA ' HG12 ' A' ' 92' ' ' VAL . 87.2 t -52.5 111.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.686 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.504 HG21 HE22 ' A' ' 46' ' ' GLN . 12.7 mm -80.93 -58.4 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.867 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.048 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -129.67 167.22 18.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.358 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.636 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -110.84 119.31 38.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.746 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.048 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.3 m-85 -84.01 106.38 15.62 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -70.46 172.84 7.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.675 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -75.61 -51.05 13.71 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.636 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -61.32 -39.14 89.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.534 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 23.6 tt0 -67.1 -29.94 69.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.607 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.859 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -45.84 -42.87 12.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.543 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -41.89 58.65 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 110.149 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -61.87 -21.32 64.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.516 178.433 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.914 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.7 -33.35 22.43 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.049 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -55.24 -34.74 64.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.3 -20.58 44.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.009 177.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.2 m-30 -66.58 -8.28 25.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.876 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 22.93 56.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.493 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 66.6 mm-40 -109.77 -61.0 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.912 0.387 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.637 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -82.18 139.45 45.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.745 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 64.3 Cg_endo -73.78 178.03 7.32 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.45 -29.8 70.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 27.3 p-80 -84.19 2.48 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.5 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.623 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -74.15 126.37 30.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 110.994 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -123.59 127.58 48.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.859 HD13 ' HB1' ' A' ' 113' ' ' ALA . 5.7 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.846 0.355 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.66 HD11 ' CE1' ' A' ' 119' ' ' TYR . 23.3 tp -103.29 118.38 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.471 ' HB ' HD22 ' A' ' 106' ' ' LEU . 19.1 t -108.08 139.11 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.628 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 66.9 m-85 -112.75 170.43 8.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.711 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.597 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.0 ttpt -48.28 143.42 4.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.47 156.17 19.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -56.1 129.85 41.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.838 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.23 -15.35 62.31 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.391 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.624 ' OE1' HD11 ' A' ' 91' ' ' LEU . 15.7 mt-30 -116.38 152.95 32.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.636 0.255 . . . . 0.0 110.401 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.9 tt0 -125.93 154.48 42.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 111.335 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 10.0 p90 -84.34 157.87 21.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.76 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.83 173.42 15.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.327 0.584 . . . . 0.0 112.204 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.689 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 2.3 tm0? -123.77 142.43 51.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.813 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.597 HG13 HD13 ' A' ' 60' ' ' LEU . 22.7 t -92.16 139.02 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 111.799 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 63' ' ' MET . 1.0 OUTLIER -115.85 -48.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.274 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -141.77 162.2 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.699 ' SD ' HD12 ' A' ' 84' ' ' ILE . 26.0 mmm -113.96 137.09 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.872 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -106.19 -69.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.896 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.23 179.65 16.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.565 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -72.37 -13.99 61.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.565 0.221 . . . . 0.0 111.259 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -118.78 8.85 12.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.824 ' HD2' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -155.4 155.98 34.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.752 0.311 . . . . 0.0 111.0 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.849 ' CD2' HD13 ' A' ' 84' ' ' ILE . 1.6 pp -147.89 164.1 34.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.379 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.859 ' HB2' HD21 ' A' ' 55' ' ' LEU . 40.4 tt0 -104.23 121.42 43.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -133.05 165.96 23.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.274 0.559 . . . . 0.0 112.262 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.876 ' HB2' HD11 ' A' ' 52' ' ' ILE . 3.7 tpp -130.14 110.92 11.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.078 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.25 133.5 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -27.27 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.502 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.37 -13.24 60.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.58 43.04 1.9 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.497 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.05 117.8 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.6 OUTLIER -90.64 112.99 24.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.1 156.84 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.872 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -92.66 107.89 19.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.856 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.6 ' HB3' HG11 ' A' ' 92' ' ' VAL . 32.3 m -84.17 118.42 24.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.376 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -82.84 123.7 29.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.765 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.69 HD12 HG12 ' A' ' 84' ' ' ILE . 5.5 tt -68.73 140.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 176.73 -161.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.793 0.33 . . . . 0.0 111.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.3 168.93 39.01 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.028 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.72 2.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.575 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.47 ' O ' HG12 ' A' ' 82' ' ' VAL . 1.2 mm? -64.47 -34.57 78.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.784 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.504 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -49.01 -27.16 3.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.292 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -56.76 -37.66 71.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -157.64 48.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.196 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.8 p -123.51 121.19 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.261 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.55 109.86 20.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.849 HD13 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.38 147.17 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.086 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -108.75 152.84 24.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.957 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 86' ' ' THR . 70.3 m -80.17 -6.36 57.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 111.69 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 p -146.2 61.69 1.24 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.687 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.96 168.52 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.186 0.517 . . . . 0.0 111.45 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.778 HG21 ' CD1' ' A' ' 116' ' ' LEU . 47.6 mm -91.81 146.78 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.213 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.64 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.2 mt -150.9 170.7 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 111.449 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.684 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.68 121.66 29.05 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.519 178.24 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 104' ' ' VAL . 15.3 m -118.66 148.4 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.13 128.4 8.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -114.83 111.54 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.735 0.302 . . . . 0.0 110.73 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.33 -75.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -55.35 -23.22 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.335 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -85.28 4.88 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.633 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 65.78 30.02 10.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 76.36 178.86 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 73.28 -60.67 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.809 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.26 151.05 22.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.674 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.464 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -148.83 151.22 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.991 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -99.44 127.96 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.751 ' HA ' HG12 ' A' ' 92' ' ' VAL . 62.0 t -54.86 111.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.471 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -82.73 -56.74 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 109.923 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.08 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -130.91 166.08 21.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.48 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.628 ' N ' HD12 ' A' ' 106' ' ' LEU . 10.4 tttt -111.74 117.93 34.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.08 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.2 m-85 -84.15 106.55 15.88 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -87.48 -178.94 6.26 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -68.38 -45.35 72.99 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.363 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.86 -39.48 77.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 116' ' ' LEU . 54.2 mt-10 -71.15 -28.7 64.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.593 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.891 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.81 -47.46 8.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.637 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.85 -28.98 64.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 109.399 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.638 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -79.7 -22.86 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.253 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.891 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.74 -34.07 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.095 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -55.18 -33.22 62.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.27 -21.1 43.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.806 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.706 ' HE2' ' CD1' ' A' ' 108' ' ' TYR . 4.0 m-30 -66.57 -9.95 40.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.11 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.55 56.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.595 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.494 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 3.0 mm-40 -108.95 -52.74 2.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.055 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.708 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.06 130.65 35.4 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.825 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 178.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.346 2.031 . . . . 0.0 112.138 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -73.42 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -84.04 1.39 44.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.57 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.94 138.12 55.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.878 0.371 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.71 125.32 44.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.869 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.3 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.819 0.343 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 115' ' ' SER . 13.0 tp -68.56 105.74 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' CG1' HD22 ' A' ' 106' ' ' LEU . 17.8 t -97.78 139.35 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.204 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 78.6 m-85 -108.58 170.72 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.995 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.447 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -44.31 158.28 0.05 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.43 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.0 156.17 35.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.087 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.86 126.2 26.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.85 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.94 -15.35 62.02 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.604 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' A' ' 91' ' ' LEU . 3.4 mm-40 -111.21 152.61 26.91 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.871 ' HB2' HD11 ' A' ' 94' ' ' LEU . 35.8 tt0 -122.89 150.6 42.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 4.4 p90 -84.79 157.86 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.295 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.82 174.0 12.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.335 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.434 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 tm0? -127.58 114.4 17.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.298 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 90' ' ' ILE . 38.4 t -68.64 131.06 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.907 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 63' ' ' MET . 30.4 mt -116.04 -37.14 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.875 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -141.14 155.86 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.608 ' C ' HD23 ' A' ' 55' ' ' LEU . 2.7 mtp -117.16 146.94 42.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.819 HD12 ' CD ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -110.68 -46.13 3.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 110.802 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.7 -137.51 2.49 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.73 -26.8 9.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.666 0.269 . . . . 0.0 110.982 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -103.57 3.72 46.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.075 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.819 ' CD ' HD12 ' A' ' 55' ' ' LEU . 6.3 ptp180 -155.28 156.37 35.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.905 0.353 . . . . 0.0 111.036 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.807 ' CD2' HD13 ' A' ' 84' ' ' ILE . 2.3 pp -148.08 167.19 25.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.505 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.799 ' HB2' HD21 ' A' ' 55' ' ' LEU . 17.8 tt0 -112.9 121.25 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.161 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -135.85 164.91 26.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.213 0.53 . . . . 0.0 112.293 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 8.0 tpp -118.24 110.3 17.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.165 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -59.14 133.25 55.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.8 m-85 -48.04 -24.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.07 -11.31 60.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.367 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.24 42.21 2.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.729 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.11 133.01 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.313 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.5 OUTLIER -103.86 112.5 25.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -145.54 164.81 30.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.003 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.73 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -98.35 108.9 21.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.737 ' HB3' HG11 ' A' ' 92' ' ' VAL . 37.4 m -89.92 118.8 29.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.922 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.43 132.67 36.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.67 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.673 HD12 HG12 ' A' ' 84' ' ' ILE . 10.8 tt -68.93 140.99 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -56.24 174.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.074 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.15 -49.82 2.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.229 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -33.52 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -71.18 -45.98 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.639 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.485 ' HA ' HG12 ' A' ' 82' ' ' VAL . 11.4 ptm180 -56.59 -25.7 53.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -28.41 64.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm -137.35 8.24 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.851 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.589 HG21 ' CB ' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -124.35 124.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.956 0.407 . . . . 0.0 111.487 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -110.79 110.41 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.807 HD13 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.32 147.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 111.416 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -117.51 157.76 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.04 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.1 m -76.06 -6.36 50.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.751 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -144.45 73.55 1.38 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.649 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.79 162.28 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.928 HG21 ' CD1' ' A' ' 116' ' ' LEU . 33.5 mm -86.94 147.31 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.603 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.681 HD13 HG22 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -150.7 171.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.43 . . . . 0.0 111.438 179.703 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.657 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -130.12 122.92 29.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.9 178.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.779 HG12 ' HA ' ' A' ' 104' ' ' VAL . 31.0 m -121.6 157.34 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.994 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.62 136.14 12.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.862 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -118.27 110.27 17.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.0 110.743 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.67 -68.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 111.108 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.2 -27.77 23.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.245 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -85.71 -0.24 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.65 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 65.8 30.27 10.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 5.6 m-20 77.88 162.55 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 85.56 -23.34 0.16 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.36 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -141.22 157.01 45.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.662 0.268 . . . . 0.0 110.449 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.779 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -148.54 174.28 12.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 0.0 111.141 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -128.64 124.22 35.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.589 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.779 ' HA ' HG12 ' A' ' 92' ' ' VAL . 49.8 t -52.55 111.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.667 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -83.41 -37.44 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 109.819 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.04 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.4 pp -152.48 164.08 38.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.419 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 90' ' ' ILE . 4.8 tmtt? -109.32 118.21 36.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 111.911 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 1.04 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.4 m-85 -79.83 106.6 11.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 112' ' ' GLU . 9.8 m-20 -60.17 166.91 2.62 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.705 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -78.0 -50.66 11.69 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.62 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.31 -42.91 99.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.474 ' OE2' ' HA ' ' A' ' 108' ' ' TYR . 0.6 OUTLIER -68.85 -26.6 65.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.01 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 1.005 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -45.68 -34.06 3.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.305 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -55.82 -39.56 71.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.421 0.629 . . . . 0.0 109.396 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.702 ' HB3' HD21 ' A' ' 39' ' ' LEU . 12.0 m -61.01 -20.85 62.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.089 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.928 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -49.55 -34.89 18.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.38 -178.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.03 -34.96 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.39 42.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.78 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.701 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -66.82 -10.53 48.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 27.55 66.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 7.8 mm-40 -114.02 -51.87 2.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.685 0.279 . . . . 0.0 111.035 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.611 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.89 139.86 21.57 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.44 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 35.1 Cg_exo -59.21 179.41 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.415 2.077 . . . . 0.0 112.103 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -72.76 -27.74 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.44 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 9.2 p-80 -79.1 -18.83 52.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.379 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.57 135.86 39.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.827 0.346 . . . . 0.0 111.411 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.46 131.1 45.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.005 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.7 mt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.271 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.769 0.319 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.12 119.0 32.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.36 90.45 0.78 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.504 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.15 -75.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 110.831 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -166.03 78.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 68.29 -70.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.941 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -163.67 109.18 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.35 -178.83 5.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -151.46 131.6 13.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.029 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.28 85.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.002 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -126.71 36.76 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -138.16 97.56 9.66 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.72 112.37 2.64 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.464 2.109 . . . . 0.0 112.276 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 3.7 mtp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.803 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.815 0.256 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.25 -179.93 6.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 60.22 93.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -92.27 91.64 7.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.08 -138.6 7.17 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.12 -67.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.08 131.37 10.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.522 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.43 -97.49 0.12 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.57 36.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.9 0.381 . . . . 0.0 110.971 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.12 160.51 32.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.41 -65.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.27 128.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -169.75 179.49 3.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.78 54.13 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.567 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -107.88 -31.15 8.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.752 0.31 . . . . 0.0 110.843 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.9 t30 60.28 46.56 10.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 67.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 61.63 97.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.798 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -64.34 131.07 46.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.36 32.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -140.32 133.76 29.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -177.57 132.17 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.61 144.81 46.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.76 87.02 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.187 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.631 HD21 ' HE1' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -81.58 142.78 32.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.455 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' HB ' HD22 ' A' ' 106' ' ' LEU . 21.8 t -116.11 138.5 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.07 0.462 . . . . 0.0 111.626 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.607 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.8 m-85 -107.48 170.49 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.364 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 2.6 ttpt -52.86 145.39 12.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 0.0 110.738 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -111.73 156.58 21.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.4 130.1 45.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.92 -15.47 61.72 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.423 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' OE1' HD11 ' A' ' 91' ' ' LEU . 17.6 mt-30 -116.32 144.91 43.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.639 0.257 . . . . 0.0 110.326 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -118.1 155.3 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.468 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.3 p90 -84.45 157.71 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.88 173.25 13.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.193 0.521 . . . . 0.0 112.328 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.483 ' HG2' HD13 ' A' ' 89' ' ' ILE . 1.2 tm0? -129.27 130.77 46.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.915 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 43.9 t -82.08 139.92 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.084 0.469 . . . . 0.0 112.051 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.493 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.0 -39.74 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -141.65 157.81 44.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.463 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.561 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -111.53 142.62 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.813 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.929 HD21 ' HB2' ' A' ' 61' ' ' GLU . 3.3 mt -103.79 -155.83 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -44.55 -84.57 0.01 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.194 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -159.76 -43.81 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.42 -0.22 71.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.007 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.694 ' HG3' HD12 ' A' ' 55' ' ' LEU . 26.3 ptt180 -151.76 167.2 28.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.094 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.734 ' CD2' HG21 ' A' ' 84' ' ' ILE . 2.0 pp -147.66 154.54 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.04 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.929 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.5 tt0 -91.78 121.75 33.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.042 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -149.78 164.82 34.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.493 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -138.75 133.27 31.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.536 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.438 ' O ' ' HE3' ' A' ' 63' ' ' MET . 49.2 t -64.41 141.6 58.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.974 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.3 m-85 -48.66 -23.19 0.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.782 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -13.78 61.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.331 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.02 34.64 3.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.76 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 110.74 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 111.037 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 63' ' ' MET . 5.5 mmtm -85.69 118.34 25.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -145.12 156.61 43.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.003 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -91.99 105.77 17.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.493 ' SG ' HG11 ' A' ' 92' ' ' VAL . 12.1 m -85.41 118.77 25.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.732 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.45 141.25 36.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.697 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.883 HD12 ' CD1' ' A' ' 84' ' ' ILE . 2.1 tt -68.6 140.28 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 26.6 tpt180 -67.27 155.33 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.352 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.08 -61.53 2.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.269 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.42 -39.75 91.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.501 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -69.15 -17.88 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.987 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.499 ' HA ' HG12 ' A' ' 82' ' ' VAL . 1.2 ptt180 -48.67 -28.72 3.73 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.292 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -75.01 -29.38 60.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.344 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.67 44.6 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 82' ' ' VAL . 11.0 p -117.45 115.7 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 110.955 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -110.74 110.27 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.883 ' CD1' HD12 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -106.1 147.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.758 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.2 m-20 -137.57 165.51 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.904 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.7 m -80.28 -6.16 57.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.596 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.08 68.62 0.94 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.579 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -150.8 164.27 36.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.929 HG21 ' CD1' ' A' ' 116' ' ' LEU . 32.0 mm -87.63 144.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.229 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.3 mt -150.68 171.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 111.241 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.741 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -127.2 122.34 33.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.706 HG12 ' HA ' ' A' ' 104' ' ' VAL . 17.0 m -120.4 139.18 48.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.432 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.456 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -80.5 146.17 27.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.293 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 93' ' ' GLY . 1.4 mt -114.64 167.3 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' CB ' ' O ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER 82.03 -8.08 1.31 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.835 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -35.7 27.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.642 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -105.66 22.83 14.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.435 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 55.5 mm-40 68.92 30.53 4.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.766 0.317 . . . . 0.0 110.77 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 100' ' ' ASN . 1.3 t0 82.99 -175.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 99' ' ' ASP . 8.5 t-20 69.62 -60.93 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.777 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -98.77 155.73 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -145.84 131.08 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -88.99 123.93 33.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.276 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.706 ' HA ' HG12 ' A' ' 92' ' ' VAL . 80.6 t -52.09 112.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.653 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -78.84 -39.46 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 109.971 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.032 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -150.56 166.61 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.372 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.595 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -108.31 123.27 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 111.813 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.032 ' CE1' HD11 ' A' ' 106' ' ' LEU . 20.3 m-85 -87.45 106.73 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.56 166.69 6.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.58 -38.61 62.6 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.515 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.36 -40.14 95.44 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.703 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.3 mm-40 -62.25 -27.47 69.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.76 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.929 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.55 -36.61 2.14 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.846 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -63.82 -33.05 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -78.48 -22.8 46.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.902 177.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.929 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.75 -31.75 27.89 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.165 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -33.33 62.82 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.47 -22.05 41.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.748 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.653 ' CG ' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.2 -11.65 57.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.07 29.28 74.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.497 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.505 ' HB2' HD23 ' A' ' 122' ' ' LEU . 34.2 mt-10 -117.09 -52.42 2.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.206 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.522 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -102.89 141.4 22.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 -179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.667 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 71.4 Cg_endo -74.54 179.11 6.24 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.51 2.14 . . . . 0.0 112.206 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -71.03 -17.22 62.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.246 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 11.9 p-80 -97.72 -1.91 42.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.638 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.667 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -59.66 154.31 18.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 111.178 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -115.37 125.87 53.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.851 HD13 ' HB1' ' A' ' 113' ' ' ALA . 13.3 mt -103.77 140.24 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.011 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -101.17 152.8 20.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.13 145.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -148.8 -46.71 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.13 145.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.4 m -67.76 76.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 61.91 118.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.51 173.23 6.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.11 174.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.592 2.194 . . . . 0.0 112.361 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -123.03 -153.52 8.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.623 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.52 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.608 0.242 . . . . 0.0 110.945 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.8 t0 47.3 71.25 0.34 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.808 0.337 . . . . 0.0 111.244 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -66.65 162.87 20.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 63.58 140.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 28.3 mt -141.57 146.52 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.015 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -114.35 166.78 11.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.014 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 62.73 -80.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 56.9 30.66 18.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.885 0.374 . . . . 0.0 110.92 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.63 -177.64 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.947 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.9 mm 65.35 82.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.109 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.24 -98.05 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.443 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.5 -69.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 111.014 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -89.84 9.97 25.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.367 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 68.41 -67.09 0.21 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.802 0.335 . . . . 0.0 111.078 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 64.79 154.88 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.48 -65.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.28 138.89 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.138 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.03 -45.26 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.028 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.45 -27.1 12.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.112 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.4 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.121 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.79 125.24 50.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.21 50.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.501 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 5.0 t -63.78 -31.9 73.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.745 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -74.65 -23.05 58.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.011 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -80.18 92.04 5.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.054 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -130.08 146.58 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -177.87 -36.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.069 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -47.9 100.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.219 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.95 118.85 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.96 -173.28 2.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 24.5 t0 67.99 75.64 0.28 Allowed Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.93 96.81 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.565 2.177 . . . . 0.0 112.227 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 6.8 ttp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 -179.904 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.785 0.244 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.6 mttt 61.69 102.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -60.77 136.91 58.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.43 93.82 4.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.63 -90.16 0.24 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.449 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.07 53.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.9 -140.1 3.73 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.74 -95.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.418 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -103.93 -31.2 9.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.56 152.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.79 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -95.55 43.8 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.973 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.35 -41.54 80.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.964 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.61 -76.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.19 40.26 0.45 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -158.96 -51.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.925 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 68.91 -67.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.37 128.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 62.37 123.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -108.11 59.6 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.42 29.34 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.861 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -64.79 127.8 33.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm 63.45 28.21 15.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -144.56 142.9 30.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -118.91 78.52 1.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.709 HD11 ' CE1' ' A' ' 119' ' ' TYR . 21.6 tp -89.96 125.91 35.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.705 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.73 140.65 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.688 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.758 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -110.75 170.41 8.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.347 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -47.78 144.13 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.709 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -119.51 164.6 15.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.405 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -56.53 131.49 48.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.726 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.03 -15.41 61.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.379 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -124.95 148.34 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.714 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.2 tt0 -124.21 154.41 40.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.231 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.0 p90 -84.18 157.89 21.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.788 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.72 14.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.27 0.557 . . . . 0.0 112.5 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.579 ' OE1' HD13 ' A' ' 89' ' ' ILE . 33.4 tp60 -129.94 109.14 10.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.12 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.511 ' CG2' HD11 ' A' ' 90' ' ' ILE . 26.7 t -56.32 141.18 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -115.67 -43.04 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.833 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 160.59 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -108.83 131.87 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.454 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -93.45 -29.19 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.991 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.15 -175.37 32.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -73.33 95.28 2.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.01 -28.16 2.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.783 ' CD ' HD12 ' A' ' 55' ' ' LEU . 26.2 ptt180 -150.27 160.22 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.989 HD22 HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.66 154.77 41.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.905 ' HB2' HD21 ' A' ' 55' ' ' LEU . 17.1 tt0 -99.72 121.6 41.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.771 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.509 ' C ' HD11 ' A' ' 52' ' ' ILE . . . -130.11 157.41 42.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.084 0.469 . . . . 0.0 111.879 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.416 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -114.9 105.36 12.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.31 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.1 m -56.98 127.55 32.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.47 -25.45 1.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.672 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 -9.94 59.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.265 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.02 37.23 4.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 70' ' ' ARG . 21.2 t -127.01 118.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 111.342 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' CA ' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.41 118.01 25.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.622 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' HG3' HG12 ' A' ' 68' ' ' VAL . 7.4 mtm180 -145.09 161.99 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.247 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.866 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -102.34 117.75 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.795 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.6 ' SG ' HG11 ' A' ' 92' ' ' VAL . 9.3 m -99.71 119.44 38.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -77.05 149.22 35.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.573 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.494 HD12 ' CD1' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -68.83 129.51 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.767 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -53.08 159.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.316 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.03 -52.21 2.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -74.31 -33.94 63.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 110.399 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.613 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -74.71 -19.79 60.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.784 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.774 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -50.36 -27.26 5.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.04 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -60.31 -30.46 69.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -153.97 36.53 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 79' ' ' ARG . 7.7 p -105.08 111.0 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.083 0.468 . . . . 0.0 110.957 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -111.23 110.21 20.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.789 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.989 HD13 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.06 147.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.896 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -129.5 161.52 30.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 52' ' ' ILE . 88.2 m -80.0 -6.63 57.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.049 0.452 . . . . 0.0 111.73 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 p -144.61 71.74 1.32 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.7 159.55 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.141 0.496 . . . . 0.0 111.537 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.889 HG21 ' CD1' ' A' ' 116' ' ' LEU . 30.1 mm -86.88 147.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.2 mt -150.54 171.23 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.399 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.75 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -127.81 122.28 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.596 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 104' ' ' VAL . 33.2 m -121.73 153.69 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.443 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.77 140.51 15.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.37 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.714 HD11 ' HB2' ' A' ' 47' ' ' GLU . 4.0 mt -113.86 177.12 4.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 0.0 111.003 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.81 8.7 6.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.454 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -93.44 -38.84 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.845 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -105.63 22.86 14.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 69.1 30.54 4.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 11.1 t0 81.07 162.79 0.16 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 9.0 t-20 84.86 -18.69 0.38 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.448 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HE2' HD23 ' A' ' 71' ' ' LEU . 15.6 mmtp -142.0 151.43 42.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -139.67 -177.06 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.9 116.04 10.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.785 ' HA ' HG12 ' A' ' 92' ' ' VAL . 91.4 t -51.22 111.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.979 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -83.18 -50.37 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 0.0 109.813 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.053 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -136.19 168.95 18.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.653 ' N ' HD12 ' A' ' 106' ' ' LEU . 11.1 ttpt -111.37 121.74 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.053 ' CE1' HD11 ' A' ' 106' ' ' LEU . 21.6 m-85 -86.77 106.47 17.71 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.93 175.4 5.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -75.68 -41.79 52.9 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.768 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -61.5 -40.22 93.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.67 ' O ' HD23 ' A' ' 116' ' ' LEU . 18.4 mt-10 -67.12 -28.23 67.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.544 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.957 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.56 -47.83 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.876 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -56.52 -29.49 61.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.396 0.617 . . . . 0.0 109.503 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.695 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -75.89 -22.18 56.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.246 178.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.34 -35.68 28.89 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.287 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -54.55 -34.78 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.17 -20.46 44.78 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.932 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.758 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.8 m-30 -66.35 -5.49 10.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.781 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 24.9 57.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.582 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 57.0 mm-40 -114.11 -60.37 1.89 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.278 . . . . 0.0 111.318 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.76 139.16 24.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.083 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 24.2 Cg_exo -63.13 -178.99 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.531 2.154 . . . . 0.0 112.129 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.66 -26.86 62.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.064 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 15.6 p-80 -82.98 -9.67 59.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.503 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -55.96 135.25 52.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.333 . . . . 0.0 111.182 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -121.99 127.6 50.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.957 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.0 mt -98.16 152.01 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -68.31 95.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.796 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 45.65 -169.59 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.357 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.4 m -141.58 156.44 45.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -40.46 119.23 1.05 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.734 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 114.92 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.35 103.26 4.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -133.49 83.36 0.29 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.416 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.77 -32.09 19.23 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.536 2.157 . . . . 0.0 112.339 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.48 161.65 50.61 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.51 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 60.23 107.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.29 34.36 5.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -150.23 143.74 25.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 69.31 -64.95 0.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.062 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.22 150.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.075 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 61.74 77.23 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.76 -49.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.11 -21.72 17.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.486 ' C ' HD12 ' A' ' 147' ' ' ILE . 0.4 OUTLIER 66.09 22.42 11.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.117 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 147' ' ' ILE . 3.6 mp 50.1 31.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.893 0.378 . . . . 0.0 111.383 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.08 -120.53 10.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.458 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.7 t0 59.56 165.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.33 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -89.35 109.93 20.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -172.25 -44.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 63.53 143.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -126.4 71.9 1.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.4 pt -148.58 99.74 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -128.98 102.47 6.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -115.51 30.83 7.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.764 179.915 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.29 48.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.05 80.22 0.88 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.548 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -117.66 145.15 44.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.342 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -120.86 50.13 1.39 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.84 175.56 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.77 -75.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -159.43 78.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.88 -27.32 21.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.411 ' O ' ' N ' ' B' ' 12' ' ' ASP . 15.3 m-70 69.97 -66.54 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' B' ' 12' ' ' ASP . 5.9 p 64.53 -71.45 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.177 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ASP . . . . . 0.469 ' N ' ' OG1' ' B' ' 11' ' ' THR . 1.0 OUTLIER 49.55 63.39 10.34 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 111.171 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.59 -173.71 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.531 2.154 . . . . 0.0 112.284 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.816 -179.982 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.789 0.246 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -76.53 -175.79 3.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.53 66.28 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -30.52 70.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.96 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.44 134.98 12.01 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -152.43 156.57 39.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.87 -40.99 2.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.343 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.83 101.49 2.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.372 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -58.31 9.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 0.0 110.981 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -118.35 171.49 8.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.965 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.56 175.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.714 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 25.39 10.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.09 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.68 68.74 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.866 0.365 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 177.96 1.98 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.594 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.96 52.88 2.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 110.781 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 62.25 62.51 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.811 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 64.08 16.1 9.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.352 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t30 47.49 92.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.774 0.321 . . . . 0.0 111.163 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -161.28 -169.34 2.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.3 p 62.9 32.81 15.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -100.65 122.8 43.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 175.43 5.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -80.81 103.46 10.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.42 128.98 53.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.896 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.644 HD11 ' HE1' ' A' ' 119' ' ' TYR . 25.4 tp -77.17 117.27 18.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.462 ' CG1' HD22 ' A' ' 106' ' ' LEU . 21.4 t -105.34 139.15 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.609 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 81.0 m-85 -114.28 170.42 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.672 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HA ' HD22 ' A' ' 91' ' ' LEU . 5.9 ttpm? -47.09 152.64 0.53 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.14 159.52 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.933 0.397 . . . . 0.0 111.155 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.35 127.66 33.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.853 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.24 61.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.618 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.518 ' CB ' HD11 ' A' ' 91' ' ' LEU . 12.8 mt-30 -115.84 146.38 42.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' CB ' HD11 ' A' ' 94' ' ' LEU . 47.3 tp10 -120.6 156.05 32.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 111.405 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 65' ' ' PHE . 1.9 p90 -84.48 157.79 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.985 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.62 173.3 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 112.141 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 62.8 tp60 -128.68 109.59 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.678 ' CG2' HD11 ' A' ' 90' ' ' ILE . 2.7 t -54.25 135.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.975 0.417 . . . . 0.0 111.853 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.932 HD13 ' HB3' ' A' ' 63' ' ' MET . 1.0 OUTLIER -115.67 -44.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.842 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -141.51 162.25 35.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.693 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.3 ttt -116.22 143.14 45.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -111.24 -57.74 2.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.705 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 149.02 9.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.607 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.89 74.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.045 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.917 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 55.1 34.04 58.1 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.705 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.892 ' HB3' HD12 ' A' ' 55' ' ' LEU . 14.7 mmt180 -144.94 129.73 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.411 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.858 HD22 HG12 ' A' ' 84' ' ' ILE . 1.1 pp -147.03 138.92 24.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.692 ' HB2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -90.95 121.25 32.62 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . . . -122.37 164.62 17.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 112.026 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.932 ' HB3' HD13 ' A' ' 52' ' ' ILE . 4.9 tpt -130.6 95.29 3.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.27 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.3 130.66 43.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.301 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 8.5 m-85 -49.57 -24.59 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.765 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.31 -9.19 58.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.258 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.5 5.34 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.65 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.18 110.98 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.197 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.25 122.27 35.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -145.23 165.67 27.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.075 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.022 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -93.5 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.548 ' SG ' HG11 ' A' ' 92' ' ' VAL . 32.8 m -90.92 134.28 34.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.572 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.39 131.29 34.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.917 HG22 ' HA2' ' A' ' 58' ' ' GLY . 17.4 tt -68.52 140.77 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.941 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.434 ' CB ' ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -62.72 151.95 37.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.82 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.36 -43.0 26.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.667 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -76.03 -31.38 58.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 75' ' ' ARG . 3.1 mm? -75.73 -50.61 14.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.6 -25.33 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -51.36 -39.76 57.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.014 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -141.52 13.0 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.452 HG22 ' HD3' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -124.32 120.69 59.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.982 0.42 . . . . 0.0 111.092 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -110.96 115.04 28.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.655 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.858 HG12 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -64.06 131.83 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 110.597 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.565 ' O ' HG21 ' A' ' 51' ' ' VAL . 5.6 m-80 -98.18 156.46 16.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.172 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 86' ' ' THR . 77.0 m -76.28 -6.45 51.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.887 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.58 80.71 1.77 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.86 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 162.85 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.967 0.413 . . . . 0.0 111.302 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 116' ' ' LEU . 29.8 mm -86.84 146.78 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.328 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.801 HD13 HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.68 171.22 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.679 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.722 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.61 121.81 29.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.661 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.78 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.3 m -118.63 148.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.115 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.79 139.19 15.68 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.795 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -125.43 137.11 53.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.726 0.298 . . . . 0.0 110.623 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -177.23 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.109 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.71 -20.61 61.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.254 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -72.3 -10.58 59.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.309 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 9.2 mt-30 68.57 28.35 5.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.367 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 8.8 t0 79.17 -47.25 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.668 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -43.0 -30.3 0.41 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.33 164.09 29.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -146.77 -177.31 5.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -137.9 112.92 9.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.78 ' HA ' HG12 ' A' ' 92' ' ' VAL . 60.3 t -50.36 111.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.9 mm -87.9 -55.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.157 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.034 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -131.28 163.79 27.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.503 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.586 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -109.41 115.63 30.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.034 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.7 m-85 -79.02 106.29 10.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -69.52 175.72 3.92 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.625 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.72 -40.2 49.4 Favored 'General case' 0 C--O 1.229 0.023 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.796 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.43 -40.11 93.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.71 ' O ' HD23 ' A' ' 116' ' ' LEU . 17.4 mt-10 -66.94 -28.35 68.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.882 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.55 -46.31 7.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.871 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -30.26 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -77.91 -22.29 49.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.153 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.914 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.16 -32.65 23.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.147 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -54.93 -33.85 62.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -21.91 41.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.76 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.675 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -66.93 -13.16 61.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.75 28.23 69.67 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.635 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.531 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.4 mt-10 -113.2 -53.74 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 111.255 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.595 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -87.58 140.51 31.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.721 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 65.3 Cg_endo -73.66 179.41 5.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -28.05 66.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.987 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 47.0 p-80 -87.07 2.45 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.535 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.721 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -81.09 127.75 32.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.883 0.373 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.22 137.22 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.882 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.5 mt -94.58 152.2 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -70.55 66.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.99 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.07 -169.47 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.113 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.4 m -78.37 -35.18 47.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t0 63.49 133.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.0 p -60.98 -176.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -75.23 60.92 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.247 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.36 -147.06 25.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.493 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.71 111.42 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.518 2.145 . . . . 0.0 112.303 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.81 13.97 64.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.722 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.5 t70 67.91 -68.3 0.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.734 0.302 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -81.31 68.15 7.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.876 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -79.14 151.36 31.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.23 106.77 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mp -136.06 -46.63 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -95.64 -175.78 3.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 60.95 82.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -100.8 -46.54 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.988 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.31 34.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.8 mt -123.19 78.26 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.07 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.6 -30.61 8.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.52 114.27 3.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -169.05 133.22 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -153.08 149.74 28.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.845 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -125.22 -79.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 55.46 61.17 2.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 29.2 mt -89.63 89.04 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 59.44 69.74 0.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -98.5 101.02 12.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.2 tt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.029 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mmt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.855 0.359 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -145.37 106.11 4.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.969 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.86 -137.83 5.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.35 87.39 2.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 63.13 114.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 65.2 m170 -61.25 174.97 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 71.51 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.832 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -90.6 175.6 6.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.66 161.27 13.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.798 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.53 87.76 2.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 19.5 p -71.24 -31.12 67.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.12 82.22 1.11 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.77 148.56 65.3 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.619 2.213 . . . . 0.0 112.338 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' MET . . . . . 0.419 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' B' ' 14' ' ' MET . 48.0 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.863 0.276 . . . . 0.0 112.24 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.91 145.54 13.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -142.9 60.21 1.42 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? 59.38 80.31 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.74 -83.58 1.73 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -123.14 -174.24 2.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.49 -134.14 8.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.426 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.94 -177.91 44.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.499 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.15 164.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 110.96 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -175.89 135.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.68 42.46 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 61.14 164.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.6 -51.25 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.014 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 146.02 -18.17 1.76 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.749 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -55.95 -22.93 29.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.709 0.29 . . . . 0.0 111.268 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.44 39.66 6.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 0.0 110.778 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 4.3 tt0 -179.49 -37.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.94 -62.14 0.46 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.035 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.31 46.56 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.096 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 31' ' ' GLU . 15.9 t -97.88 54.05 1.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.65 70.64 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -101.24 115.92 31.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 63.16 120.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -68.3 78.98 0.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.616 HD12 ' HG2' ' A' ' 112' ' ' GLU . 11.2 tp -119.54 116.19 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' O ' ' HE1' ' A' ' 108' ' ' TYR . 18.3 t -129.22 141.04 47.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.802 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.745 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 1.7 m-85 -108.24 170.3 8.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.117 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 159.66 25.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.719 0.295 . . . . 0.0 110.697 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.12 175.44 10.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.128 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -47.15 130.87 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.18 -15.33 62.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.435 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.549 ' HB3' HD11 ' A' ' 91' ' ' LEU . 5.8 mt-30 -136.67 146.61 46.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.316 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.72 158.72 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.51 157.98 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.212 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 173.88 12.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.205 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.445 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -129.78 110.99 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.303 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 41.7 t -62.66 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.008 0.432 . . . . 0.0 111.799 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 86' ' ' THR . 25.0 mt -116.11 -39.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.917 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 151.06 42.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.977 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.56 ' CE ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -110.73 125.85 53.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.912 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -89.14 -166.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.611 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.81 69.85 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.77 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 3.8 p-10 178.41 55.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 110.965 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.63 28.05 62.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.835 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.878 ' CD ' HD12 ' A' ' 55' ' ' LEU . 12.9 ptp180 -144.81 167.27 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.734 0.302 . . . . 0.0 110.912 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.97 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.22 146.48 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.108 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.912 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.2 tt0 -91.83 122.61 34.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.188 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -137.39 163.23 31.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.263 0.554 . . . . 0.0 112.315 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 8.2 tpp -123.35 110.81 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -60.32 134.26 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.9 m-85 -47.8 -26.3 1.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.804 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.39 -8.04 54.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.427 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.08 44.17 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 t -127.12 118.35 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 0.0 111.288 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 2.8 ttmt -87.61 114.89 24.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.75 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -144.07 163.53 33.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -105.42 108.27 19.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 4.4 m -84.19 119.14 24.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.303 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -76.6 155.7 33.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.34 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 1.069 HD11 HD11 ' A' ' 84' ' ' ILE . 5.3 mm -68.36 123.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.416 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' NH2' HD12 ' A' ' 105' ' ' ILE . 13.5 tpt180 -53.93 162.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.434 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.01 -53.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.272 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -35.15 76.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 3.2 mm? -78.64 -11.28 59.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.181 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -48.79 -33.88 11.25 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.847 0.356 . . . . 0.0 111.334 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -56.31 -23.25 35.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -162.27 40.9 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.252 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 82' ' ' VAL . 14.6 p -82.7 110.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 110.742 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -112.21 110.14 20.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.626 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.069 HD11 HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -112.3 145.53 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.255 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.481 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m120 -132.05 163.65 27.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 52' ' ' ILE . 39.4 m -76.47 -6.63 52.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 111.653 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 m -148.36 72.34 1.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.658 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 159.79 39.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.167 0.508 . . . . 0.0 111.364 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.878 HG21 ' CD1' ' A' ' 116' ' ' LEU . 39.9 mm -87.11 145.99 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.183 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.688 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.3 mt -150.93 171.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.119 0.485 . . . . 0.0 111.392 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.732 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.4 125.83 39.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.53 178.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.681 ' N ' HD12 ' A' ' 91' ' ' LEU . 15.9 m -122.23 155.61 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.27 126.27 8.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.706 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -109.89 126.74 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 110.76 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 -177.94 -72.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.056 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.94 -12.08 60.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.371 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 103' ' ' ASP . 39.5 m-85 -90.49 17.51 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.686 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 65.81 23.54 11.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.563 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 t0 73.42 -58.12 0.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.544 0.211 . . . . 0.0 111.556 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -41.73 -33.44 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.41 ' CB ' ' HB3' ' A' ' 97' ' ' TYR . 3.7 mptt -113.91 161.94 17.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -157.67 131.59 8.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 31.9 t70 -90.7 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.643 ' CA ' HG12 ' A' ' 92' ' ' VAL . 91.5 t -51.56 111.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.515 HD12 ' NH2' ' A' ' 75' ' ' ARG . 41.2 mm -77.53 -36.52 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.559 . . . . 0.0 109.86 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.084 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.3 pp -155.11 170.75 21.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.358 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.657 ' N ' HD12 ' A' ' 106' ' ' LEU . 15.1 pttm -112.12 126.17 54.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.084 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.1 m-85 -92.98 106.71 18.63 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.411 ' OD1' ' CG ' ' A' ' 112' ' ' GLU . 47.0 p30 -85.55 -174.35 5.13 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.654 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.71 -41.31 60.42 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.199 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.27 -40.67 91.19 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.718 ' O ' HD23 ' A' ' 116' ' ' LEU . 18.0 mt-10 -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.305 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 1.087 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.51 -48.31 7.37 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.021 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -57.23 -28.85 63.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.413 0.625 . . . . 0.0 109.498 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -80.19 -22.96 41.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.296 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.906 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.34 -34.74 24.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.09 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -54.86 -33.95 62.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -20.05 45.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.142 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.745 ' CD1' ' CD1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.08 -6.8 14.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.759 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.33 66.68 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.377 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 55.3 mm-40 -119.95 -60.02 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.419 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.748 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -90.9 128.82 46.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 38.4 Cg_exo -59.8 -179.19 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.384 2.056 . . . . 0.0 111.914 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.72 -21.92 63.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.48 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.5 p-80 -88.08 -0.94 57.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.614 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.17 158.33 11.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -117.4 147.57 42.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.087 HD12 ' HB1' ' A' ' 113' ' ' ALA . 42.7 mm -98.74 158.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.484 ' N ' HG22 ' A' ' 128' ' ' ILE . 9.7 p30 -95.88 166.96 11.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 134' ' ' PHE . 0.7 OUTLIER -59.99 153.19 21.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.878 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 m -109.74 -61.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.528 ' O ' HG23 ' A' ' 133' ' ' THR . 24.2 t70 -41.1 -76.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.71 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 179.29 149.35 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.752 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 130' ' ' GLU . 22.3 p90 -165.2 46.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.49 -90.48 2.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.26 -32.6 6.47 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.57 2.18 . . . . 0.0 112.368 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.86 -162.32 25.17 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.2 t0 59.43 171.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.85 140.82 29.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -130.14 98.38 4.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -84.14 72.42 10.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.5 tt -64.66 131.97 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.048 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -129.24 179.08 5.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -62.85 103.38 0.44 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -103.91 30.26 5.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 178.5 93.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 23.6 mt -94.21 67.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.11 -30.49 75.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.418 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -136.13 171.85 13.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.75 105.48 3.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.32 85.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.36 144.91 51.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.853 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 142.11 30.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.9 mt -70.89 126.15 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 61.44 168.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -101.24 -28.62 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.801 HD13 ' OXT' ' A' ' 157' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.19 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.747 0.308 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -176.47 -61.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.86 67.45 0.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 93.2 p -114.95 150.82 35.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.762 0.315 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 159.42 18.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -170.28 -50.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.11 142.06 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.56 -60.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -160.79 -78.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.94 61.19 2.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 110.945 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.38 139.69 56.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 59.99 81.91 0.24 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.44 70.77 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.493 2.129 . . . . 0.0 112.285 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 5.0 mtt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.844 0.268 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -133.67 113.38 12.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -105.12 -80.74 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.46 93.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.836 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.73 -150.18 18.2 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.589 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -62.13 -35.8 79.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.97 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.59 -105.54 0.23 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.482 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.52 117.63 0.63 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.44 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.36 -43.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 69.42 -65.58 0.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.026 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 mtm-85 65.53 102.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -158.52 102.68 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -136.16 133.75 37.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.28 131.19 1.19 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.499 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.3 -26.85 12.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 0.0 110.977 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 63.18 41.97 7.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -109.44 103.07 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.768 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 59.9 70.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.796 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.93 105.29 8.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.24 140.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -123.11 137.68 54.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -60.36 119.86 8.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -62.91 115.19 4.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.811 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -57.77 109.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.699 HD12 ' HG2' ' A' ' 112' ' ' GLU . 20.3 tp -72.99 101.57 3.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.499 ' CG1' HD22 ' A' ' 106' ' ' LEU . 14.4 t -91.38 139.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 111.377 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.2 m-85 -110.88 170.44 8.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.881 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.5 ttpp -52.98 152.5 3.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HB2' ' NE2' ' A' ' 46' ' ' GLN . 34.4 mt-10 -123.8 157.61 33.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.44 . . . . 0.0 111.45 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.95 132.47 49.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.93 -15.55 60.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.514 ' CB ' HD11 ' A' ' 91' ' ' LEU . 6.4 mt-30 -116.8 151.46 36.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.704 0.288 . . . . 0.0 110.521 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.773 ' HB3' HD11 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -124.42 149.45 46.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.18 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 3.2 p90 -84.21 157.58 21.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.703 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.82 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.287 0.565 . . . . 0.0 112.502 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.419 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 34.1 tp60 -130.31 119.79 23.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.808 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 85' ' ' ASN . 10.7 t -70.24 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -115.7 -43.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.867 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 162.04 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.755 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.35 143.64 34.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.652 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 71' ' ' LEU . 6.2 mt -108.09 -30.4 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.34 -166.25 31.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.38 99.18 8.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 136.67 -24.84 3.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.616 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.74 ' HG3' HD12 ' A' ' 55' ' ' LEU . 8.7 ptp180 -152.88 159.78 43.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.643 HD22 HG21 ' A' ' 84' ' ' ILE . 1.1 pp -147.41 158.25 43.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.636 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -91.94 121.56 33.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.535 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.29 165.93 24.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.274 0.559 . . . . 0.0 112.276 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.876 ' HB2' HD11 ' A' ' 52' ' ' ILE . 2.1 tpp -134.84 111.97 10.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.186 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.08 132.91 55.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.21 -26.3 1.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.876 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -74.47 -14.22 60.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.402 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.97 42.9 1.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.39 112.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.187 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 23.5 tttt -84.27 112.76 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.624 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 101' ' ' LYS . 11.4 ptp180 -145.28 161.72 38.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -102.57 108.32 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.486 ' HB3' HG11 ' A' ' 92' ' ' VAL . 9.7 m -83.74 118.38 23.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.629 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 3.7 m-70 -79.52 131.89 36.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.768 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 82' ' ' VAL . 1.4 tt -68.5 137.12 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 171.59 -161.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.315 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.54 171.45 47.12 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.232 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.85 -25.74 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.646 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.659 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -75.62 -19.82 58.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.127 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -28.22 2.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 111.231 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -26.41 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -169.18 46.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.822 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 74' ' ' ILE . 14.9 p -87.23 126.64 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -106.92 110.22 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.643 HG21 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -94.72 147.31 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.571 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.441 ' O ' HG21 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -128.2 153.54 46.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.43 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 91.7 m -80.28 -7.01 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.715 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.7 m -142.98 53.49 1.37 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.526 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.2 167.02 23.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.488 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.893 HG21 ' CD1' ' A' ' 116' ' ' LEU . 27.9 mm -90.67 146.02 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.233 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -150.12 171.2 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.095 0.474 . . . . 0.0 111.237 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.729 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -130.18 122.43 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.866 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.739 HG12 ' HA ' ' A' ' 104' ' ' VAL . 27.0 m -117.51 147.85 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.88 132.05 11.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.784 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -118.92 107.9 14.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -162.6 -79.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.939 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.6 -15.99 63.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.115 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.476 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 4.7 m-85 -72.22 -8.37 54.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.648 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 68.16 29.41 6.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.263 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 72.24 -174.42 0.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.69 -61.59 0.5 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.82 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -111.98 171.09 7.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -156.85 170.91 21.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.872 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -119.73 124.98 47.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.739 ' HA ' HG12 ' A' ' 92' ' ' VAL . 86.9 t -53.08 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.03 -54.99 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.046 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -133.19 166.62 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.414 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.596 ' N ' HD12 ' A' ' 106' ' ' LEU . 14.7 pttm -110.56 118.62 36.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.072 0.463 . . . . 0.0 112.185 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.046 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.0 m-85 -82.82 106.54 14.74 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.63 176.69 7.41 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.882 ' HB3' HG23 ' A' ' 131' ' ' THR . . . -73.07 -44.41 60.6 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.105 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.25 -39.98 88.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.699 ' HG2' HD12 ' A' ' 39' ' ' LEU . 8.5 mt-10 -69.16 -29.31 67.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.586 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 1.101 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.96 -48.33 8.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.902 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 109.599 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.626 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -75.13 -22.07 58.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.147 178.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.893 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.24 -34.03 21.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 121.124 -0.231 . . . . 0.0 111.118 -179.267 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -34.63 63.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.44 42.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.612 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.68 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.2 m-30 -66.55 -11.98 55.5 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.13 29.21 67.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.521 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 25.3 mm-40 -115.69 -50.24 2.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.738 0.304 . . . . 0.0 111.243 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.602 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -94.92 140.65 22.57 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.09 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.465 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 24.4 Cg_exo -63.09 -178.86 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.477 2.118 . . . . 0.0 112.05 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.26 -28.03 63.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.002 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 13.7 p-80 -78.92 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.24 130.89 36.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 111.272 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.63 148.55 33.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.101 HD12 ' HB1' ' A' ' 113' ' ' ALA . 26.7 mm -91.09 154.45 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.4 ' N ' HG22 ' A' ' 128' ' ' ILE . 0.7 OUTLIER -91.44 172.84 8.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.15 133.59 47.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.882 HG23 ' HB3' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -78.08 -169.48 1.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.833 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.448 ' H ' HG22 ' A' ' 131' ' ' THR . 0.8 OUTLIER 61.85 173.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.859 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.02 -176.28 3.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.92 63.67 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.843 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.78 85.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.516 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.65 147.45 63.59 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.586 2.191 . . . . 0.0 112.303 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -139.34 168.03 25.03 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.8 t0 61.81 34.45 17.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -141.87 83.45 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -68.44 151.65 46.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 59.96 176.88 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 142' ' ' ILE . 8.4 tt -105.39 59.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.004 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.63 -16.67 13.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.256 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 68.24 -75.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.808 0.337 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -148.48 -75.06 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.7 t0 59.74 89.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.828 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.7 mt 65.87 125.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.067 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.34 96.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -128.16 -54.53 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -68.23 146.46 53.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -59.89 126.61 28.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -157.87 35.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 -30.2 11.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 154' ' ' ILE . 2.3 mp -60.6 109.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.001 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -164.79 -46.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 157' ' ' ILE . 1.0 OUTLIER -102.09 -72.0 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 156' ' ' ASP . 2.0 tt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.394 -0.813 . . . . 0.0 111.461 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.858 0.361 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 59.82 78.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.22 -59.72 0.14 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.0 t -174.77 120.02 0.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.815 0.341 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.5 166.63 32.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.957 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.65 31.62 20.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -133.24 -176.52 4.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.79 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -104.14 95.04 5.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 143.06 49.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -68.03 73.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 7.8 p -99.75 -31.93 11.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -148.51 82.78 7.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.97 79.34 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.501 2.134 . . . . 0.0 112.291 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 3.7 mtt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.823 0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -155.55 87.52 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -114.43 36.39 3.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -76.11 76.72 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.78 131.96 9.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 90.68 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.837 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.24 63.65 4.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.533 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.93 179.74 26.42 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.71 166.33 21.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -163.7 36.03 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.788 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -97.25 -34.86 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -97.86 133.0 42.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -112.58 -46.95 3.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -127.98 -110.15 1.55 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.503 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttp 68.46 -68.9 0.16 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.309 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 51.5 -176.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -99.44 -82.4 0.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.879 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 58.87 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.994 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 31' ' ' GLU . 21.1 mt-10 -146.5 28.78 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 110.887 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 m -108.29 33.16 4.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.89 84.16 2.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.39 160.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -59.64 129.49 42.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -112.4 73.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.042 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.591 HD21 ' CB ' ' A' ' 115' ' ' SER . 14.2 tp -84.32 113.5 21.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.549 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.01 140.9 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.745 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.7 m-85 -107.75 169.84 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.089 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 137.83 58.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.506 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' NE2' ' A' ' 46' ' ' GLN . 11.8 pt-20 -112.87 175.27 5.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.063 0.458 . . . . 0.0 111.478 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -50.71 133.92 25.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.129 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.27 -15.36 60.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.463 ' NE2' ' HG3' ' A' ' 43' ' ' GLU . 2.3 mt-30 -130.94 148.31 52.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 110.573 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.554 ' H ' HD21 ' A' ' 94' ' ' LEU . 2.2 tt0 -130.22 159.89 35.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.086 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.31 158.16 21.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.007 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.99 173.56 14.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.246 0.546 . . . . 0.0 112.189 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -129.71 129.73 44.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.029 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 60' ' ' LEU . 47.4 t -81.82 140.77 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 0.0 112.019 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.467 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -116.42 -41.45 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.1 160.39 40.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.698 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.622 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -117.04 146.67 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -110.21 -29.79 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.913 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.94 176.77 18.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.62 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.08 107.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.821 0.344 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 132.61 -33.9 2.57 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.527 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.7 ' HD2' HD12 ' A' ' 55' ' ' LEU . 18.4 ptt180 -153.31 159.52 42.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.995 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.685 ' CD2' HG21 ' A' ' 84' ' ' ILE . 1.6 pp -147.59 155.81 42.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.048 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.866 ' HB2' HD21 ' A' ' 55' ' ' LEU . 15.6 tt0 -92.1 121.71 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.081 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.21 165.6 32.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.53 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.467 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.47 134.6 39.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.324 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.8 m -63.92 142.6 58.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.608 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 1.6 m-85 -51.17 -23.98 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.346 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.13 -11.1 60.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.35 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.98 41.13 2.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.783 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.615 HG11 HH21 ' A' ' 70' ' ' ARG . 21.2 t -127.02 110.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.007 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -82.2 116.41 21.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.051 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.615 HH21 HG11 ' A' ' 68' ' ' VAL . 8.9 ptp180 -145.05 155.77 43.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.73 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -89.68 106.93 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.579 ' HB3' HG11 ' A' ' 92' ' ' VAL . 13.6 m -84.27 118.66 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.676 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -81.92 137.9 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 82' ' ' VAL . 5.1 tt -68.68 140.13 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.782 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.31 143.45 44.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.25 38.87 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -62.88 -32.69 73.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HB ' ' A' ' 82' ' ' VAL . 1.1 mm? -82.91 -29.4 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.636 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.631 ' HA ' HG12 ' A' ' 82' ' ' VAL . 3.0 mtp180 -49.25 -27.74 4.03 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.267 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -64.32 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.0 45.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 74' ' ' ILE . 9.3 p -121.33 120.99 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.974 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 110.19 20.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.685 HG21 ' CD2' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -89.69 147.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.463 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -123.12 159.28 28.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.247 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 86' ' ' THR . 63.3 m -80.32 -5.91 57.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.442 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 70.05 0.95 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.636 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.14 165.73 35.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.224 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.894 HG21 ' CD1' ' A' ' 116' ' ' LEU . 45.9 mm -87.22 143.97 10.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.236 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.64 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.3 mt -150.35 171.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.046 0.45 . . . . 0.0 111.213 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.731 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -126.54 122.26 34.62 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.587 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.642 HG12 ' CA ' ' A' ' 104' ' ' VAL . 12.8 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.049 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.45 120.21 6.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.671 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.86 117.28 33.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.896 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -73.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.29 -25.97 62.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.424 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -91.62 14.25 15.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.547 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 20.2 mt-30 65.79 24.57 11.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.32 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 5.5 m-20 81.6 -45.65 0.2 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -42.29 -38.3 1.77 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.553 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.56 165.25 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.365 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -158.91 132.05 7.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.18 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -88.96 128.02 35.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.642 ' CA ' HG12 ' A' ' 92' ' ' VAL . 94.1 t -53.24 111.85 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.849 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.1 mm -78.21 -45.65 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -144.29 169.93 16.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.401 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.662 ' N ' HD12 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -111.79 123.77 50.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.063 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.6 m-85 -88.5 106.41 18.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -75.4 179.86 4.96 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.644 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.0 -42.21 39.6 Favored 'General case' 0 C--O 1.228 -0.068 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.431 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -61.15 -40.03 92.32 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.684 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.5 mt-10 -67.54 -27.85 67.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.461 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.4 -49.31 7.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.032 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -56.3 -27.4 55.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 109.577 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.09 -22.7 41.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.136 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.894 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.46 -34.36 24.54 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.028 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -55.0 -34.12 63.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.11 -20.59 44.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.849 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.56 -5.98 13.39 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.802 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.41 26.29 61.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.448 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 56.2 mm-40 -115.91 -60.76 1.83 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.87 124.89 59.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.539 ' HB2' ' CD2' ' A' ' 125' ' ' HIS . 40.6 Cg_exo -56.88 179.75 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.431 2.088 . . . . 0.0 112.257 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -25.06 65.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.095 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.539 ' CD2' ' HB2' ' A' ' 123' ' ' PRO . 32.6 p80 -85.89 -17.13 36.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.39 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -52.86 139.4 27.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.808 0.337 . . . . 0.0 111.24 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -117.76 137.89 52.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 113' ' ' ALA . 4.4 mt -99.45 148.84 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -61.05 164.49 5.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.45 141.07 56.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.628 HG23 ' HB1' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -79.39 171.88 14.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -41.02 117.08 0.81 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.702 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -94.03 150.92 19.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.02 72.44 10.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.13 -93.78 2.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.54 166.59 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.571 2.181 . . . . 0.0 112.264 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -172.65 167.11 39.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 165.13 121.64 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.86 0.362 . . . . 0.0 110.683 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.31 31.28 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 p30 43.19 50.97 5.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.378 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -168.88 153.98 6.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.744 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 30.0 mm -73.7 -39.58 53.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -134.34 144.45 48.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -171.78 83.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -174.83 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.967 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 60.75 -174.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.0 pt -131.69 81.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.296 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.16 91.31 0.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.566 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.7 p30 -57.95 162.22 3.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.27 69.39 4.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.09 -48.66 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.34 146.34 55.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.45 -47.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 25.6 mm -80.32 76.91 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -140.48 31.85 1.88 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.37 -30.49 68.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.498 ' C ' HD12 ' A' ' 157' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.082 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.871 0.367 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -101.16 96.47 7.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 129.5 173.58 13.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.79 158.35 3.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -149.09 173.86 12.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -117.94 37.98 3.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 92.81 3.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.08 93.1 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.862 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.27 156.12 2.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.988 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -117.79 -177.42 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.6 m -134.2 135.17 42.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -116.83 88.08 24.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.39 172.01 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.551 2.168 . . . . 0.0 112.331 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.749 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 CA-C-O 120.814 0.256 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -80.62 60.45 3.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.801 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.458 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -148.74 64.52 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.86 137.99 58.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.943 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.12 -142.16 17.2 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.553 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 tttm 60.8 74.71 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.982 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.43 48.35 0.95 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.42 47.63 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.572 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -106.64 42.25 1.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -63.51 113.11 3.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.61 177.3 5.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.009 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -35.0 77.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.983 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 60.43 90.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.07 -105.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER 62.15 157.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.704 0.288 . . . . 0.0 110.776 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 37.0 t30 172.69 58.11 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.472 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 61.55 28.21 17.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.19 40.93 27.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.985 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.39 141.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.834 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -94.44 101.84 13.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -176.02 79.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.9 mttt 179.97 122.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.829 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -69.87 137.71 51.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -112.75 86.01 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.561 HD11 ' HE1' ' A' ' 119' ' ' TYR . 24.8 tp -86.81 128.63 35.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.793 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 t -127.31 140.68 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.832 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.749 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -112.72 170.39 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.346 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -52.68 149.58 5.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.729 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.82 164.61 27.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 111.5 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.89 132.99 37.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.76 -15.34 60.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.469 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.527 ' HB3' HD11 ' A' ' 91' ' ' LEU . 17.0 mt-30 -134.73 137.21 43.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.858 ' HB2' HD11 ' A' ' 94' ' ' LEU . 3.7 tt0 -117.23 155.22 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 111.276 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 5.3 p90 -84.02 157.65 21.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.622 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.76 173.89 12.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.593 . . . . 0.0 112.521 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.528 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -131.01 117.13 18.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.037 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 60' ' ' LEU . 41.5 t -67.46 138.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 112.065 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.09 -41.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.556 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 161.33 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.745 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.573 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -116.4 144.2 44.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.722 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.805 HD11 HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -105.54 -27.98 11.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.026 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.04 59.14 10.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -177.61 63.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.1 20.73 50.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.637 ' HB2' HD12 ' A' ' 55' ' ' LEU . 1.3 mtm105 -152.36 163.53 39.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.851 HD22 HG21 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -147.85 145.23 28.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.609 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.746 ' HB2' HD21 ' A' ' 55' ' ' LEU . 6.7 tt0 -91.09 120.77 32.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.44 165.62 32.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 111.665 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 9.8 ptp -138.98 128.0 23.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.59 146.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.286 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.462 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.9 m-85 -50.33 -20.68 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.811 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 68' ' ' VAL . 29.1 p30 -73.62 -8.18 54.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.61 0.243 . . . . 0.0 111.324 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 41.03 4.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 63' ' ' MET . 20.1 t -127.15 110.27 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.659 0.266 . . . . 0.0 111.1 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -83.59 120.14 25.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 165.7 27.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.303 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.805 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -95.68 105.69 17.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.682 ' HB3' HG11 ' A' ' 92' ' ' VAL . 11.8 m -89.14 118.47 28.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 39.6 m170 -76.6 139.15 40.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.699 HD11 HG13 ' A' ' 82' ' ' VAL . 5.6 tt -68.52 138.49 22.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.86 151.92 24.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.073 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.66 -39.28 18.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.46 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -78.52 -30.75 47.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.516 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.3 mm? -77.86 -29.56 50.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.498 ' HA ' HG12 ' A' ' 82' ' ' VAL . 21.4 ptt180 -48.97 -26.9 2.77 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.34 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -38.91 74.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.313 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 48.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.363 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.699 HG13 HD11 ' A' ' 74' ' ' ILE . 8.5 p -124.18 119.74 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -110.75 109.96 20.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.991 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.851 HG21 HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -80.95 139.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.2 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 14.6 m-80 -110.57 160.51 16.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 0.0 111.529 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.433 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 66.1 m -80.3 -6.2 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.525 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -147.79 70.33 1.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 85' ' ' ASN . 0.5 OUTLIER -154.19 164.63 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.223 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.862 HG21 ' CD1' ' A' ' 116' ' ' LEU . 46.7 mm -89.4 144.39 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.341 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.676 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.22 171.13 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.047 0.451 . . . . 0.0 111.101 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 92' ' ' VAL . 0.2 OUTLIER -126.94 125.75 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.638 178.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.4 m -125.62 156.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.259 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.25 127.88 9.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.54 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -105.24 177.45 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.76 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.27 -51.12 0.43 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.522 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -41.07 12.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 111.452 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.53 23.08 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 69.17 30.24 4.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.801 0.334 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.6 175.94 0.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.618 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.34 -57.19 0.56 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.063 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.83 149.24 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.467 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -139.24 -179.37 5.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.962 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.79 121.37 19.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.764 ' HA ' HG12 ' A' ' 92' ' ' VAL . 85.5 t -51.07 111.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.683 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.27 -37.44 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 0.0 109.768 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.057 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -150.93 168.54 24.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.36 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.65 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -112.32 121.2 44.22 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.057 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.3 m-85 -86.34 106.29 17.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.42 176.6 5.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.9 -39.75 49.78 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.967 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -40.95 98.52 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.652 ' O ' HD23 ' A' ' 116' ' ' LEU . 10.4 mt-10 -66.27 -27.78 68.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.417 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.819 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.38 -48.26 6.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.055 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -27.66 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.425 0.631 . . . . 0.0 109.492 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.63 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -79.17 -22.71 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.202 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.862 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.37 -35.28 27.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.221 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -34.42 62.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.23 -20.3 44.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.013 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.749 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.51 -4.36 8.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.808 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 24.77 58.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.597 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 42.3 mm-40 -115.35 -60.93 1.82 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.808 0.337 . . . . 0.0 111.266 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.32 126.36 46.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 36.7 Cg_exo -57.41 179.82 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.417 2.078 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.39 -23.36 64.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.449 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 37.2 p-80 -90.67 2.48 55.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.582 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.24 147.71 50.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -115.61 136.68 52.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.048 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.797 HD13 ' HB1' ' A' ' 113' ' ' ALA . 7.3 mt -109.98 157.66 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.478 ' N ' HG22 ' A' ' 128' ' ' ILE . 9.6 t-20 -103.53 130.0 50.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.973 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 56.86 104.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.101 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 -23.48 16.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.065 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 44.4 67.34 0.7 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.905 0.383 . . . . 0.0 111.45 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 m -85.05 149.81 25.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -134.88 45.82 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.54 -150.78 26.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.606 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -51.06 162.97 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.671 2.248 . . . . 0.0 112.348 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.18 93.61 1.87 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.584 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.7 t70 62.94 127.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 111.06 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -133.25 87.67 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -61.27 104.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -103.73 136.11 44.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 142' ' ' ILE . 3.6 mp -95.89 -55.06 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 62.55 146.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.817 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.3 39.68 3.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -74.4 96.3 2.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.29 141.95 40.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 147' ' ' ILE . 8.6 tp -133.85 73.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.77 -157.27 7.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.388 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.39 132.69 50.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 110.848 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -107.8 142.16 38.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -152.21 150.58 29.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -166.97 150.82 6.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.19 115.86 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 21.4 mt -109.41 140.8 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -97.36 143.6 27.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.5 t70 60.71 110.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.579 ' OXT' HG22 ' A' ' 157' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.009 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 30.6 ttp . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.822 0.344 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.2 82.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.41 142.25 4.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.408 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m 69.52 -65.12 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.729 0.3 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.82 131.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -130.83 130.04 43.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -61.89 108.05 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -92.49 96.25 10.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.13 135.97 48.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 124.19 20.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 69.7 p -75.73 -6.58 51.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.46 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -55.8 109.36 1.59 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.638 0.256 . . . . 0.0 111.038 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.27 -59.45 1.19 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.502 2.135 . . . . 0.0 112.441 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.731 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 CA--C 1.527 0.156 0 CA-C-O 120.695 0.206 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 56.35 35.1 25.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.005 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -59.64 158.14 10.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -59.66 93.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.38 -162.67 25.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.76 103.68 1.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.742 0.306 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.29 140.55 4.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.451 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.57 76.18 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.461 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.42 93.54 2.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -84.98 -175.78 5.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.04 123.46 27.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.71 82.35 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -113.62 -51.73 2.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.52 -74.89 0.43 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.507 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.85 -176.31 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.686 0.279 . . . . 0.0 110.875 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 45.78 -171.28 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.551 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.87 -176.87 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.718 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.6 t30 63.78 77.54 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -139.9 55.66 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -137.4 73.83 1.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -101.01 111.31 23.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -108.22 166.82 10.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.51 158.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.65 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -148.75 130.06 14.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.793 HD11 ' HE1' ' A' ' 119' ' ' TYR . 39.4 tp -96.48 125.38 40.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.558 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.57 140.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.944 0.402 . . . . 0.0 111.897 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.77 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.3 m-30 -112.34 170.44 8.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.466 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.42 150.74 4.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -127.76 165.12 20.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.701 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.35 133.05 49.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.97 -15.5 60.72 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.447 ' CB ' HD11 ' A' ' 91' ' ' LEU . 14.3 mt-30 -126.43 140.04 52.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.9 150.32 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.147 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 6.4 p90 -84.35 156.32 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.887 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.76 173.26 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.19 0.519 . . . . 0.0 112.219 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.735 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -119.08 153.9 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.362 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 90' ' ' ILE . 12.9 t -97.29 141.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.022 0.439 . . . . 0.0 112.142 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.794 ' O ' HG23 ' A' ' 86' ' ' THR . 0.7 OUTLIER -114.13 -52.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.44 162.22 36.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.588 ' HE3' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -114.66 126.48 54.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.124 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -96.59 -29.78 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.63 178.18 21.8 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -56.39 112.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.77 0.319 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.838 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 101.5 -13.68 58.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.727 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.755 ' HB3' HD12 ' A' ' 55' ' ' LEU . 9.0 mmt180 -138.78 121.88 16.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.242 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.729 HD22 HD13 ' A' ' 84' ' ' ILE . 1.3 pp -142.36 142.23 32.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.539 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.583 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.0 tt0 -90.7 121.67 32.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -127.2 162.12 26.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -123.08 101.62 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.216 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.17 133.32 49.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.402 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -49.34 -25.94 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.523 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -13.7 60.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.177 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.39 36.02 3.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.49 122.66 59.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 111.453 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 63' ' ' MET . 11.6 ptmt -95.12 121.72 37.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.603 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -144.12 165.59 27.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.17 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.124 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -94.02 105.68 17.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.437 ' SG ' HG11 ' A' ' 92' ' ' VAL . 29.8 m -88.82 125.05 34.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -83.27 142.02 31.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.619 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.838 HG22 ' HA2' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -68.79 138.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.94 155.23 20.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 0.0 111.001 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.17 -46.08 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.548 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -76.71 -42.22 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 0.0 110.783 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.658 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -67.03 -19.72 65.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.678 ' HA ' HG12 ' A' ' 82' ' ' VAL . 1.4 ptm180 -50.64 -28.11 8.22 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.827 0.346 . . . . 0.0 111.322 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -64.86 -29.54 70.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.618 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.99 40.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 79' ' ' ARG . 7.6 p -120.87 110.88 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 110.983 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 32.2 m0 -111.39 110.36 20.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.157 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.729 HD13 HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -86.45 145.47 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.454 ' O ' HG11 ' A' ' 51' ' ' VAL . 52.4 m-20 -132.11 164.93 25.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 52' ' ' ILE . 93.8 m -78.08 -6.5 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.761 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.4 73.99 1.45 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -165.34 161.24 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.261 0.553 . . . . 0.0 111.481 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.85 HG21 ' CD1' ' A' ' 116' ' ' LEU . 32.8 mm -92.28 149.12 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.011 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.728 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.19 173.56 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.638 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -130.11 126.88 38.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.566 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.688 ' N ' HD12 ' A' ' 91' ' ' LEU . 21.0 m -121.73 156.51 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.391 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.561 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -99.44 149.79 19.02 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.648 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.568 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -125.46 135.66 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.705 0.288 . . . . 0.0 110.799 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 -177.57 -76.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.188 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.9 -18.09 38.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.407 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 101' ' ' LYS . 42.9 m-85 -72.38 -9.26 58.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.551 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 72.16 29.39 2.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.746 0.307 . . . . 0.0 111.304 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.1 -55.75 0.64 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.42 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -42.03 -31.95 0.4 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 97' ' ' TYR . 24.5 mttt -128.22 164.45 22.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.673 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -151.41 177.28 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.19 116.95 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.658 ' CA ' HG12 ' A' ' 92' ' ' VAL . 80.5 t -49.93 111.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.972 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mm -82.26 -45.56 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.191 0.52 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.007 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.6 pp -142.41 161.15 38.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.779 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.614 ' HB3' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -104.53 118.1 35.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.999 0.428 . . . . 0.0 111.792 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.007 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.0 m-85 -81.11 106.47 13.13 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 167.15 4.78 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.73 -39.52 51.56 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.422 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.57 -40.06 95.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.639 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.4 mm-40 -68.09 -26.52 65.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.275 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 1.038 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -42.75 -48.98 5.72 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.835 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -29.76 63.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.399 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.613 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -73.39 -22.03 60.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.013 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.85 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -48.95 -35.52 15.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.236 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -54.53 -35.06 62.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.14 -20.31 45.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.927 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.793 ' HE1' HD11 ' A' ' 39' ' ' LEU . 3.6 m-30 -65.98 -7.69 18.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.559 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.49 27.31 67.72 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.511 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.46 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 50.4 mm-40 -118.49 -59.79 1.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.321 . . . . 0.0 111.289 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.0 142.17 24.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.061 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 31.5 Cg_exo -61.06 -179.75 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.583 2.189 . . . . 0.0 112.146 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.94 -25.88 59.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.993 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -82.56 1.46 37.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.534 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.41 138.35 55.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.375 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 148.2 32.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.038 HD12 ' HB1' ' A' ' 113' ' ' ALA . 21.7 mm -91.96 156.56 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.431 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 128' ' ' ILE . 9.1 m120 -102.75 96.71 7.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.771 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 64.41 131.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 m -104.94 -47.61 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.949 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.54 95.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.845 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.68 174.71 7.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.973 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.38 110.05 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.65 -54.54 25.16 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.639 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.74 160.56 2.7 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.608 2.205 . . . . 0.0 112.346 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.97 -115.03 4.38 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.3 t0 61.76 18.88 10.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.616 0.246 . . . . 0.0 111.184 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 51.48 29.64 5.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.771 0.32 . . . . 0.0 111.159 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -88.73 -69.08 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -173.85 98.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.5 mt -85.11 78.25 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.22 -32.28 9.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -97.6 83.78 3.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.01 -76.38 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -164.22 94.32 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.816 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.523 HG23 ' O ' ' A' ' 147' ' ' ILE . 18.6 tt -162.86 116.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.011 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.18 -163.55 34.5 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.516 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 59.87 168.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.0 110.822 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.15 117.32 5.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.75 163.92 37.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.69 -76.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.837 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 59.94 79.77 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.92 104.98 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -60.25 110.82 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.8 82.49 1.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.4 mm . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.109 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.803 0.335 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -77.36 71.52 3.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.31 -42.83 17.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -151.59 150.19 30.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.804 0.335 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -76.07 -63.56 1.29 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -86.12 171.52 11.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 63.35 126.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.916 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -122.11 137.37 54.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.43 138.59 43.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 61.68 54.59 2.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.827 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -27.88 14.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.023 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -105.49 86.48 1.75 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.1 -26.76 30.39 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.61 2.207 . . . . 0.0 112.276 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.826 0.261 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.3 104.19 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -143.56 -48.9 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -142.27 118.49 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.5 165.35 29.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.54 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -118.41 -47.05 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.8 91.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.482 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.82 107.11 0.73 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.84 40.36 3.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.856 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -140.0 61.96 1.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -71.33 174.51 6.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.02 -57.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.0 99.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.69 154.82 7.76 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.573 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -128.55 60.25 1.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 110.801 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 68.03 12.69 8.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.487 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 46.45 71.11 0.32 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.83 0.347 . . . . 0.0 111.288 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 63.48 141.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.827 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.08 -32.05 6.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m 61.8 84.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 62.82 120.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.16 125.09 2.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -59.2 154.35 16.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.815 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.02 105.35 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.097 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.564 HD12 ' CD ' ' A' ' 112' ' ' GLU . 33.4 tp -118.52 119.82 35.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.79 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 106' ' ' LEU . 14.9 t -104.52 139.47 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.046 0.451 . . . . 0.0 111.369 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 74.7 m-85 -114.09 170.4 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.862 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HA ' HD22 ' A' ' 91' ' ' LEU . 10.3 ttpt -48.6 153.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.941 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -116.09 162.05 17.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.19 125.97 25.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.83 -15.28 63.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.662 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.558 ' OE1' HD11 ' A' ' 91' ' ' LEU . 23.2 mt-30 -113.74 148.08 37.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.636 0.255 . . . . 0.0 110.567 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.833 ' HB2' HD11 ' A' ' 94' ' ' LEU . 32.2 tt0 -121.1 156.72 31.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.219 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 3.8 p90 -84.25 157.58 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.94 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.27 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -126.52 138.84 53.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.746 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 85' ' ' ASN . 15.2 t -88.92 144.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.905 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -116.38 -46.12 4.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.84 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.3 162.18 37.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.874 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.408 ' HE3' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -112.93 136.26 52.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.848 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -99.53 -32.4 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.91 169.84 17.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.526 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.83 101.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 110.986 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 139.83 -32.69 2.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.354 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.753 ' HD2' HD12 ' A' ' 55' ' ' LEU . 16.3 ptt-85 -151.35 159.61 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.874 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.88 HD22 HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.65 152.55 38.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.848 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.4 tt0 -91.66 121.66 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -136.43 165.8 24.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 112.181 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.905 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -127.18 113.07 15.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.8 m -59.01 133.86 56.47 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.444 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 1.3 m-85 -48.83 -25.36 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -9.82 58.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.76 42.96 2.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.684 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.405 HG11 ' NE ' ' A' ' 70' ' ' ARG . 15.4 t -127.41 125.61 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.339 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HB2' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.7 115.46 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.567 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' NE ' HG11 ' A' ' 68' ' ' VAL . 62.2 mtt180 -145.27 165.06 29.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.415 . . . . 0.0 111.276 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.718 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -106.36 108.41 19.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.472 ' HB3' HG11 ' A' ' 92' ' ' VAL . 16.4 m -84.16 118.85 24.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -81.46 143.18 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.787 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.491 HG22 ' HA2' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -71.93 129.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.835 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 14.2 tpt180 -69.45 143.84 53.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.733 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 79' ' ' ARG . . . -70.01 -57.34 7.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.362 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -52.71 -30.66 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.555 HD12 ' HB ' ' A' ' 82' ' ' VAL . 1.1 mm? -86.69 -28.37 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.834 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.659 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -49.34 -27.36 3.88 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.317 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.29 -33.34 67.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.3 45.17 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 79' ' ' ARG . 11.6 p -115.91 116.25 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 111.071 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.408 ' CH2' ' HE2' ' A' ' 107' ' ' LYS . 44.1 p90 -110.5 110.18 20.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.88 HD13 HD22 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -83.26 147.11 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.457 ' O ' HG21 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -115.44 152.97 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 86' ' ' THR . 75.6 m -80.28 -6.35 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 111.886 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 p -148.38 55.07 1.02 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.705 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -140.2 169.09 18.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.174 0.511 . . . . 0.0 111.564 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.919 HG21 ' CD1' ' A' ' 116' ' ' LEU . 45.3 mm -89.24 144.81 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.024 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.2 mt -150.57 171.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.046 0.451 . . . . 0.0 111.228 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.73 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -126.01 121.97 34.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.706 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.721 HG12 ' CA ' ' A' ' 104' ' ' VAL . 30.4 m -122.48 155.3 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.156 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 105' ' ' ILE . . . -93.13 140.63 15.16 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.574 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -121.67 105.52 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 110.834 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.46 -63.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.189 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.14 -28.17 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -89.32 1.91 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.768 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 65.71 30.02 10.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 7.0 t0 78.04 162.05 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.963 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 84.53 -19.8 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.411 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.47 150.96 38.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -137.96 173.18 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 111.256 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.849 ' O ' HD12 ' A' ' 105' ' ' ILE . 37.4 t70 -130.1 116.61 18.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.721 ' CA ' HG12 ' A' ' 92' ' ' VAL . 70.4 t -52.4 111.54 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 103' ' ' ASP . 2.4 mp -81.81 -39.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.053 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -147.1 168.45 21.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.795 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 106' ' ' LEU . 4.5 pttp -111.94 119.9 40.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.053 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.0 m-85 -84.23 106.9 16.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.19 173.18 8.01 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.684 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.46 -51.19 18.03 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.313 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.37 -38.45 87.05 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.564 ' CD ' HD12 ' A' ' 39' ' ' LEU . 1.1 tp10 -66.63 -31.67 72.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.396 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.934 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -46.05 -43.25 14.34 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.821 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -48.93 -47.11 43.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.157 0.504 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -58.69 -20.82 51.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.629 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.919 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.66 -33.26 21.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.45 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -54.98 -34.34 63.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.38 -21.81 41.96 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.733 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.714 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.4 m-30 -67.01 -9.75 42.33 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.03 25.03 63.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.538 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 5.3 mm-40 -112.7 -47.41 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -108.75 150.07 40.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 70.8 Cg_endo -75.18 174.15 13.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.592 2.194 . . . . 0.0 112.242 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.48 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.4 p-80 -87.76 2.79 50.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.578 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -58.89 130.27 46.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.162 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -82.5 131.35 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.934 HD12 ' HB1' ' A' ' 113' ' ' ALA . 38.0 mm -94.66 150.86 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.984 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -62.0 156.53 20.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.06 123.35 16.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.95 133.55 55.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.5 t0 63.12 124.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.11 104.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.24 82.44 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -142.66 -154.08 6.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.409 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -51.71 163.05 1.38 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.514 2.143 . . . . 0.0 112.257 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.59 115.1 1.74 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.467 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.15 116.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.338 . . . . 0.0 110.909 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -92.73 122.85 35.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.95 -73.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -126.26 155.32 42.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.9 mm -92.72 82.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -121.0 54.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.02 165.32 12.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.849 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -132.96 164.85 26.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -74.18 -171.31 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 21.6 pt -149.52 42.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.104 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.23 121.73 3.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.526 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -72.04 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -33.05 57.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.68 99.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -118.2 -59.41 1.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -152.94 90.85 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.2 pt -84.46 136.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.168 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -174.49 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -63.35 120.43 11.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.081 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.795 0.331 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -116.34 -65.41 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -145.19 98.81 0.2 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.49 51.65 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -117.68 152.63 34.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -69.37 143.48 53.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -164.78 -52.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -146.76 -68.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -176.59 147.79 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -125.54 -63.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.08 35.52 1.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.1 53.8 1.62 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 170.71 19.69 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.62 2.214 . . . . 0.0 112.369 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.808 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--O 1.23 0.118 0 CA-C-O 120.874 0.281 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -71.35 -62.23 1.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.929 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.83 27.39 8.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.008 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.93 -68.82 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.043 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.92 -170.52 31.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.534 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.97 152.08 48.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.2 -101.54 1.61 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.559 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.51 33.47 81.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.461 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 tttp -170.93 -41.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.788 0.327 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.97 168.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.033 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.31 87.75 7.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.9 179.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -43.13 99.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.84 -94.42 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.441 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -145.66 70.95 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 0.0 110.795 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.75 34.14 14.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.786 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.42 -30.13 71.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 166.02 136.62 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.794 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -142.21 -51.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.749 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -166.45 144.05 5.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.842 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.59 94.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -74.14 114.17 12.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -71.1 156.4 39.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -145.78 128.08 15.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.693 HD11 ' CE1' ' A' ' 119' ' ' TYR . 20.1 tp -71.04 134.59 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.46 140.08 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.884 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 11.8 m-30 -113.7 170.94 7.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.42 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -42.01 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.78 168.12 13.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.169 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -67.72 123.59 20.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.35 62.95 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.531 ' CB ' HD11 ' A' ' 91' ' ' LEU . 12.9 mt-30 -115.66 145.3 42.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.395 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.735 ' HB2' HD11 ' A' ' 94' ' ' LEU . 15.4 tt0 -120.26 152.06 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 111.531 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.6 p90 -84.71 158.17 20.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.872 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.37 173.4 14.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 112.376 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.43 ' HG2' HD13 ' A' ' 89' ' ' ILE . 4.5 tm0? -128.61 115.11 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.161 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 14.8 t -65.9 139.99 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 112.077 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.918 HD11 ' HB3' ' A' ' 63' ' ' MET . 7.0 mm -116.01 -42.77 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.011 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -140.7 158.57 43.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.875 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.567 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.6 tpt -111.74 132.1 54.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.95 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -109.17 -163.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.485 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.75 156.71 4.54 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.64 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -56.76 109.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 135.03 -19.77 3.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.5 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.655 ' HD2' HD12 ' A' ' 55' ' ' LEU . 22.1 ptt180 -146.92 163.57 35.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 111.053 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.792 HD22 ' CD1' ' A' ' 84' ' ' ILE . 0.5 OUTLIER -147.68 150.78 34.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.885 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.2 tt0 -91.89 121.58 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.02 165.64 24.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 0.0 112.342 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.918 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -123.53 107.37 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.938 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.1 m -57.91 130.89 48.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.04 -25.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.705 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -74.42 -13.35 60.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.257 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.27 40.72 2.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.542 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.99 120.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.307 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 0.4 OUTLIER -88.68 114.44 25.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -143.81 165.53 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.95 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -103.27 109.81 21.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.8 m -84.28 118.33 24.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 2.4 m-70 -80.62 130.43 35.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.669 HD12 HD11 ' A' ' 84' ' ' ILE . 2.0 tt -68.59 140.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.475 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER 166.32 -167.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.002 0.43 . . . . 0.0 111.446 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.67 174.66 36.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.04 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -52.41 -23.83 6.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.968 0.413 . . . . 0.0 110.701 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -78.83 -18.61 53.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.205 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -48.09 -28.67 3.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.502 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -58.34 -22.9 55.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.883 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.79 46.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.417 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.589 HG13 HD11 ' A' ' 74' ' ' ILE . 14.2 p -84.81 128.82 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.36 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -110.72 110.04 20.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.008 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.792 ' CD1' HD22 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -95.2 147.34 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.613 179.291 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m-20 -122.32 152.3 40.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.407 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 32.7 m -80.18 -6.81 58.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 0.0 111.769 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.2 p -143.95 56.53 1.33 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.595 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 85' ' ' ASN . 0.4 OUTLIER -146.93 164.77 31.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.281 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.901 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.1 mm -87.28 146.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.233 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.664 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.1 mt -150.15 170.99 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 111.184 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.675 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -129.18 121.84 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.753 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 104' ' ' VAL . 16.0 m -116.16 150.38 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.75 131.41 10.72 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.735 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -117.86 133.19 56.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.62 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -178.06 -75.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.28 -12.65 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.322 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 34.5 m-85 -83.11 2.93 32.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.678 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 65.81 25.64 11.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.658 0.266 . . . . 0.0 111.219 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.22 -54.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.758 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -39.7 -35.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 97' ' ' TYR . 8.3 mmmm -127.27 162.76 25.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.808 0.337 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -158.61 162.65 37.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -113.1 126.7 55.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.723 ' HA ' HG12 ' A' ' 92' ' ' VAL . 61.5 t -55.02 112.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.99 -58.95 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.106 0.479 . . . . 0.0 110.023 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.055 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.3 pp -127.71 160.11 32.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.376 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.571 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -107.04 117.47 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.055 ' CE1' HD11 ' A' ' 106' ' ' LEU . 25.0 m-85 -81.73 106.11 13.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -68.17 168.76 11.56 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -70.8 -40.77 72.33 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.477 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.26 -40.35 95.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.716 ' O ' HD23 ' A' ' 116' ' ' LEU . 26.3 mt-10 -66.79 -28.54 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.49 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.906 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.43 -48.97 7.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.78 -178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -56.11 -30.67 62.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -73.93 -22.12 59.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.901 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.32 -34.94 25.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.379 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -54.6 -34.76 62.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -20.9 42.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.97 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.0 m-30 -66.56 -6.18 14.17 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.829 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.52 64.59 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.593 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.595 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 48.0 mt-10 -113.87 -64.55 1.29 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.927 0.394 . . . . 0.0 111.234 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -92.49 149.94 39.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.999 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 58.2 Cg_endo -71.7 179.55 4.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.634 2.223 . . . . 0.0 112.432 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.23 -32.17 68.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -75.83 -19.22 59.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.332 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.459 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -53.65 121.91 8.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -108.18 132.21 53.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.001 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.906 HD13 ' HB1' ' A' ' 113' ' ' ALA . 2.7 mt -100.06 153.97 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.129 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.405 ' N ' HG22 ' A' ' 128' ' ' ILE . 2.7 t-20 -65.09 163.61 14.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.707 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.13 175.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.555 HG23 ' HB3' ' A' ' 110' ' ' ALA . 0.5 OUTLIER -113.19 129.98 56.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.844 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 45.56 -163.98 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.342 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.7 m 73.67 96.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -158.0 79.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.736 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -108.5 151.01 17.08 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.53 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.21 134.41 61.57 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.663 2.242 . . . . 0.0 112.233 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.15 37.24 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.516 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.08 178.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.08 179.98 1.38 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -130.71 -51.32 1.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.52 178.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.026 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 22.2 mm -110.7 -40.19 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.054 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -107.13 142.34 36.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -136.06 85.12 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.938 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -168.27 93.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.728 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 63.78 104.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 147' ' ' ILE . 11.2 tt -120.15 63.73 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.055 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.46 -128.19 5.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.55 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.14 151.67 26.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.9 87.26 3.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -162.89 173.54 13.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -161.85 141.52 10.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.69 121.17 42.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.26 173.81 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -71.23 150.31 45.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -95.59 94.0 7.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.814 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.807 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.759 0.314 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -64.52 -47.43 78.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 158.27 162.84 12.13 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.615 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m 58.51 91.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.27 136.21 39.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.07 -178.15 4.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -130.37 165.61 22.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -145.6 32.23 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.14 -168.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -49.81 118.94 3.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 43.3 p -58.15 144.49 40.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.023 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -122.91 79.67 50.19 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.823 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.91 -34.06 11.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.587 2.191 . . . . 0.0 112.434 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.958 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.776 0.24 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.71 -58.19 1.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 60.9 96.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.22 -46.19 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.19 -137.52 8.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.24 152.82 48.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.44 45.17 2.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.608 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.99 -68.29 0.76 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.542 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.13 -78.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.778 0.323 . . . . 0.0 110.843 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -104.81 115.82 30.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.804 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.62 119.86 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.51 32.91 21.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.999 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -63.18 -49.51 74.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.73 160.32 10.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 105.44 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.393 . . . . 0.0 110.943 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 57.9 76.66 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -89.91 125.92 35.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 65.11 30.21 11.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.06 135.77 8.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -106.79 -63.72 1.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.1 144.22 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -127.17 160.5 31.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.647 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.13 120.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.846 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.23 78.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD11 ' HE1' ' A' ' 119' ' ' TYR . 14.6 tp -84.7 120.82 26.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 t -126.95 141.05 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.694 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 4.3 m-30 -109.19 170.45 8.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.612 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.1 ttpp -45.6 141.48 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.902 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -111.46 166.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 111.333 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -58.4 129.71 43.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.43 -15.37 60.24 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.589 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.487 ' CB ' HD11 ' A' ' 91' ' ' LEU . 8.4 mt-30 -118.45 154.62 32.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.624 0.25 . . . . 0.0 110.458 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -130.02 152.63 49.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 111.064 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 2.9 p90 -84.39 157.24 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.986 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.16 173.79 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.251 0.548 . . . . 0.0 112.112 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.519 ' OE1' HD13 ' A' ' 89' ' ' ILE . 38.2 tp60 -128.89 109.62 11.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.13 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.525 ' CG2' HD11 ' A' ' 90' ' ' ILE . 17.5 t -56.31 139.69 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 111.882 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 63' ' ' MET . 0.0 OUTLIER -116.42 -42.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.935 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.4 ttmm -147.71 157.58 43.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.319 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.647 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.1 ttt -108.2 143.35 37.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.789 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.863 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -111.89 -25.61 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.118 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.69 -174.63 29.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.61 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -75.37 102.87 5.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 135.28 -26.28 3.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.407 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.678 ' HD2' HD12 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -151.47 155.41 38.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.337 . . . . 0.0 110.927 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.74 150.91 35.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.863 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.4 tp10 -91.74 121.42 33.36 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.79 165.74 23.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.203 0.525 . . . . 0.0 112.145 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.535 ' HB2' HD13 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -127.16 107.07 9.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.419 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.5 133.25 55.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.063 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 3.5 m-85 -49.91 -25.22 3.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.724 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -8.46 56.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.235 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.92 43.1 3.4 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.451 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.03 113.94 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.3 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 24.8 tttt -84.22 113.51 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.751 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -145.15 165.5 28.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.2 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.854 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -100.34 108.56 20.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.979 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.721 ' HB3' HG11 ' A' ' 92' ' ' VAL . 34.0 m -84.31 118.4 24.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 20.3 m80 -82.56 134.5 35.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.628 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.626 HG22 ' HA2' ' A' ' 58' ' ' GLY . 10.0 tt -68.65 141.03 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.353 . . . . 0.0 111.01 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 2.3 mmt180 -63.95 155.59 30.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.18 -46.78 6.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.484 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -77.33 -40.53 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.6 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.727 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -64.02 -16.69 62.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.007 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.636 ' HA ' HG12 ' A' ' 82' ' ' VAL . 12.3 ptm180 -48.72 -26.13 2.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.684 0.278 . . . . 0.0 111.498 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -76.05 -35.03 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.554 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.35 34.93 3.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.652 0.263 . . . . 0.0 111.613 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.727 ' HB ' HD12 ' A' ' 78' ' ' LEU . 8.5 p -123.79 111.34 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.159 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.98 110.23 20.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.852 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.946 HG21 HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -91.95 147.16 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.415 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 13.3 m120 -139.88 157.86 45.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.636 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 52' ' ' ILE . 59.6 m -75.33 -6.45 49.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 111.772 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -143.31 76.12 1.51 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.796 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.46 161.16 16.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.847 HG21 ' CD1' ' A' ' 116' ' ' LEU . 51.3 mm -86.96 146.57 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.633 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.1 mt -150.49 171.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.362 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -130.27 122.43 28.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.866 178.544 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.791 HG12 ' HA ' ' A' ' 104' ' ' VAL . 34.9 m -119.57 146.97 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.529 ' O ' ' HB1' ' A' ' 102' ' ' ALA . . . -95.83 141.69 15.71 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.862 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 142.05 47.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.65 0.262 . . . . 0.0 110.575 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -149.11 -81.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.183 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.57 -12.16 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.328 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 101' ' ' LYS . 35.0 m-85 -71.9 -10.18 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.404 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 4.6 mt-30 65.85 25.4 11.24 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.205 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 2.8 t0 83.36 -21.88 0.26 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.36 -29.51 68.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 0.0 110.699 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.427 ' HB2' ' CG ' ' A' ' 97' ' ' TYR . 10.1 mtpt -144.27 164.85 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.688 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.542 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -163.3 171.66 15.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.106 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.34 125.65 50.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.791 ' HA ' HG12 ' A' ' 92' ' ' VAL . 99.3 t -49.96 111.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.47 -46.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.196 0.522 . . . . 0.0 109.737 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.062 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -142.06 166.93 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.31 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.601 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -110.44 120.56 42.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.114 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.062 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.7 m-85 -84.23 105.94 15.47 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -71.78 177.19 4.34 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.1 -40.03 47.38 Favored 'General case' 0 CA--C 1.524 -0.045 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.055 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -62.62 -40.99 98.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.701 ' O ' HD23 ' A' ' 116' ' ' LEU . 14.0 mt-10 -65.93 -27.93 68.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.345 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.26 -50.28 6.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.23 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -56.42 -26.8 54.66 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.246 -0.581 . . . . 0.0 109.714 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -80.17 -22.29 42.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.14 178.307 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.847 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -49.92 -33.98 19.06 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 121.22 -0.192 . . . . 0.0 111.002 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -54.75 -34.37 62.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.12 -20.39 45.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.059 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.6 m-30 -66.42 -4.37 8.07 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.927 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.55 21.08 53.8 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.735 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.473 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 58.5 mm-40 -111.45 -60.42 1.84 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.649 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.02 144.79 28.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.834 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 72.6 Cg_endo -76.08 179.8 5.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.631 2.221 . . . . 0.0 112.353 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.77 -29.31 67.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.442 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 25.6 p-80 -81.43 -0.49 41.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.473 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.484 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -66.28 145.15 56.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.836 0.35 . . . . 0.0 110.976 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -124.78 120.82 32.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.992 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.3 mt -90.96 148.3 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -64.5 86.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.169 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 56.21 -179.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.051 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.6 m -90.19 -22.14 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.42 106.6 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.768 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.9 101.2 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.89 85.18 3.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.784 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -113.95 177.12 17.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.33 94.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.715 2.277 . . . . 0.0 112.428 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -151.34 101.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.495 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 63.74 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.817 0.342 . . . . 0.0 111.102 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -160.47 144.73 14.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.967 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -77.0 80.58 3.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.973 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 59.98 162.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.15 -31.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 62.56 -83.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 25.6 t80 178.08 97.05 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.715 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -168.82 113.43 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.77 160.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 tt -156.23 42.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 56.62 -124.86 36.54 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.566 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 p30 -163.62 143.22 8.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -173.98 -46.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -130.28 175.83 8.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 58.55 52.46 6.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.07 88.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.851 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 154' ' ' ILE . 7.9 tp -90.26 71.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.049 0.452 . . . . 0.0 111.009 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -83.49 60.5 5.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.762 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -139.38 112.22 7.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.429 ' C ' HD12 ' A' ' 157' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.13 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtm . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 42.6 tpt85 61.04 109.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.21 -68.8 0.29 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.543 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -93.77 135.34 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -102.71 -161.65 0.86 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.725 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.73 136.54 27.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.857 0.36 . . . . 0.0 111.035 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -105.2 -178.16 3.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -59.62 131.44 50.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.947 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -167.73 77.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.31 120.03 18.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.16 87.52 2.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.19 100.5 9.05 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.837 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.43 175.68 5.71 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.382 2.055 . . . . 0.0 112.342 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.832 0.263 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -133.83 46.37 2.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -165.9 32.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -135.54 74.55 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.93 152.84 7.96 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.387 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.87 -69.04 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.749 0.309 . . . . 0.0 111.016 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.34 -159.71 43.2 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.57 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.66 159.15 22.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.546 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt 60.76 -179.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.811 0.339 . . . . 0.0 110.942 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -116.88 -71.82 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -53.53 8.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 62.25 40.15 11.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.805 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.38 54.64 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.27 159.36 26.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.349 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.34 -64.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.649 0.262 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -43.17 138.53 2.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.695 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -166.21 61.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.826 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.3 99.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -152.87 37.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -71.68 -170.63 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -146.45 159.34 43.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -94.92 -41.65 9.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.97 79.38 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.674 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -82.81 67.08 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.142 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.644 HD23 ' CZ ' ' A' ' 41' ' ' PHE . 16.0 tp -83.14 109.59 17.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.478 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' CG1' HD22 ' A' ' 106' ' ' LEU . 15.1 t -91.78 139.66 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.701 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.644 ' CZ ' HD23 ' A' ' 39' ' ' LEU . 79.6 m-85 -113.45 170.5 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.714 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.518 ' HA ' HD22 ' A' ' 91' ' ' LEU . 7.9 tttt -47.68 163.41 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -132.51 156.38 46.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 111.294 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -59.04 129.16 40.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.697 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.45 61.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.558 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.513 ' OE1' HD11 ' A' ' 91' ' ' LEU . 26.3 mt-30 -116.43 148.17 40.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.585 0.231 . . . . 0.0 110.439 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.09 152.56 38.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 111.613 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 11.9 p90 -84.5 157.71 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.899 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.3 173.28 15.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 112.42 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.404 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -126.5 125.5 42.17 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.082 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.689 HG13 HD13 ' A' ' 60' ' ' LEU . 12.2 t -79.32 138.3 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.942 HD11 ' HB2' ' A' ' 63' ' ' MET . 1.1 mt -116.1 -45.75 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.169 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -137.76 157.15 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.531 ' C ' HD23 ' A' ' 55' ' ' LEU . 7.8 ttm -111.41 143.53 42.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.852 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -106.49 -37.62 6.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.38 171.66 27.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -60.07 103.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 133.32 -22.57 3.95 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.616 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.728 ' CD ' HD12 ' A' ' 55' ' ' LEU . 13.3 ptp180 -154.5 157.76 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.689 HD13 HG13 ' A' ' 51' ' ' VAL . 2.8 pp -147.95 160.27 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.298 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.782 ' HB2' HD21 ' A' ' 55' ' ' LEU . 10.0 tp10 -102.18 121.47 42.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -135.98 166.18 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.352 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.942 ' HB2' HD11 ' A' ' 52' ' ' ILE . 4.3 tpp -126.89 111.61 14.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.056 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 46.6 t -58.67 134.76 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -25.28 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.581 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -74.31 -14.17 60.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.233 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.72 41.19 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.583 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.3 t -127.23 125.79 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.548 ' CA ' ' HE2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -99.99 115.25 29.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -144.19 160.8 40.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.81 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.852 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -96.32 105.68 17.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.801 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.52 ' HB3' HG11 ' A' ' 92' ' ' VAL . 14.2 m -85.16 118.75 24.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.673 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -81.39 127.77 33.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.656 HG22 ' HA2' ' A' ' 58' ' ' GLY . 6.0 tt -68.43 140.58 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.44 -165.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 0.0 111.514 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.23 169.91 46.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.179 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -48.58 -27.18 2.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.432 . . . . 0.0 110.763 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 1.0 OUTLIER -66.41 -32.86 74.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.483 ' HA ' HG12 ' A' ' 82' ' ' VAL . 23.3 ptt180 -48.83 -28.18 3.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.248 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.84 -26.53 58.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 46.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.251 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.529 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.3 p -124.34 123.07 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.705 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -111.21 109.97 20.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.538 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.881 HG22 HD13 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -65.06 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -102.06 151.48 22.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.462 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.471 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 86.2 m -80.25 -6.55 58.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.62 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.95 72.06 1.34 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.639 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -165.65 167.39 17.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.906 HG21 ' CD1' ' A' ' 116' ' ' LEU . 26.5 mm -86.9 146.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.192 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.881 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.3 171.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.383 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.681 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.57 122.31 28.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.785 178.678 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.9 m -117.83 146.68 21.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.155 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.97 140.08 14.91 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.911 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -123.51 132.6 53.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.648 0.261 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.55 -80.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.01 -15.95 63.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 103' ' ' ASP . 48.5 m-85 -72.44 -8.8 56.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.547 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 67.29 29.94 7.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.34 -175.94 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.57 -61.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.836 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.15 156.66 17.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.967 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.545 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -141.28 -177.71 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.829 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.473 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 10.5 t70 -133.96 120.31 20.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.888 ' HA ' HG12 ' A' ' 92' ' ' VAL . 59.8 t -52.87 112.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.845 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.75 -62.16 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.077 0.465 . . . . 0.0 110.057 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.5 pp -124.8 159.62 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.46 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -105.92 118.73 37.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.063 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.8 m-85 -82.24 106.28 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.09 173.39 5.58 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.643 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.48 -40.23 61.97 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.693 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.06 -40.48 95.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.716 ' O ' HD23 ' A' ' 116' ' ' LEU . 19.4 mt-10 -66.99 -28.37 68.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.505 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.987 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.63 -48.94 7.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.909 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -55.9 -30.26 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.386 0.612 . . . . 0.0 109.528 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 1.4 m -76.14 -22.46 55.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.173 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.906 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.22 -32.95 17.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.067 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.51 -34.3 61.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.74 42.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.778 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.675 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.2 m-30 -66.97 -11.64 57.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.86 23.27 65.39 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.633 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 50.8 mt-10 -109.54 -52.05 2.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.933 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.541 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.1 148.09 34.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.723 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 60.0 Cg_endo -72.52 178.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 0.0 112.339 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -30.8 69.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.401 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 56.7 p-80 -84.2 -3.49 58.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.405 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -58.35 147.64 30.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.887 0.375 . . . . 0.0 111.164 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -115.07 148.39 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.987 HD12 ' HB1' ' A' ' 113' ' ' ALA . 28.2 mm -82.73 158.35 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.011 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.46 ' N ' HG22 ' A' ' 128' ' ' ILE . 19.6 m-80 -88.7 63.37 6.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.04 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 58.77 110.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.01 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.36 -29.21 66.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 64.03 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.4 m 56.06 96.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.22 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.81 67.96 1.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.711 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.62 -174.82 31.41 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.555 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -52.19 135.81 53.3 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.592 2.195 . . . . 0.0 112.362 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -127.26 73.02 0.45 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.513 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.4 172.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -146.89 35.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -134.22 77.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -138.74 31.65 2.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.2 mt -121.35 147.04 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.089 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -66.62 93.43 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -88.21 120.0 29.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -123.73 140.62 52.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.41 136.84 32.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 30.2 mm -106.62 81.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.025 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 162.43 79.11 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -123.85 115.01 20.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.58 -51.31 65.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.58 128.99 34.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 60.35 78.42 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.31 94.74 7.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 156' ' ' ASP . 15.3 tt -64.52 146.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.12 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -113.63 -42.03 3.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.416 ' O ' HD11 ' A' ' 154' ' ' ILE . 11.6 p30 -102.83 140.33 37.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.661 ' N ' HD13 ' A' ' 157' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.159 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptp . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -129.51 115.31 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.06 28.32 9.92 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.23 73.67 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.916 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -60.65 178.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -120.5 71.24 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -60.52 119.69 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.86 122.59 14.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.872 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.28 30.8 6.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -122.15 82.64 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 30.2 p -99.18 123.64 43.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.984 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t0 59.57 79.31 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.71 84.6 1.22 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.479 2.119 . . . . 0.0 112.386 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.921 0.3 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -105.17 60.28 0.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.853 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 63.1 -79.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.031 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt 61.78 -179.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.98 143.1 0.91 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 mttt 59.26 -178.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.28 -147.56 8.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.556 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.98 99.83 0.36 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -149.27 32.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -107.07 128.19 54.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.23 106.37 18.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.79 35.02 2.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.62 -68.95 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.52 -39.53 2.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.448 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -60.26 110.77 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.22 62.05 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.795 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -78.92 104.2 9.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 63.26 120.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -143.91 130.03 19.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.88 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.99 -171.0 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -132.6 167.74 19.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.9 ptpm? -148.85 -43.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.68 140.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -70.0 152.66 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.993 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.693 HD11 ' HE1' ' A' ' 119' ' ' TYR . 30.1 tp -68.31 130.63 43.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.71 140.34 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.804 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.767 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.4 m-30 -112.51 170.95 7.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -45.24 148.61 0.6 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.952 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.75 162.43 20.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.39 . . . . 0.0 111.347 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -57.04 130.44 46.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.72 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.65 -15.36 61.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.369 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.419 ' CB ' ' HA2' ' A' ' 93' ' ' GLY . 2.0 mt-30 -123.62 144.49 49.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -118.85 153.64 34.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 111.383 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 10.1 p90 -84.22 157.71 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.698 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.31 173.52 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.362 0.601 . . . . 0.0 112.389 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.607 ' HG2' HD13 ' A' ' 89' ' ' ILE . 1.8 tm0? -128.19 120.83 28.05 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.189 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.61 HG22 ' CD1' ' A' ' 60' ' ' LEU . 29.6 t -70.8 134.91 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.985 0.421 . . . . 0.0 111.664 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.71 HD12 ' CB ' ' A' ' 63' ' ' MET . 0.5 OUTLIER -116.45 -38.58 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -140.68 159.82 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.626 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -115.74 143.07 45.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.926 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -111.66 -58.74 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.944 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.77 -168.1 16.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.647 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -83.72 0.89 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.517 0.199 . . . . 0.0 111.49 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -121.58 -8.39 7.62 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.883 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.681 ' CD ' HD12 ' A' ' 55' ' ' LEU . 22.8 ptt180 -153.36 160.17 42.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 110.779 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.892 HD22 HD13 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -147.94 149.77 32.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.894 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.2 tt0 -91.84 121.41 33.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.97 165.62 25.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 112.141 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.71 ' CB ' HD12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.1 111.84 15.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.169 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.48 135.96 57.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.3 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.0 m-85 -49.73 -25.39 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.34 -7.17 51.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.289 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.84 44.42 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.446 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.21 130.64 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 111.303 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.576 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 8.6 tttt -95.7 113.73 25.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.507 ' NH1' HD22 ' A' ' 94' ' ' LEU . 12.5 ptp180 -145.04 165.59 27.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.926 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -103.12 109.23 20.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.734 ' HB3' HG11 ' A' ' 92' ' ' VAL . 25.7 m -84.41 119.8 25.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.99 136.53 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.667 HD11 HG13 ' A' ' 82' ' ' VAL . 7.0 tt -68.73 140.73 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.928 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.437 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -73.75 145.11 45.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.108 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -48.26 34.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.311 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -29.13 70.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.363 . . . . 0.0 110.628 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.5 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.8 mm? -84.67 -29.14 25.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.805 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -48.97 -27.2 2.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -59.05 -42.16 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.266 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.83 46.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 111.434 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.667 HG13 HD11 ' A' ' 74' ' ' ILE . 9.8 p -123.95 117.9 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -110.93 110.06 20.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.066 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.892 HD13 HD22 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -83.1 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.251 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.452 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 t30 -108.33 159.35 16.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.106 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 86' ' ' THR . 58.6 m -80.12 -5.72 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 p -147.67 55.41 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.629 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.6 162.19 35.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.205 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.894 HG21 ' CD1' ' A' ' 116' ' ' LEU . 30.4 mm -87.03 146.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.288 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.2 mt -150.58 171.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.152 0.501 . . . . 0.0 111.327 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.707 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.56 122.39 29.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.448 178.443 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.734 HG11 ' HB3' ' A' ' 72' ' ' CYS . 27.2 m -121.94 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 46' ' ' GLN . . . -90.78 143.79 16.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.507 HD22 ' NH1' ' A' ' 70' ' ' ARG . 4.6 mt -113.73 26.31 10.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.956 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.02 19.41 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.2 -49.2 6.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.682 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -105.46 -11.19 16.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.221 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 65.48 29.61 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -135.48 178.45 7.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -57.38 -18.26 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.856 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 132.37 34.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.816 0.341 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -115.72 158.14 23.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.472 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -115.45 120.48 39.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.032 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.694 ' CA ' HG12 ' A' ' 92' ' ' VAL . 94.5 t -50.33 111.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.738 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.1 mm -77.94 -36.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 109.679 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.07 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -154.13 167.45 29.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.452 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 82' ' ' VAL . 14.6 pttt -110.28 121.64 45.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.15 0.5 . . . . 0.0 112.274 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.07 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.2 m-85 -86.4 106.6 17.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -73.86 178.29 4.98 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.54 -41.76 45.45 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.071 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -61.65 -40.05 93.52 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.683 ' O ' HD23 ' A' ' 116' ' ' LEU . 9.6 mt-10 -68.63 -28.0 66.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.351 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.741 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.54 -51.63 6.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.955 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -55.72 -27.22 49.36 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.662 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -76.58 -22.11 54.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.001 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.894 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.0 -34.43 21.13 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -54.85 -34.55 63.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.35 -20.92 43.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.921 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.767 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.9 m-30 -66.77 -7.28 20.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.827 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.22 24.53 65.46 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.566 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.578 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.8 mt-10 -114.05 -63.5 1.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.876 0.369 . . . . 0.0 111.191 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.42 144.59 29.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.957 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.448 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.7 Cg_endo -71.38 179.78 4.28 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.657 2.238 . . . . 0.0 112.401 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -70.89 -34.61 71.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.448 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 20.7 p-80 -72.44 -17.98 61.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -56.84 133.66 54.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.732 0.301 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -114.36 134.35 55.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.652 HD13 ' HB1' ' A' ' 113' ' ' ALA . 4.5 mt -99.11 141.7 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.097 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -67.82 157.82 33.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.02 162.28 7.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.716 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.43 141.57 54.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -39.23 136.31 0.88 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.857 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.8 p -95.74 -168.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 61.02 84.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.2 154.91 8.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.531 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.8 -166.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.52 2.146 . . . . 0.0 112.278 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -117.63 106.68 1.42 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.477 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.34 -78.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 110.985 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -170.31 -43.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.9 t70 61.74 71.53 0.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.74 81.64 1.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.781 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.0 mm -107.68 128.42 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 172.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.62 -169.54 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -176.16 -43.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -109.98 165.51 11.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 147' ' ' ILE . 4.7 tt -170.76 55.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.058 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.56 176.5 27.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.13 31.59 4.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.318 . . . . 0.0 110.821 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -98.27 36.41 1.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 t70 60.68 56.97 2.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -55.0 18.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 44.2 t0 63.57 141.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.1 pt -123.48 141.35 44.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.098 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.52 -23.59 23.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 t0 64.65 164.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.8 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.037 179.982 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.761 0.315 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -35.22 73.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.58 -82.68 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.512 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 18.1 t -148.45 -74.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.729 0.299 . . . . 0.0 110.989 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 40.43 0.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 11.7 m170 69.07 -67.19 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.022 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -105.68 138.66 41.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.013 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.76 -36.78 5.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.733 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.62 82.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 6.9 m170 53.96 -168.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.57 -80.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.748 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 55.78 75.62 0.57 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.062 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.69 -40.67 77.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.62 2.213 . . . . 0.0 112.253 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.969 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 C--O 1.231 0.137 0 CA-C-O 120.834 0.264 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 51.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -60.81 -75.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.01 -53.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.92 -151.76 6.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt 66.09 -72.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.697 0.284 . . . . 0.0 111.068 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.45 86.74 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.13 66.04 0.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -115.92 -66.64 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.863 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -75.37 110.95 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 120.46 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -115.15 33.94 5.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -116.42 -36.27 4.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.13 -113.33 5.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.483 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -149.38 112.77 4.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -41.73 -66.7 0.32 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.703 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -176.79 -178.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.933 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 59.09 -179.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.01 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -95.45 175.11 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -89.53 -64.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 58.83 77.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.15 95.68 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.78 146.27 37.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -109.37 102.77 11.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.632 HD23 ' CZ ' ' A' ' 41' ' ' PHE . 13.5 tp -68.81 99.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.704 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.497 ' CG1' HD22 ' A' ' 106' ' ' LEU . 18.9 t -88.35 139.15 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CZ ' HD23 ' A' ' 39' ' ' LEU . 86.5 m-85 -110.69 170.27 8.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.569 ' HA ' HD22 ' A' ' 91' ' ' LEU . 7.0 ttpt -52.79 148.43 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.887 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -116.85 160.52 20.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.402 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.63 130.07 45.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.48 61.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.541 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.498 ' CB ' HD11 ' A' ' 91' ' ' LEU . 4.7 mt-30 -117.53 140.97 48.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.53 0.205 . . . . 0.0 110.559 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' HD11 ' A' ' 94' ' ' LEU . 7.9 tp10 -115.66 154.36 29.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 111.408 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 5.3 p90 -84.55 157.78 21.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.21 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.01 173.18 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.225 0.536 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.04 109.05 11.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.273 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 90' ' ' ILE . 20.6 t -57.2 135.47 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.769 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.869 HD13 ' CB ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -116.07 -40.48 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.697 179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.63 158.82 43.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.735 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.638 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -115.7 139.02 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.63 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.049 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -110.72 -48.79 3.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.773 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.88 -179.27 30.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.54 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 67.65 19.53 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.304 . . . . 0.0 111.239 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.47 28.79 9.33 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.839 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HG3' HD12 ' A' ' 55' ' ' LEU . 6.2 ptt180 -154.82 155.88 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.598 HD22 ' CD1' ' A' ' 84' ' ' ILE . 1.2 pp -147.6 152.5 38.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.156 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.903 ' HB2' HD21 ' A' ' 55' ' ' LEU . 36.6 tt0 -91.75 121.39 33.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 72' ' ' CYS . . . -124.25 165.06 18.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 112.331 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.869 ' CB ' HD13 ' A' ' 52' ' ' ILE . 1.2 tpt -125.8 100.24 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.86 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.37 132.17 50.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.637 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.2 m-85 -49.93 -27.0 4.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.453 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -8.09 55.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.434 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.72 40.71 3.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.531 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.13 123.06 61.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.262 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' HE3' ' A' ' 63' ' ' MET . 1.9 tppp? -94.14 117.19 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -145.08 164.71 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.037 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.049 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -98.21 106.52 18.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.729 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.451 ' HB3' HG11 ' A' ' 92' ' ' VAL . 36.8 m -84.07 118.77 24.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 137.71 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.696 HD11 HG13 ' A' ' 82' ' ' VAL . 2.9 tt -68.66 139.18 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.704 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.11 143.9 56.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.143 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.58 -38.28 57.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.51 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -75.87 -29.4 58.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.659 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.484 ' O ' HG12 ' A' ' 82' ' ' VAL . 2.7 mm? -82.7 -28.65 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -49.63 -27.62 4.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.248 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -35.56 69.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.304 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.24 48.74 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.696 HG13 HD11 ' A' ' 74' ' ' ILE . 10.7 p -120.95 119.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.143 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -110.81 110.27 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.679 HG22 HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -87.11 147.14 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.443 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -118.84 156.32 29.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 33.3 m -80.15 -6.45 57.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.168 0.509 . . . . 0.0 111.377 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -145.34 71.24 1.28 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.43 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.73 165.18 33.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.085 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.947 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.4 mm -86.78 144.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.679 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.52 172.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 111.063 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.726 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.01 127.11 40.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.795 178.525 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.724 ' N ' HD12 ' A' ' 91' ' ' LEU . 31.6 m -122.2 149.51 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 46' ' ' GLN . . . -91.92 135.85 12.96 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.87 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -122.46 123.78 42.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.6 0.238 . . . . 0.0 110.72 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.57 -80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -61.12 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -73.52 -8.03 54.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.433 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 66.71 30.2 8.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.823 0.344 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.73 -169.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.14 -62.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.775 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -108.59 168.68 9.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.761 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 92' ' ' VAL . . . -152.68 177.2 10.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.98 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.33 119.1 21.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.833 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.713 ' HA ' HG12 ' A' ' 92' ' ' VAL . 70.9 t -49.89 111.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.906 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -82.5 -47.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.13 0.491 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.018 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.4 pp -141.52 169.16 18.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.59 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.605 ' N ' HD12 ' A' ' 106' ' ' LEU . 12.0 pttp -110.28 122.51 47.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 111.96 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.018 ' CE1' HD11 ' A' ' 106' ' ' LEU . 20.1 m-85 -85.44 107.0 17.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -64.27 168.08 5.98 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.82 -51.06 11.08 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.4 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.457 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 46.2 t0 -62.02 -38.2 87.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' OE2' ' HA ' ' A' ' 108' ' ' TYR . 0.7 OUTLIER -75.28 -26.16 58.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.018 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -45.44 -41.89 9.83 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.765 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.457 ' CG ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -53.11 -36.71 61.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.318 0.58 . . . . 0.0 109.488 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.645 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 1.0 OUTLIER -61.61 -21.04 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.971 177.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.947 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.32 -32.93 18.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.354 -178.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -34.48 65.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.1 -21.64 43.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.639 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.698 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -67.24 -10.5 51.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.077 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.72 64.83 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.619 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 65.4 mm-40 -111.3 -53.53 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.772 0.32 . . . . 0.0 111.013 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.579 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -98.04 147.2 32.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.78 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.414 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.1 Cg_endo -70.91 175.1 9.52 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.56 2.173 . . . . 0.0 112.193 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.29 -27.12 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.414 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 21.3 p-80 -81.62 -10.84 59.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.429 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.91 164.51 0.58 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -129.77 144.74 51.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.569 HD12 ' CB ' ' A' ' 113' ' ' ALA . 26.4 mm -84.06 139.72 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.97 98.55 10.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 57.87 85.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.7 m -64.09 -39.24 93.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.832 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.3 t0 59.98 176.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.8 t -152.5 157.25 40.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.06 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -113.95 46.92 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.99 117.95 5.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.454 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.85 -33.0 59.15 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.398 2.065 . . . . 0.0 112.295 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 167.66 79.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.514 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 62.29 106.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -63.65 -31.76 73.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -84.66 -163.7 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.41 -165.46 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 10.8 tt -53.5 150.86 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.311 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -106.8 141.59 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 62.54 143.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.915 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 60.44 110.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.63 42.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.38 -148.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.226 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.06 122.42 0.6 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.7 t70 61.9 63.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.931 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -124.39 -46.49 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -174.22 137.53 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.42 -62.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.68 138.92 30.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.835 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.0 pt -78.42 138.88 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 41.0 t0 60.08 66.83 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -108.05 -31.02 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.144 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.763 0.316 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 62.86 40.44 9.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 154.73 175.9 26.37 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.525 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.09 51.55 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.82 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.83 38.24 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.21 164.31 30.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -126.09 151.16 47.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -110.3 111.25 22.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.12 -177.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.83 168.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 20.3 m -118.88 73.31 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.64 67.53 1.15 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.809 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.12 151.62 34.11 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.523 2.148 . . . . 0.0 112.16 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.069 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 CA-C-O 120.869 0.279 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -102.52 143.23 32.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.048 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t30 62.81 141.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.007 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.93 121.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.97 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.28 62.93 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.468 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -100.2 115.92 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.77 -168.9 0.69 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.461 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.58 31.13 3.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.524 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 73.52 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 0.0 110.845 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -161.04 94.84 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.4 -64.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.1 88.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.71 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 63.48 53.03 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.742 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.66 173.27 4.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.575 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -105.77 -73.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 62.0 72.74 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -144.55 159.09 43.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 43.6 39.8 2.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -62.88 131.44 48.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -162.37 -60.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -66.19 120.23 12.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.15 60.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.963 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.47 80.75 6.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -74.67 150.84 39.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.018 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.524 HD11 ' HE1' ' A' ' 119' ' ' TYR . 19.7 tp -127.59 124.47 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.8 t -126.47 140.5 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.93 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.754 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 5.3 m-30 -110.6 170.64 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.442 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -46.45 147.62 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.039 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -128.1 165.05 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.283 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.47 130.51 46.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.739 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.44 -15.26 61.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.386 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.533 ' HB3' HD11 ' A' ' 91' ' ' LEU . 30.3 mt-30 -127.31 146.52 50.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.2 tt0 -125.29 153.88 42.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.022 0.439 . . . . 0.0 111.492 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 7.8 p90 -84.32 157.88 21.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.84 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.81 173.55 15.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 112.388 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 tm0? -128.75 124.27 35.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 21.7 t -76.58 140.94 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 111.95 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.935 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.8 OUTLIER -115.95 -41.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.072 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -147.66 161.25 41.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.506 ' HE2' HD12 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -110.15 142.04 42.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.441 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 61' ' ' GLU . 1.8 mt -97.04 -30.28 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.29 61.03 3.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.704 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -177.73 51.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.568 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.59 11.07 64.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.424 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.708 ' HD2' HD12 ' A' ' 55' ' ' LEU . 24.8 ptt180 -147.25 164.17 34.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.833 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.19 155.61 42.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.789 ' HB2' HD21 ' A' ' 55' ' ' LEU . 22.7 tt0 -91.71 122.09 33.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.01 165.76 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.174 0.512 . . . . 0.0 111.941 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.935 ' HB2' HD11 ' A' ' 52' ' ' ILE . 4.6 tpp -131.28 111.79 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.116 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -59.27 131.76 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.361 . . . . 0.0 110.463 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.64 -26.3 2.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.789 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.33 -14.22 60.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.84 1.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.58 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -126.92 126.28 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 111.038 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.557 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -95.01 113.23 24.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.29 163.52 34.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.627 HD22 ' N ' ' A' ' 71' ' ' LEU . 2.5 mm? -102.82 114.25 28.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.706 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.2 m -83.99 118.71 24.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 4.9 m80 -83.99 146.32 28.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.837 HD11 ' CD1' ' A' ' 84' ' ' ILE . 23.7 mm -68.6 120.12 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.31 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 28.5 tpt180 -64.79 137.98 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.19 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.96 -65.96 2.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.656 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.34 9.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -86.48 -17.78 33.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.477 ' HA ' HG12 ' A' ' 82' ' ' VAL . 11.5 ptt85 -48.73 -29.73 4.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.238 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -55.32 -27.07 44.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.98 38.78 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.058 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 82' ' ' VAL . 13.2 p -81.74 111.15 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.398 . . . . 0.0 110.758 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -111.15 110.52 21.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.482 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -115.05 147.47 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.489 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -132.27 160.77 35.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.686 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 86' ' ' THR . 74.7 m -80.59 -6.73 58.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.153 0.501 . . . . 0.0 111.805 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -147.51 69.86 1.16 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.746 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.96 161.98 36.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.133 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.82 HG21 ' CD1' ' A' ' 116' ' ' LEU . 1.5 mp -86.76 147.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.643 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.6 mt -150.42 172.37 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 111.58 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.64 ' H ' HG22 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -128.2 122.0 30.79 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.48 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 104' ' ' VAL . 13.6 m -117.86 157.01 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.55 123.23 7.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.539 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -115.39 111.79 21.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.764 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -176.98 -71.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.44 -12.48 61.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.52 10.74 16.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.62 29.75 10.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.977 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.7 t0 68.45 -178.9 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.29 -61.06 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -96.36 163.6 13.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.676 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -163.74 139.82 6.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.96 129.4 36.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.69 ' HA ' HG12 ' A' ' 92' ' ' VAL . 96.2 t -55.01 111.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.808 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 mm -77.53 -48.76 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.135 0.493 . . . . 0.0 109.853 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.071 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -140.94 167.3 22.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.255 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -111.82 119.59 39.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 112.305 -178.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.071 ' CE1' HD11 ' A' ' 106' ' ' LEU . 24.2 m-85 -83.86 106.08 15.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -72.2 177.86 4.21 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.13 -40.54 45.33 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.175 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -61.41 -40.49 94.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.694 ' O ' HD23 ' A' ' 116' ' ' LEU . 11.5 mt-10 -67.03 -27.91 67.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.508 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.872 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.31 -49.47 6.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.984 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -28.15 56.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.348 0.594 . . . . 0.0 109.5 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.98 -22.79 42.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.167 178.414 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.872 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.89 -33.75 25.43 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.064 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -55.2 -34.18 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.02 -20.32 45.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.932 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.754 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.4 -6.14 13.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.83 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.46 24.8 53.55 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.791 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 49.2 mm-40 -114.27 -56.28 2.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.737 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -90.85 153.29 45.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 73.5 Cg_endo -75.81 -179.79 5.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.723 2.282 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.0 -31.28 67.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.088 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.447 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 29.4 p-80 -84.17 2.71 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.532 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.533 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -61.1 122.28 14.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.158 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -108.82 121.53 45.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.815 HD13 ' HB1' ' A' ' 113' ' ' ALA . 2.9 mt -96.77 158.69 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 128' ' ' ILE . 11.4 p-10 -67.83 172.95 4.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.14 162.48 19.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.563 HG22 ' OG1' ' A' ' 133' ' ' THR . 6.5 m -63.42 -48.97 75.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.0 t0 63.05 44.09 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.563 ' OG1' HG22 ' A' ' 131' ' ' THR . 1.8 m -129.33 99.38 5.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -173.01 127.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 123.79 80.86 0.49 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.521 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.498 ' HG2' HG22 ' A' ' 142' ' ' ILE . 50.9 Cg_exo -53.03 -49.65 16.85 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.617 2.211 . . . . 0.0 112.308 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -162.55 42.92 0.36 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.552 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.29 113.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.98 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 43.32 80.99 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.438 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.24 125.96 4.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.846 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -87.91 97.88 11.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' A' ' 136' ' ' PRO . 6.1 tt -112.79 23.5 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.146 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -134.9 121.14 20.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -84.6 -45.76 12.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.033 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -67.74 132.56 47.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.31 -170.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 147' ' ' ILE . 29.7 mt -101.31 34.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -125.91 -160.5 10.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.59 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -98.19 116.07 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.769 0.319 . . . . 0.0 110.823 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -87.72 172.72 9.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.952 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -106.17 36.09 2.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -140.09 76.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -106.98 -174.01 2.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.783 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 154' ' ' ILE . 0.6 OUTLIER -93.33 48.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -68.23 157.87 34.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.37 169.4 17.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.106 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.83 0.348 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -101.05 -74.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.85 83.29 0.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.51 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -129.91 136.12 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.781 0.324 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -111.33 116.17 30.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -134.41 -48.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -144.6 85.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -93.53 131.46 38.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -136.35 172.33 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -134.67 150.96 50.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.61 51.74 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -146.93 89.9 5.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -51.98 -28.28 31.47 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.565 2.177 . . . . 0.0 112.327 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 2.0 ttp . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.893 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.767 0.236 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt 64.78 91.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -58.61 -78.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.1 mptt 55.36 45.07 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.881 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.43 -25.95 43.16 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.616 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -129.86 169.08 15.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.59 88.61 0.11 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.557 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.11 152.66 21.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.27 -52.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 0.0 110.945 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 61.71 30.22 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.97 163.58 14.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 tpt85 -129.26 85.32 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.927 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -72.01 -174.37 1.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.23 -122.42 2.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.38 178.11 5.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 59.23 170.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.968 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.99 69.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.73 56.44 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 63.53 144.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.73 96.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 60.59 160.36 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -123.7 123.91 41.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.849 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 61.4 111.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.825 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -174.47 100.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.01 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.526 HD11 ' HE1' ' A' ' 119' ' ' TYR . 22.9 tp -68.09 122.73 18.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 15.4 t -114.69 139.88 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.617 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 24.5 m-85 -116.9 170.07 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.582 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -86.44 158.19 19.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.792 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -144.46 178.04 8.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.361 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -44.52 137.02 3.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.27 61.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.474 ' CB ' HD11 ' A' ' 91' ' ' LEU . 2.5 mt-30 -141.73 139.2 32.82 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.2 tt0 -123.4 157.63 32.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.007 0.432 . . . . 0.0 111.535 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 4.9 p90 -84.5 158.05 21.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.521 ' HB2' HH21 ' A' ' 70' ' ' ARG . . . -151.93 173.86 14.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.248 0.547 . . . . 0.0 112.2 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.412 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -128.78 120.6 26.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.019 179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.606 HG13 HD13 ' A' ' 60' ' ' LEU . 23.4 t -70.89 135.46 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 112.039 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 63' ' ' MET . 14.0 mt -116.29 -40.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 157.62 46.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.543 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -117.12 131.6 56.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.747 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.996 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -105.89 -32.68 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.8 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.42 -171.67 48.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.57 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 m120 61.9 26.49 16.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.718 0.294 . . . . 0.0 111.049 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 83.85 32.19 24.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.616 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.578 ' HG3' HD12 ' A' ' 55' ' ' LEU . 12.1 ptt180 -155.4 157.27 36.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.605 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 84' ' ' ILE . 2.6 pp -148.04 160.91 42.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 111.611 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.901 ' HB2' HD21 ' A' ' 55' ' ' LEU . 34.4 tt0 -104.41 120.83 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -136.51 164.68 27.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.23 0.538 . . . . 0.0 112.033 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.648 ' HE3' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -120.08 114.8 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.191 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.2 m -59.45 133.47 56.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.502 ' CG ' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -48.2 -25.54 1.54 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.622 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.0 -14.07 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.339 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.89 39.75 2.45 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.664 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.34 129.6 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 111.428 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.648 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 1.7 ttmp? -91.66 117.94 30.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.521 HH21 ' HB2' ' A' ' 49' ' ' ALA . 33.2 ptt180 -142.7 165.57 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.981 0.42 . . . . 0.0 111.165 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.996 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -104.29 108.08 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.632 ' HB3' HG11 ' A' ' 92' ' ' VAL . 12.5 m -84.87 118.75 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.498 ' N ' ' CD2' ' A' ' 73' ' ' HIS . 19.5 m170 -85.01 130.32 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 84' ' ' ILE . 12.0 tt -68.64 140.91 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.047 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 14.2 tpt180 -76.6 148.51 36.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.087 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.22 -79.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.984 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.39 -26.1 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.722 0.296 . . . . 0.0 111.544 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -79.93 -45.33 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.186 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HA ' HG12 ' A' ' 82' ' ' VAL . 3.5 ptt180 -58.46 -24.12 59.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -58.64 -33.43 70.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 8.44 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.585 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.495 ' CB ' HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -124.18 119.69 57.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.132 0.491 . . . . 0.0 111.167 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -111.07 110.32 20.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.766 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.843 HD13 HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.49 147.59 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.3 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -118.97 159.33 24.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 86' ' ' THR . 40.2 m -76.12 -6.09 49.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.697 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.1 p -145.83 71.57 1.27 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.702 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.59 160.52 39.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.079 0.466 . . . . 0.0 111.208 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.857 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.3 mm -86.94 146.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.489 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.643 HD13 HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.41 171.14 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.241 0.543 . . . . 0.0 111.631 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.716 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.07 124.37 34.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.429 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG12 ' CA ' ' A' ' 104' ' ' VAL . 16.9 m -122.69 160.26 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.351 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.93 135.77 12.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 47' ' ' GLU . 2.8 mt -100.45 159.1 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 60.87 22.82 12.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.178 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.04 -47.37 7.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.674 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 103' ' ' ASP . 46.2 m-85 -96.95 4.15 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.136 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 65.82 29.71 10.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.722 0.296 . . . . 0.0 110.796 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.61 175.32 13.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.438 . . . . 0.0 111.109 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -17.58 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.109 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -77.67 124.79 28.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 111.369 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.478 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -111.5 156.16 22.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.053 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.409 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 13.1 p30 -102.82 120.67 41.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.881 0.372 . . . . 0.0 111.426 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.67 ' CA ' HG12 ' A' ' 92' ' ' VAL . 80.3 t -52.62 111.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.325 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.408 ' HB ' ' HG ' ' A' ' 91' ' ' LEU . 32.6 mm -79.02 -33.25 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.266 0.555 . . . . 0.0 109.81 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.04 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.6 pp -159.1 166.83 30.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.442 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.54 ' N ' HD12 ' A' ' 106' ' ' LEU . 1.6 tttt -109.9 116.94 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.061 0.457 . . . . 0.0 112.145 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.04 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.3 m-85 -79.23 106.12 11.04 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -73.44 177.15 5.45 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.671 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.03 -40.16 54.03 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.001 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.07 -40.81 97.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.678 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.9 mt-10 -67.76 -28.1 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.381 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.44 -49.13 7.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.829 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.39 -29.21 61.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.31 0.576 . . . . 0.0 109.489 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -78.32 -22.56 47.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.181 178.306 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.857 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.08 -33.86 27.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.024 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -33.76 61.54 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -21.01 43.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.729 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.702 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.0 m-30 -66.73 -8.44 28.08 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.89 23.46 51.18 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.418 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 2.9 mm-40 -109.93 -51.55 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.724 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -97.99 125.21 44.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 35.6 Cg_exo -57.27 179.0 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.327 2.018 . . . . 0.0 112.15 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.59 -28.63 67.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 10.3 p-80 -80.78 -23.28 39.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.222 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.545 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -55.39 141.21 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.284 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -124.14 146.51 48.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.863 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.6 mt -99.98 152.51 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -67.1 164.69 17.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.76 127.15 30.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 110' ' ' ALA . 20.7 m -58.5 -22.0 53.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.195 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.7 t0 65.04 42.22 4.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.922 0.391 . . . . 0.0 110.81 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.4 m -83.11 97.34 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.59 114.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.18 99.14 2.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.481 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.74 101.86 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.471 2.114 . . . . 0.0 112.213 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.21 -28.28 64.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t70 62.15 97.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.22 145.25 28.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.13 -178.82 3.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.47 -63.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.47 67.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.57 117.11 29.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -104.64 126.83 52.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.767 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.93 111.93 1.67 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -144.19 128.66 17.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 147' ' ' ILE . 6.4 tp -100.44 82.91 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.151 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -95.74 171.19 28.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.43 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -110.83 -37.19 5.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.783 0.325 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -65.75 114.04 4.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.34 101.7 11.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.45 31.54 5.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -111.75 -69.49 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.6 tp -145.17 144.55 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -159.76 83.64 0.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 66.66 -71.25 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.516 HD12 ' H ' ' A' ' 157' ' ' ILE . 3.5 mp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.078 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.923 0.392 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -74.58 100.37 3.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.844 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.39 43.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.459 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.18 152.11 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.33 120.0 4.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.973 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.72 57.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.762 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -87.88 -31.14 19.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.54 -167.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 m80 63.04 -79.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -120.83 58.24 0.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.6 156.52 19.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -151.36 63.16 5.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.42 97.45 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.561 2.174 . . . . 0.0 112.167 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 120.786 0.244 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.95 56.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.04 -39.27 42.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.2 153.2 34.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.51 72.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.574 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -80.14 119.18 22.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.16 101.57 2.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.46 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.96 134.0 14.28 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -107.68 -29.1 9.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.76 0.315 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.27 175.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.3 mmt-85 -63.03 99.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -117.81 121.94 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -115.58 91.14 3.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.85 27.44 19.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.539 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -109.72 -172.17 1.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.845 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 m120 61.97 105.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -127.65 42.21 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.8 m120 60.65 -174.63 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -167.49 58.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 t -97.38 113.32 24.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.806 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 62.09 -161.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.594 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.4 tttt 73.9 60.38 0.09 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.937 0.399 . . . . 0.0 110.88 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 59.98 101.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.39 88.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.477 HD21 ' CB ' ' A' ' 115' ' ' SER . 13.7 tp -118.9 130.51 55.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.549 HG11 ' CD2' ' A' ' 106' ' ' LEU . 17.7 t -121.84 139.58 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.097 0.475 . . . . 0.0 111.402 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 119' ' ' TYR . 53.8 m-85 -115.22 171.7 7.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -39.44 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -133.81 158.49 43.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 126.78 28.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.74 78.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.97 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.656 ' OE1' HD11 ' A' ' 91' ' ' LEU . 3.0 mt-30 -115.12 143.77 44.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.824 0.312 . . . . 0.0 110.658 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.865 ' HB2' HD11 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -119.22 166.21 13.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.129 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.597 ' CZ ' ' CE2' ' A' ' 108' ' ' TYR . 3.8 m-85 -84.78 156.82 21.21 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.706 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 64' ' ' CYS . . . -149.5 142.75 25.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.681 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.29 108.43 16.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.946 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 60' ' ' LEU . 21.5 t -55.42 137.56 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.461 HD11 ' C ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -116.13 -42.62 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.15 151.95 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.462 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -99.47 134.04 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.679 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 ' HD2' ' A' ' 59' ' ' ARG . 1.2 mt -93.72 -35.63 12.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.825 0.345 . . . . 0.0 110.772 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.25 -132.35 3.2 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -112.6 89.52 3.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.324 . . . . 0.0 110.976 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 147.75 -24.21 1.48 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.822 ' HD2' HD12 ' A' ' 55' ' ' LEU . 14.6 ptt180 -152.87 160.25 43.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.634 0.254 . . . . 0.0 110.534 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.838 HD22 ' CD1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.21 150.05 34.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 111.367 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.682 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.3 tt0 -91.72 121.64 33.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.461 ' C ' HD11 ' A' ' 52' ' ' ILE . . . -137.56 166.11 24.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.237 0.541 . . . . 0.0 112.318 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.478 ' HE3' ' CG ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -115.17 95.92 5.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.095 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 18.7 t -45.8 125.91 6.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.88 ' CZ ' HD22 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -48.46 -23.35 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.91 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -13.2 60.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.599 0.238 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.43 34.36 4.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.687 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.19 124.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' CG ' ' HE3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -85.86 112.47 21.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.58 165.77 27.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.907 0.385 . . . . 0.0 111.304 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.705 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -97.12 108.01 20.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.484 ' SG ' HG11 ' A' ' 92' ' ' VAL . 29.6 m -84.24 125.76 32.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.614 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -82.75 137.08 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.697 HD11 HG13 ' A' ' 82' ' ' VAL . 8.1 tt -68.87 140.3 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.821 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.421 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.31 145.69 43.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.913 0.387 . . . . 0.0 111.348 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.89 -51.23 15.61 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.272 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -31.56 64.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.986 0.422 . . . . 0.0 110.501 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.5 mm? -85.9 -31.71 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.453 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.526 ' HA ' HG12 ' A' ' 82' ' ' VAL . 8.1 mtp180 -49.01 -28.84 4.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.314 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -56.9 -27.48 60.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -169.37 49.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.36 . . . . 0.0 111.165 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 107' ' ' LYS . 9.4 p -123.0 122.94 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.644 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -111.03 109.58 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.673 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.838 ' CD1' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -81.12 123.77 38.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 179.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -84.72 152.82 23.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 86' ' ' THR . 63.0 m -79.92 -5.92 56.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.512 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 p -146.54 51.77 1.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -133.71 165.0 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 111.57 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.841 HG21 ' CD1' ' A' ' 116' ' ' LEU . 1.5 mp -87.72 146.58 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.875 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.75 HG23 ' HA ' ' A' ' 107' ' ' LYS . 1.3 mt -150.42 170.5 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.054 0.454 . . . . 0.0 111.195 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.667 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -123.27 122.4 38.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.93 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 104' ' ' VAL . 19.4 m -120.55 154.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.676 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -97.04 153.81 20.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.851 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -137.17 131.25 32.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 179.55 -68.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.094 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.28 -15.02 60.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 101' ' ' LYS . 16.8 m-85 -72.58 -11.4 60.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.582 0.229 . . . . 0.0 111.556 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 64.87 29.72 12.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.857 0.36 . . . . 0.0 110.807 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.9 OUTLIER 62.85 97.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 99' ' ' ASP . 18.4 t30 165.12 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . 24.3 mttt -141.94 162.39 35.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.474 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.651 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -139.29 170.99 14.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -128.79 111.33 13.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.71 ' HA ' HG12 ' A' ' 92' ' ' VAL . 68.5 t -49.94 112.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.3 mm -83.94 -43.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.175 0.512 . . . . 0.0 109.764 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.027 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -144.46 165.82 26.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.421 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.816 ' HG2' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.87 120.7 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.923 -179.448 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.027 ' CE1' HD11 ' A' ' 106' ' ' LEU . 27.3 m-85 -83.11 105.91 14.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.97 166.77 4.31 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.12 -35.96 66.63 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.402 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.96 -40.22 97.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.738 ' O ' HD23 ' A' ' 116' ' ' LEU . 51.7 mt-10 -64.18 -28.19 69.58 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.561 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.954 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.58 -38.43 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.675 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -33.98 77.16 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.647 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 5.1 p -77.58 -23.09 50.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.867 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.954 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -52.54 -31.36 35.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.18 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -33.11 62.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.31 -21.79 42.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.731 177.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.736 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.44 -7.55 26.23 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.858 0.361 . . . . 0.0 110.218 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.11 84.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.003 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.479 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 38.2 mm-40 -125.83 -56.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.88 HD22 ' CZ ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -93.62 118.64 67.51 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 51.2 Cg_exo -54.3 178.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.206 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 10.0 p-80 -77.23 -17.85 58.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.246 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -52.62 128.73 27.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.363 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -106.76 133.03 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.853 HD13 ' HB1' ' A' ' 113' ' ' ALA . 5.4 mt -101.77 155.74 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.418 ' N ' HG22 ' A' ' 128' ' ' ILE . 12.0 p-10 -72.39 63.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 54.34 -174.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.128 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.7 m -117.73 -64.41 1.3 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.98 88.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.5 p -99.13 174.4 6.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.965 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 134' ' ' PHE . 16.0 p90 -124.42 100.37 6.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 178.79 98.18 0.11 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.473 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.42 179.23 2.61 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.507 2.138 . . . . 0.0 112.335 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.87 -144.63 22.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.482 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.77 131.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.765 0.317 . . . . 0.0 110.993 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.63 117.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.024 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -60.16 103.36 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.98 -46.41 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 22.8 mt -140.67 118.88 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.223 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -100.14 -15.76 18.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.203 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -53.79 -43.92 69.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.802 0.334 . . . . 0.0 111.016 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.28 42.04 15.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.53 76.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 147' ' ' ILE . 0.7 OUTLIER -151.42 109.81 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.078 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.17 -179.25 51.7 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 61.54 155.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.861 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.94 131.97 38.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -136.35 43.33 2.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.71 106.48 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -103.28 -24.03 13.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.695 ' N ' HD13 ' A' ' 154' ' ' ILE . 0.1 OUTLIER -132.79 68.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.919 0.39 . . . . 0.0 111.072 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -144.09 121.14 11.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.845 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -139.89 125.23 18.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.3 mm . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.141 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.79 0.328 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 62.29 159.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.797 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.08 42.6 0.19 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.529 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.82 70.66 1.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.893 0.378 . . . . 0.0 110.869 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -119.42 32.35 6.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -133.19 174.6 10.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -164.01 107.48 0.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.96 145.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 33.7 m170 60.72 -178.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 62.08 29.59 17.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.002 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 51.2 m -87.05 70.09 10.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.786 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.45 76.36 0.51 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 172.82 11.84 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.54 2.16 . . . . 0.0 112.327 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 C--O 1.231 0.151 0 CA-C-O 120.739 0.224 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.9 -64.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 64.37 73.69 0.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -110.5 -23.24 11.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.135 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.42 122.73 16.3 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.716 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -82.45 -59.47 2.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.36 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.44 -56.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.45 -102.83 0.65 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.453 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? 61.09 29.21 18.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.708 0.289 . . . . 0.0 110.929 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -176.39 37.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.753 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.24 50.06 4.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.99 89.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 28.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.014 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.95 -29.38 3.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.424 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 67.66 -70.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.752 0.31 . . . . 0.0 111.061 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.94 86.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.39 -57.57 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 m120 64.97 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.821 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -92.61 -11.67 33.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.283 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 p 64.93 110.92 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.845 0.355 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.38 43.77 1.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -59.63 -32.8 70.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.23 102.84 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.41 137.23 53.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD21 ' CB ' ' A' ' 115' ' ' SER . 16.4 tp -127.21 123.73 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.4 140.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.6 m-85 -111.04 170.06 8.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.085 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -69.48 149.13 48.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.685 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.25 176.41 7.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.346 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -49.64 134.1 20.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.081 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.45 -15.09 60.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.504 HE22 HG21 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -134.12 139.42 45.9 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -125.06 157.2 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.07 0.462 . . . . 0.0 111.496 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 2.9 p90 -84.6 158.12 20.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.034 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.37 173.65 13.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.233 0.539 . . . . 0.0 111.997 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.446 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 38.4 tp60 -128.64 108.94 10.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.92 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.518 HG21 HD11 ' A' ' 90' ' ' ILE . 12.0 t -60.98 136.14 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.047 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 63' ' ' MET . 1.2 mp -116.2 -40.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.703 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 157.95 44.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.644 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.5 ttt -116.9 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.66 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -117.35 -167.62 1.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.729 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.37 -178.53 19.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.441 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.36 39.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.73 52.15 53.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.76 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.544 ' HG3' HD12 ' A' ' 55' ' ' LEU . 8.2 ptt180 -154.81 162.66 41.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.311 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.06 152.26 38.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.291 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.895 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.5 tt0 -94.02 121.82 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.907 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.29 161.36 30.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.235 0.54 . . . . 0.0 112.093 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.654 ' HB3' HD13 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -119.97 101.65 8.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.146 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.05 129.22 40.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.37 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 3.4 m-85 -50.63 -24.54 3.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.468 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -8.42 56.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 35.63 5.0 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.685 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.23 124.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.377 . . . . 0.0 111.087 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 9.8 tptm -96.36 115.21 27.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -141.48 160.99 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.038 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -95.67 110.79 22.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.464 ' HB3' HG11 ' A' ' 92' ' ' VAL . 12.5 m -84.25 119.02 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -79.85 141.49 36.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.373 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -68.63 126.76 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -179.23 -168.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.645 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.47 171.16 40.97 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.298 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -21.6 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.848 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.5 HD12 ' HG2' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -68.71 -10.81 58.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.412 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -47.6 -28.52 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.611 0.243 . . . . 0.0 111.48 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -61.96 -26.28 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.43 ' HE3' ' CZ2' ' A' ' 83' ' ' TRP . 10.2 mtpt -170.31 52.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 82' ' ' VAL . 14.3 p -81.97 111.07 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.43 ' CZ2' ' HE3' ' A' ' 81' ' ' LYS . 10.3 m0 -111.62 109.62 19.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.606 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.033 HD13 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -97.06 147.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.63 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.4 m-80 -119.58 153.38 35.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.927 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 86' ' ' THR . 55.9 m -80.25 -6.4 57.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 111.675 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.7 62.37 1.32 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.98 165.73 34.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.261 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 116' ' ' LEU . 37.2 mm -86.93 145.7 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.29 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.675 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.84 171.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.72 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.01 122.24 29.62 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.536 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.636 HG12 ' CA ' ' A' ' 104' ' ' VAL . 10.1 m -115.18 164.14 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.92 123.21 6.86 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.532 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -109.98 119.76 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.755 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -163.96 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -12.16 60.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -84.81 10.99 10.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.685 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 66.79 26.79 9.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 72.8 -57.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.462 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -40.71 -32.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.717 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -123.61 158.96 30.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -153.07 156.34 38.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -107.23 126.5 52.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.636 ' CA ' HG12 ' A' ' 92' ' ' VAL . 87.2 t -52.5 111.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.686 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.504 HG21 HE22 ' A' ' 46' ' ' GLN . 12.7 mm -80.93 -58.4 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.867 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.048 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -129.67 167.22 18.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.358 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.636 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -110.84 119.31 38.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.746 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.048 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.3 m-85 -84.01 106.38 15.62 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -70.46 172.84 7.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.675 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -75.61 -51.05 13.71 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.636 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -61.32 -39.14 89.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.534 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 23.6 tt0 -67.1 -29.94 69.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.607 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.859 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -45.84 -42.87 12.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.543 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -41.89 58.65 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 110.149 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -61.87 -21.32 64.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.516 178.433 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.914 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.7 -33.35 22.43 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.049 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -55.24 -34.74 64.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.3 -20.58 44.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.009 177.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.2 m-30 -66.58 -8.28 25.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.876 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 22.93 56.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.493 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 66.6 mm-40 -109.77 -61.0 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.912 0.387 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.637 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -82.18 139.45 45.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.745 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 64.3 Cg_endo -73.78 178.03 7.32 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.45 -29.8 70.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 27.3 p-80 -84.19 2.48 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.5 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.623 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -74.15 126.37 30.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 110.994 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -123.59 127.58 48.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.859 HD13 ' HB1' ' A' ' 113' ' ' ALA . 5.7 mt -91.95 156.38 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.455 ' N ' HG22 ' A' ' 128' ' ' ILE . 70.2 m-20 -78.81 151.03 32.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.98 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.622 HG23 ' HB3' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -62.08 139.12 58.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.26 -45.29 2.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.842 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.81 -175.97 4.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.952 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -162.27 93.72 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.974 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 116.46 -93.9 0.62 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.633 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.6 -178.66 3.16 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.542 2.161 . . . . 0.0 112.52 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.25 -95.54 0.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 59.03 77.85 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.404 ' OD1' HD13 ' A' ' 147' ' ' ILE . 10.0 t70 -160.5 52.02 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.5 -28.82 68.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.3 160.53 18.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.94 -31.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.466 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.35 94.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 111.26 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 62.51 122.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -137.26 142.18 41.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -164.52 47.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 147' ' ' ILE . 3.8 mp -101.18 38.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.12 -175.57 13.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.517 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.35 136.38 54.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 110.949 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.62 169.97 9.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 t0 62.11 39.09 13.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -85.92 129.45 34.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.14 147.98 37.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 154' ' ' ILE . 1.6 pp -113.83 171.49 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.102 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.1 t0 61.69 97.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.0 t0 62.9 -168.04 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.427 HD12 ' OXT' ' A' ' 157' ' ' ILE . 1.5 pp . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.11 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.731 0.3 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -37.5 79.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.827 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 109.78 113.75 3.57 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -146.57 105.85 3.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.33 . . . . 0.0 110.908 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -170.9 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.949 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -137.9 161.81 35.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -113.85 86.09 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -63.03 -179.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -104.8 116.23 31.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -153.17 111.78 3.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.442 HG22 ' HD3' ' B' ' 13' ' ' PRO . 35.0 m -95.75 127.91 42.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.854 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -143.06 83.37 11.23 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.442 ' HD3' HG22 ' B' ' 11' ' ' THR . 51.6 Cg_endo -69.18 -177.87 1.87 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.217 . . . . 0.0 112.261 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.797 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.816 0.257 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -84.4 81.34 8.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -87.42 153.32 21.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -87.5 -24.43 24.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.02 125.99 34.7 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.644 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.96 -172.18 2.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 0.0 110.9 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.74 34.62 78.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.557 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.0 85.59 0.11 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -156.03 66.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -173.63 121.05 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.797 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -100.31 170.07 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 mpp_? -70.22 110.42 5.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 106.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.899 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.9 43.39 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -70.56 -20.18 62.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.697 0.284 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 65.03 133.0 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 59.4 101.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.83 112.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -111.32 71.67 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.849 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -115.0 153.34 30.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.98 71.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.924 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -157.21 -72.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -176.8 147.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -100.04 98.5 9.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.047 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.66 HD11 ' CE1' ' A' ' 119' ' ' TYR . 23.3 tp -103.29 118.38 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.471 ' HB ' HD22 ' A' ' 106' ' ' LEU . 19.1 t -108.08 139.11 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.628 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 66.9 m-85 -112.75 170.43 8.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.711 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.597 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.0 ttpt -48.28 143.42 4.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.47 156.17 19.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -56.1 129.85 41.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.838 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.23 -15.35 62.31 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.391 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.624 ' OE1' HD11 ' A' ' 91' ' ' LEU . 15.7 mt-30 -116.38 152.95 32.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.636 0.255 . . . . 0.0 110.401 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.9 tt0 -125.93 154.48 42.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 111.335 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 10.0 p90 -84.34 157.87 21.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.76 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.83 173.42 15.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.327 0.584 . . . . 0.0 112.204 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.689 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 2.3 tm0? -123.77 142.43 51.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.813 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.597 HG13 HD13 ' A' ' 60' ' ' LEU . 22.7 t -92.16 139.02 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 111.799 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 63' ' ' MET . 1.0 OUTLIER -115.85 -48.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.274 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -141.77 162.2 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.699 ' SD ' HD12 ' A' ' 84' ' ' ILE . 26.0 mmm -113.96 137.09 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.872 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -106.19 -69.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.896 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.23 179.65 16.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.565 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -72.37 -13.99 61.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.565 0.221 . . . . 0.0 111.259 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -118.78 8.85 12.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.824 ' HD2' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -155.4 155.98 34.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.752 0.311 . . . . 0.0 111.0 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.849 ' CD2' HD13 ' A' ' 84' ' ' ILE . 1.6 pp -147.89 164.1 34.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.379 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.859 ' HB2' HD21 ' A' ' 55' ' ' LEU . 40.4 tt0 -104.23 121.42 43.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -133.05 165.96 23.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.274 0.559 . . . . 0.0 112.262 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.876 ' HB2' HD11 ' A' ' 52' ' ' ILE . 3.7 tpp -130.14 110.92 11.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.078 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.25 133.5 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -27.27 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.502 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.37 -13.24 60.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.58 43.04 1.9 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.497 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.05 117.8 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.6 OUTLIER -90.64 112.99 24.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.1 156.84 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.872 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -92.66 107.89 19.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.856 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.6 ' HB3' HG11 ' A' ' 92' ' ' VAL . 32.3 m -84.17 118.42 24.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.376 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -82.84 123.7 29.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.765 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.69 HD12 HG12 ' A' ' 84' ' ' ILE . 5.5 tt -68.73 140.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 176.73 -161.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.793 0.33 . . . . 0.0 111.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.3 168.93 39.01 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.028 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.72 2.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.575 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.47 ' O ' HG12 ' A' ' 82' ' ' VAL . 1.2 mm? -64.47 -34.57 78.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.784 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.504 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -49.01 -27.16 3.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.292 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -56.76 -37.66 71.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -157.64 48.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.196 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.8 p -123.51 121.19 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.261 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.55 109.86 20.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.849 HD13 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.38 147.17 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.086 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -108.75 152.84 24.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.957 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 86' ' ' THR . 70.3 m -80.17 -6.36 57.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 111.69 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 p -146.2 61.69 1.24 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.687 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.96 168.52 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.186 0.517 . . . . 0.0 111.45 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.778 HG21 ' CD1' ' A' ' 116' ' ' LEU . 47.6 mm -91.81 146.78 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.213 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.64 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.2 mt -150.9 170.7 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 111.449 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.684 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.68 121.66 29.05 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.519 178.24 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 104' ' ' VAL . 15.3 m -118.66 148.4 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.13 128.4 8.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -114.83 111.54 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.735 0.302 . . . . 0.0 110.73 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.33 -75.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -55.35 -23.22 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.335 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -85.28 4.88 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.633 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 65.78 30.02 10.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 76.36 178.86 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 73.28 -60.67 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.809 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.26 151.05 22.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.674 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.464 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -148.83 151.22 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.991 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -99.44 127.96 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.751 ' HA ' HG12 ' A' ' 92' ' ' VAL . 62.0 t -54.86 111.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.471 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -82.73 -56.74 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 109.923 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.08 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -130.91 166.08 21.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.48 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.628 ' N ' HD12 ' A' ' 106' ' ' LEU . 10.4 tttt -111.74 117.93 34.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.08 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.2 m-85 -84.15 106.55 15.88 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -87.48 -178.94 6.26 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -68.38 -45.35 72.99 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.363 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.86 -39.48 77.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 116' ' ' LEU . 54.2 mt-10 -71.15 -28.7 64.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.593 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.891 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.81 -47.46 8.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.637 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.85 -28.98 64.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 109.399 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.638 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -79.7 -22.86 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.253 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.891 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.74 -34.07 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.095 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -55.18 -33.22 62.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.27 -21.1 43.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.806 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.706 ' HE2' ' CD1' ' A' ' 108' ' ' TYR . 4.0 m-30 -66.57 -9.95 40.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.11 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.55 56.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.595 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.494 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 3.0 mm-40 -108.95 -52.74 2.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.055 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.708 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.06 130.65 35.4 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.825 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 178.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.346 2.031 . . . . 0.0 112.138 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -73.42 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -84.04 1.39 44.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.57 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.94 138.12 55.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.878 0.371 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.71 125.32 44.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.869 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.3 mt -94.75 142.94 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.44 162.37 23.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.829 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.13 -170.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 m -61.55 -59.34 5.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.67 91.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.81 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.0 m -143.9 62.11 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.8 41.05 2.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.825 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -52.5 107.28 0.49 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.733 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.12 88.91 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.438 2.092 . . . . 0.0 112.239 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.13 -97.17 1.02 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.527 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 62.0 116.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -173.72 160.48 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -168.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -152.77 42.97 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.62 HG23 ' HG3' ' A' ' 143' ' ' GLN . 11.2 tt -56.56 -38.99 59.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.257 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.62 ' HG3' HG23 ' A' ' 142' ' ' ILE . 30.6 mt-30 -86.01 145.94 26.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.916 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -65.56 130.81 44.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.11 38.29 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.32 106.04 6.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.65 ' N ' HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -125.15 79.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.43 162.81 36.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.368 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -168.67 133.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -76.66 -42.31 42.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -79.48 179.07 7.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.8 134.47 47.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -81.77 149.77 28.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.9 mt 63.56 81.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -110.63 56.1 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -108.19 68.35 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.147 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.84 0.352 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.12 179.07 6.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 125.83 135.51 4.3 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.87 112.0 14.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -119.37 60.58 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 61.2 99.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -170.33 131.68 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -162.84 44.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 56.5 m170 60.64 83.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -115.04 -44.49 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -162.64 36.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -135.85 110.44 10.17 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.68 -11.36 31.86 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.437 2.092 . . . . 0.0 112.544 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 24.5 tpp . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.922 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.807 0.253 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -74.75 78.9 2.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -81.63 78.45 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mttp 64.12 -77.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.098 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.59 -120.52 15.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.46 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -109.93 65.92 0.62 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.5 92.91 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.519 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.1 -123.25 7.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.517 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.44 -68.54 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 111.002 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -57.86 89.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -156.42 138.83 14.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -131.98 91.08 2.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.5 89.67 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.88 -97.46 2.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.91 -78.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.762 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 57.5 -165.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 65.36 52.9 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.06 179.57 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.057 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.58 -168.44 1.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 p -138.58 137.83 37.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -170.96 48.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.82 31.86 18.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -104.08 73.26 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.878 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -129.04 81.44 2.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 115' ' ' SER . 13.0 tp -68.56 105.74 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' CG1' HD22 ' A' ' 106' ' ' LEU . 17.8 t -97.78 139.35 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.204 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 78.6 m-85 -108.58 170.72 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.995 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.447 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -44.31 158.28 0.05 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.43 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.0 156.17 35.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.087 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.86 126.2 26.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.85 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.94 -15.35 62.02 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.604 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' A' ' 91' ' ' LEU . 3.4 mm-40 -111.21 152.61 26.91 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.871 ' HB2' HD11 ' A' ' 94' ' ' LEU . 35.8 tt0 -122.89 150.6 42.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 4.4 p90 -84.79 157.86 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.295 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.82 174.0 12.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.335 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.434 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 tm0? -127.58 114.4 17.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.298 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 90' ' ' ILE . 38.4 t -68.64 131.06 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.907 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 63' ' ' MET . 30.4 mt -116.04 -37.14 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.875 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -141.14 155.86 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.608 ' C ' HD23 ' A' ' 55' ' ' LEU . 2.7 mtp -117.16 146.94 42.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.819 HD12 ' CD ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -110.68 -46.13 3.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 110.802 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.7 -137.51 2.49 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.73 -26.8 9.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.666 0.269 . . . . 0.0 110.982 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -103.57 3.72 46.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.075 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.819 ' CD ' HD12 ' A' ' 55' ' ' LEU . 6.3 ptp180 -155.28 156.37 35.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.905 0.353 . . . . 0.0 111.036 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.807 ' CD2' HD13 ' A' ' 84' ' ' ILE . 2.3 pp -148.08 167.19 25.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.505 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.799 ' HB2' HD21 ' A' ' 55' ' ' LEU . 17.8 tt0 -112.9 121.25 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.161 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -135.85 164.91 26.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.213 0.53 . . . . 0.0 112.293 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 8.0 tpp -118.24 110.3 17.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.165 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -59.14 133.25 55.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.8 m-85 -48.04 -24.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.07 -11.31 60.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.367 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.24 42.21 2.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.729 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.11 133.01 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.313 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.5 OUTLIER -103.86 112.5 25.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -145.54 164.81 30.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.003 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.73 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -98.35 108.9 21.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.737 ' HB3' HG11 ' A' ' 92' ' ' VAL . 37.4 m -89.92 118.8 29.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.922 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.43 132.67 36.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.67 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.673 HD12 HG12 ' A' ' 84' ' ' ILE . 10.8 tt -68.93 140.99 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -56.24 174.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.074 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.15 -49.82 2.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.229 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -33.52 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -71.18 -45.98 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.639 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.485 ' HA ' HG12 ' A' ' 82' ' ' VAL . 11.4 ptm180 -56.59 -25.7 53.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -28.41 64.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm -137.35 8.24 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.851 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.589 HG21 ' CB ' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -124.35 124.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.956 0.407 . . . . 0.0 111.487 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -110.79 110.41 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.807 HD13 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.32 147.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 111.416 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -117.51 157.76 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.04 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.1 m -76.06 -6.36 50.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.751 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -144.45 73.55 1.38 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.649 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.79 162.28 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.928 HG21 ' CD1' ' A' ' 116' ' ' LEU . 33.5 mm -86.94 147.31 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.603 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.681 HD13 HG22 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -150.7 171.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.43 . . . . 0.0 111.438 179.703 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.657 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -130.12 122.92 29.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.9 178.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.779 HG12 ' HA ' ' A' ' 104' ' ' VAL . 31.0 m -121.6 157.34 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.994 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.62 136.14 12.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.862 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -118.27 110.27 17.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.0 110.743 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.67 -68.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 111.108 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.2 -27.77 23.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.245 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -85.71 -0.24 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.65 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 65.8 30.27 10.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 5.6 m-20 77.88 162.55 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 85.56 -23.34 0.16 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.36 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -141.22 157.01 45.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.662 0.268 . . . . 0.0 110.449 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.779 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -148.54 174.28 12.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 0.0 111.141 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -128.64 124.22 35.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.589 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.779 ' HA ' HG12 ' A' ' 92' ' ' VAL . 49.8 t -52.55 111.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.667 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -83.41 -37.44 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 109.819 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.04 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.4 pp -152.48 164.08 38.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.419 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 90' ' ' ILE . 4.8 tmtt? -109.32 118.21 36.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 111.911 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 1.04 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.4 m-85 -79.83 106.6 11.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 112' ' ' GLU . 9.8 m-20 -60.17 166.91 2.62 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.705 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -78.0 -50.66 11.69 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.62 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.31 -42.91 99.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' OE2' ' HA ' ' A' ' 108' ' ' TYR . 0.6 OUTLIER -68.85 -26.6 65.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.01 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 1.005 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -45.68 -34.06 3.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.305 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -55.82 -39.56 71.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.421 0.629 . . . . 0.0 109.396 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.702 ' HB3' HD21 ' A' ' 39' ' ' LEU . 12.0 m -61.01 -20.85 62.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.089 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.928 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -49.55 -34.89 18.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.38 -178.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.03 -34.96 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.39 42.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.78 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.701 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -66.82 -10.53 48.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 27.55 66.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 7.8 mm-40 -114.02 -51.87 2.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.685 0.279 . . . . 0.0 111.035 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.611 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.89 139.86 21.57 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.44 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 35.1 Cg_exo -59.21 179.41 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.415 2.077 . . . . 0.0 112.103 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -72.76 -27.74 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.44 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 9.2 p-80 -79.1 -18.83 52.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.379 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.57 135.86 39.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.827 0.346 . . . . 0.0 111.411 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.46 131.1 45.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.005 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.7 mt -102.38 158.72 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.271 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 128' ' ' ILE . 0.8 OUTLIER -109.47 171.45 7.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.94 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 59.74 45.8 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.975 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -81.35 165.7 21.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.68 139.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.7 m -67.54 156.61 36.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.04 88.19 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.32 -91.03 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.05 98.48 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.538 2.159 . . . . 0.0 112.346 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.51 -140.3 16.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.478 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.0 t0 60.1 71.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.83 32.33 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.28 67.14 4.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.41 175.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.6 tt -91.03 146.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.25 -179.66 4.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.04 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 59.17 177.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -142.03 -175.82 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.956 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.2 t0 62.61 48.31 4.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 147' ' ' ILE . 12.0 tt -148.83 111.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.082 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.64 -130.56 1.4 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.448 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.02 137.67 53.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.832 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -177.22 -172.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.4 t0 65.01 122.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -123.63 161.66 24.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.46 88.17 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.82 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 154' ' ' ILE . 16.8 tt -173.52 116.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.034 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t0 60.87 77.9 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.484 ' O ' HG22 ' A' ' 157' ' ' ILE . 8.8 m-20 -155.38 142.41 19.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 156' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.507 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.817 0.341 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.631 HD21 ' HE1' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -81.58 142.78 32.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.455 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' HB ' HD22 ' A' ' 106' ' ' LEU . 21.8 t -116.11 138.5 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.07 0.462 . . . . 0.0 111.626 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.607 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.8 m-85 -107.48 170.49 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.364 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 2.6 ttpt -52.86 145.39 12.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 0.0 110.738 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -111.73 156.58 21.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.4 130.1 45.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.92 -15.47 61.72 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.423 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' OE1' HD11 ' A' ' 91' ' ' LEU . 17.6 mt-30 -116.32 144.91 43.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.639 0.257 . . . . 0.0 110.326 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -118.1 155.3 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.468 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.3 p90 -84.45 157.71 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.88 173.25 13.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.193 0.521 . . . . 0.0 112.328 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.483 ' HG2' HD13 ' A' ' 89' ' ' ILE . 1.2 tm0? -129.27 130.77 46.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.915 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 43.9 t -82.08 139.92 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.084 0.469 . . . . 0.0 112.051 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.493 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.0 -39.74 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -141.65 157.81 44.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.463 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.561 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -111.53 142.62 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.813 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.929 HD21 ' HB2' ' A' ' 61' ' ' GLU . 3.3 mt -103.79 -155.83 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -44.55 -84.57 0.01 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.194 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -159.76 -43.81 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.42 -0.22 71.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.007 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.694 ' HG3' HD12 ' A' ' 55' ' ' LEU . 26.3 ptt180 -151.76 167.2 28.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.094 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.734 ' CD2' HG21 ' A' ' 84' ' ' ILE . 2.0 pp -147.66 154.54 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.04 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.929 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.5 tt0 -91.78 121.75 33.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.042 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -149.78 164.82 34.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.493 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -138.75 133.27 31.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.536 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.438 ' O ' ' HE3' ' A' ' 63' ' ' MET . 49.2 t -64.41 141.6 58.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.974 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.3 m-85 -48.66 -23.19 0.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.782 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -13.78 61.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.331 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.02 34.64 3.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.76 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 110.74 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 111.037 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 63' ' ' MET . 5.5 mmtm -85.69 118.34 25.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -145.12 156.61 43.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.003 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -91.99 105.77 17.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.493 ' SG ' HG11 ' A' ' 92' ' ' VAL . 12.1 m -85.41 118.77 25.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.732 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.45 141.25 36.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.697 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.883 HD12 ' CD1' ' A' ' 84' ' ' ILE . 2.1 tt -68.6 140.28 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 26.6 tpt180 -67.27 155.33 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.352 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.08 -61.53 2.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.269 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.42 -39.75 91.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.501 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -69.15 -17.88 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.987 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.499 ' HA ' HG12 ' A' ' 82' ' ' VAL . 1.2 ptt180 -48.67 -28.72 3.73 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.292 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -75.01 -29.38 60.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.344 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.67 44.6 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 82' ' ' VAL . 11.0 p -117.45 115.7 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 110.955 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -110.74 110.27 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.883 ' CD1' HD12 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -106.1 147.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.758 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.2 m-20 -137.57 165.51 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.904 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.7 m -80.28 -6.16 57.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.596 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.08 68.62 0.94 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.579 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -150.8 164.27 36.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.929 HG21 ' CD1' ' A' ' 116' ' ' LEU . 32.0 mm -87.63 144.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.229 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.3 mt -150.68 171.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 111.241 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.741 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -127.2 122.34 33.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.706 HG12 ' HA ' ' A' ' 104' ' ' VAL . 17.0 m -120.4 139.18 48.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.432 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.456 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -80.5 146.17 27.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.293 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 93' ' ' GLY . 1.4 mt -114.64 167.3 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' CB ' ' O ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER 82.03 -8.08 1.31 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.835 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -35.7 27.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.642 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -105.66 22.83 14.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.435 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 55.5 mm-40 68.92 30.53 4.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.766 0.317 . . . . 0.0 110.77 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 100' ' ' ASN . 1.3 t0 82.99 -175.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 99' ' ' ASP . 8.5 t-20 69.62 -60.93 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.777 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -98.77 155.73 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -145.84 131.08 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -88.99 123.93 33.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.276 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.706 ' HA ' HG12 ' A' ' 92' ' ' VAL . 80.6 t -52.09 112.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.653 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -78.84 -39.46 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 109.971 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.032 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -150.56 166.61 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.372 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.595 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -108.31 123.27 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 111.813 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.032 ' CE1' HD11 ' A' ' 106' ' ' LEU . 20.3 m-85 -87.45 106.73 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.56 166.69 6.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.58 -38.61 62.6 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.515 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.36 -40.14 95.44 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.703 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.3 mm-40 -62.25 -27.47 69.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.76 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.929 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.55 -36.61 2.14 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.846 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -63.82 -33.05 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -78.48 -22.8 46.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.902 177.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.929 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.75 -31.75 27.89 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.165 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -33.33 62.82 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.47 -22.05 41.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.748 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.653 ' CG ' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.2 -11.65 57.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.07 29.28 74.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.497 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.505 ' HB2' HD23 ' A' ' 122' ' ' LEU . 34.2 mt-10 -117.09 -52.42 2.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.206 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.522 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -102.89 141.4 22.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 -179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.667 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 71.4 Cg_endo -74.54 179.11 6.24 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.51 2.14 . . . . 0.0 112.206 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -71.03 -17.22 62.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.246 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 11.9 p-80 -97.72 -1.91 42.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.638 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.667 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -59.66 154.31 18.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 111.178 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -115.37 125.87 53.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.851 HD13 ' HB1' ' A' ' 113' ' ' ALA . 13.3 mt . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.011 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.799 0.333 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.709 HD11 ' CE1' ' A' ' 119' ' ' TYR . 21.6 tp -89.96 125.91 35.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.705 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.73 140.65 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.688 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.758 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -110.75 170.41 8.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.347 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -47.78 144.13 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.709 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -119.51 164.6 15.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.405 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -56.53 131.49 48.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.726 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.03 -15.41 61.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.379 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -124.95 148.34 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.714 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.2 tt0 -124.21 154.41 40.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.231 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.0 p90 -84.18 157.89 21.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.788 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.72 14.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.27 0.557 . . . . 0.0 112.5 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.579 ' OE1' HD13 ' A' ' 89' ' ' ILE . 33.4 tp60 -129.94 109.14 10.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.12 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.511 ' CG2' HD11 ' A' ' 90' ' ' ILE . 26.7 t -56.32 141.18 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -115.67 -43.04 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.833 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 160.59 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -108.83 131.87 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.454 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -93.45 -29.19 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.991 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.15 -175.37 32.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -73.33 95.28 2.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.01 -28.16 2.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.783 ' CD ' HD12 ' A' ' 55' ' ' LEU . 26.2 ptt180 -150.27 160.22 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.989 HD22 HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.66 154.77 41.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.905 ' HB2' HD21 ' A' ' 55' ' ' LEU . 17.1 tt0 -99.72 121.6 41.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.771 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.509 ' C ' HD11 ' A' ' 52' ' ' ILE . . . -130.11 157.41 42.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.084 0.469 . . . . 0.0 111.879 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.416 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -114.9 105.36 12.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.31 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.1 m -56.98 127.55 32.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.47 -25.45 1.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.672 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 -9.94 59.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.265 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.02 37.23 4.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 70' ' ' ARG . 21.2 t -127.01 118.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 111.342 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' CA ' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.41 118.01 25.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.622 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.431 ' HG3' HG12 ' A' ' 68' ' ' VAL . 7.4 mtm180 -145.09 161.99 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.247 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.866 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -102.34 117.75 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.795 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.6 ' SG ' HG11 ' A' ' 92' ' ' VAL . 9.3 m -99.71 119.44 38.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -77.05 149.22 35.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.573 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.494 HD12 ' CD1' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -68.83 129.51 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.767 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -53.08 159.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.316 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.03 -52.21 2.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -74.31 -33.94 63.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 110.399 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.613 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -74.71 -19.79 60.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.784 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.774 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -50.36 -27.26 5.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.04 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -60.31 -30.46 69.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -153.97 36.53 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 79' ' ' ARG . 7.7 p -105.08 111.0 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.083 0.468 . . . . 0.0 110.957 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -111.23 110.21 20.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.789 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.989 HD13 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.06 147.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.896 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -129.5 161.52 30.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 52' ' ' ILE . 88.2 m -80.0 -6.63 57.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.049 0.452 . . . . 0.0 111.73 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 p -144.61 71.74 1.32 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.7 159.55 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.141 0.496 . . . . 0.0 111.537 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.889 HG21 ' CD1' ' A' ' 116' ' ' LEU . 30.1 mm -86.88 147.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.2 mt -150.54 171.23 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.399 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.75 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -127.81 122.28 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.596 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 104' ' ' VAL . 33.2 m -121.73 153.69 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.443 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.77 140.51 15.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.37 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.714 HD11 ' HB2' ' A' ' 47' ' ' GLU . 4.0 mt -113.86 177.12 4.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 0.0 111.003 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.81 8.7 6.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.454 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -93.44 -38.84 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.845 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -105.63 22.86 14.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 69.1 30.54 4.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 11.1 t0 81.07 162.79 0.16 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 9.0 t-20 84.86 -18.69 0.38 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.448 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HE2' HD23 ' A' ' 71' ' ' LEU . 15.6 mmtp -142.0 151.43 42.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -139.67 -177.06 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.9 116.04 10.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.785 ' HA ' HG12 ' A' ' 92' ' ' VAL . 91.4 t -51.22 111.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.979 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -83.18 -50.37 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 0.0 109.813 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.053 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -136.19 168.95 18.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.653 ' N ' HD12 ' A' ' 106' ' ' LEU . 11.1 ttpt -111.37 121.74 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.053 ' CE1' HD11 ' A' ' 106' ' ' LEU . 21.6 m-85 -86.77 106.47 17.71 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.93 175.4 5.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -75.68 -41.79 52.9 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.768 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -61.5 -40.22 93.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.67 ' O ' HD23 ' A' ' 116' ' ' LEU . 18.4 mt-10 -67.12 -28.23 67.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.544 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.957 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.56 -47.83 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.876 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -56.52 -29.49 61.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.396 0.617 . . . . 0.0 109.503 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.695 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -75.89 -22.18 56.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.246 178.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.34 -35.68 28.89 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.287 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -54.55 -34.78 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.17 -20.46 44.78 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.932 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.758 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.8 m-30 -66.35 -5.49 10.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.781 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 24.9 57.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.582 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 57.0 mm-40 -114.11 -60.37 1.89 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.278 . . . . 0.0 111.318 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.76 139.16 24.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.083 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 24.2 Cg_exo -63.13 -178.99 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.531 2.154 . . . . 0.0 112.129 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.66 -26.86 62.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.064 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 15.6 p-80 -82.98 -9.67 59.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.503 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -55.96 135.25 52.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.333 . . . . 0.0 111.182 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -121.99 127.6 50.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.957 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.0 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.34 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.644 HD11 ' HE1' ' A' ' 119' ' ' TYR . 25.4 tp -77.17 117.27 18.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.462 ' CG1' HD22 ' A' ' 106' ' ' LEU . 21.4 t -105.34 139.15 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.609 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 81.0 m-85 -114.28 170.42 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.672 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HA ' HD22 ' A' ' 91' ' ' LEU . 5.9 ttpm? -47.09 152.64 0.53 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.14 159.52 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.933 0.397 . . . . 0.0 111.155 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.35 127.66 33.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.853 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.24 61.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.618 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.518 ' CB ' HD11 ' A' ' 91' ' ' LEU . 12.8 mt-30 -115.84 146.38 42.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.586 ' CB ' HD11 ' A' ' 94' ' ' LEU . 47.3 tp10 -120.6 156.05 32.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 111.405 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 65' ' ' PHE . 1.9 p90 -84.48 157.79 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.985 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.62 173.3 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 112.141 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 62.8 tp60 -128.68 109.59 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.678 ' CG2' HD11 ' A' ' 90' ' ' ILE . 2.7 t -54.25 135.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.975 0.417 . . . . 0.0 111.853 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.932 HD13 ' HB3' ' A' ' 63' ' ' MET . 1.0 OUTLIER -115.67 -44.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.842 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -141.51 162.25 35.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.693 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.3 ttt -116.22 143.14 45.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -111.24 -57.74 2.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.705 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 149.02 9.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.607 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.89 74.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.045 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.917 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 55.1 34.04 58.1 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.705 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.892 ' HB3' HD12 ' A' ' 55' ' ' LEU . 14.7 mmt180 -144.94 129.73 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.411 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.858 HD22 HG12 ' A' ' 84' ' ' ILE . 1.1 pp -147.03 138.92 24.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.692 ' HB2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -90.95 121.25 32.62 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . . . -122.37 164.62 17.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 112.026 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.932 ' HB3' HD13 ' A' ' 52' ' ' ILE . 4.9 tpt -130.6 95.29 3.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.27 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.3 130.66 43.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.301 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 8.5 m-85 -49.57 -24.59 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.765 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.31 -9.19 58.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.258 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.5 5.34 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.65 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.18 110.98 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.197 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.25 122.27 35.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -145.23 165.67 27.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.075 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.022 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -93.5 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.548 ' SG ' HG11 ' A' ' 92' ' ' VAL . 32.8 m -90.92 134.28 34.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.572 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.39 131.29 34.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.917 HG22 ' HA2' ' A' ' 58' ' ' GLY . 17.4 tt -68.52 140.77 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.941 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.434 ' CB ' ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -62.72 151.95 37.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.82 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.36 -43.0 26.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.667 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -76.03 -31.38 58.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 75' ' ' ARG . 3.1 mm? -75.73 -50.61 14.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.6 -25.33 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -51.36 -39.76 57.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.014 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -141.52 13.0 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.452 HG22 ' HD3' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -124.32 120.69 59.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.982 0.42 . . . . 0.0 111.092 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -110.96 115.04 28.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.655 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.858 HG12 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -64.06 131.83 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 110.597 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.565 ' O ' HG21 ' A' ' 51' ' ' VAL . 5.6 m-80 -98.18 156.46 16.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.172 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 86' ' ' THR . 77.0 m -76.28 -6.45 51.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.887 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.58 80.71 1.77 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.86 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 162.85 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.967 0.413 . . . . 0.0 111.302 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 116' ' ' LEU . 29.8 mm -86.84 146.78 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.328 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.801 HD13 HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.68 171.22 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.679 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.722 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.61 121.81 29.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.661 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.78 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.3 m -118.63 148.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.115 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.79 139.19 15.68 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.795 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -125.43 137.11 53.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.726 0.298 . . . . 0.0 110.623 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -177.23 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.109 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.71 -20.61 61.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.254 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -72.3 -10.58 59.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.309 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 9.2 mt-30 68.57 28.35 5.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.367 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 8.8 t0 79.17 -47.25 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.668 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -43.0 -30.3 0.41 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.33 164.09 29.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -146.77 -177.31 5.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -137.9 112.92 9.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.78 ' HA ' HG12 ' A' ' 92' ' ' VAL . 60.3 t -50.36 111.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.9 mm -87.9 -55.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.157 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.034 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -131.28 163.79 27.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.503 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.586 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -109.41 115.63 30.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.034 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.7 m-85 -79.02 106.29 10.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -69.52 175.72 3.92 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.625 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.72 -40.2 49.4 Favored 'General case' 0 C--O 1.229 0.023 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.796 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.43 -40.11 93.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.71 ' O ' HD23 ' A' ' 116' ' ' LEU . 17.4 mt-10 -66.94 -28.35 68.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.882 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.55 -46.31 7.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.871 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -30.26 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -77.91 -22.29 49.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.153 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.914 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.16 -32.65 23.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.147 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -54.93 -33.85 62.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -21.91 41.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.76 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.675 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -66.93 -13.16 61.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.75 28.23 69.67 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.635 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.531 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.4 mt-10 -113.2 -53.74 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 111.255 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.595 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -87.58 140.51 31.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.721 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 65.3 Cg_endo -73.66 179.41 5.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -28.05 66.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.987 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 47.0 p-80 -87.07 2.45 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.535 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.721 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -81.09 127.75 32.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.883 0.373 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.22 137.22 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.882 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.5 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.765 0.317 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.616 HD12 ' HG2' ' A' ' 112' ' ' GLU . 11.2 tp -119.54 116.19 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' O ' ' HE1' ' A' ' 108' ' ' TYR . 18.3 t -129.22 141.04 47.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.802 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.745 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 1.7 m-85 -108.24 170.3 8.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.117 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 159.66 25.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.719 0.295 . . . . 0.0 110.697 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.12 175.44 10.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.128 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -47.15 130.87 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.18 -15.33 62.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.435 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.618 HE21 HD11 ' A' ' 91' ' ' LEU . 2.0 mt-30 -136.67 146.61 46.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.316 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.72 158.72 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.51 157.98 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.212 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 173.88 12.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.205 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.445 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -129.78 110.99 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.303 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 41.7 t -62.66 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.008 0.432 . . . . 0.0 111.799 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 86' ' ' THR . 25.0 mt -116.11 -39.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.917 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 151.06 42.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.977 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.56 ' CE ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -110.73 125.85 53.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.912 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -89.14 -166.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.611 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.81 69.85 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.77 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 3.8 p-10 178.41 55.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 110.965 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.63 28.05 62.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.835 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.878 ' CD ' HD12 ' A' ' 55' ' ' LEU . 12.9 ptp180 -144.81 167.27 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.734 0.302 . . . . 0.0 110.912 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.97 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.22 146.48 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.108 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.912 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.2 tt0 -91.83 122.61 34.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.188 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -137.39 163.23 31.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.263 0.554 . . . . 0.0 112.315 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 8.2 tpp -123.35 110.81 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -60.32 134.26 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.9 m-85 -47.8 -26.3 1.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.804 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.39 -8.04 54.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.427 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.08 44.17 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 t -127.12 118.35 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 0.0 111.288 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 2.8 ttmt -87.61 114.89 24.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.75 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -144.07 163.53 33.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -105.42 108.27 19.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 4.4 m -84.19 119.14 24.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.303 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -76.6 155.7 33.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.34 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 1.069 HD11 HD11 ' A' ' 84' ' ' ILE . 5.3 mm -68.36 123.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.416 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.515 ' NH2' HD12 ' A' ' 105' ' ' ILE . 13.5 tpt180 -53.93 162.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.434 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.01 -53.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.272 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -35.15 76.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 3.2 mm? -78.64 -11.28 59.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.181 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -48.79 -33.88 11.25 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.847 0.356 . . . . 0.0 111.334 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -56.31 -23.25 35.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -162.27 40.9 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.252 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 82' ' ' VAL . 14.6 p -82.7 110.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 110.742 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -112.21 110.14 20.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.626 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.069 HD11 HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -112.3 145.53 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.255 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.481 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m120 -132.05 163.65 27.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 52' ' ' ILE . 39.4 m -76.47 -6.63 52.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 111.653 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 m -148.36 72.34 1.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.658 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 159.79 39.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.167 0.508 . . . . 0.0 111.364 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.878 HG21 ' CD1' ' A' ' 116' ' ' LEU . 39.9 mm -87.11 145.99 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.183 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.688 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.3 mt -150.93 171.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.119 0.485 . . . . 0.0 111.392 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.732 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.4 125.83 39.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.53 178.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.681 ' N ' HD12 ' A' ' 91' ' ' LEU . 15.9 m -122.23 155.61 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.27 126.27 8.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.706 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -109.89 126.74 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 110.76 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 -177.94 -72.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.056 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.94 -12.08 60.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.371 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 103' ' ' ASP . 39.5 m-85 -90.49 17.51 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.686 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 65.81 23.54 11.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.563 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 t0 73.42 -58.12 0.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.544 0.211 . . . . 0.0 111.556 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -41.73 -33.44 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.41 ' CB ' ' HB3' ' A' ' 97' ' ' TYR . 3.7 mptt -113.91 161.94 17.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -157.67 131.59 8.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 31.9 t70 -90.7 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.643 ' CA ' HG12 ' A' ' 92' ' ' VAL . 91.5 t -51.56 111.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.515 HD12 ' NH2' ' A' ' 75' ' ' ARG . 41.2 mm -77.53 -36.52 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.559 . . . . 0.0 109.86 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.084 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.3 pp -155.11 170.75 21.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.358 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.657 ' N ' HD12 ' A' ' 106' ' ' LEU . 15.1 pttm -112.12 126.17 54.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.084 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.1 m-85 -92.98 106.71 18.63 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.411 ' OD1' ' CG ' ' A' ' 112' ' ' GLU . 47.0 p30 -85.55 -174.35 5.13 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.654 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.71 -41.31 60.42 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.199 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.27 -40.67 91.19 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.718 ' O ' HD23 ' A' ' 116' ' ' LEU . 18.0 mt-10 -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.305 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 1.087 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.51 -48.31 7.37 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.021 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -57.23 -28.85 63.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.413 0.625 . . . . 0.0 109.498 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -80.19 -22.96 41.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.296 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.906 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.34 -34.74 24.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.09 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -54.86 -33.95 62.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -20.05 45.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.142 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.745 ' CD1' ' CD1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.08 -6.8 14.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.759 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.33 66.68 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.377 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 55.3 mm-40 -119.95 -60.02 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.419 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.748 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -90.9 128.82 46.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 38.4 Cg_exo -59.8 -179.19 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.384 2.056 . . . . 0.0 111.914 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.72 -21.92 63.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.48 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.5 p-80 -88.08 -0.94 57.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.614 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.17 158.33 11.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -117.4 147.57 42.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.087 HD12 ' HB1' ' A' ' 113' ' ' ALA . 42.7 mm . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.856 0.36 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.699 HD12 ' HG2' ' A' ' 112' ' ' GLU . 20.3 tp -72.99 101.57 3.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.499 ' CG1' HD22 ' A' ' 106' ' ' LEU . 14.4 t -91.38 139.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 111.377 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.2 m-85 -110.88 170.44 8.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.881 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.5 ttpp -52.98 152.5 3.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -123.8 157.61 33.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.44 . . . . 0.0 111.45 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.95 132.47 49.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.93 -15.55 60.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.713 HE21 HD11 ' A' ' 91' ' ' LEU . 2.3 mt-30 -116.8 151.46 36.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.704 0.288 . . . . 0.0 110.521 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.773 ' HB3' HD11 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -124.42 149.45 46.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.18 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 3.2 p90 -84.21 157.58 21.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.703 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.82 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.287 0.565 . . . . 0.0 112.502 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.419 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 34.1 tp60 -130.31 119.79 23.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.808 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 85' ' ' ASN . 10.7 t -70.24 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -115.7 -43.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.867 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 162.04 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.755 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.35 143.64 34.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.652 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 71' ' ' LEU . 6.2 mt -108.09 -30.4 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.34 -166.25 31.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.38 99.18 8.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 136.67 -24.84 3.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.616 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.74 ' HG3' HD12 ' A' ' 55' ' ' LEU . 8.7 ptp180 -152.88 159.78 43.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.643 HD22 HG21 ' A' ' 84' ' ' ILE . 1.1 pp -147.41 158.25 43.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.636 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -91.94 121.56 33.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.535 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.29 165.93 24.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.274 0.559 . . . . 0.0 112.276 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.876 ' HB2' HD11 ' A' ' 52' ' ' ILE . 2.1 tpp -134.84 111.97 10.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.186 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.08 132.91 55.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.21 -26.3 1.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.876 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -74.47 -14.22 60.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.402 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.97 42.9 1.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.39 112.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.187 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 23.5 tttt -84.27 112.76 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.624 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 101' ' ' LYS . 11.4 ptp180 -145.28 161.72 38.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -102.57 108.32 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.486 ' HB3' HG11 ' A' ' 92' ' ' VAL . 9.7 m -83.74 118.38 23.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.629 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 3.7 m-70 -79.52 131.89 36.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.768 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 82' ' ' VAL . 1.4 tt -68.5 137.12 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 171.59 -161.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.315 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.54 171.45 47.12 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.232 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.85 -25.74 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.646 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.659 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -75.62 -19.82 58.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.127 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -28.22 2.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 111.231 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -26.41 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -169.18 46.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.822 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 74' ' ' ILE . 14.9 p -87.23 126.64 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -106.92 110.22 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.643 HG21 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -94.72 147.31 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.571 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.441 ' O ' HG21 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -128.2 153.54 46.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.43 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 91.7 m -80.28 -7.01 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.715 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.7 m -142.98 53.49 1.37 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.526 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.2 167.02 23.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.488 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.893 HG21 ' CD1' ' A' ' 116' ' ' LEU . 27.9 mm -90.67 146.02 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.233 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -150.12 171.2 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.095 0.474 . . . . 0.0 111.237 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.729 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -130.18 122.43 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.866 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.739 HG12 ' HA ' ' A' ' 104' ' ' VAL . 27.0 m -117.51 147.85 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.88 132.05 11.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.784 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -118.92 107.9 14.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -162.6 -79.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.939 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.6 -15.99 63.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.115 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.476 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 4.7 m-85 -72.22 -8.37 54.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.648 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 68.16 29.41 6.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.263 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 72.24 -174.42 0.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.69 -61.59 0.5 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.82 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -111.98 171.09 7.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -156.85 170.91 21.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.872 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -119.73 124.98 47.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.739 ' HA ' HG12 ' A' ' 92' ' ' VAL . 86.9 t -53.08 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.03 -54.99 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.046 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -133.19 166.62 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.414 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.596 ' N ' HD12 ' A' ' 106' ' ' LEU . 14.7 pttm -110.56 118.62 36.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.072 0.463 . . . . 0.0 112.185 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.046 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.0 m-85 -82.82 106.54 14.74 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.63 176.69 7.41 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.07 -44.41 60.6 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.105 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.25 -39.98 88.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.699 ' HG2' HD12 ' A' ' 39' ' ' LEU . 8.5 mt-10 -69.16 -29.31 67.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.586 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 1.101 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.96 -48.33 8.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.902 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 109.599 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.626 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -75.13 -22.07 58.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.147 178.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.893 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.24 -34.03 21.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 121.124 -0.231 . . . . 0.0 111.118 -179.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -34.63 63.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.44 42.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.612 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.68 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.2 m-30 -66.55 -11.98 55.5 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.13 29.21 67.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.521 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 25.3 mm-40 -115.69 -50.24 2.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.738 0.304 . . . . 0.0 111.243 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.602 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -94.92 140.65 22.57 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.09 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.465 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 24.4 Cg_exo -63.09 -178.86 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.477 2.118 . . . . 0.0 112.05 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.26 -28.03 63.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.002 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 13.7 p-80 -78.92 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.24 130.89 36.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 111.272 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.63 148.55 33.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.101 HD12 ' HB1' ' A' ' 113' ' ' ALA . 26.7 mm . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.816 0.341 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.591 HD21 ' CB ' ' A' ' 115' ' ' SER . 14.2 tp -84.32 113.5 21.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.549 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.01 140.9 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.745 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.7 m-85 -107.75 169.84 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.089 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 137.83 58.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.506 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.87 175.27 5.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.063 0.458 . . . . 0.0 111.478 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -50.71 133.92 25.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.129 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.27 -15.36 60.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.451 HE21 HD11 ' A' ' 91' ' ' LEU . 0.3 OUTLIER -130.94 148.31 52.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 110.573 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.554 ' H ' HD21 ' A' ' 94' ' ' LEU . 2.2 tt0 -130.22 159.89 35.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.086 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.31 158.16 21.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.007 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.99 173.56 14.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.246 0.546 . . . . 0.0 112.189 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -129.71 129.73 44.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.029 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 60' ' ' LEU . 47.4 t -81.82 140.77 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 0.0 112.019 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.467 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -116.42 -41.45 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.1 160.39 40.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.698 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.622 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -117.04 146.67 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -110.21 -29.79 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.913 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.94 176.77 18.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.62 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.08 107.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.821 0.344 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 132.61 -33.9 2.57 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.527 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.7 ' HD2' HD12 ' A' ' 55' ' ' LEU . 18.4 ptt180 -153.31 159.52 42.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.995 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.685 ' CD2' HG21 ' A' ' 84' ' ' ILE . 1.6 pp -147.59 155.81 42.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.048 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.866 ' HB2' HD21 ' A' ' 55' ' ' LEU . 15.6 tt0 -92.1 121.71 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.081 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.21 165.6 32.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.53 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.467 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.47 134.6 39.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.324 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.8 m -63.92 142.6 58.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.608 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 1.6 m-85 -51.17 -23.98 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.346 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.13 -11.1 60.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.35 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.98 41.13 2.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.783 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.615 HG11 HH21 ' A' ' 70' ' ' ARG . 21.2 t -127.02 110.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.007 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -82.2 116.41 21.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.051 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.615 HH21 HG11 ' A' ' 68' ' ' VAL . 8.9 ptp180 -145.05 155.77 43.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.73 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -89.68 106.93 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.579 ' HB3' HG11 ' A' ' 92' ' ' VAL . 13.6 m -84.27 118.66 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.676 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -81.92 137.9 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 82' ' ' VAL . 5.1 tt -68.68 140.13 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.782 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.31 143.45 44.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.25 38.87 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -62.88 -32.69 73.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HB ' ' A' ' 82' ' ' VAL . 1.1 mm? -82.91 -29.4 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.636 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.631 ' HA ' HG12 ' A' ' 82' ' ' VAL . 3.0 mtp180 -49.25 -27.74 4.03 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.267 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -64.32 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.0 45.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 74' ' ' ILE . 9.3 p -121.33 120.99 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.974 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 110.19 20.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.685 HG21 ' CD2' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -89.69 147.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.463 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -123.12 159.28 28.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.247 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 86' ' ' THR . 63.3 m -80.32 -5.91 57.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.442 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 70.05 0.95 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.636 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.14 165.73 35.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.224 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.894 HG21 ' CD1' ' A' ' 116' ' ' LEU . 45.9 mm -87.22 143.97 10.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.236 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.64 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.3 mt -150.35 171.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.046 0.45 . . . . 0.0 111.213 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.731 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -126.54 122.26 34.62 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.587 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.642 HG12 ' CA ' ' A' ' 104' ' ' VAL . 12.8 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.049 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.45 120.21 6.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.671 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.86 117.28 33.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.896 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -73.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.29 -25.97 62.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.424 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -91.62 14.25 15.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.547 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 20.2 mt-30 65.79 24.57 11.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.32 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 5.5 m-20 81.6 -45.65 0.2 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -42.29 -38.3 1.77 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.553 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.56 165.25 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.365 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -158.91 132.05 7.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.18 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -88.96 128.02 35.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.642 ' CA ' HG12 ' A' ' 92' ' ' VAL . 94.1 t -53.24 111.85 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.849 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.1 mm -78.21 -45.65 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -144.29 169.93 16.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.401 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.662 ' N ' HD12 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -111.79 123.77 50.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.063 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.6 m-85 -88.5 106.41 18.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -75.4 179.86 4.96 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.644 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.0 -42.21 39.6 Favored 'General case' 0 C--O 1.228 -0.068 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.431 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -61.15 -40.03 92.32 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.684 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.5 mt-10 -67.54 -27.85 67.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.461 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.4 -49.31 7.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.032 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -56.3 -27.4 55.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 109.577 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.09 -22.7 41.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.136 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.894 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.46 -34.36 24.54 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.028 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -55.0 -34.12 63.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.11 -20.59 44.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.849 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.56 -5.98 13.39 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.802 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.41 26.29 61.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.448 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 56.2 mm-40 -115.91 -60.76 1.83 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.87 124.89 59.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 40.6 Cg_exo -56.88 179.75 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.431 2.088 . . . . 0.0 112.257 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -25.06 65.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.095 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 37.1 p-80 -85.89 -17.13 36.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.39 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -52.86 139.4 27.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.808 0.337 . . . . 0.0 111.24 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -117.76 137.89 52.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 113' ' ' ALA . 4.4 mt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.8 0.333 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.561 HD11 ' HE1' ' A' ' 119' ' ' TYR . 24.8 tp -86.81 128.63 35.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.793 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 t -127.31 140.68 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.832 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.749 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -112.72 170.39 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.346 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -52.68 149.58 5.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.729 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.82 164.61 27.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 111.5 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.89 132.99 37.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.76 -15.34 60.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.469 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.527 ' HB3' HD11 ' A' ' 91' ' ' LEU . 17.0 mt-30 -134.73 137.21 43.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.858 ' HB2' HD11 ' A' ' 94' ' ' LEU . 3.7 tt0 -117.23 155.22 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 111.276 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 5.3 p90 -84.02 157.65 21.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.622 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.76 173.89 12.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.593 . . . . 0.0 112.521 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.528 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -131.01 117.13 18.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.037 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 60' ' ' LEU . 41.5 t -67.46 138.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 112.065 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.09 -41.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.556 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 161.33 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.745 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.573 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -116.4 144.2 44.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.722 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.805 HD11 HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -105.54 -27.98 11.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.026 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.04 59.14 10.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -177.61 63.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.1 20.73 50.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.637 ' HB2' HD12 ' A' ' 55' ' ' LEU . 1.3 mtm105 -152.36 163.53 39.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.851 HD22 HG21 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -147.85 145.23 28.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.609 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.746 ' HB2' HD21 ' A' ' 55' ' ' LEU . 6.7 tt0 -91.09 120.77 32.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.44 165.62 32.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 111.665 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 9.8 ptp -138.98 128.0 23.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.59 146.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.286 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.462 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.9 m-85 -50.33 -20.68 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.811 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 68' ' ' VAL . 29.1 p30 -73.62 -8.18 54.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.61 0.243 . . . . 0.0 111.324 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 41.03 4.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 63' ' ' MET . 20.1 t -127.15 110.27 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.659 0.266 . . . . 0.0 111.1 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -83.59 120.14 25.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 165.7 27.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.303 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.805 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -95.68 105.69 17.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.682 ' HB3' HG11 ' A' ' 92' ' ' VAL . 11.8 m -89.14 118.47 28.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.423 ' CE1' ' HD3' ' A' ' 59' ' ' ARG . 2.1 m-70 -76.6 139.15 40.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.699 HD11 HG13 ' A' ' 82' ' ' VAL . 5.6 tt -68.52 138.49 22.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.86 151.92 24.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.073 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.66 -39.28 18.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.46 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -78.52 -30.75 47.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.516 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.3 mm? -77.86 -29.56 50.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.498 ' HA ' HG12 ' A' ' 82' ' ' VAL . 21.4 ptt180 -48.97 -26.9 2.77 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.34 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -38.91 74.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.313 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 48.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.363 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.699 HG13 HD11 ' A' ' 74' ' ' ILE . 8.5 p -124.18 119.74 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -110.75 109.96 20.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.991 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.851 HG21 HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -80.95 139.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.2 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 14.6 m-80 -110.57 160.51 16.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 0.0 111.529 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.433 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 66.1 m -80.3 -6.2 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.525 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -147.79 70.33 1.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 85' ' ' ASN . 0.5 OUTLIER -154.19 164.63 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.223 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.862 HG21 ' CD1' ' A' ' 116' ' ' LEU . 46.7 mm -89.4 144.39 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.341 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.676 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.22 171.13 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.047 0.451 . . . . 0.0 111.101 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 92' ' ' VAL . 0.2 OUTLIER -126.94 125.75 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.638 178.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.4 m -125.62 156.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.259 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.25 127.88 9.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.54 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -105.24 177.45 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.76 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.27 -51.12 0.43 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.522 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -41.07 12.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 111.452 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.53 23.08 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 69.17 30.24 4.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.801 0.334 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.6 175.94 0.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.618 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.34 -57.19 0.56 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.063 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.83 149.24 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.467 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -139.24 -179.37 5.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.962 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.79 121.37 19.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.764 ' HA ' HG12 ' A' ' 92' ' ' VAL . 85.5 t -51.07 111.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.683 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.27 -37.44 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 0.0 109.768 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.057 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -150.93 168.54 24.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.36 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.65 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -112.32 121.2 44.22 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.057 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.3 m-85 -86.34 106.29 17.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.42 176.6 5.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.9 -39.75 49.78 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.967 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -40.95 98.52 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.652 ' O ' HD23 ' A' ' 116' ' ' LEU . 10.4 mt-10 -66.27 -27.78 68.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.417 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.819 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.38 -48.26 6.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.055 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -27.66 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.425 0.631 . . . . 0.0 109.492 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.63 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -79.17 -22.71 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.202 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.862 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.37 -35.28 27.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.221 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -34.42 62.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.23 -20.3 44.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.013 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.749 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.51 -4.36 8.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.808 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 24.77 58.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.597 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 42.3 mm-40 -115.35 -60.93 1.82 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.808 0.337 . . . . 0.0 111.266 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.32 126.36 46.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 36.7 Cg_exo -57.41 179.82 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.417 2.078 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.39 -23.36 64.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.449 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 37.2 p-80 -90.67 2.48 55.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.582 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.24 147.71 50.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -115.61 136.68 52.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.048 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.797 HD13 ' HB1' ' A' ' 113' ' ' ALA . 7.3 mt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.836 0.35 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.793 HD11 ' HE1' ' A' ' 119' ' ' TYR . 39.4 tp -96.48 125.38 40.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.558 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.57 140.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.944 0.402 . . . . 0.0 111.897 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.77 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.3 m-30 -112.34 170.44 8.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.466 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.42 150.74 4.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -127.76 165.12 20.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.701 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.35 133.05 49.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.97 -15.5 60.72 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.447 ' CB ' HD11 ' A' ' 91' ' ' LEU . 14.3 mt-30 -126.43 140.04 52.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.9 150.32 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.147 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 6.4 p90 -84.35 156.32 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.887 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.76 173.26 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.19 0.519 . . . . 0.0 112.219 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.735 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -119.08 153.9 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.362 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 90' ' ' ILE . 12.9 t -97.29 141.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.022 0.439 . . . . 0.0 112.142 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.794 ' O ' HG23 ' A' ' 86' ' ' THR . 0.7 OUTLIER -114.13 -52.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.44 162.22 36.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.588 ' HE3' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -114.66 126.48 54.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.124 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -96.59 -29.78 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.63 178.18 21.8 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -56.39 112.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.77 0.319 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.838 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 101.5 -13.68 58.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.727 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.755 ' HB3' HD12 ' A' ' 55' ' ' LEU . 9.0 mmt180 -138.78 121.88 16.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.242 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.729 HD22 HD13 ' A' ' 84' ' ' ILE . 1.3 pp -142.36 142.23 32.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.539 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.583 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.0 tt0 -90.7 121.67 32.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -127.2 162.12 26.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -123.08 101.62 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.216 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.17 133.32 49.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.402 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -49.34 -25.94 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.523 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -13.7 60.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.177 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.39 36.02 3.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.49 122.66 59.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 111.453 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 63' ' ' MET . 11.6 ptmt -95.12 121.72 37.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.603 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -144.12 165.59 27.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.17 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.124 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -94.02 105.68 17.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.437 ' SG ' HG11 ' A' ' 92' ' ' VAL . 29.8 m -88.82 125.05 34.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -83.27 142.02 31.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.619 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.838 HG22 ' HA2' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -68.79 138.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.94 155.23 20.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 0.0 111.001 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.17 -46.08 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.548 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -76.71 -42.22 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 0.0 110.783 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.658 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -67.03 -19.72 65.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.678 ' HA ' HG12 ' A' ' 82' ' ' VAL . 1.4 ptm180 -50.64 -28.11 8.22 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.827 0.346 . . . . 0.0 111.322 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -64.86 -29.54 70.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.618 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.99 40.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 79' ' ' ARG . 7.6 p -120.87 110.88 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 110.983 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 32.2 m0 -111.39 110.36 20.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.157 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.729 HD13 HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -86.45 145.47 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.454 ' O ' HG11 ' A' ' 51' ' ' VAL . 52.4 m-20 -132.11 164.93 25.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 52' ' ' ILE . 93.8 m -78.08 -6.5 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.761 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.4 73.99 1.45 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -165.34 161.24 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.261 0.553 . . . . 0.0 111.481 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.85 HG21 ' CD1' ' A' ' 116' ' ' LEU . 32.8 mm -92.28 149.12 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.011 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.728 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.19 173.56 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.638 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -130.11 126.88 38.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.566 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.688 ' N ' HD12 ' A' ' 91' ' ' LEU . 21.0 m -121.73 156.51 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.391 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.561 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -99.44 149.79 19.02 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.648 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.568 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -125.46 135.66 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.705 0.288 . . . . 0.0 110.799 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 -177.57 -76.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.188 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.9 -18.09 38.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.407 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 101' ' ' LYS . 42.9 m-85 -72.38 -9.26 58.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.551 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 72.16 29.39 2.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.746 0.307 . . . . 0.0 111.304 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.1 -55.75 0.64 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.42 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -42.03 -31.95 0.4 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 97' ' ' TYR . 24.5 mttt -128.22 164.45 22.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.673 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -151.41 177.28 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.19 116.95 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.658 ' CA ' HG12 ' A' ' 92' ' ' VAL . 80.5 t -49.93 111.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.972 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mm -82.26 -45.56 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.191 0.52 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.007 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.6 pp -142.41 161.15 38.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.779 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.614 ' HB3' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -104.53 118.1 35.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.999 0.428 . . . . 0.0 111.792 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.007 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.0 m-85 -81.11 106.47 13.13 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 167.15 4.78 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.73 -39.52 51.56 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.422 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.57 -40.06 95.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.639 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.4 mm-40 -68.09 -26.52 65.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.275 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 1.038 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -42.75 -48.98 5.72 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.835 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -29.76 63.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.399 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.613 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -73.39 -22.03 60.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.013 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.85 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -48.95 -35.52 15.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.236 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -54.53 -35.06 62.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.14 -20.31 45.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.927 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.793 ' HE1' HD11 ' A' ' 39' ' ' LEU . 3.6 m-30 -65.98 -7.69 18.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.559 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.49 27.31 67.72 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.511 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.46 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 50.4 mm-40 -118.49 -59.79 1.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.321 . . . . 0.0 111.289 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.0 142.17 24.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.061 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 31.5 Cg_exo -61.06 -179.75 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.583 2.189 . . . . 0.0 112.146 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.94 -25.88 59.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.993 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -82.56 1.46 37.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.534 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.41 138.35 55.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.375 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 148.2 32.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.038 HD12 ' HB1' ' A' ' 113' ' ' ALA . 21.7 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.431 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.564 HD12 ' CD ' ' A' ' 112' ' ' GLU . 33.4 tp -118.52 119.82 35.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.79 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 106' ' ' LEU . 14.9 t -104.52 139.47 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.046 0.451 . . . . 0.0 111.369 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 74.7 m-85 -114.09 170.4 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.862 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HA ' HD22 ' A' ' 91' ' ' LEU . 10.3 ttpt -48.6 153.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.941 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -116.09 162.05 17.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.19 125.97 25.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.83 -15.28 63.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.662 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.558 ' OE1' HD11 ' A' ' 91' ' ' LEU . 23.2 mt-30 -113.74 148.08 37.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.636 0.255 . . . . 0.0 110.567 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.833 ' HB2' HD11 ' A' ' 94' ' ' LEU . 32.2 tt0 -121.1 156.72 31.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.219 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 3.8 p90 -84.25 157.58 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.94 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.27 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.491 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -126.52 138.84 53.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.746 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 85' ' ' ASN . 15.2 t -88.92 144.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.905 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -116.38 -46.12 4.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.84 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.3 162.18 37.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.874 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.408 ' HE3' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -112.93 136.26 52.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.848 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -99.53 -32.4 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.91 169.84 17.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.526 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.83 101.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 110.986 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 139.83 -32.69 2.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.354 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.753 ' HD2' HD12 ' A' ' 55' ' ' LEU . 16.3 ptt-85 -151.35 159.61 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.874 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.88 HD22 HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.65 152.55 38.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.848 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.4 tt0 -91.66 121.66 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -136.43 165.8 24.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 112.181 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.905 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -127.18 113.07 15.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.8 m -59.01 133.86 56.47 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.444 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 1.3 m-85 -48.83 -25.36 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -9.82 58.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.76 42.96 2.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.684 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.405 HG11 ' NE ' ' A' ' 70' ' ' ARG . 15.4 t -127.41 125.61 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.339 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HB2' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.7 115.46 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.567 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' NE ' HG11 ' A' ' 68' ' ' VAL . 62.2 mtt180 -145.27 165.06 29.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.415 . . . . 0.0 111.276 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.718 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -106.36 108.41 19.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.472 ' HB3' HG11 ' A' ' 92' ' ' VAL . 16.4 m -84.16 118.85 24.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.42 ' CD2' ' OH ' ' A' ' 97' ' ' TYR . 1.7 m-70 -81.46 143.18 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.787 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.491 HG22 ' HA2' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -71.93 129.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.835 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 14.2 tpt180 -69.45 143.84 53.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.733 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 79' ' ' ARG . . . -70.01 -57.34 7.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.362 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -52.71 -30.66 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.555 HD12 ' HB ' ' A' ' 82' ' ' VAL . 1.1 mm? -86.69 -28.37 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.834 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.659 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -49.34 -27.36 3.88 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.317 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.29 -33.34 67.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.3 45.17 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 79' ' ' ARG . 11.6 p -115.91 116.25 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 111.071 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.408 ' CH2' ' HE2' ' A' ' 107' ' ' LYS . 44.1 p90 -110.5 110.18 20.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.88 HD13 HD22 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -83.26 147.11 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.457 ' O ' HG21 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -115.44 152.97 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 86' ' ' THR . 75.6 m -80.28 -6.35 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 111.886 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 p -148.38 55.07 1.02 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.705 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -140.2 169.09 18.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.174 0.511 . . . . 0.0 111.564 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.919 HG21 ' CD1' ' A' ' 116' ' ' LEU . 45.3 mm -89.24 144.81 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.024 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.2 mt -150.57 171.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.046 0.451 . . . . 0.0 111.228 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.73 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -126.01 121.97 34.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.706 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.721 HG12 ' CA ' ' A' ' 104' ' ' VAL . 30.4 m -122.48 155.3 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.156 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 105' ' ' ILE . . . -93.13 140.63 15.16 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.574 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -121.67 105.52 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 110.834 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.46 -63.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.189 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.14 -28.17 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 73' ' ' HIS . 16.4 m-85 -89.32 1.91 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.768 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 65.71 30.02 10.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 7.0 t0 78.04 162.05 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.963 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 84.53 -19.8 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.411 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.47 150.96 38.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -137.96 173.18 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 111.256 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.849 ' O ' HD12 ' A' ' 105' ' ' ILE . 37.4 t70 -130.1 116.61 18.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.721 ' CA ' HG12 ' A' ' 92' ' ' VAL . 70.4 t -52.4 111.54 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 103' ' ' ASP . 2.4 mp -81.81 -39.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.053 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -147.1 168.45 21.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.795 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 106' ' ' LEU . 4.5 pttp -111.94 119.9 40.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.053 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.0 m-85 -84.23 106.9 16.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.19 173.18 8.01 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.684 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.46 -51.19 18.03 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.313 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.37 -38.45 87.05 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.564 ' CD ' HD12 ' A' ' 39' ' ' LEU . 1.1 tp10 -66.63 -31.67 72.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.396 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.934 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -46.05 -43.25 14.34 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.821 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -48.93 -47.11 43.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.157 0.504 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -58.69 -20.82 51.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.629 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.919 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.66 -33.26 21.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.45 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -54.98 -34.34 63.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.38 -21.81 41.96 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.733 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.714 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.4 m-30 -67.01 -9.75 42.33 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.03 25.03 63.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.538 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 5.3 mm-40 -112.7 -47.41 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -108.75 150.07 40.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 70.8 Cg_endo -75.18 174.15 13.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.592 2.194 . . . . 0.0 112.242 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.48 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.4 p-80 -87.76 2.79 50.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.578 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -58.89 130.27 46.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.162 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -82.5 131.35 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.934 HD12 ' HB1' ' A' ' 113' ' ' ALA . 38.0 mm . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.984 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.841 0.353 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.693 HD11 ' CE1' ' A' ' 119' ' ' TYR . 20.1 tp -71.04 134.59 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.46 140.08 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.884 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 11.8 m-30 -113.7 170.94 7.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.42 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -42.01 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.78 168.12 13.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.169 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -67.72 123.59 20.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.35 62.95 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.531 ' CB ' HD11 ' A' ' 91' ' ' LEU . 12.9 mt-30 -115.66 145.3 42.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.395 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.735 ' HB2' HD11 ' A' ' 94' ' ' LEU . 15.4 tt0 -120.26 152.06 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 111.531 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.6 p90 -84.71 158.17 20.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.872 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.37 173.4 14.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 112.376 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.43 ' HG2' HD13 ' A' ' 89' ' ' ILE . 4.5 tm0? -128.61 115.11 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.161 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 14.8 t -65.9 139.99 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 112.077 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.918 HD11 ' HB3' ' A' ' 63' ' ' MET . 7.0 mm -116.01 -42.77 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.011 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -140.7 158.57 43.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.875 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.567 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.6 tpt -111.74 132.1 54.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.95 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -109.17 -163.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.485 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.75 156.71 4.54 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.64 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -56.76 109.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 135.03 -19.77 3.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.5 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.655 ' HD2' HD12 ' A' ' 55' ' ' LEU . 22.1 ptt180 -146.92 163.57 35.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 111.053 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.792 HD22 ' CD1' ' A' ' 84' ' ' ILE . 0.5 OUTLIER -147.68 150.78 34.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.885 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.2 tt0 -91.89 121.58 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.02 165.64 24.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 0.0 112.342 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.918 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -123.53 107.37 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.938 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.1 m -57.91 130.89 48.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.04 -25.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.705 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -74.42 -13.35 60.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.257 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.27 40.72 2.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.542 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.99 120.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.307 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 0.4 OUTLIER -88.68 114.44 25.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -143.81 165.53 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.95 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -103.27 109.81 21.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.8 m -84.28 118.33 24.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 2.4 m-70 -80.62 130.43 35.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.669 HD12 HD11 ' A' ' 84' ' ' ILE . 2.0 tt -68.59 140.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.475 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER 166.32 -167.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.002 0.43 . . . . 0.0 111.446 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.67 174.66 36.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.04 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -52.41 -23.83 6.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.968 0.413 . . . . 0.0 110.701 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -78.83 -18.61 53.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.205 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -48.09 -28.67 3.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.502 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -58.34 -22.9 55.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.883 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.79 46.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.417 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.589 HG13 HD11 ' A' ' 74' ' ' ILE . 14.2 p -84.81 128.82 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.36 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -110.72 110.04 20.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.008 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.792 ' CD1' HD22 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -95.2 147.34 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.613 179.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m-20 -122.32 152.3 40.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.407 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 32.7 m -80.18 -6.81 58.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 0.0 111.769 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.2 p -143.95 56.53 1.33 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.595 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 85' ' ' ASN . 0.4 OUTLIER -146.93 164.77 31.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.281 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.901 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.1 mm -87.28 146.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.233 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.664 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.1 mt -150.15 170.99 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 111.184 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.675 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -129.18 121.84 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.753 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 104' ' ' VAL . 16.0 m -116.16 150.38 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.75 131.41 10.72 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.735 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -117.86 133.19 56.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.62 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -178.06 -75.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.28 -12.65 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.322 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 34.5 m-85 -83.11 2.93 32.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.678 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 65.81 25.64 11.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.658 0.266 . . . . 0.0 111.219 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.22 -54.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.758 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -39.7 -35.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 97' ' ' TYR . 8.3 mmmm -127.27 162.76 25.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.808 0.337 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -158.61 162.65 37.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -113.1 126.7 55.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.723 ' HA ' HG12 ' A' ' 92' ' ' VAL . 61.5 t -55.02 112.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.99 -58.95 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.106 0.479 . . . . 0.0 110.023 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.055 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.3 pp -127.71 160.11 32.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.376 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.571 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -107.04 117.47 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.055 ' CE1' HD11 ' A' ' 106' ' ' LEU . 25.0 m-85 -81.73 106.11 13.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -68.17 168.76 11.56 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -70.8 -40.77 72.33 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.477 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.26 -40.35 95.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.716 ' O ' HD23 ' A' ' 116' ' ' LEU . 26.3 mt-10 -66.79 -28.54 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.49 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.906 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.43 -48.97 7.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.78 -178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -56.11 -30.67 62.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -73.93 -22.12 59.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.901 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.32 -34.94 25.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.379 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -54.6 -34.76 62.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -20.9 42.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.97 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.0 m-30 -66.56 -6.18 14.17 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.829 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.52 64.59 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.593 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.595 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 48.0 mt-10 -113.87 -64.55 1.29 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.927 0.394 . . . . 0.0 111.234 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -92.49 149.94 39.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.999 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 58.2 Cg_endo -71.7 179.55 4.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.634 2.223 . . . . 0.0 112.432 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.23 -32.17 68.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -75.83 -19.22 59.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.332 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.459 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -53.65 121.91 8.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -108.18 132.21 53.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.001 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.906 HD13 ' HB1' ' A' ' 113' ' ' ALA . 2.7 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.129 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD11 ' HE1' ' A' ' 119' ' ' TYR . 14.6 tp -84.7 120.82 26.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 t -126.95 141.05 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.694 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 4.3 m-30 -109.19 170.45 8.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.612 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.1 ttpp -45.6 141.48 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.902 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -111.46 166.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 111.333 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -58.4 129.71 43.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.43 -15.37 60.24 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.589 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.487 ' CB ' HD11 ' A' ' 91' ' ' LEU . 8.4 mt-30 -118.45 154.62 32.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.624 0.25 . . . . 0.0 110.458 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -130.02 152.63 49.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 111.064 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 2.9 p90 -84.39 157.24 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.986 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.16 173.79 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.251 0.548 . . . . 0.0 112.112 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.519 ' OE1' HD13 ' A' ' 89' ' ' ILE . 38.2 tp60 -128.89 109.62 11.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.13 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.525 ' CG2' HD11 ' A' ' 90' ' ' ILE . 17.5 t -56.31 139.69 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 111.882 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 63' ' ' MET . 0.0 OUTLIER -116.42 -42.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.935 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.4 ttmm -147.71 157.58 43.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.319 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.647 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.1 ttt -108.2 143.35 37.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.789 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.863 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -111.89 -25.61 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.118 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.69 -174.63 29.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.61 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -75.37 102.87 5.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 135.28 -26.28 3.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.407 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.678 ' HD2' HD12 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -151.47 155.41 38.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.337 . . . . 0.0 110.927 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.74 150.91 35.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.863 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.4 tp10 -91.74 121.42 33.36 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.79 165.74 23.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.203 0.525 . . . . 0.0 112.145 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.535 ' HB2' HD13 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -127.16 107.07 9.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.419 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.5 133.25 55.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.063 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 3.5 m-85 -49.91 -25.22 3.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.724 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -8.46 56.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.235 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.92 43.1 3.4 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.451 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.03 113.94 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.3 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 24.8 tttt -84.22 113.51 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.751 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -145.15 165.5 28.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.2 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.854 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -100.34 108.56 20.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.979 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.721 ' HB3' HG11 ' A' ' 92' ' ' VAL . 34.0 m -84.31 118.4 24.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 20.3 m80 -82.56 134.5 35.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.628 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.626 HG22 ' HA2' ' A' ' 58' ' ' GLY . 10.0 tt -68.65 141.03 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.353 . . . . 0.0 111.01 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 2.3 mmt180 -63.95 155.59 30.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.18 -46.78 6.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.484 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -77.33 -40.53 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.6 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.727 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -64.02 -16.69 62.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.007 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.636 ' HA ' HG12 ' A' ' 82' ' ' VAL . 12.3 ptm180 -48.72 -26.13 2.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.684 0.278 . . . . 0.0 111.498 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -76.05 -35.03 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.554 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.35 34.93 3.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.652 0.263 . . . . 0.0 111.613 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.727 ' HB ' HD12 ' A' ' 78' ' ' LEU . 8.5 p -123.79 111.34 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.159 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.98 110.23 20.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.852 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.946 HG21 HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -91.95 147.16 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.415 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 13.3 m120 -139.88 157.86 45.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.636 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 52' ' ' ILE . 59.6 m -75.33 -6.45 49.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 111.772 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -143.31 76.12 1.51 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.796 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.46 161.16 16.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.847 HG21 ' CD1' ' A' ' 116' ' ' LEU . 51.3 mm -86.96 146.57 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.633 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.1 mt -150.49 171.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.362 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -130.27 122.43 28.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.866 178.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.791 HG12 ' HA ' ' A' ' 104' ' ' VAL . 34.9 m -119.57 146.97 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.529 ' O ' ' HB1' ' A' ' 102' ' ' ALA . . . -95.83 141.69 15.71 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.862 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 142.05 47.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.65 0.262 . . . . 0.0 110.575 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -149.11 -81.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.183 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.57 -12.16 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.328 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 101' ' ' LYS . 35.0 m-85 -71.9 -10.18 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.404 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 4.6 mt-30 65.85 25.4 11.24 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.205 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 2.8 t0 83.36 -21.88 0.26 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.36 -29.51 68.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 0.0 110.699 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.427 ' HB2' ' CG ' ' A' ' 97' ' ' TYR . 10.1 mtpt -144.27 164.85 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.688 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.542 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -163.3 171.66 15.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.106 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.34 125.65 50.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.791 ' HA ' HG12 ' A' ' 92' ' ' VAL . 99.3 t -49.96 111.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.47 -46.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.196 0.522 . . . . 0.0 109.737 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.062 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -142.06 166.93 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.31 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.601 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -110.44 120.56 42.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.062 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.7 m-85 -84.23 105.94 15.47 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -71.78 177.19 4.34 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.1 -40.03 47.38 Favored 'General case' 0 CA--C 1.524 -0.045 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.055 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -62.62 -40.99 98.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.701 ' O ' HD23 ' A' ' 116' ' ' LEU . 14.0 mt-10 -65.93 -27.93 68.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.345 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.26 -50.28 6.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.23 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -56.42 -26.8 54.66 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.246 -0.581 . . . . 0.0 109.714 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -80.17 -22.29 42.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.14 178.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.847 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -49.92 -33.98 19.06 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 121.22 -0.192 . . . . 0.0 111.002 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -54.75 -34.37 62.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.12 -20.39 45.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.059 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.6 m-30 -66.42 -4.37 8.07 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.927 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.55 21.08 53.8 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.735 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.473 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 58.5 mm-40 -111.45 -60.42 1.84 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.649 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.02 144.79 28.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.834 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 72.6 Cg_endo -76.08 179.8 5.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.631 2.221 . . . . 0.0 112.353 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.77 -29.31 67.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.442 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 25.6 p-80 -81.43 -0.49 41.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.473 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.484 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -66.28 145.15 56.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.836 0.35 . . . . 0.0 110.976 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -124.78 120.82 32.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.992 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.3 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.946 0.403 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.644 HD23 ' CZ ' ' A' ' 41' ' ' PHE . 16.0 tp -83.14 109.59 17.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.478 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' CG1' HD22 ' A' ' 106' ' ' LEU . 15.1 t -91.78 139.66 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.701 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.644 ' CZ ' HD23 ' A' ' 39' ' ' LEU . 79.6 m-85 -113.45 170.5 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.714 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.518 ' HA ' HD22 ' A' ' 91' ' ' LEU . 7.9 tttt -47.68 163.41 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -132.51 156.38 46.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 111.294 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -59.04 129.16 40.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.697 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.45 61.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.558 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.513 ' OE1' HD11 ' A' ' 91' ' ' LEU . 26.3 mt-30 -116.43 148.17 40.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.585 0.231 . . . . 0.0 110.439 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.09 152.56 38.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 111.613 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 11.9 p90 -84.5 157.71 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.899 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.3 173.28 15.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 112.42 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.404 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -126.5 125.5 42.17 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.082 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.689 HG13 HD13 ' A' ' 60' ' ' LEU . 12.2 t -79.32 138.3 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.942 HD11 ' HB2' ' A' ' 63' ' ' MET . 1.1 mt -116.1 -45.75 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.169 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -137.76 157.15 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.531 ' C ' HD23 ' A' ' 55' ' ' LEU . 7.8 ttm -111.41 143.53 42.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.852 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -106.49 -37.62 6.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.38 171.66 27.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -60.07 103.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 133.32 -22.57 3.95 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.616 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.728 ' CD ' HD12 ' A' ' 55' ' ' LEU . 13.3 ptp180 -154.5 157.76 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.689 HD13 HG13 ' A' ' 51' ' ' VAL . 2.8 pp -147.95 160.27 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.298 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.782 ' HB2' HD21 ' A' ' 55' ' ' LEU . 10.0 tp10 -102.18 121.47 42.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -135.98 166.18 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.352 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.942 ' HB2' HD11 ' A' ' 52' ' ' ILE . 4.3 tpp -126.89 111.61 14.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.056 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 46.6 t -58.67 134.76 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -25.28 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.581 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -74.31 -14.17 60.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.233 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.72 41.19 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.583 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.3 t -127.23 125.79 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.548 ' CA ' ' HE2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -99.99 115.25 29.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -144.19 160.8 40.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.81 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.852 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -96.32 105.68 17.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.801 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.52 ' HB3' HG11 ' A' ' 92' ' ' VAL . 14.2 m -85.16 118.75 24.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.673 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -81.39 127.77 33.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.656 HG22 ' HA2' ' A' ' 58' ' ' GLY . 6.0 tt -68.43 140.58 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.44 -165.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 0.0 111.514 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.23 169.91 46.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.179 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -48.58 -27.18 2.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.432 . . . . 0.0 110.763 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 1.0 OUTLIER -66.41 -32.86 74.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.483 ' HA ' HG12 ' A' ' 82' ' ' VAL . 23.3 ptt180 -48.83 -28.18 3.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.248 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.84 -26.53 58.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 46.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.251 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.529 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.3 p -124.34 123.07 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.705 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -111.21 109.97 20.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.538 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.881 HG22 HD13 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -65.06 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -102.06 151.48 22.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.462 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.471 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 86.2 m -80.25 -6.55 58.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.62 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.95 72.06 1.34 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.639 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -165.65 167.39 17.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.906 HG21 ' CD1' ' A' ' 116' ' ' LEU . 26.5 mm -86.9 146.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.192 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.881 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.3 171.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.383 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.681 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.57 122.31 28.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.785 178.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.9 m -117.83 146.68 21.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.155 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.97 140.08 14.91 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.911 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -123.51 132.6 53.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.648 0.261 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.55 -80.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.01 -15.95 63.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 103' ' ' ASP . 48.5 m-85 -72.44 -8.8 56.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.547 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 67.29 29.94 7.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.34 -175.94 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.57 -61.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.836 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.15 156.66 17.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.967 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.545 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -141.28 -177.71 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.829 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.473 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 10.5 t70 -133.96 120.31 20.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.888 ' HA ' HG12 ' A' ' 92' ' ' VAL . 59.8 t -52.87 112.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.845 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.75 -62.16 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.077 0.465 . . . . 0.0 110.057 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.5 pp -124.8 159.62 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.46 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -105.92 118.73 37.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.063 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.8 m-85 -82.24 106.28 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.09 173.39 5.58 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.643 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.48 -40.23 61.97 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.693 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.06 -40.48 95.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.716 ' O ' HD23 ' A' ' 116' ' ' LEU . 19.4 mt-10 -66.99 -28.37 68.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.505 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.987 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.63 -48.94 7.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.909 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -55.9 -30.26 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.386 0.612 . . . . 0.0 109.528 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 1.4 m -76.14 -22.46 55.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.173 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.906 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.22 -32.95 17.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.067 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.51 -34.3 61.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.74 42.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.778 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.675 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.2 m-30 -66.97 -11.64 57.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.86 23.27 65.39 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.633 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 50.8 mt-10 -109.54 -52.05 2.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.933 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.541 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.1 148.09 34.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.723 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 60.0 Cg_endo -72.52 178.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 0.0 112.339 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -30.8 69.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.401 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 56.7 p-80 -84.2 -3.49 58.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.405 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -58.35 147.64 30.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.887 0.375 . . . . 0.0 111.164 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -115.07 148.39 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.987 HD12 ' HB1' ' A' ' 113' ' ' ALA . 28.2 mm . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.011 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.85 0.357 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.693 HD11 ' HE1' ' A' ' 119' ' ' TYR . 30.1 tp -68.31 130.63 43.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.71 140.34 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.804 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.767 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.4 m-30 -112.51 170.95 7.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -45.24 148.61 0.6 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.952 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.75 162.43 20.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.39 . . . . 0.0 111.347 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -57.04 130.44 46.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.72 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.65 -15.36 61.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.369 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.419 ' CB ' ' HA2' ' A' ' 93' ' ' GLY . 2.0 mt-30 -123.62 144.49 49.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -118.85 153.64 34.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 111.383 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 10.1 p90 -84.22 157.71 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.698 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.31 173.52 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.362 0.601 . . . . 0.0 112.389 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.607 ' HG2' HD13 ' A' ' 89' ' ' ILE . 1.8 tm0? -128.19 120.83 28.05 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.189 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.61 HG22 ' CD1' ' A' ' 60' ' ' LEU . 29.6 t -70.8 134.91 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.985 0.421 . . . . 0.0 111.664 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.71 HD12 ' CB ' ' A' ' 63' ' ' MET . 0.5 OUTLIER -116.45 -38.58 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -140.68 159.82 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.626 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -115.74 143.07 45.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.926 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -111.66 -58.74 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.944 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.77 -168.1 16.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.647 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -83.72 0.89 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.517 0.199 . . . . 0.0 111.49 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -121.58 -8.39 7.62 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.883 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.681 ' CD ' HD12 ' A' ' 55' ' ' LEU . 22.8 ptt180 -153.36 160.17 42.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 110.779 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.892 HD22 HD13 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -147.94 149.77 32.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.894 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.2 tt0 -91.84 121.41 33.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.97 165.62 25.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 112.141 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.71 ' CB ' HD12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.1 111.84 15.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.169 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.48 135.96 57.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.3 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.0 m-85 -49.73 -25.39 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.34 -7.17 51.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.289 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.84 44.42 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.446 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.21 130.64 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 111.303 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.576 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 8.6 tttt -95.7 113.73 25.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.507 ' NH1' HD22 ' A' ' 94' ' ' LEU . 12.5 ptp180 -145.04 165.59 27.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.926 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -103.12 109.23 20.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.734 ' HB3' HG11 ' A' ' 92' ' ' VAL . 25.7 m -84.41 119.8 25.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.99 136.53 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.667 HD11 HG13 ' A' ' 82' ' ' VAL . 7.0 tt -68.73 140.73 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.928 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.437 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -73.75 145.11 45.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.108 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -48.26 34.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.311 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -29.13 70.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.363 . . . . 0.0 110.628 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.5 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.8 mm? -84.67 -29.14 25.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.805 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -48.97 -27.2 2.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -59.05 -42.16 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.266 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.83 46.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 111.434 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.667 HG13 HD11 ' A' ' 74' ' ' ILE . 9.8 p -123.95 117.9 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -110.93 110.06 20.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.066 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.892 HD13 HD22 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -83.1 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.251 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.452 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 t30 -108.33 159.35 16.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.106 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 86' ' ' THR . 58.6 m -80.12 -5.72 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 p -147.67 55.41 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.629 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.6 162.19 35.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.205 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.894 HG21 ' CD1' ' A' ' 116' ' ' LEU . 30.4 mm -87.03 146.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.288 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.2 mt -150.58 171.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.152 0.501 . . . . 0.0 111.327 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.707 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.56 122.39 29.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.448 178.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.734 HG11 ' HB3' ' A' ' 72' ' ' CYS . 27.2 m -121.94 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 46' ' ' GLN . . . -90.78 143.79 16.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.507 HD22 ' NH1' ' A' ' 70' ' ' ARG . 4.6 mt -113.73 26.31 10.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.956 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.02 19.41 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.2 -49.2 6.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.682 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -105.46 -11.19 16.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.221 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 65.48 29.61 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -135.48 178.45 7.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -57.38 -18.26 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.856 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 132.37 34.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.816 0.341 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -115.72 158.14 23.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.472 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -115.45 120.48 39.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.032 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.694 ' CA ' HG12 ' A' ' 92' ' ' VAL . 94.5 t -50.33 111.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.738 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.1 mm -77.94 -36.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 109.679 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.07 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -154.13 167.45 29.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.452 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 82' ' ' VAL . 14.6 pttt -110.28 121.64 45.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.15 0.5 . . . . 0.0 112.274 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.07 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.2 m-85 -86.4 106.6 17.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -73.86 178.29 4.98 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.54 -41.76 45.45 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.071 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -61.65 -40.05 93.52 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.683 ' O ' HD23 ' A' ' 116' ' ' LEU . 9.6 mt-10 -68.63 -28.0 66.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.351 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.741 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.54 -51.63 6.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.955 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -55.72 -27.22 49.36 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.662 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -76.58 -22.11 54.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.001 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.894 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.0 -34.43 21.13 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -54.85 -34.55 63.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.35 -20.92 43.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.921 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.767 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.9 m-30 -66.77 -7.28 20.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.827 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.22 24.53 65.46 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.566 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.578 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.8 mt-10 -114.05 -63.5 1.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.876 0.369 . . . . 0.0 111.191 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.42 144.59 29.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.957 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.448 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.7 Cg_endo -71.38 179.78 4.28 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.657 2.238 . . . . 0.0 112.401 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -70.89 -34.61 71.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.448 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 20.7 p-80 -72.44 -17.98 61.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -56.84 133.66 54.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.732 0.301 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -114.36 134.35 55.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.652 HD13 ' HB1' ' A' ' 113' ' ' ALA . 4.5 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.097 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.632 HD23 ' CZ ' ' A' ' 41' ' ' PHE . 13.5 tp -68.81 99.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.704 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.497 ' CG1' HD22 ' A' ' 106' ' ' LEU . 18.9 t -88.35 139.15 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CZ ' HD23 ' A' ' 39' ' ' LEU . 86.5 m-85 -110.69 170.27 8.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.569 ' HA ' HD22 ' A' ' 91' ' ' LEU . 7.0 ttpt -52.79 148.43 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.887 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -116.85 160.52 20.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.402 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.63 130.07 45.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.48 61.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.541 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.649 HE21 HD11 ' A' ' 91' ' ' LEU . 1.5 mt-30 -117.53 140.97 48.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.53 0.205 . . . . 0.0 110.559 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' HD11 ' A' ' 94' ' ' LEU . 7.9 tp10 -115.66 154.36 29.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 111.408 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 5.3 p90 -84.55 157.78 21.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.21 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.01 173.18 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.225 0.536 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.04 109.05 11.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.273 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 90' ' ' ILE . 20.6 t -57.2 135.47 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.769 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.869 HD13 ' CB ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -116.07 -40.48 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.697 179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.63 158.82 43.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.735 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.638 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -115.7 139.02 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.63 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.049 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -110.72 -48.79 3.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.773 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.88 -179.27 30.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.54 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 67.65 19.53 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.304 . . . . 0.0 111.239 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.47 28.79 9.33 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.839 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HG3' HD12 ' A' ' 55' ' ' LEU . 6.2 ptt180 -154.82 155.88 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.598 HD22 ' CD1' ' A' ' 84' ' ' ILE . 1.2 pp -147.6 152.5 38.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.156 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.903 ' HB2' HD21 ' A' ' 55' ' ' LEU . 36.6 tt0 -91.75 121.39 33.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 72' ' ' CYS . . . -124.25 165.06 18.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 112.331 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.869 ' CB ' HD13 ' A' ' 52' ' ' ILE . 1.2 tpt -125.8 100.24 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.86 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.37 132.17 50.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.637 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.2 m-85 -49.93 -27.0 4.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.453 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -8.09 55.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.434 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.72 40.71 3.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.531 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.13 123.06 61.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.262 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' HE3' ' A' ' 63' ' ' MET . 1.9 tppp? -94.14 117.19 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -145.08 164.71 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.037 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.049 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -98.21 106.52 18.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.729 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.451 ' HB3' HG11 ' A' ' 92' ' ' VAL . 36.8 m -84.07 118.77 24.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 137.71 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.696 HD11 HG13 ' A' ' 82' ' ' VAL . 2.9 tt -68.66 139.18 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.704 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.11 143.9 56.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.143 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.58 -38.28 57.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.51 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -75.87 -29.4 58.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.659 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.484 ' O ' HG12 ' A' ' 82' ' ' VAL . 2.7 mm? -82.7 -28.65 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -49.63 -27.62 4.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.248 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -35.56 69.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.304 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.24 48.74 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.696 HG13 HD11 ' A' ' 74' ' ' ILE . 10.7 p -120.95 119.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.143 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -110.81 110.27 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.679 HG22 HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -87.11 147.14 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.443 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -118.84 156.32 29.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 33.3 m -80.15 -6.45 57.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.168 0.509 . . . . 0.0 111.377 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -145.34 71.24 1.28 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.43 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.73 165.18 33.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.085 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.947 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.4 mm -86.78 144.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.679 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.52 172.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 111.063 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.726 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.01 127.11 40.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.795 178.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.724 ' N ' HD12 ' A' ' 91' ' ' LEU . 31.6 m -122.2 149.51 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 46' ' ' GLN . . . -91.92 135.85 12.96 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.87 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -122.46 123.78 42.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.6 0.238 . . . . 0.0 110.72 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.57 -80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -61.12 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -73.52 -8.03 54.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.433 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 66.71 30.2 8.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.823 0.344 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.73 -169.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.14 -62.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.775 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -108.59 168.68 9.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.761 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 92' ' ' VAL . . . -152.68 177.2 10.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.98 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.33 119.1 21.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.833 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.713 ' HA ' HG12 ' A' ' 92' ' ' VAL . 70.9 t -49.89 111.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.906 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -82.5 -47.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.13 0.491 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.018 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.4 pp -141.52 169.16 18.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.59 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.605 ' N ' HD12 ' A' ' 106' ' ' LEU . 12.0 pttp -110.28 122.51 47.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 111.96 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.018 ' CE1' HD11 ' A' ' 106' ' ' LEU . 20.1 m-85 -85.44 107.0 17.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -64.27 168.08 5.98 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.82 -51.06 11.08 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.4 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.457 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 46.2 t0 -62.02 -38.2 87.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.506 ' OE2' ' HA ' ' A' ' 108' ' ' TYR . 0.7 OUTLIER -75.28 -26.16 58.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.018 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -45.44 -41.89 9.83 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.765 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.457 ' CG ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -53.11 -36.71 61.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.318 0.58 . . . . 0.0 109.488 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.645 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 1.0 OUTLIER -61.61 -21.04 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.971 177.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.947 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.32 -32.93 18.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.354 -178.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -34.48 65.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.1 -21.64 43.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.639 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.698 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -67.24 -10.5 51.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.077 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.72 64.83 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.619 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 65.4 mm-40 -111.3 -53.53 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.772 0.32 . . . . 0.0 111.013 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.579 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -98.04 147.2 32.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.78 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.414 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.1 Cg_endo -70.91 175.1 9.52 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.56 2.173 . . . . 0.0 112.193 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.29 -27.12 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.414 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 21.3 p-80 -81.62 -10.84 59.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.429 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.91 164.51 0.58 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -129.77 144.74 51.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.569 HD12 ' CB ' ' A' ' 113' ' ' ALA . 26.4 mm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.871 0.367 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.524 HD11 ' HE1' ' A' ' 119' ' ' TYR . 19.7 tp -127.59 124.47 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.8 t -126.47 140.5 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.93 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.754 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 5.3 m-30 -110.6 170.64 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.442 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -46.45 147.62 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.039 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -128.1 165.05 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.283 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.47 130.51 46.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.739 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.44 -15.26 61.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.386 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.533 ' HB3' HD11 ' A' ' 91' ' ' LEU . 30.3 mt-30 -127.31 146.52 50.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.2 tt0 -125.29 153.88 42.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.022 0.439 . . . . 0.0 111.492 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 7.8 p90 -84.32 157.88 21.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.84 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.81 173.55 15.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 112.388 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 tm0? -128.75 124.27 35.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 21.7 t -76.58 140.94 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 111.95 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.935 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.8 OUTLIER -115.95 -41.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.072 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -147.66 161.25 41.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.506 ' HE2' HD12 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -110.15 142.04 42.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.441 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 61' ' ' GLU . 1.8 mt -97.04 -30.28 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.29 61.03 3.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.704 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -177.73 51.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.568 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.59 11.07 64.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.424 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.708 ' HD2' HD12 ' A' ' 55' ' ' LEU . 24.8 ptt180 -147.25 164.17 34.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.833 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.19 155.61 42.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.789 ' HB2' HD21 ' A' ' 55' ' ' LEU . 22.7 tt0 -91.71 122.09 33.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.01 165.76 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.174 0.512 . . . . 0.0 111.941 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.935 ' HB2' HD11 ' A' ' 52' ' ' ILE . 4.6 tpp -131.28 111.79 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.116 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -59.27 131.76 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.361 . . . . 0.0 110.463 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.64 -26.3 2.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.789 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.33 -14.22 60.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.84 1.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.58 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -126.92 126.28 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 111.038 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.557 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -95.01 113.23 24.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.29 163.52 34.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.627 HD22 ' N ' ' A' ' 71' ' ' LEU . 2.5 mm? -102.82 114.25 28.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.706 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.2 m -83.99 118.71 24.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 4.9 m80 -83.99 146.32 28.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.837 HD11 ' CD1' ' A' ' 84' ' ' ILE . 23.7 mm -68.6 120.12 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.31 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 28.5 tpt180 -64.79 137.98 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.19 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.96 -65.96 2.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.656 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.34 9.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -86.48 -17.78 33.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.477 ' HA ' HG12 ' A' ' 82' ' ' VAL . 11.5 ptt85 -48.73 -29.73 4.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.238 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -55.32 -27.07 44.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.98 38.78 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.058 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 82' ' ' VAL . 13.2 p -81.74 111.15 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.398 . . . . 0.0 110.758 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -111.15 110.52 21.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.482 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -115.05 147.47 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.489 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -132.27 160.77 35.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.686 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 86' ' ' THR . 74.7 m -80.59 -6.73 58.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.153 0.501 . . . . 0.0 111.805 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -147.51 69.86 1.16 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.746 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.96 161.98 36.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.133 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.82 HG21 ' CD1' ' A' ' 116' ' ' LEU . 1.5 mp -86.76 147.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.643 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.6 mt -150.42 172.37 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 111.58 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.64 ' H ' HG22 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -128.2 122.0 30.79 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.48 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 104' ' ' VAL . 13.6 m -117.86 157.01 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.55 123.23 7.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.539 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -115.39 111.79 21.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.764 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -176.98 -71.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.44 -12.48 61.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.52 10.74 16.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.62 29.75 10.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.977 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.7 t0 68.45 -178.9 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.29 -61.06 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -96.36 163.6 13.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.676 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -163.74 139.82 6.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.96 129.4 36.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.69 ' HA ' HG12 ' A' ' 92' ' ' VAL . 96.2 t -55.01 111.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.808 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 mm -77.53 -48.76 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.135 0.493 . . . . 0.0 109.853 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.071 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -140.94 167.3 22.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.255 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -111.82 119.59 39.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 112.305 -178.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.071 ' CE1' HD11 ' A' ' 106' ' ' LEU . 24.2 m-85 -83.86 106.08 15.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -72.2 177.86 4.21 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.13 -40.54 45.33 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.175 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -61.41 -40.49 94.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.694 ' O ' HD23 ' A' ' 116' ' ' LEU . 11.5 mt-10 -67.03 -27.91 67.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.508 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.872 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.31 -49.47 6.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.984 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -28.15 56.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.348 0.594 . . . . 0.0 109.5 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.98 -22.79 42.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.167 178.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.872 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.89 -33.75 25.43 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.064 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -55.2 -34.18 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.02 -20.32 45.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.932 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.754 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.4 -6.14 13.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.83 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.46 24.8 53.55 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.791 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 49.2 mm-40 -114.27 -56.28 2.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.737 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -90.85 153.29 45.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 73.5 Cg_endo -75.81 -179.79 5.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.723 2.282 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.0 -31.28 67.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.088 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.447 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 29.4 p-80 -84.17 2.71 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.532 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.533 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -61.1 122.28 14.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.158 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -108.82 121.53 45.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.815 HD13 ' HB1' ' A' ' 113' ' ' ALA . 2.9 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.809 0.337 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.526 HD11 ' HE1' ' A' ' 119' ' ' TYR . 22.9 tp -68.09 122.73 18.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 15.4 t -114.69 139.88 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.617 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 24.5 m-85 -116.9 170.07 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.582 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -86.44 158.19 19.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.792 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -144.46 178.04 8.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.361 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -44.52 137.02 3.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.27 61.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.474 ' CB ' HD11 ' A' ' 91' ' ' LEU . 2.5 mt-30 -141.73 139.2 32.82 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.2 tt0 -123.4 157.63 32.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.007 0.432 . . . . 0.0 111.535 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 4.9 p90 -84.5 158.05 21.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.521 ' HB2' HH21 ' A' ' 70' ' ' ARG . . . -151.93 173.86 14.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.248 0.547 . . . . 0.0 112.2 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.412 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -128.78 120.6 26.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.019 179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.606 HG13 HD13 ' A' ' 60' ' ' LEU . 23.4 t -70.89 135.46 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 112.039 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 63' ' ' MET . 14.0 mt -116.29 -40.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 157.62 46.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.543 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -117.12 131.6 56.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.747 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.996 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -105.89 -32.68 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.8 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.42 -171.67 48.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.57 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 m120 61.9 26.49 16.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.718 0.294 . . . . 0.0 111.049 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 83.85 32.19 24.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.616 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.578 ' HG3' HD12 ' A' ' 55' ' ' LEU . 12.1 ptt180 -155.4 157.27 36.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.605 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 84' ' ' ILE . 2.6 pp -148.04 160.91 42.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 111.611 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.901 ' HB2' HD21 ' A' ' 55' ' ' LEU . 34.4 tt0 -104.41 120.83 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -136.51 164.68 27.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.23 0.538 . . . . 0.0 112.033 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.648 ' HE3' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -120.08 114.8 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.191 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.2 m -59.45 133.47 56.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.502 ' CG ' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -48.2 -25.54 1.54 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.622 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.0 -14.07 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.339 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.89 39.75 2.45 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.664 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.34 129.6 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 111.428 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.648 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 1.7 ttmp? -91.66 117.94 30.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.521 HH21 ' HB2' ' A' ' 49' ' ' ALA . 33.2 ptt180 -142.7 165.57 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.981 0.42 . . . . 0.0 111.165 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.996 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -104.29 108.08 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.632 ' HB3' HG11 ' A' ' 92' ' ' VAL . 12.5 m -84.87 118.75 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.416 ' CD2' ' CE2' ' A' ' 97' ' ' TYR . 2.2 m-70 -85.01 130.32 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 84' ' ' ILE . 12.0 tt -68.64 140.91 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.047 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 14.2 tpt180 -76.6 148.51 36.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.087 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.22 -79.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.984 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.39 -26.1 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.722 0.296 . . . . 0.0 111.544 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -79.93 -45.33 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.186 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HA ' HG12 ' A' ' 82' ' ' VAL . 3.5 ptt180 -58.46 -24.12 59.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -58.64 -33.43 70.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 8.44 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.585 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.495 ' CB ' HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -124.18 119.69 57.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.132 0.491 . . . . 0.0 111.167 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -111.07 110.32 20.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.766 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.843 HD13 HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.49 147.59 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.3 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -118.97 159.33 24.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 86' ' ' THR . 40.2 m -76.12 -6.09 49.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.697 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.1 p -145.83 71.57 1.27 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.702 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.59 160.52 39.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.079 0.466 . . . . 0.0 111.208 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.857 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.3 mm -86.94 146.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.489 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.643 HD13 HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.41 171.14 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.241 0.543 . . . . 0.0 111.631 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.716 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.07 124.37 34.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.429 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG12 ' CA ' ' A' ' 104' ' ' VAL . 16.9 m -122.69 160.26 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.351 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.93 135.77 12.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 47' ' ' GLU . 2.8 mt -100.45 159.1 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 60.87 22.82 12.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.178 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.04 -47.37 7.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.674 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.416 ' CE2' ' CD2' ' A' ' 73' ' ' HIS . 46.2 m-85 -96.95 4.15 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.136 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 65.82 29.71 10.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.722 0.296 . . . . 0.0 110.796 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.61 175.32 13.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.438 . . . . 0.0 111.109 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -17.58 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.109 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -77.67 124.79 28.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 111.369 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.478 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -111.5 156.16 22.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.053 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.409 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 13.1 p30 -102.82 120.67 41.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.881 0.372 . . . . 0.0 111.426 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.67 ' CA ' HG12 ' A' ' 92' ' ' VAL . 80.3 t -52.62 111.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.325 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.408 ' HB ' ' HG ' ' A' ' 91' ' ' LEU . 32.6 mm -79.02 -33.25 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.266 0.555 . . . . 0.0 109.81 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.04 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.6 pp -159.1 166.83 30.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.442 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.54 ' N ' HD12 ' A' ' 106' ' ' LEU . 1.6 tttt -109.9 116.94 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.061 0.457 . . . . 0.0 112.145 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.04 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.3 m-85 -79.23 106.12 11.04 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -73.44 177.15 5.45 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.671 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.03 -40.16 54.03 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.001 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.07 -40.81 97.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.678 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.9 mt-10 -67.76 -28.1 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.381 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.44 -49.13 7.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.829 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.39 -29.21 61.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.31 0.576 . . . . 0.0 109.489 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -78.32 -22.56 47.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.181 178.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.857 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.08 -33.86 27.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.024 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -33.76 61.54 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -21.01 43.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.729 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.702 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.0 m-30 -66.73 -8.44 28.08 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.89 23.46 51.18 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.418 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 2.9 mm-40 -109.93 -51.55 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.724 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -97.99 125.21 44.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 35.6 Cg_exo -57.27 179.0 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.327 2.018 . . . . 0.0 112.15 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.59 -28.63 67.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 10.3 p-80 -80.78 -23.28 39.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.222 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.545 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -55.39 141.21 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.284 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -124.14 146.51 48.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.863 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.6 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.477 HD21 ' CB ' ' A' ' 115' ' ' SER . 13.7 tp -118.9 130.51 55.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.549 HG11 ' CD2' ' A' ' 106' ' ' LEU . 17.7 t -121.84 139.58 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.097 0.475 . . . . 0.0 111.402 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 119' ' ' TYR . 53.8 m-85 -115.22 171.7 7.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -39.44 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -133.81 158.49 43.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 126.78 28.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.74 78.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.97 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.656 ' OE1' HD11 ' A' ' 91' ' ' LEU . 3.0 mt-30 -115.12 143.77 44.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.824 0.312 . . . . 0.0 110.658 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.865 ' HB2' HD11 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -119.22 166.21 13.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.129 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.597 ' CZ ' ' CE2' ' A' ' 108' ' ' TYR . 3.8 m-85 -84.78 156.82 21.21 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.706 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 64' ' ' CYS . . . -149.5 142.75 25.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.681 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.29 108.43 16.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.946 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 60' ' ' LEU . 21.5 t -55.42 137.56 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.461 HD11 ' C ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -116.13 -42.62 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.15 151.95 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.462 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -99.47 134.04 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.679 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 ' HD2' ' A' ' 59' ' ' ARG . 1.2 mt -93.72 -35.63 12.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.825 0.345 . . . . 0.0 110.772 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.25 -132.35 3.2 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -112.6 89.52 3.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.324 . . . . 0.0 110.976 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 147.75 -24.21 1.48 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.822 ' HD2' HD12 ' A' ' 55' ' ' LEU . 14.6 ptt180 -152.87 160.25 43.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.634 0.254 . . . . 0.0 110.534 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.838 HD22 ' CD1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.21 150.05 34.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 111.367 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.682 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.3 tt0 -91.72 121.64 33.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.461 ' C ' HD11 ' A' ' 52' ' ' ILE . . . -137.56 166.11 24.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.237 0.541 . . . . 0.0 112.318 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.478 ' HE3' ' CG ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -115.17 95.92 5.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.095 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 18.7 t -45.8 125.91 6.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.88 ' CZ ' HD22 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -48.46 -23.35 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.91 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -13.2 60.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.599 0.238 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.43 34.36 4.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.687 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.19 124.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.478 ' CG ' ' HE3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -85.86 112.47 21.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.58 165.77 27.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.907 0.385 . . . . 0.0 111.304 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.705 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -97.12 108.01 20.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.484 ' SG ' HG11 ' A' ' 92' ' ' VAL . 29.6 m -84.24 125.76 32.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.614 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.75 137.08 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.697 HD11 HG13 ' A' ' 82' ' ' VAL . 8.1 tt -68.87 140.3 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.821 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.421 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.31 145.69 43.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.913 0.387 . . . . 0.0 111.348 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.89 -51.23 15.61 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.272 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -31.56 64.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.986 0.422 . . . . 0.0 110.501 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.5 mm? -85.9 -31.71 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.453 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.526 ' HA ' HG12 ' A' ' 82' ' ' VAL . 8.1 mtp180 -49.01 -28.84 4.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.314 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -56.9 -27.48 60.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -169.37 49.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.36 . . . . 0.0 111.165 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 107' ' ' LYS . 9.4 p -123.0 122.94 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.644 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -111.03 109.58 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.673 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.838 ' CD1' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -81.12 123.77 38.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 179.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -84.72 152.82 23.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 86' ' ' THR . 63.0 m -79.92 -5.92 56.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.512 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 p -146.54 51.77 1.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -133.71 165.0 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 111.57 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.841 HG21 ' CD1' ' A' ' 116' ' ' LEU . 1.5 mp -87.72 146.58 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.875 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.75 HG23 ' HA ' ' A' ' 107' ' ' LYS . 1.3 mt -150.42 170.5 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.054 0.454 . . . . 0.0 111.195 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.667 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -123.27 122.4 38.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.93 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 104' ' ' VAL . 19.4 m -120.55 154.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.676 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -97.04 153.81 20.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.851 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -137.17 131.25 32.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 179.55 -68.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.094 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.28 -15.02 60.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 101' ' ' LYS . 16.8 m-85 -72.58 -11.4 60.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.582 0.229 . . . . 0.0 111.556 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 64.87 29.72 12.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.857 0.36 . . . . 0.0 110.807 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.9 OUTLIER 62.85 97.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 99' ' ' ASP . 4.3 t-20 165.12 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . 24.3 mttt -141.94 162.39 35.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.474 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.651 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -139.29 170.99 14.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -128.79 111.33 13.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.71 ' HA ' HG12 ' A' ' 92' ' ' VAL . 68.5 t -49.94 112.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.3 mm -83.94 -43.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.175 0.512 . . . . 0.0 109.764 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.027 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -144.46 165.82 26.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.421 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.816 ' HG2' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.87 120.7 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.923 -179.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.027 ' CE1' HD11 ' A' ' 106' ' ' LEU . 27.3 m-85 -83.11 105.91 14.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.97 166.77 4.31 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.12 -35.96 66.63 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.402 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.96 -40.22 97.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.738 ' O ' HD23 ' A' ' 116' ' ' LEU . 51.7 mt-10 -64.18 -28.19 69.58 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.561 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.954 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.58 -38.43 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.675 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -33.98 77.16 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.647 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 5.1 p -77.58 -23.09 50.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.867 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.954 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -52.54 -31.36 35.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.18 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -33.11 62.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.31 -21.79 42.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.731 177.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.736 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.44 -7.55 26.23 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.858 0.361 . . . . 0.0 110.218 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.11 84.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.003 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.479 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 38.2 mm-40 -125.83 -56.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.88 HD22 ' CZ ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -93.62 118.64 67.51 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 51.2 Cg_exo -54.3 178.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.206 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 10.0 p-80 -77.23 -17.85 58.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.246 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -52.62 128.73 27.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.363 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -106.76 133.03 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.853 HD13 ' HB1' ' A' ' 113' ' ' ALA . 5.4 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.826 0.346 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD21 ' CB ' ' A' ' 115' ' ' SER . 16.4 tp -127.21 123.73 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.4 140.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.6 m-85 -111.04 170.06 8.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.085 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -69.48 149.13 48.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.685 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.25 176.41 7.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.346 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -49.64 134.1 20.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.081 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.45 -15.09 60.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.504 HE22 HG21 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -134.12 139.42 45.9 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -125.06 157.2 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.07 0.462 . . . . 0.0 111.496 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 2.9 p90 -84.6 158.12 20.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.034 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.37 173.65 13.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.233 0.539 . . . . 0.0 111.997 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.446 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 38.4 tp60 -128.64 108.94 10.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.92 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.518 HG21 HD11 ' A' ' 90' ' ' ILE . 12.0 t -60.98 136.14 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.047 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 63' ' ' MET . 1.2 mp -116.2 -40.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.703 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 157.95 44.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.644 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.5 ttt -116.9 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.66 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -117.35 -167.62 1.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.729 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.37 -178.53 19.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.441 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.36 39.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.73 52.15 53.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.76 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.544 ' HG3' HD12 ' A' ' 55' ' ' LEU . 8.2 ptt180 -154.81 162.66 41.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.311 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.06 152.26 38.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.291 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.895 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.5 tt0 -94.02 121.82 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.907 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.29 161.36 30.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.235 0.54 . . . . 0.0 112.093 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.654 ' HB3' HD13 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -119.97 101.65 8.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.146 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.05 129.22 40.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.37 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 3.4 m-85 -50.63 -24.54 3.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.468 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -8.42 56.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 35.63 5.0 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.685 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.23 124.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.377 . . . . 0.0 111.087 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 9.8 tptm -96.36 115.21 27.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -141.48 160.99 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.038 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -95.67 110.79 22.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.464 ' HB3' HG11 ' A' ' 92' ' ' VAL . 12.5 m -84.25 119.02 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -79.85 141.49 36.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.373 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -68.63 126.76 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -179.23 -168.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.645 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.47 171.16 40.97 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.298 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -21.6 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.848 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.5 HD12 ' HG2' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -68.71 -10.81 58.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.412 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -47.6 -28.52 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.611 0.243 . . . . 0.0 111.48 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -61.96 -26.28 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.43 ' HE3' ' CZ2' ' A' ' 83' ' ' TRP . 10.2 mtpt -170.31 52.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 82' ' ' VAL . 14.3 p -81.97 111.07 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.43 ' CZ2' ' HE3' ' A' ' 81' ' ' LYS . 10.3 m0 -111.62 109.62 19.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.606 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.033 HD13 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -97.06 147.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.63 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.4 m-80 -119.58 153.38 35.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.927 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 86' ' ' THR . 55.9 m -80.25 -6.4 57.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 111.675 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.7 62.37 1.32 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.98 165.73 34.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.261 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 116' ' ' LEU . 37.2 mm -86.93 145.7 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.29 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.675 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.84 171.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.72 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.01 122.24 29.62 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.536 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.636 HG12 ' CA ' ' A' ' 104' ' ' VAL . 10.1 m -115.18 164.14 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.92 123.21 6.86 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.532 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -109.98 119.76 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.755 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -163.96 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -12.16 60.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -84.81 10.99 10.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.685 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 66.79 26.79 9.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 72.8 -57.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.462 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -40.71 -32.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.717 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -123.61 158.96 30.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -153.07 156.34 38.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -107.23 126.5 52.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.636 ' CA ' HG12 ' A' ' 92' ' ' VAL . 87.2 t -52.5 111.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.686 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.504 HG21 HE22 ' A' ' 46' ' ' GLN . 12.7 mm -80.93 -58.4 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.867 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.048 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -129.67 167.22 18.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.358 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.636 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -110.84 119.31 38.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.048 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.3 m-85 -84.01 106.38 15.62 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -70.46 172.84 7.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.675 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -75.61 -51.05 13.71 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.636 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -61.32 -39.14 89.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.534 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 23.6 tt0 -67.1 -29.94 69.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.607 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.859 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -45.84 -42.87 12.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.543 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -41.89 58.65 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 110.149 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -61.87 -21.32 64.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.516 178.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.914 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.7 -33.35 22.43 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -55.24 -34.74 64.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.3 -20.58 44.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.009 177.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.2 m-30 -66.58 -8.28 25.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.876 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 22.93 56.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.493 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 66.6 mm-40 -109.77 -61.0 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.912 0.387 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.637 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -82.18 139.45 45.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.745 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 64.3 Cg_endo -73.78 178.03 7.32 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.45 -29.8 70.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 27.3 p-80 -84.19 2.48 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.5 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.623 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -74.15 126.37 30.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 110.994 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -123.59 127.58 48.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.859 HD13 ' HB1' ' A' ' 113' ' ' ALA . 5.7 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.846 0.355 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.66 HD11 ' CE1' ' A' ' 119' ' ' TYR . 23.3 tp -103.29 118.38 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.471 ' HB ' HD22 ' A' ' 106' ' ' LEU . 19.1 t -108.08 139.11 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.628 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 66.9 m-85 -112.75 170.43 8.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.711 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.597 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.0 ttpt -48.28 143.42 4.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.47 156.17 19.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -56.1 129.85 41.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.838 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.23 -15.35 62.31 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.391 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.624 ' OE1' HD11 ' A' ' 91' ' ' LEU . 15.7 mt-30 -116.38 152.95 32.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.636 0.255 . . . . 0.0 110.401 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.9 tt0 -125.93 154.48 42.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 111.335 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 10.0 p90 -84.34 157.87 21.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.76 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.83 173.42 15.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.327 0.584 . . . . 0.0 112.204 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.689 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 2.3 tm0? -123.77 142.43 51.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.813 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.597 HG13 HD13 ' A' ' 60' ' ' LEU . 22.7 t -92.16 139.02 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 111.799 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 63' ' ' MET . 1.0 OUTLIER -115.85 -48.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.274 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -141.77 162.2 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.699 ' SD ' HD12 ' A' ' 84' ' ' ILE . 26.0 mmm -113.96 137.09 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.872 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -106.19 -69.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.896 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.23 179.65 16.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.565 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -72.37 -13.99 61.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.565 0.221 . . . . 0.0 111.259 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -118.78 8.85 12.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.824 ' HD2' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -155.4 155.98 34.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.752 0.311 . . . . 0.0 111.0 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.849 ' CD2' HD13 ' A' ' 84' ' ' ILE . 1.6 pp -147.89 164.1 34.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.379 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.859 ' HB2' HD21 ' A' ' 55' ' ' LEU . 40.4 tt0 -104.23 121.42 43.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -133.05 165.96 23.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.274 0.559 . . . . 0.0 112.262 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.876 ' HB2' HD11 ' A' ' 52' ' ' ILE . 3.7 tpp -130.14 110.92 11.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.078 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.25 133.5 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -27.27 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.502 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.37 -13.24 60.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.58 43.04 1.9 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.497 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.05 117.8 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.6 OUTLIER -90.64 112.99 24.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.1 156.84 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.872 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -92.66 107.89 19.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.856 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.6 ' HB3' HG11 ' A' ' 92' ' ' VAL . 32.3 m -84.17 118.42 24.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.376 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -82.84 123.7 29.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.765 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.69 HD12 HG12 ' A' ' 84' ' ' ILE . 5.5 tt -68.73 140.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 176.73 -161.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.793 0.33 . . . . 0.0 111.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.3 168.93 39.01 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.028 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.72 2.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.575 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.47 ' O ' HG12 ' A' ' 82' ' ' VAL . 1.2 mm? -64.47 -34.57 78.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.784 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.504 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -49.01 -27.16 3.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.292 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -56.76 -37.66 71.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -157.64 48.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.196 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.8 p -123.51 121.19 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.261 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.55 109.86 20.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.849 HD13 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.38 147.17 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.086 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -108.75 152.84 24.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.957 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 86' ' ' THR . 70.3 m -80.17 -6.36 57.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 111.69 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 p -146.2 61.69 1.24 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.687 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.96 168.52 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.186 0.517 . . . . 0.0 111.45 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.778 HG21 ' CD1' ' A' ' 116' ' ' LEU . 47.6 mm -91.81 146.78 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.213 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.64 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.2 mt -150.9 170.7 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 111.449 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.684 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.68 121.66 29.05 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.519 178.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 104' ' ' VAL . 15.3 m -118.66 148.4 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.13 128.4 8.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -114.83 111.54 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.735 0.302 . . . . 0.0 110.73 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.33 -75.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -55.35 -23.22 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.335 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -85.28 4.88 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.633 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 65.78 30.02 10.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 76.36 178.86 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 73.28 -60.67 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.809 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.26 151.05 22.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.674 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.464 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -148.83 151.22 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.991 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -99.44 127.96 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.751 ' HA ' HG12 ' A' ' 92' ' ' VAL . 62.0 t -54.86 111.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.471 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -82.73 -56.74 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 109.923 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.08 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -130.91 166.08 21.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.48 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.628 ' N ' HD12 ' A' ' 106' ' ' LEU . 10.4 tttt -111.74 117.93 34.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.08 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.2 m-85 -84.15 106.55 15.88 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -87.48 -178.94 6.26 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -68.38 -45.35 72.99 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.363 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.86 -39.48 77.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 116' ' ' LEU . 54.2 mt-10 -71.15 -28.7 64.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.593 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.891 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.81 -47.46 8.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.637 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.85 -28.98 64.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 109.399 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.638 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -79.7 -22.86 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.253 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.891 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.74 -34.07 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.095 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -55.18 -33.22 62.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.27 -21.1 43.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.806 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.706 ' HE2' ' CD1' ' A' ' 108' ' ' TYR . 4.0 m-30 -66.57 -9.95 40.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.11 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.55 56.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.595 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.494 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 3.0 mm-40 -108.95 -52.74 2.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.055 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.708 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.06 130.65 35.4 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.825 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 178.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.346 2.031 . . . . 0.0 112.138 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -73.42 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -84.04 1.39 44.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.57 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.94 138.12 55.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.878 0.371 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.71 125.32 44.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.869 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.3 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.819 0.343 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 115' ' ' SER . 13.0 tp -68.56 105.74 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' CG1' HD22 ' A' ' 106' ' ' LEU . 17.8 t -97.78 139.35 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.204 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 78.6 m-85 -108.58 170.72 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.995 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.447 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -44.31 158.28 0.05 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.43 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.0 156.17 35.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.087 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.86 126.2 26.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.85 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.94 -15.35 62.02 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.604 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' A' ' 91' ' ' LEU . 3.4 mm-40 -111.21 152.61 26.91 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.871 ' HB2' HD11 ' A' ' 94' ' ' LEU . 35.8 tt0 -122.89 150.6 42.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 4.4 p90 -84.79 157.86 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.295 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.82 174.0 12.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.335 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.434 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 tm0? -127.58 114.4 17.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.298 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 90' ' ' ILE . 38.4 t -68.64 131.06 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.907 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 63' ' ' MET . 30.4 mt -116.04 -37.14 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.875 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -141.14 155.86 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.608 ' C ' HD23 ' A' ' 55' ' ' LEU . 2.7 mtp -117.16 146.94 42.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.819 HD12 ' CD ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -110.68 -46.13 3.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 110.802 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.7 -137.51 2.49 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.73 -26.8 9.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.666 0.269 . . . . 0.0 110.982 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -103.57 3.72 46.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.075 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.819 ' CD ' HD12 ' A' ' 55' ' ' LEU . 6.3 ptp180 -155.28 156.37 35.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.905 0.353 . . . . 0.0 111.036 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.807 ' CD2' HD13 ' A' ' 84' ' ' ILE . 2.3 pp -148.08 167.19 25.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.505 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.799 ' HB2' HD21 ' A' ' 55' ' ' LEU . 17.8 tt0 -112.9 121.25 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.161 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -135.85 164.91 26.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.213 0.53 . . . . 0.0 112.293 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 8.0 tpp -118.24 110.3 17.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.165 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -59.14 133.25 55.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.8 m-85 -48.04 -24.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.07 -11.31 60.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.367 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.24 42.21 2.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.729 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.11 133.01 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.313 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.5 OUTLIER -103.86 112.5 25.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -145.54 164.81 30.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.003 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.73 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -98.35 108.9 21.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.737 ' HB3' HG11 ' A' ' 92' ' ' VAL . 37.4 m -89.92 118.8 29.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.922 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.43 132.67 36.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.67 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.673 HD12 HG12 ' A' ' 84' ' ' ILE . 10.8 tt -68.93 140.99 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -56.24 174.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.074 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.15 -49.82 2.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.229 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -33.52 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -71.18 -45.98 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.639 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.485 ' HA ' HG12 ' A' ' 82' ' ' VAL . 11.4 ptm180 -56.59 -25.7 53.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -28.41 64.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm -137.35 8.24 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.851 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.589 HG21 ' CB ' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -124.35 124.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.956 0.407 . . . . 0.0 111.487 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -110.79 110.41 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.807 HD13 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.32 147.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 111.416 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -117.51 157.76 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.04 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.1 m -76.06 -6.36 50.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.751 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -144.45 73.55 1.38 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.649 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.79 162.28 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.928 HG21 ' CD1' ' A' ' 116' ' ' LEU . 33.5 mm -86.94 147.31 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.603 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.681 HD13 HG22 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -150.7 171.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.43 . . . . 0.0 111.438 179.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.657 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -130.12 122.92 29.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.9 178.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.779 HG12 ' HA ' ' A' ' 104' ' ' VAL . 31.0 m -121.6 157.34 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.994 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.62 136.14 12.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.862 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -118.27 110.27 17.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.0 110.743 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.67 -68.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 111.108 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.2 -27.77 23.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.245 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -85.71 -0.24 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.65 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 65.8 30.27 10.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 5.6 m-20 77.88 162.55 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 85.56 -23.34 0.16 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.36 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -141.22 157.01 45.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.662 0.268 . . . . 0.0 110.449 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.779 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -148.54 174.28 12.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 0.0 111.141 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -128.64 124.22 35.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.589 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.779 ' HA ' HG12 ' A' ' 92' ' ' VAL . 49.8 t -52.55 111.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.667 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -83.41 -37.44 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 109.819 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.04 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.4 pp -152.48 164.08 38.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.419 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 90' ' ' ILE . 4.8 tmtt? -109.32 118.21 36.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 111.911 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 1.04 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.4 m-85 -79.83 106.6 11.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 112' ' ' GLU . 9.8 m-20 -60.17 166.91 2.62 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.705 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -78.0 -50.66 11.69 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.62 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.31 -42.91 99.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.474 ' OE2' ' HA ' ' A' ' 108' ' ' TYR . 0.6 OUTLIER -68.85 -26.6 65.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.01 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 1.005 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -45.68 -34.06 3.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.305 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -55.82 -39.56 71.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.421 0.629 . . . . 0.0 109.396 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.702 ' HB3' HD21 ' A' ' 39' ' ' LEU . 12.0 m -61.01 -20.85 62.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.089 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.928 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -49.55 -34.89 18.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.38 -178.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.03 -34.96 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.39 42.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.78 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.701 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -66.82 -10.53 48.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 27.55 66.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 7.8 mm-40 -114.02 -51.87 2.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.685 0.279 . . . . 0.0 111.035 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.611 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.89 139.86 21.57 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.44 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 35.1 Cg_exo -59.21 179.41 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.415 2.077 . . . . 0.0 112.103 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -72.76 -27.74 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.44 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 9.2 p-80 -79.1 -18.83 52.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.379 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.57 135.86 39.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.827 0.346 . . . . 0.0 111.411 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.46 131.1 45.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.005 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.7 mt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.271 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.769 0.319 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.12 119.0 32.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.36 90.45 0.78 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.504 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.15 -75.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 110.831 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -166.03 78.01 0.25 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 68.29 -70.74 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.941 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -163.67 109.18 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.35 -178.83 5.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -151.46 131.6 13.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.029 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.28 85.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.002 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -126.71 36.76 4.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -138.16 97.56 9.66 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.72 112.37 2.64 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.464 2.109 . . . . 0.0 112.276 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 3.7 mtp . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.803 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.815 0.256 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.25 -179.93 6.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 60.22 93.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -92.27 91.64 7.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.08 -138.6 7.17 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.12 -67.08 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.08 131.37 10.75 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.522 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.43 -97.49 0.12 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.57 36.12 0.19 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.9 0.381 . . . . 0.0 110.971 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.12 160.51 32.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.41 -65.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.27 128.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.931 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -169.75 179.49 3.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.78 54.13 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.567 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -107.88 -31.15 8.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.752 0.31 . . . . 0.0 110.843 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.9 t30 60.28 46.56 10.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 67.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.783 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 61.63 97.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.798 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -64.34 131.07 46.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.36 32.63 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -140.32 133.76 29.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -177.57 132.17 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.61 144.81 46.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.76 87.02 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.187 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.631 HD21 ' HE1' ' A' ' 119' ' ' TYR . 0.4 OUTLIER -81.58 142.78 32.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.455 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' HB ' HD22 ' A' ' 106' ' ' LEU . 21.8 t -116.11 138.5 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.07 0.462 . . . . 0.0 111.626 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.607 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.8 m-85 -107.48 170.49 7.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.364 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HA ' ' OH ' ' A' ' 108' ' ' TYR . 2.6 ttpt -52.86 145.39 12.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 0.0 110.738 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -111.73 156.58 21.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.4 130.1 45.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.652 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.92 -15.47 61.72 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.423 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' OE1' HD11 ' A' ' 91' ' ' LEU . 17.6 mt-30 -116.32 144.91 43.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.639 0.257 . . . . 0.0 110.326 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -118.1 155.3 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.983 0.42 . . . . 0.0 111.468 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.3 p90 -84.45 157.71 21.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.871 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.88 173.25 13.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.193 0.521 . . . . 0.0 112.328 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.483 ' HG2' HD13 ' A' ' 89' ' ' ILE . 1.2 tm0? -129.27 130.77 46.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.915 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.463 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 43.9 t -82.08 139.92 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.084 0.469 . . . . 0.0 112.051 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.493 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.0 -39.74 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.574 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -141.65 157.81 44.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.463 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.561 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -111.53 142.62 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.813 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.929 HD21 ' HB2' ' A' ' 61' ' ' GLU . 3.3 mt -103.79 -155.83 0.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -44.55 -84.57 0.01 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.194 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -159.76 -43.81 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.768 0.318 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.42 -0.22 71.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.007 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.694 ' HG3' HD12 ' A' ' 55' ' ' LEU . 26.3 ptt180 -151.76 167.2 28.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.761 0.315 . . . . 0.0 111.094 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.734 ' CD2' HG21 ' A' ' 84' ' ' ILE . 2.0 pp -147.66 154.54 40.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.04 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.929 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.5 tt0 -91.78 121.75 33.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.042 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -149.78 164.82 34.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.662 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.493 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -138.75 133.27 31.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.536 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.438 ' O ' ' HE3' ' A' ' 63' ' ' MET . 49.2 t -64.41 141.6 58.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.974 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.3 m-85 -48.66 -23.19 0.94 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.782 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -13.78 61.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.331 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.02 34.64 3.39 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.76 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.34 110.74 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 111.037 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 63' ' ' MET . 5.5 mmtm -85.69 118.34 25.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -145.12 156.61 43.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.003 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -91.99 105.77 17.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.991 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.493 ' SG ' HG11 ' A' ' 92' ' ' VAL . 12.1 m -85.41 118.77 25.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.732 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.45 141.25 36.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.697 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.883 HD12 ' CD1' ' A' ' 84' ' ' ILE . 2.1 tt -68.6 140.28 19.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 26.6 tpt180 -67.27 155.33 39.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.352 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.08 -61.53 2.11 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.269 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.42 -39.75 91.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.981 0.42 . . . . 0.0 110.501 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -69.15 -17.88 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.987 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.499 ' HA ' HG12 ' A' ' 82' ' ' VAL . 1.2 ptt180 -48.67 -28.72 3.73 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.926 0.393 . . . . 0.0 111.292 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -75.01 -29.38 60.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.344 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.67 44.6 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 111.453 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 82' ' ' VAL . 11.0 p -117.45 115.7 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 110.955 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -110.74 110.27 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.821 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.883 ' CD1' HD12 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -106.1 147.7 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.758 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.2 m-20 -137.57 165.51 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.904 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.7 m -80.28 -6.16 57.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.596 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.08 68.62 0.94 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.579 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -150.8 164.27 36.62 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.329 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.929 HG21 ' CD1' ' A' ' 116' ' ' LEU . 32.0 mm -87.63 144.8 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.229 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.3 mt -150.68 171.65 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.062 0.458 . . . . 0.0 111.241 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.741 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -127.2 122.34 33.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 178.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.706 HG12 ' HA ' ' A' ' 104' ' ' VAL . 17.0 m -120.4 139.18 48.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.432 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.456 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -80.5 146.17 27.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.293 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 93' ' ' GLY . 1.4 mt -114.64 167.3 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' CB ' ' O ' ' A' ' 94' ' ' LEU . 0.3 OUTLIER 82.03 -8.08 1.31 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.835 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.28 -35.7 27.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.642 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -105.66 22.83 14.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.435 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 55.5 mm-40 68.92 30.53 4.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.766 0.317 . . . . 0.0 110.77 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 100' ' ' ASN . 1.3 t0 82.99 -175.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.731 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 99' ' ' ASP . 8.5 t-20 69.62 -60.93 0.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.777 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -98.77 155.73 17.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 110.785 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -145.84 131.08 18.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -88.99 123.93 33.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.871 0.367 . . . . 0.0 111.276 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.706 ' HA ' HG12 ' A' ' 92' ' ' VAL . 80.6 t -52.09 112.11 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.653 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -78.84 -39.46 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.236 0.541 . . . . 0.0 109.971 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.032 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -150.56 166.61 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.372 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.595 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -108.31 123.27 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 111.813 -179.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.032 ' CE1' HD11 ' A' ' 106' ' ' LEU . 20.3 m-85 -87.45 106.73 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.56 166.69 6.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.58 -38.61 62.6 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.515 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.36 -40.14 95.44 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.703 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.3 mm-40 -62.25 -27.47 69.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.76 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.929 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.55 -36.61 2.14 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.846 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -63.82 -33.05 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -78.48 -22.8 46.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.902 177.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.929 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.75 -31.75 27.89 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.165 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -33.33 62.82 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.47 -22.05 41.43 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.748 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.653 ' CG ' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.2 -11.65 57.93 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.07 29.28 74.47 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.497 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.505 ' HB2' HD23 ' A' ' 122' ' ' LEU . 34.2 mt-10 -117.09 -52.42 2.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.338 . . . . 0.0 111.206 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.522 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -102.89 141.4 22.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 -179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.667 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 71.4 Cg_endo -74.54 179.11 6.24 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.51 2.14 . . . . 0.0 112.206 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -71.03 -17.22 62.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.246 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 11.9 p-80 -97.72 -1.91 42.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.638 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.667 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -59.66 154.31 18.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.82 0.343 . . . . 0.0 111.178 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -115.37 125.87 53.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.851 HD13 ' HB1' ' A' ' 113' ' ' ALA . 13.3 mt -103.77 140.24 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.011 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -101.17 152.8 20.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.13 145.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -148.8 -46.71 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.13 145.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.4 m -67.76 76.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 61.91 118.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 67.51 173.23 6.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.11 174.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.592 2.194 . . . . 0.0 112.361 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -123.03 -153.52 8.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.623 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.52 -83.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.608 0.242 . . . . 0.0 110.945 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.8 t0 47.3 71.25 0.34 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.808 0.337 . . . . 0.0 111.244 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -66.65 162.87 20.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 63.58 140.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 28.3 mt -141.57 146.52 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.015 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -114.35 166.78 11.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.014 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 62.73 -80.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 56.9 30.66 18.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.885 0.374 . . . . 0.0 110.92 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.63 -177.64 5.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.947 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 22.9 mm 65.35 82.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.109 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.24 -98.05 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.443 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.5 -69.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 0.0 111.014 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -89.84 9.97 25.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.367 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 68.41 -67.09 0.21 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.802 0.335 . . . . 0.0 111.078 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 64.79 154.88 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.48 -65.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.4 pp -124.28 138.89 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.138 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.03 -45.26 1.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.028 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -104.45 -27.1 12.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.112 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.4 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.121 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.852 0.358 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.79 125.24 50.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.21 50.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.501 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 5.0 t -63.78 -31.9 73.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.842 0.353 . . . . 0.0 110.745 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -74.65 -23.05 58.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.011 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -80.18 92.04 5.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.054 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -130.08 146.58 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.697 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -177.87 -36.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.069 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -47.9 100.4 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.219 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -142.95 118.85 10.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.96 -173.28 2.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 24.5 t0 67.99 75.64 0.28 Allowed Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.93 96.81 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.565 2.177 . . . . 0.0 112.227 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 6.8 ttp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 -179.904 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.785 0.244 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.6 mttt 61.69 102.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -60.77 136.91 58.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.43 93.82 4.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.63 -90.16 0.24 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.449 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.07 53.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.9 -140.1 3.73 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.74 -95.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.418 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -103.93 -31.2 9.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.887 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.56 152.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.79 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -95.55 43.8 1.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.973 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.35 -41.54 80.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.964 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.61 -76.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.03 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.19 40.26 0.45 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -158.96 -51.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 110.925 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 68.91 -67.22 0.22 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.015 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.37 128.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 62.37 123.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -108.11 59.6 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.941 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.42 29.34 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.861 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -64.79 127.8 33.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm 63.45 28.21 15.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -144.56 142.9 30.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -118.91 78.52 1.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.709 HD11 ' CE1' ' A' ' 119' ' ' TYR . 21.6 tp -89.96 125.91 35.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.705 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -126.73 140.65 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.688 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.758 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -110.75 170.41 8.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.347 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -47.78 144.13 3.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.709 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -119.51 164.6 15.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.405 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -56.53 131.49 48.81 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.726 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.03 -15.41 61.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.379 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -124.95 148.34 48.43 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.612 0.244 . . . . 0.0 110.366 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.714 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.2 tt0 -124.21 154.41 40.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.887 0.375 . . . . 0.0 111.231 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.484 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.0 p90 -84.18 157.89 21.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.788 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.45 173.72 14.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.27 0.557 . . . . 0.0 112.5 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.579 ' OE1' HD13 ' A' ' 89' ' ' ILE . 33.4 tp60 -129.94 109.14 10.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.12 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.511 ' CG2' HD11 ' A' ' 90' ' ' ILE . 26.7 t -56.32 141.18 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 86' ' ' THR . 0.1 OUTLIER -115.67 -43.04 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.833 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 160.59 43.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.904 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -108.83 131.87 54.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.454 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.905 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -93.45 -29.19 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.991 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.15 -175.37 32.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -73.33 95.28 2.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.787 0.327 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.01 -28.16 2.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.537 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.783 ' CD ' HD12 ' A' ' 55' ' ' LEU . 26.2 ptt180 -150.27 160.22 43.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.989 HD22 HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.66 154.77 41.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.213 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.905 ' HB2' HD21 ' A' ' 55' ' ' LEU . 17.1 tt0 -99.72 121.6 41.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.771 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.509 ' C ' HD11 ' A' ' 52' ' ' ILE . . . -130.11 157.41 42.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.084 0.469 . . . . 0.0 111.879 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.416 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -114.9 105.36 12.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.31 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.1 m -56.98 127.55 32.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.47 -25.45 1.67 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.672 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.4 -9.94 59.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.265 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.02 37.23 4.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 70' ' ' ARG . 21.2 t -127.01 118.37 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 0.0 111.342 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' CA ' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.41 118.01 25.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.622 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.431 ' HG3' HG12 ' A' ' 68' ' ' VAL . 7.4 mtm180 -145.09 161.99 38.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.247 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.866 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -102.34 117.75 35.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.795 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.6 ' SG ' HG11 ' A' ' 92' ' ' VAL . 9.3 m -99.71 119.44 38.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.095 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -77.05 149.22 35.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.573 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.494 HD12 ' CD1' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -68.83 129.51 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.75 0.31 . . . . 0.0 110.767 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -53.08 159.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.316 -179.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.03 -52.21 2.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.332 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -74.31 -33.94 63.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.98 0.419 . . . . 0.0 110.399 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.613 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -74.71 -19.79 60.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.784 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.774 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -50.36 -27.26 5.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.04 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -60.31 -30.46 69.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.365 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -153.97 36.53 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 79' ' ' ARG . 7.7 p -105.08 111.0 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.083 0.468 . . . . 0.0 110.957 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -111.23 110.21 20.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.789 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.989 HD13 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.06 147.1 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.896 179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -129.5 161.52 30.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 52' ' ' ILE . 88.2 m -80.0 -6.63 57.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.049 0.452 . . . . 0.0 111.73 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 p -144.61 71.74 1.32 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.661 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.7 159.55 30.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.141 0.496 . . . . 0.0 111.537 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.889 HG21 ' CD1' ' A' ' 116' ' ' LEU . 30.1 mm -86.88 147.03 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.2 mt -150.54 171.23 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.001 0.429 . . . . 0.0 111.399 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.75 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -127.81 122.28 32.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.596 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 104' ' ' VAL . 33.2 m -121.73 153.69 25.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.443 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.77 140.51 15.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.37 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.714 HD11 ' HB2' ' A' ' 47' ' ' GLU . 4.0 mt -113.86 177.12 4.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.975 0.417 . . . . 0.0 111.003 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.81 8.7 6.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.454 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -93.44 -38.84 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.845 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -105.63 22.86 14.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.275 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 69.1 30.54 4.36 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.725 0.298 . . . . 0.0 110.869 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.433 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 11.1 t0 81.07 162.79 0.16 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.906 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 9.0 t-20 84.86 -18.69 0.38 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.448 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HE2' HD23 ' A' ' 71' ' ' LEU . 15.6 mmtp -142.0 151.43 42.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.779 0.323 . . . . 0.0 110.628 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -139.67 -177.06 4.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.902 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -139.9 116.04 10.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.785 ' HA ' HG12 ' A' ' 92' ' ' VAL . 91.4 t -51.22 111.72 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.979 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -83.18 -50.37 15.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.209 0.528 . . . . 0.0 109.813 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.053 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -136.19 168.95 18.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.44 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.653 ' N ' HD12 ' A' ' 106' ' ' LEU . 11.1 ttpt -111.37 121.74 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.053 ' CE1' HD11 ' A' ' 106' ' ' LEU . 21.6 m-85 -86.77 106.47 17.71 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.93 175.4 5.89 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -75.68 -41.79 52.9 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.768 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -61.5 -40.22 93.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.67 ' O ' HD23 ' A' ' 116' ' ' LEU . 18.4 mt-10 -67.12 -28.23 67.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.544 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.957 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.56 -47.83 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.876 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -56.52 -29.49 61.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.396 0.617 . . . . 0.0 109.503 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.695 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -75.89 -22.18 56.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.246 178.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.34 -35.68 28.89 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.287 -179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -54.55 -34.78 62.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.17 -20.46 44.78 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.932 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.758 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.8 m-30 -66.35 -5.49 10.93 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.781 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.5 24.9 57.26 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.582 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 57.0 mm-40 -114.11 -60.37 1.89 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.683 0.278 . . . . 0.0 111.318 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.76 139.16 24.75 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.083 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 24.2 Cg_exo -63.13 -178.99 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.531 2.154 . . . . 0.0 112.129 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.66 -26.86 62.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.064 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 15.6 p-80 -82.98 -9.67 59.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.503 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -55.96 135.25 52.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.333 . . . . 0.0 111.182 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -121.99 127.6 50.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.957 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.0 mt -98.16 152.01 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -68.31 95.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.796 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 45.65 -169.59 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.357 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.4 m -141.58 156.44 45.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -40.46 119.23 1.05 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.734 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.38 114.92 3.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.35 103.26 4.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -133.49 83.36 0.29 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.416 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.77 -32.09 19.23 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.536 2.157 . . . . 0.0 112.339 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.48 161.65 50.61 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.51 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 60.23 107.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.29 34.36 5.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -150.23 143.74 25.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.017 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 69.31 -64.95 0.32 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.062 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.22 150.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.075 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 61.74 77.23 0.34 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.76 -49.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.11 -21.72 17.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.486 ' C ' HD12 ' A' ' 147' ' ' ILE . 0.4 OUTLIER 66.09 22.42 11.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.117 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 147' ' ' ILE . 3.6 mp 50.1 31.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.893 0.378 . . . . 0.0 111.383 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.08 -120.53 10.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.458 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.7 t0 59.56 165.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.33 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -89.35 109.93 20.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -172.25 -44.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 63.53 143.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -126.4 71.9 1.3 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.788 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 8.4 pt -148.58 99.74 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -128.98 102.47 6.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.849 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -115.51 30.83 7.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.764 179.915 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.765 0.317 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.29 48.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.05 80.22 0.88 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.548 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -117.66 145.15 44.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.817 0.342 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -120.86 50.13 1.39 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.84 175.56 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' B' ' 8' ' ' HIS . 0.1 OUTLIER -65.77 -75.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' B' ' 7' ' ' HIS . 1.9 m170 -159.43 78.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.88 -27.32 21.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.411 ' O ' ' N ' ' B' ' 12' ' ' ASP . 15.3 m-70 69.97 -66.54 0.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.469 ' OG1' ' N ' ' B' ' 12' ' ' ASP . 5.9 p 64.53 -71.45 0.07 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.177 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . 0.469 ' N ' ' OG1' ' B' ' 11' ' ' THR . 1.0 OUTLIER 49.55 63.39 10.34 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 111.171 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.59 -173.71 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.531 2.154 . . . . 0.0 112.284 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.816 -179.982 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.789 0.246 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 tttm -76.53 -175.79 3.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.53 66.28 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -30.52 70.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.96 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.44 134.98 12.01 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.543 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -152.43 156.57 39.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.87 -40.99 2.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.343 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -86.83 101.49 2.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.372 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -58.31 9.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 0.0 110.981 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -118.35 171.49 8.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.965 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.56 175.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.714 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 25.39 10.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.09 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 54.68 68.74 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.866 0.365 . . . . 0.0 110.926 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 177.96 1.98 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.594 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.96 52.88 2.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 110.781 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 62.25 62.51 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.811 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 64.08 16.1 9.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.352 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t30 47.49 92.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.774 0.321 . . . . 0.0 111.163 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -161.28 -169.34 2.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.983 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.3 p 62.9 32.81 15.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -100.65 122.8 43.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 175.43 5.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -80.81 103.46 10.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.78 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.42 128.98 53.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.896 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.644 HD11 ' HE1' ' A' ' 119' ' ' TYR . 25.4 tp -77.17 117.27 18.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.462 ' CG1' HD22 ' A' ' 106' ' ' LEU . 21.4 t -105.34 139.15 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.035 0.445 . . . . 0.0 111.13 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.609 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 81.0 m-85 -114.28 170.42 8.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.672 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' HA ' HD22 ' A' ' 91' ' ' LEU . 5.9 ttpm? -47.09 152.64 0.53 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -120.14 159.52 24.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.933 0.397 . . . . 0.0 111.155 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.35 127.66 33.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.853 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.24 61.8 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.618 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.518 ' CB ' HD11 ' A' ' 91' ' ' LEU . 12.8 mt-30 -115.84 146.38 42.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.484 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' CB ' HD11 ' A' ' 94' ' ' LEU . 47.3 tp10 -120.6 156.05 32.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.944 0.402 . . . . 0.0 111.405 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE2' ' CD1' ' A' ' 65' ' ' PHE . 1.9 p90 -84.48 157.79 21.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.985 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.62 173.3 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 112.141 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 62.8 tp60 -128.68 109.59 11.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.954 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.678 ' CG2' HD11 ' A' ' 90' ' ' ILE . 2.7 t -54.25 135.87 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.975 0.417 . . . . 0.0 111.853 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.932 HD13 ' HB3' ' A' ' 63' ' ' MET . 1.0 OUTLIER -115.67 -44.7 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.842 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -141.51 162.25 35.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.716 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.693 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.3 ttt -116.22 143.14 45.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.829 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -111.24 -57.74 2.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.705 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 149.02 9.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.607 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.7 m120 61.89 74.56 0.44 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.779 0.323 . . . . 0.0 111.045 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.917 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 55.1 34.04 58.1 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.705 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.892 ' HB3' HD12 ' A' ' 55' ' ' LEU . 14.7 mmt180 -144.94 129.73 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.908 0.385 . . . . 0.0 111.411 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.858 HD22 HG12 ' A' ' 84' ' ' ILE . 1.1 pp -147.03 138.92 24.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.461 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.692 ' HB2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -90.95 121.25 32.62 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . . . -122.37 164.62 17.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.208 0.527 . . . . 0.0 112.026 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.932 ' HB3' HD13 ' A' ' 52' ' ' ILE . 4.9 tpt -130.6 95.29 3.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.27 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.3 130.66 43.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.301 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 8.5 m-85 -49.57 -24.59 2.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.765 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.31 -9.19 58.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.258 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.5 5.34 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.65 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.18 110.98 24.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.808 0.337 . . . . 0.0 111.197 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.25 122.27 35.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.816 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -145.23 165.67 27.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.075 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.022 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -93.5 105.62 17.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.548 ' SG ' HG11 ' A' ' 92' ' ' VAL . 32.8 m -90.92 134.28 34.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.572 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -87.39 131.29 34.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.574 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.917 HG22 ' HA2' ' A' ' 58' ' ' GLY . 17.4 tt -68.52 140.77 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.941 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.434 ' CB ' ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -62.72 151.95 37.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.82 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.36 -43.0 26.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.667 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -76.03 -31.38 58.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.434 ' HB2' ' CB ' ' A' ' 75' ' ' ARG . 3.1 mm? -75.73 -50.61 14.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.821 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -50.6 -25.33 4.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.555 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -51.36 -39.76 57.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.014 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -141.52 13.0 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.452 HG22 ' HD3' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -124.32 120.69 59.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 120.982 0.42 . . . . 0.0 111.092 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -110.96 115.04 28.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.655 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.858 HG12 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -64.06 131.83 29.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 110.597 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.565 ' O ' HG21 ' A' ' 51' ' ' VAL . 5.6 m-80 -98.18 156.46 16.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.172 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 86' ' ' THR . 77.0 m -76.28 -6.45 51.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.887 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.58 80.71 1.77 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.86 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.88 162.85 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.967 0.413 . . . . 0.0 111.302 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 116' ' ' LEU . 29.8 mm -86.84 146.78 5.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.328 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.801 HD13 HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.68 171.22 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.164 0.506 . . . . 0.0 111.679 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.722 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.61 121.81 29.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.661 178.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.78 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.3 m -118.63 148.12 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.115 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.79 139.19 15.68 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.795 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.586 HD11 ' CB ' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -125.43 137.11 53.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.726 0.298 . . . . 0.0 110.623 179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -177.23 -81.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.109 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.71 -20.61 61.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.254 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -72.3 -10.58 59.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.309 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 9.2 mt-30 68.57 28.35 5.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.367 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 8.8 t0 79.17 -47.25 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.668 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -43.0 -30.3 0.41 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.33 164.09 29.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -146.77 -177.31 5.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -137.9 112.92 9.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.78 ' HA ' HG12 ' A' ' 92' ' ' VAL . 60.3 t -50.36 111.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.9 mm -87.9 -55.19 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.125 0.488 . . . . 0.0 110.157 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.034 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -131.28 163.79 27.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.503 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.586 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.7 OUTLIER -109.41 115.63 30.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.034 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.7 m-85 -79.02 106.29 10.95 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -69.52 175.72 3.92 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.625 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.72 -40.2 49.4 Favored 'General case' 0 C--O 1.229 0.023 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.796 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -61.43 -40.11 93.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.71 ' O ' HD23 ' A' ' 116' ' ' LEU . 17.4 mt-10 -66.94 -28.35 68.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.598 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.882 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.55 -46.31 7.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.871 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.8 -30.26 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.351 0.596 . . . . 0.0 109.405 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.628 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -77.91 -22.29 49.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.153 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.914 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.16 -32.65 23.87 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.147 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -54.93 -33.85 62.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -21.91 41.68 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.76 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.675 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -66.93 -13.16 61.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.75 28.23 69.67 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.635 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.531 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.4 mt-10 -113.2 -53.74 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 111.255 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.595 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -87.58 140.51 31.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.853 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.721 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 65.3 Cg_endo -73.66 179.41 5.64 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.33 -28.05 66.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.987 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 47.0 p-80 -87.07 2.45 49.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.535 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.721 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -81.09 127.75 32.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.883 0.373 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.22 137.22 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.882 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.5 mt -94.58 152.2 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -70.55 66.15 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.99 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.07 -169.47 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.113 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.4 m -78.37 -35.18 47.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 t0 63.49 133.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.0 p -60.98 -176.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.438 ' O ' ' CG ' ' A' ' 134' ' ' PHE . 0.0 OUTLIER -75.23 60.92 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.247 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.36 -147.06 25.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.493 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.71 111.42 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.518 2.145 . . . . 0.0 112.303 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.81 13.97 64.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.722 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.5 t70 67.91 -68.3 0.17 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.734 0.302 . . . . 0.0 111.019 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -81.31 68.15 7.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.876 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -79.14 151.36 31.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.23 106.77 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 mp -136.06 -46.63 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.02 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -95.64 -175.78 3.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 60.95 82.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -100.8 -46.54 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.988 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.31 34.91 1.5 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.8 mt -123.19 78.26 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.07 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.6 -30.61 8.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.477 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.52 114.27 3.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -169.05 133.22 1.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -153.08 149.74 28.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.845 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -125.22 -79.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 55.46 61.17 2.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.979 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 29.2 mt -89.63 89.04 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 59.44 69.74 0.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -98.5 101.02 12.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 11.2 tt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.029 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 7.2 mmt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.855 0.359 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -145.37 106.11 4.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.969 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.86 -137.83 5.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.35 87.39 2.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 63.13 114.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 65.2 m170 -61.25 174.97 0.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 71.51 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.832 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -90.6 175.6 6.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.907 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.66 161.27 13.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.798 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.53 87.76 2.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 19.5 p -71.24 -31.12 67.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.12 82.22 1.11 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.77 148.56 65.3 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.619 2.213 . . . . 0.0 112.338 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . 0.419 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' B' ' 14' ' ' MET . 48.0 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.863 0.276 . . . . 0.0 112.24 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.91 145.54 13.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -142.9 60.21 1.42 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? 59.38 80.31 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.74 -83.58 1.73 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -123.14 -174.24 2.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.821 0.343 . . . . 0.0 110.859 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.49 -134.14 8.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.426 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.94 -177.91 44.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.499 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.15 164.21 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 110.96 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -175.89 135.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.68 42.46 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 61.14 164.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -126.6 -51.25 1.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.014 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 146.02 -18.17 1.76 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.749 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -55.95 -22.93 29.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.709 0.29 . . . . 0.0 111.268 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.44 39.66 6.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 0.0 110.778 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 34' ' ' SER . 4.3 tt0 -179.49 -37.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 74.94 -62.14 0.46 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.035 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.31 46.56 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.096 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 31' ' ' GLU . 15.9 t -97.88 54.05 1.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.747 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -110.65 70.64 0.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -101.24 115.92 31.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 63.16 120.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -68.3 78.98 0.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.616 HD12 ' HG2' ' A' ' 112' ' ' GLU . 11.2 tp -119.54 116.19 25.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' O ' ' HE1' ' A' ' 108' ' ' TYR . 18.3 t -129.22 141.04 47.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.802 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.745 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 1.7 m-85 -108.24 170.3 8.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.117 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.93 159.66 25.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.719 0.295 . . . . 0.0 110.697 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.12 175.44 10.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.128 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -47.15 130.87 12.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.18 -15.33 62.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.435 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.618 HE21 HD11 ' A' ' 91' ' ' LEU . 2.0 mt-30 -136.67 146.61 46.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.65 0.262 . . . . 0.0 110.316 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -132.72 158.72 41.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.51 157.98 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.212 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 173.88 12.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.205 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.445 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -129.78 110.99 12.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.303 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 41.7 t -62.66 136.24 26.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.008 0.432 . . . . 0.0 111.799 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.466 ' O ' HG23 ' A' ' 86' ' ' THR . 25.0 mt -116.11 -39.71 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.917 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 151.06 42.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.977 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.56 ' CE ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -110.73 125.85 53.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.912 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -89.14 -166.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.611 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -136.81 69.85 0.5 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.77 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 3.8 p-10 178.41 55.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 110.965 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.63 28.05 62.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.835 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.878 ' CD ' HD12 ' A' ' 55' ' ' LEU . 12.9 ptp180 -144.81 167.27 22.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.734 0.302 . . . . 0.0 110.912 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.97 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.22 146.48 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.108 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.912 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.2 tt0 -91.83 122.61 34.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.188 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -137.39 163.23 31.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.263 0.554 . . . . 0.0 112.315 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 8.2 tpp -123.35 110.81 15.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.514 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -60.32 134.26 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.467 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.9 m-85 -47.8 -26.3 1.57 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.804 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.39 -8.04 54.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.427 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.08 44.17 3.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.406 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.9 t -127.12 118.35 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.361 . . . . 0.0 111.288 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 2.8 ttmt -87.61 114.89 24.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.75 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -144.07 163.53 33.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.749 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -105.42 108.27 19.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 4.4 m -84.19 119.14 24.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.303 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -76.6 155.7 33.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.34 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 1.069 HD11 HD11 ' A' ' 84' ' ' ILE . 5.3 mm -68.36 123.25 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.416 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' NH2' HD12 ' A' ' 105' ' ' ILE . 13.5 tpt180 -53.93 162.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.434 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.01 -53.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.272 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.06 -35.15 76.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 3.2 mm? -78.64 -11.28 59.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.181 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -48.79 -33.88 11.25 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.847 0.356 . . . . 0.0 111.334 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -56.31 -23.25 35.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -162.27 40.9 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.252 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 82' ' ' VAL . 14.6 p -82.7 110.36 17.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.005 0.431 . . . . 0.0 110.742 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -112.21 110.14 20.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.626 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.069 HD11 HD11 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -112.3 145.53 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.255 178.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.481 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m120 -132.05 163.65 27.97 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.968 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 52' ' ' ILE . 39.4 m -76.47 -6.63 52.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.154 0.502 . . . . 0.0 111.653 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.0 m -148.36 72.34 1.2 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.658 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 159.79 39.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.167 0.508 . . . . 0.0 111.364 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.878 HG21 ' CD1' ' A' ' 116' ' ' LEU . 39.9 mm -87.11 145.99 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.183 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.688 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.3 mt -150.93 171.59 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.119 0.485 . . . . 0.0 111.392 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.732 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.4 125.83 39.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.53 178.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.681 ' N ' HD12 ' A' ' 91' ' ' LEU . 15.9 m -122.23 155.61 27.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.27 126.27 8.68 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.706 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -109.89 126.74 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 110.76 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 -177.94 -72.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.056 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.94 -12.08 60.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.371 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 103' ' ' ASP . 39.5 m-85 -90.49 17.51 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.686 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 65.81 23.54 11.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.563 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 t0 73.42 -58.12 0.61 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.544 0.211 . . . . 0.0 111.556 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -41.73 -33.44 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.625 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.41 ' CB ' ' HB3' ' A' ' 97' ' ' TYR . 3.7 mptt -113.91 161.94 17.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.555 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -157.67 131.59 8.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 111.275 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 31.9 t70 -90.7 126.37 35.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.643 ' CA ' HG12 ' A' ' 92' ' ' VAL . 91.5 t -51.56 111.58 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.515 HD12 ' NH2' ' A' ' 75' ' ' ARG . 41.2 mm -77.53 -36.52 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.273 0.559 . . . . 0.0 109.86 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.084 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.3 pp -155.11 170.75 21.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.358 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.657 ' N ' HD12 ' A' ' 106' ' ' LEU . 15.1 pttm -112.12 126.17 54.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.084 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.1 m-85 -92.98 106.71 18.63 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.411 ' OD1' ' CG ' ' A' ' 112' ' ' GLU . 47.0 p30 -85.55 -174.35 5.13 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.654 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.71 -41.31 60.42 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.199 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.27 -40.67 91.19 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.718 ' O ' HD23 ' A' ' 116' ' ' LEU . 18.0 mt-10 -70.46 -28.07 64.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.305 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 1.087 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.51 -48.31 7.37 Favored 'General case' 0 N--CA 1.461 0.08 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.021 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -57.23 -28.85 63.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.413 0.625 . . . . 0.0 109.498 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -80.19 -22.96 41.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.296 178.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.906 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.34 -34.74 24.91 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.09 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -54.86 -33.95 62.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -20.05 45.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.846 -1.524 . . . . 0.0 111.142 177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.745 ' CD1' ' CD1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.08 -6.8 14.28 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.759 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.61 29.33 66.68 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.325 -0.94 . . . . 0.0 111.377 -178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 55.3 mm-40 -119.95 -60.02 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.419 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.748 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -90.9 128.82 46.5 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.12 -179.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 38.4 Cg_exo -59.8 -179.19 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.384 2.056 . . . . 0.0 111.914 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.72 -21.92 63.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.098 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.48 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.5 p-80 -88.08 -0.94 57.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.614 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.17 158.33 11.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -117.4 147.57 42.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.087 HD12 ' HB1' ' A' ' 113' ' ' ALA . 42.7 mm -98.74 158.53 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.484 ' N ' HG22 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -95.88 166.96 11.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 134' ' ' PHE . 0.7 OUTLIER -59.99 153.19 21.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.878 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 m -109.74 -61.16 1.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.528 ' O ' HG23 ' A' ' 133' ' ' THR . 24.2 t70 -41.1 -76.8 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.71 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 179.29 149.35 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.752 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 130' ' ' GLU . 22.3 p90 -165.2 46.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.49 -90.48 2.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.26 -32.6 6.47 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.57 2.18 . . . . 0.0 112.368 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 93.86 -162.32 25.17 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.2 t0 59.43 171.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.85 140.82 29.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -130.14 98.38 4.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.919 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -84.14 72.42 10.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.5 tt -64.66 131.97 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.048 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -129.24 179.08 5.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -62.85 103.38 0.44 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -103.91 30.26 5.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 178.5 93.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 23.6 mt -94.21 67.75 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.11 -30.49 75.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.418 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -136.13 171.85 13.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.75 105.48 3.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.32 85.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.36 144.91 51.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.853 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 142.11 30.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.9 mt -70.89 126.15 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 61.44 168.1 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -101.24 -28.62 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.801 HD13 ' OXT' ' A' ' 157' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.19 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.747 0.308 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -176.47 -61.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.86 67.45 0.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.496 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 93.2 p -114.95 150.82 35.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.762 0.315 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 159.42 18.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -170.28 -50.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.11 142.06 7.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.56 -60.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -160.79 -78.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.94 61.19 2.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.037 0.446 . . . . 0.0 110.945 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.38 139.69 56.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.93 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 59.99 81.91 0.24 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.44 70.77 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.493 2.129 . . . . 0.0 112.285 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 5.0 mtt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.924 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.844 0.268 . . . . 0.0 112.255 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -133.67 113.38 12.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -105.12 -80.74 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.46 93.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.836 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.73 -150.18 18.2 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.589 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -62.13 -35.8 79.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.97 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.59 -105.54 0.23 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.482 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.52 117.63 0.63 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.44 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.36 -43.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 110.91 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 69.42 -65.58 0.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.026 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 mtm-85 65.53 102.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.873 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -158.52 102.68 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -136.16 133.75 37.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.28 131.19 1.19 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.499 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.3 -26.85 12.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 0.0 110.977 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 63.18 41.97 7.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -109.44 103.07 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.768 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 59.9 70.36 0.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.796 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.93 105.29 8.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.24 140.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -123.11 137.68 54.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -60.36 119.86 8.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -62.91 115.19 4.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.811 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -57.77 109.43 0.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.699 HD12 ' HG2' ' A' ' 112' ' ' GLU . 20.3 tp -72.99 101.57 3.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.499 ' CG1' HD22 ' A' ' 106' ' ' LEU . 14.4 t -91.38 139.33 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.023 0.44 . . . . 0.0 111.377 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 82.2 m-85 -110.88 170.44 8.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.881 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.572 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.5 ttpp -52.98 152.5 3.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -123.8 157.61 33.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.023 0.44 . . . . 0.0 111.45 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.95 132.47 49.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.93 -15.55 60.54 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.568 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.713 HE21 HD11 ' A' ' 91' ' ' LEU . 2.3 mt-30 -116.8 151.46 36.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.704 0.288 . . . . 0.0 110.521 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.773 ' HB3' HD11 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -124.42 149.45 46.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 0.0 111.18 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.497 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 3.2 p90 -84.21 157.58 21.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.703 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.82 13.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.287 0.565 . . . . 0.0 112.502 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.419 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 34.1 tp60 -130.31 119.79 23.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.808 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 85' ' ' ASN . 10.7 t -70.24 142.56 15.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -115.7 -43.66 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.867 179.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 162.04 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.755 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.35 143.64 34.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.652 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.031 HD11 HD12 ' A' ' 71' ' ' LEU . 6.2 mt -108.09 -30.4 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.351 . . . . 0.0 110.947 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.34 -166.25 31.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.38 99.18 8.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 136.67 -24.84 3.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.616 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.74 ' HG3' HD12 ' A' ' 55' ' ' LEU . 8.7 ptp180 -152.88 159.78 43.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.813 0.34 . . . . 0.0 110.714 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.643 HD22 HG21 ' A' ' 84' ' ' ILE . 1.1 pp -147.41 158.25 43.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.636 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -91.94 121.56 33.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.535 178.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.29 165.93 24.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.274 0.559 . . . . 0.0 112.276 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.876 ' HB2' HD11 ' A' ' 52' ' ' ILE . 2.1 tpp -134.84 111.97 10.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.186 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.08 132.91 55.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.21 -26.3 1.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.876 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -74.47 -14.22 60.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.402 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.97 42.9 1.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.476 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -124.39 112.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.788 0.328 . . . . 0.0 111.187 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 23.5 tttt -84.27 112.76 20.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.624 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 101' ' ' LYS . 11.4 ptp180 -145.28 161.72 38.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.963 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -102.57 108.32 19.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.461 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.486 ' HB3' HG11 ' A' ' 92' ' ' VAL . 9.7 m -83.74 118.38 23.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.629 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 3.7 m-70 -79.52 131.89 36.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.768 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 82' ' ' VAL . 1.4 tt -68.5 137.12 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.436 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 171.59 -161.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.315 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.54 171.45 47.12 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.232 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.85 -25.74 8.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 110.646 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.659 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -75.62 -19.82 58.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.127 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.24 -28.22 2.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 111.231 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -26.41 63.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.776 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -169.18 46.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.822 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 74' ' ' ILE . 14.9 p -87.23 126.64 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.198 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -106.92 110.22 22.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.643 HG21 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -94.72 147.31 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.571 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.441 ' O ' HG21 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -128.2 153.54 46.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.43 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 91.7 m -80.28 -7.01 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.715 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.7 m -142.98 53.49 1.37 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.526 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.2 167.02 23.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.488 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.893 HG21 ' CD1' ' A' ' 116' ' ' LEU . 27.9 mm -90.67 146.02 6.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.233 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.631 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -150.12 171.2 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.095 0.474 . . . . 0.0 111.237 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.729 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -130.18 122.43 28.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.866 178.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.739 HG12 ' HA ' ' A' ' 104' ' ' VAL . 27.0 m -117.51 147.85 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.88 132.05 11.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.784 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -118.92 107.9 14.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 110.679 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -162.6 -79.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.939 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.6 -15.99 63.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.115 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.476 ' O ' ' HG2' ' A' ' 98' ' ' GLN . 4.7 m-85 -72.22 -8.37 54.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.648 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER 68.16 29.41 6.19 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.966 0.412 . . . . 0.0 111.263 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 72.24 -174.42 0.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.69 -61.59 0.5 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.82 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -111.98 171.09 7.71 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.718 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -156.85 170.91 21.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.872 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -119.73 124.98 47.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.739 ' HA ' HG12 ' A' ' 92' ' ' VAL . 86.9 t -53.08 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.946 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.03 -54.99 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.046 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -133.19 166.62 22.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.414 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.596 ' N ' HD12 ' A' ' 106' ' ' LEU . 14.7 pttm -110.56 118.62 36.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.072 0.463 . . . . 0.0 112.185 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.046 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.0 m-85 -82.82 106.54 14.74 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -75.63 176.69 7.41 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.882 ' HB3' HG23 ' A' ' 131' ' ' THR . . . -73.07 -44.41 60.6 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.105 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.25 -39.98 88.69 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.699 ' HG2' HD12 ' A' ' 39' ' ' LEU . 8.5 mt-10 -69.16 -29.31 67.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.586 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 1.101 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.96 -48.33 8.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.902 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -55.55 -30.78 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.307 0.575 . . . . 0.0 109.599 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.626 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -75.13 -22.07 58.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.147 178.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.893 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.24 -34.03 21.62 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 121.124 -0.231 . . . . 0.0 111.118 -179.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -34.63 63.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.44 42.63 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.612 177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.68 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.2 m-30 -66.55 -11.98 55.5 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.13 29.21 67.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.521 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 25.3 mm-40 -115.69 -50.24 2.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.738 0.304 . . . . 0.0 111.243 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.602 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -94.92 140.65 22.57 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.09 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.465 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 24.4 Cg_exo -63.09 -178.86 0.47 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.477 2.118 . . . . 0.0 112.05 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -71.26 -28.03 63.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.002 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 13.7 p-80 -78.92 -15.4 58.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.371 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.24 130.89 36.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 111.272 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.63 148.55 33.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.945 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.101 HD12 ' HB1' ' A' ' 113' ' ' ALA . 26.7 mm -91.09 154.45 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.4 ' N ' HG22 ' A' ' 128' ' ' ILE . 0.7 OUTLIER -91.44 172.84 8.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.15 133.59 47.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.882 HG23 ' HB3' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -78.08 -169.48 1.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.833 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.448 ' H ' HG22 ' A' ' 131' ' ' THR . 0.8 OUTLIER 61.85 173.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.859 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.02 -176.28 3.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.92 63.67 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.843 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.78 85.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.516 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.65 147.45 63.59 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.586 2.191 . . . . 0.0 112.303 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -139.34 168.03 25.03 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.8 t0 61.81 34.45 17.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.81 0.338 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -141.87 83.45 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -68.44 151.65 46.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 59.96 176.88 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 142' ' ' ILE . 8.4 tt -105.39 59.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.004 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.63 -16.67 13.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.256 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 68.24 -75.14 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.808 0.337 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -148.48 -75.06 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.7 t0 59.74 89.42 0.06 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.828 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.7 mt 65.87 125.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.067 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.34 96.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -128.16 -54.53 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -68.23 146.46 53.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -59.89 126.61 28.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -157.87 35.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.91 -30.2 11.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 154' ' ' ILE . 2.3 mp -60.6 109.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.001 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -164.79 -46.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 157' ' ' ILE . 1.0 OUTLIER -102.09 -72.0 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 156' ' ' ASP . 2.0 tt . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.394 -0.813 . . . . 0.0 111.461 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.858 0.361 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 59.82 78.07 0.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.22 -59.72 0.14 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 29.0 t -174.77 120.02 0.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.815 0.341 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -155.5 166.63 32.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.957 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.65 31.62 20.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -133.24 -176.52 4.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.79 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -104.14 95.04 5.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 143.06 49.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -68.03 73.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 7.8 p -99.75 -31.93 11.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -148.51 82.78 7.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.97 79.34 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.501 2.134 . . . . 0.0 112.291 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 3.7 mtt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--O 1.231 0.169 0 CA-C-O 120.823 0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -155.55 87.52 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -114.43 36.39 3.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -76.11 76.72 2.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.78 131.96 9.96 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 90.68 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.837 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.24 63.65 4.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.533 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.93 179.74 26.42 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -79.71 166.33 21.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -163.7 36.03 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.788 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -97.25 -34.86 10.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.922 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -97.86 133.0 42.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -112.58 -46.95 3.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -127.98 -110.15 1.55 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.503 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttp 68.46 -68.9 0.16 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.309 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 51.5 -176.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -99.44 -82.4 0.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.879 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 58.87 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.994 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 31' ' ' GLU . 21.1 mt-10 -146.5 28.78 1.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 110.887 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.8 m -108.29 33.16 4.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.97 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.89 84.16 2.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.794 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.39 160.5 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -59.64 129.49 42.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -112.4 73.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.042 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.591 HD21 ' CB ' ' A' ' 115' ' ' SER . 14.2 tp -84.32 113.5 21.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.549 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -122.01 140.9 44.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.745 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.751 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.7 m-85 -107.75 169.84 8.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.089 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 137.83 58.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.723 0.297 . . . . 0.0 110.506 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.87 175.27 5.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.063 0.458 . . . . 0.0 111.478 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -50.71 133.92 25.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.129 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.27 -15.36 60.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.499 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.451 HE21 HD11 ' A' ' 91' ' ' LEU . 0.3 OUTLIER -130.94 148.31 52.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 110.573 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.554 ' H ' HD21 ' A' ' 94' ' ' LEU . 2.2 tt0 -130.22 159.89 35.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.086 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 3.9 p90 -84.31 158.16 21.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.007 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.99 173.56 14.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.246 0.546 . . . . 0.0 112.189 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -129.71 129.73 44.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.029 179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 60' ' ' LEU . 47.4 t -81.82 140.77 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.429 . . . . 0.0 112.019 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.467 HG12 ' HG2' ' A' ' 63' ' ' MET . 0.1 OUTLIER -116.42 -41.45 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.654 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.1 160.39 40.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.698 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.622 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -117.04 146.67 42.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -110.21 -29.79 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.913 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 143.94 176.77 18.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.62 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -59.08 107.44 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.821 0.344 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 132.61 -33.9 2.57 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.527 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.7 ' HD2' HD12 ' A' ' 55' ' ' LEU . 18.4 ptt180 -153.31 159.52 42.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.75 0.31 . . . . 0.0 110.995 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.685 ' CD2' HG21 ' A' ' 84' ' ' ILE . 1.6 pp -147.59 155.81 42.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.048 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.866 ' HB2' HD21 ' A' ' 55' ' ' LEU . 15.6 tt0 -92.1 121.71 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.081 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.21 165.6 32.44 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.53 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.467 ' HG2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.47 134.6 39.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.324 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.8 m -63.92 142.6 58.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.608 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 1.6 m-85 -51.17 -23.98 3.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.346 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.13 -11.1 60.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.35 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.98 41.13 2.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.783 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.615 HG11 HH21 ' A' ' 70' ' ' ARG . 21.2 t -127.02 110.64 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.007 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -82.2 116.41 21.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.051 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.615 HH21 HG11 ' A' ' 68' ' ' VAL . 8.9 ptp180 -145.05 155.77 43.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.73 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -89.68 106.93 18.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.579 ' HB3' HG11 ' A' ' 92' ' ' VAL . 13.6 m -84.27 118.66 24.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.676 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -81.92 137.9 35.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 82' ' ' VAL . 5.1 tt -68.68 140.13 19.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.782 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.466 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.31 143.45 44.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.252 -179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.25 38.87 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.254 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -62.88 -32.69 73.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 0.0 110.491 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD12 ' HB ' ' A' ' 82' ' ' VAL . 1.1 mm? -82.91 -29.4 29.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.636 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.631 ' HA ' HG12 ' A' ' 82' ' ' VAL . 3.0 mtp180 -49.25 -27.74 4.03 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.267 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -64.32 -31.11 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.286 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.0 45.13 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 74' ' ' ILE . 9.3 p -121.33 120.99 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.974 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 110.19 20.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.685 HG21 ' CD2' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -89.69 147.19 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.25 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.463 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -123.12 159.28 28.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.247 -179.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 86' ' ' THR . 63.3 m -80.32 -5.91 57.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.442 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 70.05 0.95 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.636 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.14 165.73 35.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.224 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.894 HG21 ' CD1' ' A' ' 116' ' ' LEU . 45.9 mm -87.22 143.97 10.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.236 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.64 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.3 mt -150.35 171.76 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.046 0.45 . . . . 0.0 111.213 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.731 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -126.54 122.26 34.62 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.587 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.642 HG12 ' CA ' ' A' ' 104' ' ' VAL . 12.8 m -119.0 156.57 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.049 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -98.45 120.21 6.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.671 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -105.86 117.28 33.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.896 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -73.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.124 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -58.29 -25.97 62.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.424 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -91.62 14.25 15.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.547 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 20.2 mt-30 65.79 24.57 11.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.32 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 5.5 m-20 81.6 -45.65 0.2 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.728 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -42.29 -38.3 1.77 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.553 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.56 165.25 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.365 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -158.91 132.05 7.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.18 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -88.96 128.02 35.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.642 ' CA ' HG12 ' A' ' 92' ' ' VAL . 94.1 t -53.24 111.85 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.849 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.1 mm -78.21 -45.65 26.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.234 0.54 . . . . 0.0 109.693 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -144.29 169.93 16.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.401 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.662 ' N ' HD12 ' A' ' 106' ' ' LEU . 1.0 OUTLIER -111.79 123.77 50.94 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.063 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.6 m-85 -88.5 106.41 18.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.9 m-20 -75.4 179.86 4.96 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.644 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.0 -42.21 39.6 Favored 'General case' 0 C--O 1.228 -0.068 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.431 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -61.15 -40.03 92.32 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.684 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.5 mt-10 -67.54 -27.85 67.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.461 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.4 -49.31 7.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.032 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -56.3 -27.4 55.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.323 0.582 . . . . 0.0 109.577 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.09 -22.7 41.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.136 178.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.894 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.46 -34.36 24.54 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.028 -179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -55.0 -34.12 63.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.11 -20.59 44.67 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 113.809 -1.541 . . . . 0.0 110.849 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.751 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.56 -5.98 13.39 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.802 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.41 26.29 61.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.448 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 56.2 mm-40 -115.91 -60.76 1.83 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 111.407 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.699 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.87 124.89 59.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.006 -179.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 40.6 Cg_exo -56.88 179.75 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.431 2.088 . . . . 0.0 112.257 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -25.06 65.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.095 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 37.1 p-80 -85.89 -17.13 36.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.39 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -52.86 139.4 27.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.808 0.337 . . . . 0.0 111.24 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -117.76 137.89 52.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 113' ' ' ALA . 4.4 mt -99.45 148.84 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -61.05 164.49 5.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.45 141.07 56.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.628 HG23 ' HB1' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -79.39 171.88 14.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -41.02 117.08 0.81 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.702 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 71.7 p -94.03 150.92 19.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.831 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.02 72.44 10.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.13 -93.78 2.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.54 166.59 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.571 2.181 . . . . 0.0 112.264 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -172.65 167.11 39.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 165.13 121.64 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.86 0.362 . . . . 0.0 110.683 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.31 31.28 4.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 p30 43.19 50.97 5.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.378 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -168.88 153.98 6.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.744 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 30.0 mm -73.7 -39.58 53.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.108 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -134.34 144.45 48.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -171.78 83.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -174.83 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.967 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 60.75 -174.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.0 pt -131.69 81.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.296 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.16 91.31 0.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.566 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 19.7 p30 -57.95 162.22 3.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -78.27 69.39 4.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.09 -48.66 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.34 146.34 55.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.45 -47.51 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.837 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 25.6 mm -80.32 76.91 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -140.48 31.85 1.88 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.37 -30.49 68.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.498 ' C ' HD12 ' A' ' 157' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.082 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.871 0.367 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -101.16 96.47 7.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 129.5 173.58 13.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.79 158.35 3.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -149.09 173.86 12.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -117.94 37.98 3.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.918 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 92.81 3.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.08 93.1 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.862 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.27 156.12 2.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.988 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -117.79 -177.42 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 11.6 m -134.2 135.17 42.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -116.83 88.08 24.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.39 172.01 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.551 2.168 . . . . 0.0 112.331 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.749 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 CA-C-O 120.814 0.256 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -80.62 60.45 3.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.801 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -148.74 64.52 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.011 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.86 137.99 58.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.943 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.12 -142.16 17.2 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.553 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 tttm 60.8 74.71 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 110.982 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.43 48.35 0.95 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.42 47.63 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.572 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -106.64 42.25 1.31 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -63.51 113.11 3.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.856 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.61 177.3 5.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.009 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -35.0 77.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.983 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 60.43 90.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.07 -105.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER 62.15 157.19 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.704 0.288 . . . . 0.0 110.776 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 37.0 t30 172.69 58.11 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.472 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 61.55 28.21 17.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.19 40.93 27.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.985 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.39 141.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.834 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -94.44 101.84 13.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -176.02 79.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.9 mttt 179.97 122.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.829 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -69.87 137.71 51.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -112.75 86.01 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.561 HD11 ' HE1' ' A' ' 119' ' ' TYR . 24.8 tp -86.81 128.63 35.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.793 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.2 t -127.31 140.68 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.832 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.749 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.2 m-30 -112.72 170.39 8.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.346 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -52.68 149.58 5.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.729 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.82 164.61 27.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.946 0.403 . . . . 0.0 111.5 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -52.89 132.99 37.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.834 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.76 -15.34 60.79 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.469 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.527 ' HB3' HD11 ' A' ' 91' ' ' LEU . 17.0 mt-30 -134.73 137.21 43.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.783 0.325 . . . . 0.0 110.541 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.858 ' HB2' HD11 ' A' ' 94' ' ' LEU . 3.7 tt0 -117.23 155.22 29.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 111.276 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 5.3 p90 -84.02 157.65 21.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.622 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.76 173.89 12.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.344 0.593 . . . . 0.0 112.521 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.528 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -131.01 117.13 18.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.037 179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 60' ' ' LEU . 41.5 t -67.46 138.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.075 0.464 . . . . 0.0 112.065 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -116.09 -41.29 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.556 179.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.37 161.33 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.745 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.573 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -116.4 144.2 44.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.722 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.805 HD11 HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -105.54 -27.98 11.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.026 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.04 59.14 10.03 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -177.61 63.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 59.1 20.73 50.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.498 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.637 ' HB2' HD12 ' A' ' 55' ' ' LEU . 1.3 mtm105 -152.36 163.53 39.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.851 HD22 HG21 ' A' ' 84' ' ' ILE . 0.9 OUTLIER -147.85 145.23 28.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.609 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.746 ' HB2' HD21 ' A' ' 55' ' ' LEU . 6.7 tt0 -91.09 120.77 32.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -150.44 165.62 32.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 111.665 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 9.8 ptp -138.98 128.0 23.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.7 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.7 m -59.59 146.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.286 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.462 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 4.9 m-85 -50.33 -20.68 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.811 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' OD1' HG23 ' A' ' 68' ' ' VAL . 29.1 p30 -73.62 -8.18 54.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.61 0.243 . . . . 0.0 111.324 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 41.03 4.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 63' ' ' MET . 20.1 t -127.15 110.27 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.659 0.266 . . . . 0.0 111.1 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 63' ' ' MET . 0.2 OUTLIER -83.59 120.14 25.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 165.7 27.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.303 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.805 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -95.68 105.69 17.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.682 ' HB3' HG11 ' A' ' 92' ' ' VAL . 11.8 m -89.14 118.47 28.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.398 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.423 ' CE1' ' HD3' ' A' ' 59' ' ' ARG . 2.1 m-70 -76.6 139.15 40.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.699 HD11 HG13 ' A' ' 82' ' ' VAL . 5.6 tt -68.52 138.49 22.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -59.86 151.92 24.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.073 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.66 -39.28 18.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.46 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -78.52 -30.75 47.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.516 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.3 mm? -77.86 -29.56 50.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.498 ' HA ' HG12 ' A' ' 82' ' ' VAL . 21.4 ptt180 -48.97 -26.9 2.77 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.34 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.16 -38.91 74.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.313 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.33 48.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.363 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.699 HG13 HD11 ' A' ' 74' ' ' ILE . 8.5 p -124.18 119.74 57.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -110.75 109.96 20.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.991 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.851 HG21 HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -80.95 139.21 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.2 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 88' ' ' ASP . 14.6 m-80 -110.57 160.51 16.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.969 0.414 . . . . 0.0 111.529 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.433 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 66.1 m -80.3 -6.2 57.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.525 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -147.79 70.33 1.16 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 85' ' ' ASN . 0.5 OUTLIER -154.19 164.63 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.223 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.862 HG21 ' CD1' ' A' ' 116' ' ' LEU . 46.7 mm -89.4 144.39 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.341 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.676 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.22 171.13 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.047 0.451 . . . . 0.0 111.101 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 92' ' ' VAL . 0.2 OUTLIER -126.94 125.75 42.06 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.638 178.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.4 m -125.62 156.41 35.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.259 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.25 127.88 9.2 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.54 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -105.24 177.45 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.729 0.299 . . . . 0.0 110.76 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.27 -51.12 0.43 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.522 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.29 -41.07 12.66 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.808 0.337 . . . . 0.0 111.452 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.53 23.08 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 69.17 30.24 4.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.801 0.334 . . . . 0.0 110.7 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.6 175.94 0.22 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.618 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 76.34 -57.19 0.56 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.063 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.83 149.24 27.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.467 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -139.24 -179.37 5.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.962 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -135.79 121.37 19.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.764 ' HA ' HG12 ' A' ' 92' ' ' VAL . 85.5 t -51.07 111.63 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.683 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.27 -37.44 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.263 0.554 . . . . 0.0 109.768 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.057 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.9 pp -150.93 168.54 24.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.36 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.65 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -112.32 121.2 44.22 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.057 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.3 m-85 -86.34 106.29 17.29 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -72.42 176.6 5.2 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.667 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.9 -39.75 49.78 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.967 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.59 -40.95 98.52 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.652 ' O ' HD23 ' A' ' 116' ' ' LEU . 10.4 mt-10 -66.27 -27.78 68.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.417 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.819 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.38 -48.26 6.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.055 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -56.08 -27.66 54.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.425 0.631 . . . . 0.0 109.492 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.63 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -79.17 -22.71 44.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.202 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.862 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.37 -35.28 27.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 116.806 -0.179 . . . . 0.0 111.221 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -34.42 62.3 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.23 -20.3 44.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 113.891 -1.504 . . . . 0.0 111.013 177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.749 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.51 -4.36 8.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.808 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 24.77 58.53 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.597 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 42.3 mm-40 -115.35 -60.93 1.82 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.808 0.337 . . . . 0.0 111.266 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.733 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.32 126.36 46.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 36.7 Cg_exo -57.41 179.82 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.417 2.078 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.39 -23.36 64.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.228 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.449 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 37.2 p-80 -90.67 2.48 55.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.582 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.24 147.71 50.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.844 0.354 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -115.61 136.68 52.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.048 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.797 HD13 ' HB1' ' A' ' 113' ' ' ALA . 7.3 mt -109.98 157.66 10.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.478 ' N ' HG22 ' A' ' 128' ' ' ILE . 9.6 t-20 -103.53 130.0 50.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.973 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 56.86 104.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.101 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 -23.48 16.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.065 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 44.4 67.34 0.7 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.905 0.383 . . . . 0.0 111.45 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 m -85.05 149.81 25.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -134.88 45.82 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.757 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.54 -150.78 26.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.606 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -51.06 162.97 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.671 2.248 . . . . 0.0 112.348 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.18 93.61 1.87 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.584 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.7 t70 62.94 127.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 111.06 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -133.25 87.67 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -61.27 104.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -103.73 136.11 44.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 142' ' ' ILE . 3.6 mp -95.89 -55.06 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 62.55 146.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.817 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.3 39.68 3.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -74.4 96.3 2.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -109.29 141.95 40.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.823 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 147' ' ' ILE . 8.6 tp -133.85 73.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.153 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.77 -157.27 7.64 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.388 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -127.39 132.69 50.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 110.848 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -107.8 142.16 38.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -152.21 150.58 29.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -166.97 150.82 6.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.95 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.19 115.86 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 21.4 mt -109.41 140.8 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -97.36 143.6 27.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.5 t70 60.71 110.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.579 ' OXT' HG22 ' A' ' 157' ' ' ILE . 2.6 mp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.009 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 30.6 ttp . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.822 0.344 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.2 82.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.41 142.25 4.21 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.408 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m 69.52 -65.12 0.32 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.729 0.3 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.82 131.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.904 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -130.83 130.04 43.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -61.89 108.05 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -92.49 96.25 10.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.13 135.97 48.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 124.19 20.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 69.7 p -75.73 -6.58 51.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.46 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -55.8 109.36 1.59 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-O 120.638 0.256 . . . . 0.0 111.038 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.27 -59.45 1.19 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.502 2.135 . . . . 0.0 112.441 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.731 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 CA--C 1.527 0.156 0 CA-C-O 120.695 0.206 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 tttt 56.35 35.1 25.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.005 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -59.64 158.14 10.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -59.66 93.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.38 -162.67 25.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.76 103.68 1.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.742 0.306 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.29 140.55 4.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.451 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 137.57 76.18 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.461 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.42 93.54 2.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -84.98 -175.78 5.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.04 123.46 27.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.71 82.35 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -113.62 -51.73 2.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.52 -74.89 0.43 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.507 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.85 -176.31 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.686 0.279 . . . . 0.0 110.875 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 45.78 -171.28 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.551 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.87 -176.87 1.27 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.718 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.6 t30 63.78 77.54 0.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -139.9 55.66 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -137.4 73.83 1.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -101.01 111.31 23.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -108.22 166.82 10.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.51 158.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.65 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -148.75 130.06 14.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.793 HD11 ' HE1' ' A' ' 119' ' ' TYR . 39.4 tp -96.48 125.38 40.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.558 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -124.57 140.32 48.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.944 0.402 . . . . 0.0 111.897 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.77 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.3 m-30 -112.34 170.44 8.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.466 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.42 150.74 4.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.707 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -127.76 165.12 20.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.976 0.417 . . . . 0.0 111.701 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.35 133.05 49.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.794 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.97 -15.5 60.72 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.447 ' CB ' HD11 ' A' ' 91' ' ' LEU . 14.3 mt-30 -126.43 140.04 52.79 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.9 150.32 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.147 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 6.4 p90 -84.35 156.32 21.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.887 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.76 173.26 15.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.19 0.519 . . . . 0.0 112.219 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.735 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -119.08 153.9 34.03 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.362 179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 90' ' ' ILE . 12.9 t -97.29 141.43 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.022 0.439 . . . . 0.0 112.142 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.794 ' O ' HG23 ' A' ' 86' ' ' THR . 0.7 OUTLIER -114.13 -52.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.419 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.44 162.22 36.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.778 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.588 ' HE3' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -114.66 126.48 54.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.124 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -96.59 -29.78 13.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.558 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.63 178.18 21.8 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -56.39 112.05 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.77 0.319 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.838 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 101.5 -13.68 58.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.727 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.755 ' HB3' HD12 ' A' ' 55' ' ' LEU . 9.0 mmt180 -138.78 121.88 16.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.896 0.379 . . . . 0.0 111.242 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.729 HD22 HD13 ' A' ' 84' ' ' ILE . 1.3 pp -142.36 142.23 32.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.539 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.583 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.0 tt0 -90.7 121.67 32.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -127.2 162.12 26.92 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -123.08 101.62 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.216 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 33.6 m -55.17 133.32 49.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.402 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -49.34 -25.94 2.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.523 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.37 -13.7 60.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.177 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.39 36.02 3.2 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.49 122.66 59.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 111.453 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 63' ' ' MET . 11.6 ptmt -95.12 121.72 37.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.603 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -144.12 165.59 27.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.17 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.124 HD12 HD11 ' A' ' 55' ' ' LEU . 2.6 mm? -94.02 105.68 17.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.437 ' SG ' HG11 ' A' ' 92' ' ' VAL . 29.8 m -88.82 125.05 34.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -83.27 142.02 31.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.619 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.838 HG22 ' HA2' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -68.79 138.19 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.501 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.94 155.23 20.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.917 0.389 . . . . 0.0 111.001 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.17 -46.08 6.33 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.548 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -76.71 -42.22 42.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.9 0.381 . . . . 0.0 110.783 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.658 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -67.03 -19.72 65.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.002 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.678 ' HA ' HG12 ' A' ' 82' ' ' VAL . 1.4 ptm180 -50.64 -28.11 8.22 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.827 0.346 . . . . 0.0 111.322 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -64.86 -29.54 70.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.618 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.99 40.58 0.72 Allowed 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 79' ' ' ARG . 7.6 p -120.87 110.88 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 110.983 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 32.2 m0 -111.39 110.36 20.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.157 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.729 HD13 HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -86.45 145.47 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.434 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.454 ' O ' HG11 ' A' ' 51' ' ' VAL . 52.4 m-20 -132.11 164.93 25.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.2 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 52' ' ' ILE . 93.8 m -78.08 -6.5 54.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.761 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.4 73.99 1.45 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.738 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -165.34 161.24 18.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.261 0.553 . . . . 0.0 111.481 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.85 HG21 ' CD1' ' A' ' 116' ' ' LEU . 32.8 mm -92.28 149.12 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.011 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.728 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.19 173.56 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 0.0 111.638 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 92' ' ' VAL . 0.1 OUTLIER -130.11 126.88 38.63 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.566 178.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.688 ' N ' HD12 ' A' ' 91' ' ' LEU . 21.0 m -121.73 156.51 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.391 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.561 ' C ' HD23 ' A' ' 94' ' ' LEU . . . -99.44 149.79 19.02 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.648 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.568 ' CD2' ' HB2' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -125.46 135.66 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.705 0.288 . . . . 0.0 110.799 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.5 ttt85 -177.57 -76.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.188 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.9 -18.09 38.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.407 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 101' ' ' LYS . 42.9 m-85 -72.38 -9.26 58.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.551 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 72.16 29.39 2.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.746 0.307 . . . . 0.0 111.304 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.1 -55.75 0.64 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.42 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -42.03 -31.95 0.4 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 97' ' ' TYR . 24.5 mttt -128.22 164.45 22.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.673 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.568 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -151.41 177.28 10.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -131.19 116.95 18.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.682 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.658 ' CA ' HG12 ' A' ' 92' ' ' VAL . 80.5 t -49.93 111.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.972 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mm -82.26 -45.56 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.191 0.52 . . . . 0.0 109.944 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.007 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.6 pp -142.41 161.15 38.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.779 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.614 ' HB3' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -104.53 118.1 35.77 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.999 0.428 . . . . 0.0 111.792 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.007 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.0 m-85 -81.11 106.47 13.13 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.75 167.15 4.78 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.73 -39.52 51.56 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.422 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -63.57 -40.06 95.99 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.639 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.4 mm-40 -68.09 -26.52 65.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.275 177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 1.038 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -42.75 -48.98 5.72 Favored 'General case' 0 C--O 1.23 0.057 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.835 -178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -29.76 63.36 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.399 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.613 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -73.39 -22.03 60.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.013 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.85 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -48.95 -35.52 15.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.236 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -54.53 -35.06 62.79 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.14 -20.31 45.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.927 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.793 ' HE1' HD11 ' A' ' 39' ' ' LEU . 3.6 m-30 -65.98 -7.69 18.47 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.559 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.49 27.31 67.72 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.511 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.46 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 50.4 mm-40 -118.49 -59.79 1.84 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.773 0.321 . . . . 0.0 111.289 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.747 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.0 142.17 24.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.061 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 31.5 Cg_exo -61.06 -179.75 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.583 2.189 . . . . 0.0 112.146 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.94 -25.88 59.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.993 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -82.56 1.46 37.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.534 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.41 138.35 55.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.375 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.66 148.2 32.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.744 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.038 HD12 ' HB1' ' A' ' 113' ' ' ALA . 21.7 mm -91.96 156.56 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.431 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 128' ' ' ILE . 9.1 m120 -102.75 96.71 7.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.771 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 64.41 131.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 m -104.94 -47.61 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.949 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 t0 62.54 95.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.845 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.68 174.71 7.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.973 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.38 110.05 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.65 -54.54 25.16 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.639 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.74 160.56 2.7 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.608 2.205 . . . . 0.0 112.346 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.97 -115.03 4.38 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.588 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.3 t0 61.76 18.88 10.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.616 0.246 . . . . 0.0 111.184 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 51.48 29.64 5.53 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.771 0.32 . . . . 0.0 111.159 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -88.73 -69.08 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -173.85 98.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.5 mt -85.11 78.25 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.132 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.22 -32.28 9.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -97.6 83.78 3.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.01 -76.38 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -164.22 94.32 0.72 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.816 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.523 HG23 ' O ' ' A' ' 147' ' ' ILE . 18.6 tt -162.86 116.94 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.011 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.18 -163.55 34.5 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.516 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 59.87 168.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.0 110.822 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.15 117.32 5.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.75 163.92 37.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.69 -76.52 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.837 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 59.94 79.77 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 36.7 mm -67.92 104.98 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -60.25 110.82 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -73.8 82.49 1.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.4 mm . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.109 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.803 0.335 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -77.36 71.52 3.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.31 -42.83 17.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.457 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.5 m -151.59 150.19 30.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.804 0.335 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -76.07 -63.56 1.29 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -86.12 171.52 11.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 63.35 126.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.916 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -122.11 137.37 54.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.962 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.43 138.59 43.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 61.68 54.59 2.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.827 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.15 -27.88 14.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.023 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -105.49 86.48 1.75 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.1 -26.76 30.39 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.61 2.207 . . . . 0.0 112.276 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.826 0.261 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.3 104.19 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -143.56 -48.9 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -142.27 118.49 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.864 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.5 165.35 29.82 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.54 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -118.41 -47.05 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.8 91.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.482 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.82 107.11 0.73 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.84 40.36 3.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.856 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -140.0 61.96 1.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -71.33 174.51 6.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.02 -57.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.0 99.13 0.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 162.69 154.82 7.76 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.573 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -128.55 60.25 1.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 110.801 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 68.03 12.69 8.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.487 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 46.45 71.11 0.32 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.83 0.347 . . . . 0.0 111.288 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 63.48 141.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.827 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.08 -32.05 6.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m 61.8 84.5 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 62.82 120.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.16 125.09 2.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -59.2 154.35 16.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.815 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.02 105.35 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.097 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.564 HD12 ' CD ' ' A' ' 112' ' ' GLU . 33.4 tp -118.52 119.82 35.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.79 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 106' ' ' LEU . 14.9 t -104.52 139.47 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.046 0.451 . . . . 0.0 111.369 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 74.7 m-85 -114.09 170.4 8.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.862 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HA ' HD22 ' A' ' 91' ' ' LEU . 10.3 ttpt -48.6 153.94 0.73 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.941 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -116.09 162.05 17.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.291 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.19 125.97 25.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.831 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.83 -15.28 63.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.662 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.558 ' OE1' HD11 ' A' ' 91' ' ' LEU . 23.2 mt-30 -113.74 148.08 37.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.636 0.255 . . . . 0.0 110.567 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.833 ' HB2' HD11 ' A' ' 94' ' ' LEU . 32.2 tt0 -121.1 156.72 31.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.219 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 3.8 p90 -84.25 157.58 21.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.94 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.46 173.27 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -126.52 138.84 53.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.746 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 85' ' ' ASN . 15.2 t -88.92 144.0 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.905 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -116.38 -46.12 4.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.84 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.3 162.18 37.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.874 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.408 ' HE3' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -112.93 136.26 52.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.848 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -99.53 -32.4 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.838 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.91 169.84 17.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.526 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -56.83 101.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 110.986 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 139.83 -32.69 2.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.354 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.753 ' HD2' HD12 ' A' ' 55' ' ' LEU . 16.3 ptt-85 -151.35 159.61 44.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.745 0.307 . . . . 0.0 110.874 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.88 HD22 HD13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.65 152.55 38.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.156 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.848 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.4 tt0 -91.66 121.66 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -136.43 165.8 24.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.273 0.559 . . . . 0.0 112.181 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.905 ' HB2' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -127.18 113.07 15.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 179.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 14.8 m -59.01 133.86 56.47 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.444 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 1.3 m-85 -48.83 -25.36 1.84 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.455 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -9.82 58.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.219 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.76 42.96 2.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.684 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.405 HG11 ' NE ' ' A' ' 70' ' ' ARG . 15.4 t -127.41 125.61 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 111.339 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HB2' ' CE ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -86.7 115.46 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.567 179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' NE ' HG11 ' A' ' 68' ' ' VAL . 62.2 mtt180 -145.27 165.06 29.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.97 0.415 . . . . 0.0 111.276 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.718 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -106.36 108.41 19.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.472 ' HB3' HG11 ' A' ' 92' ' ' VAL . 16.4 m -84.16 118.85 24.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.887 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.42 ' CD2' ' OH ' ' A' ' 97' ' ' TYR . 1.7 m-70 -81.46 143.18 32.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.787 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.491 HG22 ' HA2' ' A' ' 58' ' ' GLY . 0.6 OUTLIER -71.93 129.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.835 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 14.2 tpt180 -69.45 143.84 53.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.733 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 79' ' ' ARG . . . -70.01 -57.34 7.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.362 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -52.71 -30.66 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.979 0.418 . . . . 0.0 110.753 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.555 HD12 ' HB ' ' A' ' 82' ' ' VAL . 1.1 mm? -86.69 -28.37 23.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.834 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.659 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -49.34 -27.36 3.88 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.317 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.29 -33.34 67.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.223 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.3 45.17 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.336 . . . . 0.0 111.249 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG12 ' HA ' ' A' ' 79' ' ' ARG . 11.6 p -115.91 116.25 51.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 0.0 111.071 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.408 ' CH2' ' HE2' ' A' ' 107' ' ' LYS . 44.1 p90 -110.5 110.18 20.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.88 HD13 HD22 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -83.26 147.11 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.677 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.457 ' O ' HG21 ' A' ' 51' ' ' VAL . 0.7 OUTLIER -115.44 152.97 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.774 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 86' ' ' THR . 75.6 m -80.28 -6.35 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 111.886 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.5 p -148.38 55.07 1.02 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.705 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -140.2 169.09 18.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.174 0.511 . . . . 0.0 111.564 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.919 HG21 ' CD1' ' A' ' 116' ' ' LEU . 45.3 mm -89.24 144.81 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.024 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 91' ' ' LEU . 1.2 mt -150.57 171.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.046 0.451 . . . . 0.0 111.228 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.73 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -126.01 121.97 34.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.706 178.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.721 HG12 ' CA ' ' A' ' 104' ' ' VAL . 30.4 m -122.48 155.3 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.156 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 105' ' ' ILE . . . -93.13 140.63 15.16 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.574 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -121.67 105.52 10.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.727 0.298 . . . . 0.0 110.834 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.46 -63.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.189 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.14 -28.17 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 73' ' ' HIS . 16.4 m-85 -89.32 1.91 55.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.768 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 65.71 30.02 10.48 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.657 0.265 . . . . 0.0 110.979 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 7.0 t0 78.04 162.05 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.963 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 84.53 -19.8 0.33 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.411 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.47 150.96 38.49 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -137.96 173.18 11.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 111.256 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.849 ' O ' HD12 ' A' ' 105' ' ' ILE . 37.4 t70 -130.1 116.61 18.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.633 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.721 ' CA ' HG12 ' A' ' 92' ' ' VAL . 70.4 t -52.4 111.54 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 103' ' ' ASP . 2.4 mp -81.81 -39.1 16.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.053 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -147.1 168.45 21.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.795 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 106' ' ' LEU . 4.5 pttp -111.94 119.9 40.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.053 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.0 m-85 -84.23 106.9 16.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.19 173.18 8.01 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.684 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.46 -51.19 18.03 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.313 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -61.37 -38.45 87.05 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.564 ' CD ' HD12 ' A' ' 39' ' ' LEU . 1.1 tp10 -66.63 -31.67 72.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.396 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.934 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -46.05 -43.25 14.34 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.821 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -48.93 -47.11 43.9 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.157 0.504 . . . . 0.0 110.475 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -58.69 -20.82 51.91 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.629 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.919 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.66 -33.26 21.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.45 -178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -54.98 -34.34 63.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.38 -21.81 41.96 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.733 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.714 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 4.4 m-30 -67.01 -9.75 42.33 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.03 25.03 63.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.538 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 5.3 mm-40 -112.7 -47.41 3.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -108.75 150.07 40.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.814 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 70.8 Cg_endo -75.18 174.15 13.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.592 2.194 . . . . 0.0 112.242 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.48 -28.2 69.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 18.4 p-80 -87.76 2.79 50.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.578 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -58.89 130.27 46.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.824 0.345 . . . . 0.0 111.162 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -82.5 131.35 35.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.934 HD12 ' HB1' ' A' ' 113' ' ' ALA . 38.0 mm -94.66 150.86 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.984 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -62.0 156.53 20.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -60.06 123.35 16.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -57.95 133.55 55.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.5 t0 63.12 124.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.11 104.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.24 82.44 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -142.66 -154.08 6.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.409 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -51.71 163.05 1.38 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.514 2.143 . . . . 0.0 112.257 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.59 115.1 1.74 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.467 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 62.15 116.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.338 . . . . 0.0 110.909 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -92.73 122.85 35.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.89 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.95 -73.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -126.26 155.32 42.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.9 mm -92.72 82.65 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.171 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -121.0 54.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.02 165.32 12.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.849 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -132.96 164.85 26.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -74.18 -171.31 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 21.6 pt -149.52 42.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.104 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.23 121.73 3.44 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.526 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -72.04 0.12 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.824 0.345 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -33.05 57.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.68 99.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -118.2 -59.41 1.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -152.94 90.85 1.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.2 pt -84.46 136.22 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.168 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -174.49 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -63.35 120.43 11.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.816 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.081 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.795 0.331 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 6.4 tpm_? -116.34 -65.41 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.907 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -145.19 98.81 0.2 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.49 51.65 1.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -117.68 152.63 34.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -69.37 143.48 53.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -164.78 -52.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -146.76 -68.61 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -176.59 147.79 0.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -125.54 -63.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.08 35.52 1.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.1 53.8 1.62 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.53 170.71 19.69 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.62 2.214 . . . . 0.0 112.369 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.808 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--O 1.23 0.118 0 CA-C-O 120.874 0.281 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -71.35 -62.23 1.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.929 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -120.83 27.39 8.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.008 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.93 -68.82 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.043 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.92 -170.52 31.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.534 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.97 152.08 48.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.971 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.2 -101.54 1.61 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.559 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.51 33.47 81.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.461 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.4 tttp -170.93 -41.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.788 0.327 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.97 168.2 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.033 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.31 87.75 7.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.9 179.92 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -43.13 99.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 153.84 -94.42 0.14 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.441 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -145.66 70.95 1.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.835 0.35 . . . . 0.0 110.795 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 62.75 34.14 14.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.786 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.42 -30.13 71.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 p30 166.02 136.62 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.794 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -142.21 -51.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.749 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.4 p -166.45 144.05 5.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.842 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -56.59 94.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -74.14 114.17 12.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -71.1 156.4 39.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.84 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -145.78 128.08 15.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.693 HD11 ' CE1' ' A' ' 119' ' ' TYR . 20.1 tp -71.04 134.59 47.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.4 t -128.46 140.08 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.884 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 11.8 m-30 -113.7 170.94 7.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.42 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -42.01 155.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.261 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -124.78 168.12 13.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.169 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -67.72 123.59 20.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.738 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.35 62.95 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.495 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.531 ' CB ' HD11 ' A' ' 91' ' ' LEU . 12.9 mt-30 -115.66 145.3 42.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.596 0.236 . . . . 0.0 110.395 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.735 ' HB2' HD11 ' A' ' 94' ' ' LEU . 15.4 tt0 -120.26 152.06 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.047 0.451 . . . . 0.0 111.531 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 6.6 p90 -84.71 158.17 20.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.872 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.37 173.4 14.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.215 0.531 . . . . 0.0 112.376 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.43 ' HG2' HD13 ' A' ' 89' ' ' ILE . 4.5 tm0? -128.61 115.11 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.161 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 14.8 t -65.9 139.99 20.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 112.077 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.918 HD11 ' HB3' ' A' ' 63' ' ' MET . 7.0 mm -116.01 -42.77 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.011 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -140.7 158.57 43.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.875 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.567 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.6 tpt -111.74 132.1 54.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.806 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.95 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -109.17 -163.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.485 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.75 156.71 4.54 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.64 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -56.76 109.56 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 135.03 -19.77 3.87 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.5 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.655 ' HD2' HD12 ' A' ' 55' ' ' LEU . 22.1 ptt180 -146.92 163.57 35.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 111.053 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.792 HD22 ' CD1' ' A' ' 84' ' ' ILE . 0.5 OUTLIER -147.68 150.78 34.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.885 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.2 tt0 -91.89 121.58 33.63 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.02 165.64 24.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.293 0.568 . . . . 0.0 112.342 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.918 ' HB3' HD11 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -123.53 107.37 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.938 179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 12.1 m -57.91 130.89 48.59 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.4 m-85 -48.04 -25.99 1.63 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.705 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -74.42 -13.35 60.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.257 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.27 40.72 2.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.542 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.99 120.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 111.307 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.498 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 0.4 OUTLIER -88.68 114.44 25.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -143.81 165.53 27.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.95 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -103.27 109.81 21.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.8 m -84.28 118.33 24.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.516 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 2.4 m-70 -80.62 130.43 35.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.755 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.669 HD12 HD11 ' A' ' 84' ' ' ILE . 2.0 tt -68.59 140.09 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.475 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER 166.32 -167.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.002 0.43 . . . . 0.0 111.446 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.67 174.66 36.83 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.04 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -52.41 -23.83 6.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.968 0.413 . . . . 0.0 110.701 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -78.83 -18.61 53.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.205 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -48.09 -28.67 3.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.749 0.309 . . . . 0.0 111.502 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -58.34 -22.9 55.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.883 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.79 46.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.417 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.589 HG13 HD11 ' A' ' 74' ' ' ILE . 14.2 p -84.81 128.82 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.36 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -110.72 110.04 20.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.008 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.792 ' CD1' HD22 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -95.2 147.34 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.613 179.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 m-20 -122.32 152.3 40.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.407 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 32.7 m -80.18 -6.81 58.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 0.0 111.769 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.2 p -143.95 56.53 1.33 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.595 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 85' ' ' ASN . 0.4 OUTLIER -146.93 164.77 31.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.281 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.901 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.1 mm -87.28 146.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.233 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.664 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.1 mt -150.15 170.99 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 111.184 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.675 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -129.18 121.84 28.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.753 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 104' ' ' VAL . 16.0 m -116.16 150.38 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.75 131.41 10.72 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.696 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.735 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -117.86 133.19 56.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.675 0.274 . . . . 0.0 110.62 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -178.06 -75.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -80.28 -12.65 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.322 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 34.5 m-85 -83.11 2.93 32.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.678 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 65.81 25.64 11.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.658 0.266 . . . . 0.0 111.219 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.22 -54.42 0.6 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.758 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -39.7 -35.47 0.33 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 97' ' ' TYR . 8.3 mmmm -127.27 162.76 25.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.808 0.337 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -158.61 162.65 37.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.054 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -113.1 126.7 55.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.958 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.723 ' HA ' HG12 ' A' ' 92' ' ' VAL . 61.5 t -55.02 112.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.801 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.99 -58.95 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.106 0.479 . . . . 0.0 110.023 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.055 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.3 pp -127.71 160.11 32.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.376 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.571 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -107.04 117.47 34.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.055 ' CE1' HD11 ' A' ' 106' ' ' LEU . 25.0 m-85 -81.73 106.11 13.4 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -68.17 168.76 11.56 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -70.8 -40.77 72.33 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.477 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.26 -40.35 95.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.716 ' O ' HD23 ' A' ' 116' ' ' LEU . 26.3 mt-10 -66.79 -28.54 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.49 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.906 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.43 -48.97 7.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.78 -178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -56.11 -30.67 62.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.362 0.601 . . . . 0.0 109.443 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.625 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.8 OUTLIER -73.93 -22.12 59.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.901 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.32 -34.94 25.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.379 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -54.6 -34.76 62.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.44 -20.9 42.8 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.97 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.0 m-30 -66.56 -6.18 14.17 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.829 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.52 64.59 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.593 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.595 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 48.0 mt-10 -113.87 -64.55 1.29 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.927 0.394 . . . . 0.0 111.234 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -92.49 149.94 39.07 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.999 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 58.2 Cg_endo -71.7 179.55 4.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.634 2.223 . . . . 0.0 112.432 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.23 -32.17 68.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -75.83 -19.22 59.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.332 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.459 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -53.65 121.91 8.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 111.28 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -108.18 132.21 53.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.001 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.906 HD13 ' HB1' ' A' ' 113' ' ' ALA . 2.7 mt -100.06 153.97 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.129 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.405 ' N ' HG22 ' A' ' 128' ' ' ILE . 2.7 t-20 -65.09 163.61 14.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.707 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.13 175.16 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.555 HG23 ' HB3' ' A' ' 110' ' ' ALA . 0.5 OUTLIER -113.19 129.98 56.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.844 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 45.56 -163.98 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.342 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.7 m 73.67 96.01 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -158.0 79.79 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.736 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -108.5 151.01 17.08 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.53 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.21 134.41 61.57 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.663 2.242 . . . . 0.0 112.233 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -177.15 37.24 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.516 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.08 178.04 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.08 179.98 1.38 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -130.71 -51.32 1.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 56.52 178.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.026 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 22.2 mm -110.7 -40.19 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.054 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -107.13 142.34 36.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -136.06 85.12 2.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.938 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -168.27 93.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.728 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 63.78 104.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 147' ' ' ILE . 11.2 tt -120.15 63.73 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.055 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.46 -128.19 5.86 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.55 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.14 151.67 26.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.9 87.26 3.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -162.89 173.54 13.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.964 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -161.85 141.52 10.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.69 121.17 42.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.89 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.4 pt -112.26 173.81 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -71.23 150.31 45.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -95.59 94.0 7.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.814 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.7 pt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.807 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.759 0.314 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -64.52 -47.43 78.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 158.27 162.84 12.13 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.615 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m 58.51 91.97 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.27 136.21 39.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -133.07 -178.15 4.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -130.37 165.61 22.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -145.6 32.23 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.14 -168.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.825 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -49.81 118.94 3.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 43.3 p -58.15 144.49 40.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.023 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -122.91 79.67 50.19 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.823 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.91 -34.06 11.32 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.587 2.191 . . . . 0.0 112.434 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.958 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.776 0.24 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.71 -58.19 1.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.956 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 60.9 96.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.22 -46.19 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.85 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.19 -137.52 8.72 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.455 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.24 152.82 48.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.746 0.308 . . . . 0.0 110.894 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.44 45.17 2.4 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.608 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.99 -68.29 0.76 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.542 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.13 -78.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.778 0.323 . . . . 0.0 110.843 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -104.81 115.82 30.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.804 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.62 119.86 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.95 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.51 32.91 21.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.999 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -63.18 -49.51 74.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.73 160.32 10.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.33 105.44 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.393 . . . . 0.0 110.943 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 57.9 76.66 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.956 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -89.91 125.92 35.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 65.11 30.21 11.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.801 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.06 135.77 8.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.833 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -106.79 -63.72 1.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -158.1 144.22 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -127.17 160.5 31.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.647 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.13 120.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.846 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.23 78.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD11 ' HE1' ' A' ' 119' ' ' TYR . 14.6 tp -84.7 120.82 26.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.735 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 t -126.95 141.05 47.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.694 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.756 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 4.3 m-30 -109.19 170.45 8.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.612 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.1 ttpp -45.6 141.48 2.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.902 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -111.46 166.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 111.333 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -58.4 129.71 43.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.43 -15.37 60.24 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.589 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.487 ' CB ' HD11 ' A' ' 91' ' ' LEU . 8.4 mt-30 -118.45 154.62 32.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.624 0.25 . . . . 0.0 110.458 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -130.02 152.63 49.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.828 0.347 . . . . 0.0 111.064 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 2.9 p90 -84.39 157.24 21.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.986 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.16 173.79 13.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.251 0.548 . . . . 0.0 112.112 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.519 ' OE1' HD13 ' A' ' 89' ' ' ILE . 38.2 tp60 -128.89 109.62 11.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.13 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.525 ' CG2' HD11 ' A' ' 90' ' ' ILE . 17.5 t -56.31 139.69 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.99 0.424 . . . . 0.0 111.882 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 63' ' ' MET . 0.0 OUTLIER -116.42 -42.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.935 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 16.4 ttmm -147.71 157.58 43.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.319 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.647 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.1 ttt -108.2 143.35 37.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.789 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.863 HD21 ' HB2' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -111.89 -25.61 9.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.118 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.69 -174.63 29.98 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.61 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -75.37 102.87 5.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 135.28 -26.28 3.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.407 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.678 ' HD2' HD12 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -151.47 155.41 38.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.337 . . . . 0.0 110.927 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.946 HD22 HG21 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.74 150.91 35.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.863 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.4 tp10 -91.74 121.42 33.36 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.79 165.74 23.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.203 0.525 . . . . 0.0 112.145 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.535 ' HB2' HD13 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -127.16 107.07 9.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.419 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.5 133.25 55.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.063 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 3.5 m-85 -49.91 -25.22 3.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.724 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.32 -8.46 56.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.235 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.92 43.1 3.4 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.451 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.03 113.94 34.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.3 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 24.8 tttt -84.22 113.51 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.751 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -145.15 165.5 28.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.2 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.854 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -100.34 108.56 20.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.979 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.721 ' HB3' HG11 ' A' ' 92' ' ' VAL . 34.0 m -84.31 118.4 24.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.538 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 20.3 m80 -82.56 134.5 35.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.628 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.626 HG22 ' HA2' ' A' ' 58' ' ' GLY . 10.0 tt -68.65 141.03 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.353 . . . . 0.0 111.01 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 2.3 mmt180 -63.95 155.59 30.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.18 -46.78 6.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.484 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -77.33 -40.53 43.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.6 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.727 HD12 ' HB ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -64.02 -16.69 62.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.007 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.636 ' HA ' HG12 ' A' ' 82' ' ' VAL . 12.3 ptm180 -48.72 -26.13 2.17 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.684 0.278 . . . . 0.0 111.498 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -76.05 -35.03 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.554 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.35 34.93 3.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.652 0.263 . . . . 0.0 111.613 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.727 ' HB ' HD12 ' A' ' 78' ' ' LEU . 8.5 p -123.79 111.34 28.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.159 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -110.98 110.23 20.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.852 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.946 HG21 HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -91.95 147.16 5.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.415 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 13.3 m120 -139.88 157.86 45.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.636 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 52' ' ' ILE . 59.6 m -75.33 -6.45 49.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.021 0.439 . . . . 0.0 111.772 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.9 m -143.31 76.12 1.51 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.796 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.46 161.16 16.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.148 0.499 . . . . 0.0 111.389 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.847 HG21 ' CD1' ' A' ' 116' ' ' LEU . 51.3 mm -86.96 146.57 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.316 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.633 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.1 mt -150.49 171.66 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.362 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.664 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -130.27 122.43 28.0 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.866 178.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.791 HG12 ' HA ' ' A' ' 104' ' ' VAL . 34.9 m -119.57 146.97 23.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.529 ' O ' ' HB1' ' A' ' 102' ' ' ALA . . . -95.83 141.69 15.71 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.862 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 142.05 47.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.65 0.262 . . . . 0.0 110.575 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -149.11 -81.55 0.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.183 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.57 -12.16 40.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.328 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CG ' ' HB2' ' A' ' 101' ' ' LYS . 35.0 m-85 -71.9 -10.18 59.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.404 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.433 ' O ' ' CB ' ' A' ' 99' ' ' ASP . 4.6 mt-30 65.85 25.4 11.24 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.205 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' A' ' 98' ' ' GLN . 2.8 t0 83.36 -21.88 0.26 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.714 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.36 -29.51 68.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.833 0.349 . . . . 0.0 110.699 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.427 ' HB2' ' CG ' ' A' ' 97' ' ' TYR . 10.1 mtpt -144.27 164.85 29.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.688 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.542 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -163.3 171.66 15.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.106 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -118.34 125.65 50.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.687 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.791 ' HA ' HG12 ' A' ' 92' ' ' VAL . 99.3 t -49.96 111.75 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.47 -46.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.196 0.522 . . . . 0.0 109.737 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.062 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -142.06 166.93 23.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.31 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.601 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -110.44 120.56 42.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.062 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.7 m-85 -84.23 105.94 15.47 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -71.78 177.19 4.34 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.1 -40.03 47.38 Favored 'General case' 0 CA--C 1.524 -0.045 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.055 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -62.62 -40.99 98.73 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.701 ' O ' HD23 ' A' ' 116' ' ' LEU . 14.0 mt-10 -65.93 -27.93 68.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.345 177.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.26 -50.28 6.56 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.23 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -56.42 -26.8 54.66 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 120.246 -0.581 . . . . 0.0 109.714 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.624 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -80.17 -22.29 42.13 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.14 178.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.847 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -49.92 -33.98 19.06 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 121.22 -0.192 . . . . 0.0 111.002 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -54.75 -34.37 62.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.12 -20.39 45.11 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.059 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.756 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.6 m-30 -66.42 -4.37 8.07 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.927 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.55 21.08 53.8 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.303 -0.951 . . . . 0.0 111.735 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.473 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 58.5 mm-40 -111.45 -60.42 1.84 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.649 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -95.02 144.79 28.4 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.834 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 72.6 Cg_endo -76.08 179.8 5.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.631 2.221 . . . . 0.0 112.353 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -68.77 -29.31 67.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.442 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 25.6 p-80 -81.43 -0.49 41.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.473 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.484 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -66.28 145.15 56.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.836 0.35 . . . . 0.0 110.976 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -124.78 120.82 32.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.992 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.3 mt -90.96 148.3 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -64.5 86.73 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.169 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 56.21 -179.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.051 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.6 m -90.19 -22.14 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 169.42 106.6 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.768 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.9 101.2 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.963 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.89 85.18 3.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.784 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -113.95 177.12 17.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.33 94.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.715 2.277 . . . . 0.0 112.428 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -151.34 101.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.495 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 63.74 -78.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.817 0.342 . . . . 0.0 111.102 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -160.47 144.73 14.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.967 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -77.0 80.58 3.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.973 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 59.98 162.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 12.3 tt -103.15 -31.97 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 62.56 -83.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 25.6 t80 178.08 97.05 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.715 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -168.82 113.43 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.77 160.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 tt -156.23 42.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 56.62 -124.86 36.54 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.566 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 p30 -163.62 143.22 8.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -173.98 -46.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -130.28 175.83 8.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 58.55 52.46 6.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.07 88.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.851 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.623 ' O ' HG23 ' A' ' 154' ' ' ILE . 7.9 tp -90.26 71.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.049 0.452 . . . . 0.0 111.009 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -83.49 60.5 5.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.762 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -139.38 112.22 7.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.429 ' C ' HD12 ' A' ' 157' ' ' ILE . 1.7 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.336 -0.84 . . . . 0.0 111.13 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 42.8 mtm . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.828 0.347 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 42.6 tpt85 61.04 109.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.21 -68.8 0.29 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.543 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -93.77 135.34 35.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.883 0.373 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -102.71 -161.65 0.86 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.725 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.73 136.54 27.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.857 0.36 . . . . 0.0 111.035 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -105.2 -178.16 3.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -59.62 131.44 50.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.947 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -167.73 77.96 0.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.31 120.03 18.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.855 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.16 87.52 2.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.19 100.5 9.05 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.837 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.43 175.68 5.71 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.382 2.055 . . . . 0.0 112.342 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.832 0.263 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -133.83 46.37 2.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -165.9 32.32 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.882 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -135.54 74.55 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.93 152.84 7.96 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.387 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.87 -69.04 0.15 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.749 0.309 . . . . 0.0 111.016 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.34 -159.71 43.2 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.57 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -128.66 159.15 22.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.546 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt 60.76 -179.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.811 0.339 . . . . 0.0 110.942 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -116.88 -71.82 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -53.53 8.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 62.25 40.15 11.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.805 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.38 54.64 2.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.27 159.36 26.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.349 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.34 -64.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.649 0.262 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -43.17 138.53 2.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.695 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -166.21 61.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.826 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.3 99.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -152.87 37.95 0.51 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 m -71.68 -170.63 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -146.45 159.34 43.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.972 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -94.92 -41.65 9.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.97 79.38 0.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.674 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -82.81 67.08 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.142 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.644 HD23 ' CZ ' ' A' ' 41' ' ' PHE . 16.0 tp -83.14 109.59 17.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.478 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' CG1' HD22 ' A' ' 106' ' ' LEU . 15.1 t -91.78 139.66 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.01 0.433 . . . . 0.0 111.701 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.644 ' CZ ' HD23 ' A' ' 39' ' ' LEU . 79.6 m-85 -113.45 170.5 8.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.714 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.518 ' HA ' HD22 ' A' ' 91' ' ' LEU . 7.9 tttt -47.68 163.41 0.05 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.113 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -132.51 156.38 46.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.935 0.398 . . . . 0.0 111.294 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -59.04 129.16 40.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.697 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.72 -15.45 61.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.558 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.513 ' OE1' HD11 ' A' ' 91' ' ' LEU . 26.3 mt-30 -116.43 148.17 40.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.585 0.231 . . . . 0.0 110.439 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -121.09 152.56 38.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 111.613 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 11.9 p90 -84.5 157.71 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.899 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.3 173.28 15.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.302 0.572 . . . . 0.0 112.42 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.404 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -126.5 125.5 42.17 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.082 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.689 HG13 HD13 ' A' ' 60' ' ' LEU . 12.2 t -79.32 138.3 20.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.942 HD11 ' HB2' ' A' ' 63' ' ' MET . 1.1 mt -116.1 -45.75 4.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.169 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -137.76 157.15 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.531 ' C ' HD23 ' A' ' 55' ' ' LEU . 7.8 ttm -111.41 143.53 42.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.668 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.852 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -106.49 -37.62 6.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 161.38 171.66 27.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.471 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -60.07 103.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.8 0.333 . . . . 0.0 110.907 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.656 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 133.32 -22.57 3.95 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.616 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.728 ' CD ' HD12 ' A' ' 55' ' ' LEU . 13.3 ptp180 -154.5 157.76 38.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.301 . . . . 0.0 111.063 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.689 HD13 HG13 ' A' ' 51' ' ' VAL . 2.8 pp -147.95 160.27 42.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.298 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.782 ' HB2' HD21 ' A' ' 55' ' ' LEU . 10.0 tp10 -102.18 121.47 42.29 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -135.98 166.18 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.328 0.585 . . . . 0.0 112.352 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.942 ' HB2' HD11 ' A' ' 52' ' ' ILE . 4.3 tpp -126.89 111.61 14.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.056 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 46.6 t -58.67 134.76 57.07 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -25.28 2.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.581 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -74.31 -14.17 60.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.233 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.72 41.19 2.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.583 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.3 t -127.23 125.79 66.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.548 ' CA ' ' HE2' ' A' ' 63' ' ' MET . 0.2 OUTLIER -99.99 115.25 29.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.944 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -144.19 160.8 40.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.81 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.852 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -96.32 105.68 17.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.801 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.52 ' HB3' HG11 ' A' ' 92' ' ' VAL . 14.2 m -85.16 118.75 24.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.673 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -81.39 127.77 33.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.656 HG22 ' HA2' ' A' ' 58' ' ' GLY . 6.0 tt -68.43 140.58 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.44 -165.05 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 0.0 111.514 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.23 169.91 46.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.179 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -48.58 -27.18 2.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.432 . . . . 0.0 110.763 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 1.0 OUTLIER -66.41 -32.86 74.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.732 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.483 ' HA ' HG12 ' A' ' 82' ' ' VAL . 23.3 ptt180 -48.83 -28.18 3.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.248 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -56.84 -26.53 58.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 46.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.759 0.314 . . . . 0.0 111.251 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.529 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.3 p -124.34 123.07 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.705 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -111.21 109.97 20.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.538 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.881 HG22 HD13 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -65.06 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.947 0.403 . . . . 0.0 110.617 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -102.06 151.48 22.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.462 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.471 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 86.2 m -80.25 -6.55 58.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.62 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.95 72.06 1.34 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.639 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -165.65 167.39 17.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.294 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.906 HG21 ' CD1' ' A' ' 116' ' ' LEU . 26.5 mm -86.9 146.79 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.192 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.881 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.3 171.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.383 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.681 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.57 122.31 28.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.785 178.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 104' ' ' VAL . 26.9 m -117.83 146.68 21.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.155 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.97 140.08 14.91 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.911 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -123.51 132.6 53.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.648 0.261 . . . . 0.0 110.616 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.55 -80.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.01 -15.95 63.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.473 ' CE2' ' HB2' ' A' ' 103' ' ' ASP . 48.5 m-85 -72.44 -8.8 56.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.547 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 67.29 29.94 7.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.896 0.379 . . . . 0.0 110.682 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.34 -175.94 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.57 -61.13 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.836 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -105.15 156.66 17.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.967 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.545 ' HB2' HD22 ' A' ' 94' ' ' LEU . . . -141.28 -177.71 5.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.829 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.473 ' HB2' ' CE2' ' A' ' 97' ' ' TYR . 10.5 t70 -133.96 120.31 20.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.888 ' HA ' HG12 ' A' ' 92' ' ' VAL . 59.8 t -52.87 112.19 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.845 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.4 mm -87.75 -62.16 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.077 0.465 . . . . 0.0 110.057 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.5 pp -124.8 159.62 30.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.46 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -105.92 118.73 37.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.063 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.8 m-85 -82.24 106.28 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.09 173.39 5.58 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.643 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -74.48 -40.23 61.97 Favored 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.693 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -62.06 -40.48 95.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.716 ' O ' HD23 ' A' ' 116' ' ' LEU . 19.4 mt-10 -66.99 -28.37 68.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.505 177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.987 ' HB1' HD12 ' A' ' 128' ' ' ILE . . . -43.63 -48.94 7.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.909 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -55.9 -30.26 61.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.386 0.612 . . . . 0.0 109.528 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 1.4 m -76.14 -22.46 55.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.173 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.906 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.22 -32.95 17.88 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.067 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.51 -34.3 61.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.74 42.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.778 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.675 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.2 m-30 -66.97 -11.64 57.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.86 23.27 65.39 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.633 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 50.8 mt-10 -109.54 -52.05 2.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.855 0.359 . . . . 0.0 110.933 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.541 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.1 148.09 34.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.723 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 60.0 Cg_endo -72.52 178.34 6.34 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 0.0 112.339 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -30.8 69.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.401 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 56.7 p-80 -84.2 -3.49 58.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.405 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -58.35 147.64 30.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.887 0.375 . . . . 0.0 111.164 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.0 mtmm -115.07 148.39 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.987 HD12 ' HB1' ' A' ' 113' ' ' ALA . 28.2 mm -82.73 158.35 3.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.011 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.46 ' N ' HG22 ' A' ' 128' ' ' ILE . 19.6 m-80 -88.7 63.37 6.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.04 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 58.77 110.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.01 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.36 -29.21 66.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.007 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 64.03 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.4 m 56.06 96.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.22 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.81 67.96 1.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.711 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.62 -174.82 31.41 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.555 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -52.19 135.81 53.3 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.592 2.195 . . . . 0.0 112.362 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -127.26 73.02 0.45 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.513 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.4 172.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.863 0.363 . . . . 0.0 110.912 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -146.89 35.85 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -134.22 77.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -138.74 31.65 2.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.2 mt -121.35 147.04 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.089 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -66.62 93.43 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -88.21 120.0 29.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -123.73 140.62 52.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -86.41 136.84 32.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 30.2 mm -106.62 81.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.025 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 162.43 79.11 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -123.85 115.01 20.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.58 -51.31 65.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -79.58 128.99 34.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 60.35 78.42 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -96.31 94.74 7.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.416 HD11 ' O ' ' A' ' 156' ' ' ASP . 15.3 tt -64.52 146.15 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.12 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -113.63 -42.03 3.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.416 ' O ' HD11 ' A' ' 154' ' ' ILE . 11.6 p30 -102.83 140.33 37.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.661 ' N ' HD13 ' A' ' 157' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.159 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptp . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.0 mtt-85 -129.51 115.31 17.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.06 28.32 9.92 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.23 73.67 3.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 110.916 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -60.65 178.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -120.5 71.24 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -60.52 119.69 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.86 122.59 14.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.872 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.28 30.8 6.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -122.15 82.64 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.855 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 30.2 p -99.18 123.64 43.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.984 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t0 59.57 79.31 0.3 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.71 84.6 1.22 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.479 2.119 . . . . 0.0 112.386 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.921 0.3 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -105.17 60.28 0.68 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.853 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 63.1 -79.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.031 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt 61.78 -179.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.98 143.1 0.91 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.465 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 mttt 59.26 -178.75 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.347 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.28 -147.56 8.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.556 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 141.98 99.83 0.36 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -149.27 32.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -107.07 128.19 54.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.23 106.37 18.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.79 35.02 2.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.923 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.62 -68.95 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.52 -39.53 2.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.448 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -60.26 110.77 1.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.783 0.325 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.22 62.05 1.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.795 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -78.92 104.2 9.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 63.26 120.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -143.91 130.03 19.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.88 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.99 -171.0 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.94 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -132.6 167.74 19.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.9 ptpm? -148.85 -43.66 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.68 140.03 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -70.0 152.66 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.993 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.693 HD11 ' HE1' ' A' ' 119' ' ' TYR . 30.1 tp -68.31 130.63 43.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -127.71 140.34 49.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.804 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.767 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 7.4 m-30 -112.51 170.95 7.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.426 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -45.24 148.61 0.6 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.952 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -121.75 162.43 20.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.39 . . . . 0.0 111.347 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -57.04 130.44 46.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.72 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.65 -15.36 61.73 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.369 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.419 ' CB ' ' HA2' ' A' ' 93' ' ' GLY . 2.0 mt-30 -123.62 144.49 49.58 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -118.85 153.64 34.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 111.383 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 10.1 p90 -84.22 157.71 21.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.698 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.31 173.52 14.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.362 0.601 . . . . 0.0 112.389 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.607 ' HG2' HD13 ' A' ' 89' ' ' ILE . 1.8 tm0? -128.19 120.83 28.05 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.189 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.61 HG22 ' CD1' ' A' ' 60' ' ' LEU . 29.6 t -70.8 134.91 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.985 0.421 . . . . 0.0 111.664 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.71 HD12 ' CB ' ' A' ' 63' ' ' MET . 0.5 OUTLIER -116.45 -38.58 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.512 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -140.68 159.82 41.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.816 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.626 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -115.74 143.07 45.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.719 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.926 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -111.66 -58.74 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.944 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.77 -168.1 16.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.647 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -83.72 0.89 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.517 0.199 . . . . 0.0 111.49 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -121.58 -8.39 7.62 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.883 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.681 ' CD ' HD12 ' A' ' 55' ' ' LEU . 22.8 ptt180 -153.36 160.17 42.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.749 0.309 . . . . 0.0 110.779 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.892 HD22 HD13 ' A' ' 84' ' ' ILE . 0.6 OUTLIER -147.94 149.77 32.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.067 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.894 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.2 tt0 -91.84 121.41 33.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.97 165.62 25.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.259 0.552 . . . . 0.0 112.141 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.71 ' CB ' HD12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.1 111.84 15.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.169 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.4 t -58.48 135.96 57.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.3 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.0 m-85 -49.73 -25.39 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.577 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.34 -7.17 51.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.289 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.84 44.42 3.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.446 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.21 130.64 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.865 0.364 . . . . 0.0 111.303 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.576 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 8.6 tttt -95.7 113.73 25.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.507 ' NH1' HD22 ' A' ' 94' ' ' LEU . 12.5 ptp180 -145.04 165.59 27.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.926 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -103.12 109.23 20.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.886 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.734 ' HB3' HG11 ' A' ' 92' ' ' VAL . 25.7 m -84.41 119.8 25.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.99 136.53 34.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.691 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.667 HD11 HG13 ' A' ' 82' ' ' VAL . 7.0 tt -68.73 140.73 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.928 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.437 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -73.75 145.11 45.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.108 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.87 -48.26 34.82 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.311 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.89 -29.13 70.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.363 . . . . 0.0 110.628 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.5 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.8 mm? -84.67 -29.14 25.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.805 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -48.97 -27.2 2.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -59.05 -42.16 89.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.266 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.83 46.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 111.434 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.667 HG13 HD11 ' A' ' 74' ' ' ILE . 9.8 p -123.95 117.9 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 111.121 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -110.93 110.06 20.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.066 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.892 HD13 HD22 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -83.1 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.251 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.452 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 1.6 t30 -108.33 159.35 16.71 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.106 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 86' ' ' THR . 58.6 m -80.12 -5.72 56.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.6 p -147.67 55.41 1.07 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.629 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.6 162.19 35.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.205 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.894 HG21 ' CD1' ' A' ' 116' ' ' LEU . 30.4 mm -87.03 146.51 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.288 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.724 ' CD1' HG22 ' A' ' 84' ' ' ILE . 1.2 mt -150.58 171.92 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.152 0.501 . . . . 0.0 111.327 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.707 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.56 122.39 29.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.448 178.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.734 HG11 ' HB3' ' A' ' 72' ' ' CYS . 27.2 m -121.94 152.06 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 46' ' ' GLN . . . -90.78 143.79 16.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.507 HD22 ' NH1' ' A' ' 70' ' ' ARG . 4.6 mt -113.73 26.31 10.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 110.956 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.02 19.41 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.119 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.2 -49.2 6.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.806 0.336 . . . . 0.0 110.682 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -105.46 -11.19 16.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.221 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 65.48 29.61 11.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.801 0.334 . . . . 0.0 110.667 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.8 p30 -135.48 178.45 7.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.089 0.471 . . . . 0.0 111.232 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -57.38 -18.26 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.856 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 132.37 34.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.816 0.341 . . . . 0.0 111.19 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -115.72 158.14 23.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.472 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -115.45 120.48 39.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.81 0.338 . . . . 0.0 111.032 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.694 ' CA ' HG12 ' A' ' 92' ' ' VAL . 94.5 t -50.33 111.41 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.738 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.1 mm -77.94 -36.19 21.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.323 0.582 . . . . 0.0 109.679 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.07 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.2 pp -154.13 167.45 29.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.452 178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 82' ' ' VAL . 14.6 pttt -110.28 121.64 45.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.15 0.5 . . . . 0.0 112.274 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.07 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.2 m-85 -86.4 106.6 17.55 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -73.86 178.29 4.98 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.652 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.54 -41.76 45.45 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.071 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -61.65 -40.05 93.52 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.683 ' O ' HD23 ' A' ' 116' ' ' LEU . 9.6 mt-10 -68.63 -28.0 66.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.351 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.741 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.54 -51.63 6.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.955 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -55.72 -27.22 49.36 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.662 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -76.58 -22.11 54.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.001 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.894 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.0 -34.43 21.13 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -54.85 -34.55 63.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.35 -20.92 43.07 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.921 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.767 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.9 m-30 -66.77 -7.28 20.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.827 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.22 24.53 65.46 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.566 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.578 ' HG3' ' HB3' ' A' ' 119' ' ' TYR . 47.8 mt-10 -114.05 -63.5 1.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.876 0.369 . . . . 0.0 111.191 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.607 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -91.42 144.59 29.91 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.957 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.448 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.7 Cg_endo -71.38 179.78 4.28 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.657 2.238 . . . . 0.0 112.401 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -70.89 -34.61 71.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.026 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.448 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 20.7 p-80 -72.44 -17.98 61.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.294 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -56.84 133.66 54.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.732 0.301 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -114.36 134.35 55.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.652 HD13 ' HB1' ' A' ' 113' ' ' ALA . 4.5 mt -99.11 141.7 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.097 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -67.82 157.82 33.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.02 162.28 7.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.716 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.43 141.57 54.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -39.23 136.31 0.88 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.857 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.8 p -95.74 -168.81 1.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 61.02 84.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.2 154.91 8.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.531 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.8 -166.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.52 2.146 . . . . 0.0 112.278 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -117.63 106.68 1.42 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.477 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.34 -78.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 110.985 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -170.31 -43.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.9 t70 61.74 71.53 0.54 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.74 81.64 1.83 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.781 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.0 mm -107.68 128.42 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.94 172.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.62 -169.54 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -176.16 -43.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -109.98 165.51 11.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 147' ' ' ILE . 4.7 tt -170.76 55.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.058 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.56 176.5 27.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.13 31.59 4.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.318 . . . . 0.0 110.821 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -98.27 36.41 1.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 t70 60.68 56.97 2.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -55.0 18.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 44.2 t0 63.57 141.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.1 pt -123.48 141.35 44.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.098 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.52 -23.59 23.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 t0 64.65 164.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.8 mt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.037 179.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.761 0.315 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -35.22 73.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.58 -82.68 0.24 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.512 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 18.1 t -148.45 -74.22 0.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.729 0.299 . . . . 0.0 110.989 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.46 40.43 0.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 11.7 m170 69.07 -67.19 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.022 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -105.68 138.66 41.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.013 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -110.76 -36.78 5.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.733 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 60.62 82.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 6.9 m170 53.96 -168.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.57 -80.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.748 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 55.78 75.62 0.57 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.062 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -57.69 -40.67 77.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.62 2.213 . . . . 0.0 112.253 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.969 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo . . . . . 0 C--O 1.231 0.137 0 CA-C-O 120.834 0.264 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 51.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -60.81 -75.34 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.01 -53.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.92 -151.76 6.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt 66.09 -72.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.697 0.284 . . . . 0.0 111.068 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.45 86.74 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.514 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.13 66.04 0.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -115.92 -66.64 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 110.863 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -75.37 110.95 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 120.46 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -115.15 33.94 5.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -116.42 -36.27 4.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.13 -113.33 5.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.483 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -149.38 112.77 4.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -41.73 -66.7 0.32 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.703 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -176.79 -178.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.933 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 59.09 -179.47 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.01 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -95.45 175.11 6.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -89.53 -64.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 58.83 77.58 0.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -166.15 95.68 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.78 146.27 37.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -109.37 102.77 11.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.632 HD23 ' CZ ' ' A' ' 41' ' ' PHE . 13.5 tp -68.81 99.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.704 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.497 ' CG1' HD22 ' A' ' 106' ' ' LEU . 18.9 t -88.35 139.15 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.407 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.632 ' CZ ' HD23 ' A' ' 39' ' ' LEU . 86.5 m-85 -110.69 170.27 8.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.569 ' HA ' HD22 ' A' ' 91' ' ' LEU . 7.0 ttpt -52.79 148.43 7.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.887 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -116.85 160.52 20.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 111.402 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.63 130.07 45.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.43 -15.48 61.23 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.541 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.649 HE21 HD11 ' A' ' 91' ' ' LEU . 1.5 mt-30 -117.53 140.97 48.92 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.53 0.205 . . . . 0.0 110.559 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' HD11 ' A' ' 94' ' ' LEU . 7.9 tp10 -115.66 154.36 29.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 0.0 111.408 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 5.3 p90 -84.55 157.78 21.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.21 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.01 173.18 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.225 0.536 . . . . 0.0 112.099 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -128.04 109.05 11.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.273 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 90' ' ' ILE . 20.6 t -57.2 135.47 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.769 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.869 HD13 ' CB ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -116.07 -40.48 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.697 179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.63 158.82 43.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.735 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.638 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -115.7 139.02 50.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.63 179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.049 HD11 HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -110.72 -48.79 3.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.773 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.88 -179.27 30.05 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.54 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 67.65 19.53 9.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.737 0.304 . . . . 0.0 111.239 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.47 28.79 9.33 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.839 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HG3' HD12 ' A' ' 55' ' ' LEU . 6.2 ptt180 -154.82 155.88 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.598 HD22 ' CD1' ' A' ' 84' ' ' ILE . 1.2 pp -147.6 152.5 38.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.156 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.903 ' HB2' HD21 ' A' ' 55' ' ' LEU . 36.6 tt0 -91.75 121.39 33.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.41 ' HB3' ' SG ' ' A' ' 72' ' ' CYS . . . -124.25 165.06 18.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 112.331 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.869 ' CB ' HD13 ' A' ' 52' ' ' ILE . 1.2 tpt -125.8 100.24 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.86 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.4 m -56.37 132.17 50.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.637 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . 2.2 m-85 -49.93 -27.0 4.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.453 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.42 -8.09 55.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.434 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.72 40.71 3.78 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.531 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -127.13 123.06 61.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.262 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HA ' ' HE3' ' A' ' 63' ' ' MET . 1.9 tppp? -94.14 117.19 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -145.08 164.71 30.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.037 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.049 HD12 HD11 ' A' ' 55' ' ' LEU . 2.8 mm? -98.21 106.52 18.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.729 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.451 ' HB3' HG11 ' A' ' 92' ' ' VAL . 36.8 m -84.07 118.77 24.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -80.13 137.71 36.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.696 HD11 HG13 ' A' ' 82' ' ' VAL . 2.9 tt -68.66 139.18 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.704 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.436 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -67.11 143.9 56.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.143 -179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.58 -38.28 57.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.51 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -75.87 -29.4 58.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 110.659 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.484 ' O ' HG12 ' A' ' 82' ' ' VAL . 2.7 mm? -82.7 -28.65 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.565 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -49.63 -27.62 4.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.248 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -35.56 69.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.304 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.24 48.74 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.38 . . . . 0.0 111.261 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.696 HG13 HD11 ' A' ' 74' ' ' ILE . 10.7 p -120.95 119.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.143 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -110.81 110.27 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.956 0.408 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.679 HG22 HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -87.11 147.14 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.443 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -118.84 156.32 29.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 33.3 m -80.15 -6.45 57.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.168 0.509 . . . . 0.0 111.377 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -145.34 71.24 1.28 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.43 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.73 165.18 33.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.085 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.947 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.4 mm -86.78 144.97 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.679 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.52 172.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.423 . . . . 0.0 111.063 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.726 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.01 127.11 40.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.795 178.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.724 ' N ' HD12 ' A' ' 91' ' ' LEU . 31.6 m -122.2 149.51 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.4 ' HA2' ' CB ' ' A' ' 46' ' ' GLN . . . -91.92 135.85 12.96 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.87 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -122.46 123.78 42.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.6 0.238 . . . . 0.0 110.72 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.57 -80.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -61.12 -23.76 65.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -73.52 -8.03 54.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.433 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 66.71 30.2 8.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.823 0.344 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 76.73 -169.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.842 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.14 -62.46 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.775 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -108.59 168.68 9.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.761 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 92' ' ' VAL . . . -152.68 177.2 10.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.98 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -131.33 119.1 21.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.833 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.713 ' HA ' HG12 ' A' ' 92' ' ' VAL . 70.9 t -49.89 111.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.906 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.6 mm -82.5 -47.33 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.13 0.491 . . . . 0.0 109.828 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.018 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.4 pp -141.52 169.16 18.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.59 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.605 ' N ' HD12 ' A' ' 106' ' ' LEU . 12.0 pttp -110.28 122.51 47.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.972 0.415 . . . . 0.0 111.96 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.018 ' CE1' HD11 ' A' ' 106' ' ' LEU . 20.1 m-85 -85.44 107.0 17.2 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -64.27 168.08 5.98 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.82 -51.06 11.08 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.4 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.457 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 46.2 t0 -62.02 -38.2 87.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.506 ' OE2' ' HA ' ' A' ' 108' ' ' TYR . 0.7 OUTLIER -75.28 -26.16 58.53 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.018 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -45.44 -41.89 9.83 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.765 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.457 ' CG ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -53.11 -36.71 61.05 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.318 0.58 . . . . 0.0 109.488 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.645 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 1.0 OUTLIER -61.61 -21.04 64.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.971 177.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.947 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.32 -32.93 18.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.354 -178.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.66 -34.48 65.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 175.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.1 -21.64 43.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.639 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.698 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -67.24 -10.5 51.21 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.077 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.8 24.72 64.83 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.619 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 65.4 mm-40 -111.3 -53.53 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.772 0.32 . . . . 0.0 111.013 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.579 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -98.04 147.2 32.75 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.78 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.414 ' CG ' ' CE1' ' A' ' 125' ' ' HIS . 57.1 Cg_endo -70.91 175.1 9.52 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.56 2.173 . . . . 0.0 112.193 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -70.29 -27.12 64.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.414 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 21.3 p-80 -81.62 -10.84 59.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.429 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.91 164.51 0.58 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -129.77 144.74 51.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.569 HD12 ' CB ' ' A' ' 113' ' ' ALA . 26.4 mm -84.06 139.72 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.962 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -85.97 98.55 10.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 57.87 85.35 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.7 m -64.09 -39.24 93.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.832 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.3 t0 59.98 176.36 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.8 t -152.5 157.25 40.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.06 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -113.95 46.92 1.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.99 117.95 5.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.454 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.85 -33.0 59.15 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.398 2.065 . . . . 0.0 112.295 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 167.66 79.38 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.514 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 62.29 106.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -63.65 -31.76 73.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -84.66 -163.7 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 70.41 -165.46 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.827 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 10.8 tt -53.5 150.86 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.311 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -106.8 141.59 37.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 62.54 143.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.915 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 60.44 110.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -95.63 42.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.38 -148.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.226 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.06 122.42 0.6 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.7 t70 61.9 63.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.91 0.386 . . . . 0.0 110.931 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -124.39 -46.49 1.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.941 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -174.22 137.53 0.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.42 -62.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.68 138.92 30.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.835 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.0 pt -78.42 138.88 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 41.0 t0 60.08 66.83 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -108.05 -31.02 8.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.3 mm . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.157 -0.925 . . . . 0.0 111.144 179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.6 ttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.763 0.316 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 62.86 40.44 9.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 154.73 175.9 26.37 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.525 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.09 51.55 2.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.82 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.83 38.24 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.21 164.31 30.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -126.09 151.16 47.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -110.3 111.25 22.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.12 -177.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.83 168.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.923 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 20.3 m -118.88 73.31 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.64 67.53 1.15 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.809 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.12 151.62 34.11 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.523 2.148 . . . . 0.0 112.16 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.069 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 CA-C-O 120.869 0.279 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -102.52 143.23 32.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.048 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t30 62.81 141.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.007 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.93 121.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.97 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.28 62.93 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.468 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -100.2 115.92 31.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.77 -168.9 0.69 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.461 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.58 31.13 3.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.524 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 73.52 1.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 0.0 110.845 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -161.04 94.84 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.4 -64.27 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.1 88.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.71 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 63.48 53.03 2.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.742 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.66 173.27 4.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.575 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -105.77 -73.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 0.0 110.899 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 62.0 72.74 0.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -144.55 159.09 43.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.7 p30 43.6 39.8 2.56 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -62.88 131.44 48.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -162.37 -60.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -66.19 120.23 12.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.839 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -138.15 60.45 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.963 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.47 80.75 6.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.766 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -74.67 150.84 39.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.018 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.524 HD11 ' HE1' ' A' ' 119' ' ' TYR . 19.7 tp -127.59 124.47 38.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.68 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.8 t -126.47 140.5 48.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.93 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.754 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 5.3 m-30 -110.6 170.64 7.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.442 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -46.45 147.62 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.039 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -128.1 165.05 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.283 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -57.47 130.51 46.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.739 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.44 -15.26 61.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.386 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.533 ' HB3' HD11 ' A' ' 91' ' ' LEU . 30.3 mt-30 -127.31 146.52 50.42 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.2 tt0 -125.29 153.88 42.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.022 0.439 . . . . 0.0 111.492 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 65' ' ' PHE . 7.8 p90 -84.32 157.88 21.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.84 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.81 173.55 15.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 112.388 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.4 tm0? -128.75 124.27 35.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.118 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 85' ' ' ASN . 21.7 t -76.58 140.94 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 111.95 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.935 HD11 ' HB2' ' A' ' 63' ' ' MET . 0.8 OUTLIER -115.95 -41.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.072 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -147.66 161.25 41.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.057 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.506 ' HE2' HD12 ' A' ' 84' ' ' ILE . 0.3 OUTLIER -110.15 142.04 42.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.441 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 61' ' ' GLU . 1.8 mt -97.04 -30.28 13.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 111.011 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.29 61.03 3.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.704 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -177.73 51.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.955 0.407 . . . . 0.0 110.568 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.59 11.07 64.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.424 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.708 ' HD2' HD12 ' A' ' 55' ' ' LEU . 24.8 ptt180 -147.25 164.17 34.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.833 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.19 155.61 42.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.789 ' HB2' HD21 ' A' ' 55' ' ' LEU . 22.7 tt0 -91.71 122.09 33.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.01 165.76 24.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.174 0.512 . . . . 0.0 111.941 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.935 ' HB2' HD11 ' A' ' 52' ' ' ILE . 4.6 tpp -131.28 111.79 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.116 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -59.27 131.76 51.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.361 . . . . 0.0 110.463 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 4.5 m-85 -48.64 -26.3 2.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.789 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -74.33 -14.22 60.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.84 1.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.58 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -126.92 126.28 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.868 0.366 . . . . 0.0 111.038 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.557 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.9 OUTLIER -95.01 113.23 24.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.29 163.52 34.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.627 HD22 ' N ' ' A' ' 71' ' ' LEU . 2.5 mm? -102.82 114.25 28.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.706 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 102' ' ' ALA . 12.2 m -83.99 118.71 24.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.49 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 4.9 m80 -83.99 146.32 28.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.837 HD11 ' CD1' ' A' ' 84' ' ' ILE . 23.7 mm -68.6 120.12 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.31 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 104' ' ' VAL . 28.5 tpt180 -64.79 137.98 58.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.19 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.96 -65.96 2.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.656 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -25.34 9.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 111.103 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -86.48 -17.78 33.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.477 ' HA ' HG12 ' A' ' 82' ' ' VAL . 11.5 ptt85 -48.73 -29.73 4.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.238 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -55.32 -27.07 44.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.98 38.78 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.058 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.614 ' O ' HG13 ' A' ' 82' ' ' VAL . 13.2 p -81.74 111.15 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.937 0.398 . . . . 0.0 110.758 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -111.15 110.52 21.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.482 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -115.05 147.47 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.489 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -132.27 160.77 35.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.686 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 86' ' ' THR . 74.7 m -80.59 -6.73 58.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.153 0.501 . . . . 0.0 111.805 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -147.51 69.86 1.16 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.746 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.96 161.98 36.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.133 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.82 HG21 ' CD1' ' A' ' 116' ' ' LEU . 1.5 mp -86.76 147.21 5.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.66 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.643 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.6 mt -150.42 172.37 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 111.58 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.64 ' H ' HG22 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -128.2 122.0 30.79 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.48 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 104' ' ' VAL . 13.6 m -117.86 157.01 19.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.55 123.23 7.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.539 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -115.39 111.79 21.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.764 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 ttm-85 -176.98 -71.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -70.44 -12.48 61.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -87.52 10.74 16.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.566 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.62 29.75 10.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.977 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.7 t0 68.45 -178.9 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.778 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.29 -61.06 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -96.36 163.6 13.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.676 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -163.74 139.82 6.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.96 129.4 36.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.026 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.69 ' HA ' HG12 ' A' ' 92' ' ' VAL . 96.2 t -55.01 111.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.808 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 mm -77.53 -48.76 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.135 0.493 . . . . 0.0 109.853 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.071 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.1 pp -140.94 167.3 22.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.255 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -111.82 119.59 39.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 112.305 -178.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.071 ' CE1' HD11 ' A' ' 106' ' ' LEU . 24.2 m-85 -83.86 106.08 15.26 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -72.2 177.86 4.21 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -77.13 -40.54 45.33 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.175 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -61.41 -40.49 94.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.694 ' O ' HD23 ' A' ' 116' ' ' LEU . 11.5 mt-10 -67.03 -27.91 67.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.508 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.872 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.31 -49.47 6.82 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.984 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -28.15 56.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.348 0.594 . . . . 0.0 109.5 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -79.98 -22.79 42.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.167 178.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.872 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -50.89 -33.75 25.43 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.064 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -55.2 -34.18 63.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.02 -20.32 45.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.932 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.754 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 3.7 m-30 -66.4 -6.14 13.39 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.83 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.46 24.8 53.55 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.791 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.457 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 49.2 mm-40 -114.27 -56.28 2.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.813 0.339 . . . . 0.0 111.414 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.737 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -90.85 153.29 45.24 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 73.5 Cg_endo -75.81 -179.79 5.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.723 2.282 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -71.0 -31.28 67.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.088 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.447 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 29.4 p-80 -84.17 2.71 38.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.532 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.533 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -61.1 122.28 14.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.158 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -108.82 121.53 45.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.815 HD13 ' HB1' ' A' ' 113' ' ' ALA . 2.9 mt -96.77 158.69 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.183 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 128' ' ' ILE . 11.4 p-10 -67.83 172.95 4.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.14 162.48 19.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.563 HG22 ' OG1' ' A' ' 133' ' ' THR . 6.5 m -63.42 -48.97 75.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.0 t0 63.05 44.09 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.563 ' OG1' HG22 ' A' ' 131' ' ' THR . 1.8 m -129.33 99.38 5.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -173.01 127.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 123.79 80.86 0.49 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.521 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.498 ' HG2' HG22 ' A' ' 142' ' ' ILE . 50.9 Cg_exo -53.03 -49.65 16.85 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.617 2.211 . . . . 0.0 112.308 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -162.55 42.92 0.36 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.552 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.29 113.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 0.0 110.98 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 43.32 80.99 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.438 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -160.24 125.96 4.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.846 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -87.91 97.88 11.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.993 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' A' ' 136' ' ' PRO . 6.1 tt -112.79 23.5 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.146 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -134.9 121.14 20.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.796 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -84.6 -45.76 12.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.033 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -67.74 132.56 47.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.31 -170.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 147' ' ' ILE . 29.7 mt -101.31 34.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -125.91 -160.5 10.66 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.59 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -98.19 116.07 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.769 0.319 . . . . 0.0 110.823 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -87.72 172.72 9.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.952 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -106.17 36.09 2.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -140.09 76.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -106.98 -174.01 2.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.783 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 154' ' ' ILE . 0.6 OUTLIER -93.33 48.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -68.23 157.87 34.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.37 169.4 17.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.106 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.83 0.348 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -101.05 -74.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.85 83.29 0.35 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.51 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -129.91 136.12 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.781 0.324 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -111.33 116.17 30.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -134.41 -48.62 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -144.6 85.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -93.53 131.46 38.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -136.35 172.33 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -134.67 150.96 50.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.871 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.61 51.74 2.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -146.93 89.9 5.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -51.98 -28.28 31.47 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.565 2.177 . . . . 0.0 112.327 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 2.0 ttp . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.893 -179.983 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.767 0.236 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt 64.78 91.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.883 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -58.61 -78.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.1 mptt 55.36 45.07 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.881 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.43 -25.95 43.16 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.616 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -129.86 169.08 15.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.59 88.61 0.11 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.557 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -167.11 152.66 21.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.27 -52.18 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.824 0.345 . . . . 0.0 110.945 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 61.71 30.22 18.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.97 163.58 14.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 tpt85 -129.26 85.32 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.927 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -72.01 -174.37 1.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.23 -122.42 2.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.496 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.38 178.11 5.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 59.23 170.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.968 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.99 69.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.73 56.44 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 63.53 144.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.73 96.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 60.59 160.36 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.93 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -123.7 123.91 41.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.849 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 61.4 111.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.825 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -174.47 100.38 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.01 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.526 HD11 ' HE1' ' A' ' 119' ' ' TYR . 22.9 tp -68.09 122.73 18.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 106' ' ' LEU . 15.4 t -114.69 139.88 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 111.617 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 24.5 m-85 -116.9 170.07 8.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.582 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB2' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -86.44 158.19 19.65 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.705 0.288 . . . . 0.0 110.792 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -144.46 178.04 8.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 111.361 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -44.52 137.02 3.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.303 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.82 -15.27 61.04 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.515 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.474 ' CB ' HD11 ' A' ' 91' ' ' LEU . 2.5 mt-30 -141.73 139.2 32.82 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.2 tt0 -123.4 157.63 32.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.007 0.432 . . . . 0.0 111.535 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 121' ' ' GLU . 4.9 p90 -84.5 158.05 21.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.152 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.521 ' HB2' HH21 ' A' ' 70' ' ' ARG . . . -151.93 173.86 14.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.248 0.547 . . . . 0.0 112.2 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.412 ' HG2' HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -128.78 120.6 26.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.019 179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.606 HG13 HD13 ' A' ' 60' ' ' LEU . 23.4 t -70.89 135.46 28.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 112.039 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.438 HD11 ' HB3' ' A' ' 63' ' ' MET . 14.0 mt -116.29 -40.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.434 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.5 157.62 46.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.835 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.543 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -117.12 131.6 56.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.747 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.996 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -105.89 -32.68 8.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.8 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.42 -171.67 48.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.57 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 m120 61.9 26.49 16.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.718 0.294 . . . . 0.0 111.049 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . 83.85 32.19 24.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.616 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.578 ' HG3' HD12 ' A' ' 55' ' ' LEU . 12.1 ptt180 -155.4 157.27 36.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.657 0.265 . . . . 0.0 110.605 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.843 HD23 HD13 ' A' ' 84' ' ' ILE . 2.6 pp -148.04 160.91 42.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.967 0.413 . . . . 0.0 111.611 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.901 ' HB2' HD21 ' A' ' 55' ' ' LEU . 34.4 tt0 -104.41 120.83 42.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -136.51 164.68 27.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.23 0.538 . . . . 0.0 112.033 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.648 ' HE3' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -120.08 114.8 22.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.191 179.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.2 m -59.45 133.47 56.13 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.502 ' CG ' ' CE2' ' A' ' 48' ' ' TYR . 4.6 m-85 -48.2 -25.54 1.54 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.622 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.0 -14.07 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.339 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.89 39.75 2.45 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.664 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.34 129.6 70.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.79 0.328 . . . . 0.0 111.428 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.648 ' HG3' ' HE3' ' A' ' 63' ' ' MET . 1.7 ttmp? -91.66 117.94 30.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.603 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.521 HH21 ' HB2' ' A' ' 49' ' ' ALA . 33.2 ptt180 -142.7 165.57 27.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.981 0.42 . . . . 0.0 111.165 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.996 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -104.29 108.08 19.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.632 ' HB3' HG11 ' A' ' 92' ' ' VAL . 12.5 m -84.87 118.75 24.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.416 ' CD2' ' CE2' ' A' ' 97' ' ' TYR . 2.2 m-70 -85.01 130.32 34.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 84' ' ' ILE . 12.0 tt -68.64 140.91 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.893 0.378 . . . . 0.0 111.047 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 14.2 tpt180 -76.6 148.51 36.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.087 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.22 -79.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.984 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.39 -26.1 4.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.722 0.296 . . . . 0.0 111.544 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -79.93 -45.33 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.186 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.4 ' HA ' HG12 ' A' ' 82' ' ' VAL . 3.5 ptt180 -58.46 -24.12 59.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.795 0.331 . . . . 0.0 111.062 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -58.64 -33.43 70.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.067 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 8.44 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.585 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.495 ' CB ' HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -124.18 119.69 57.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.132 0.491 . . . . 0.0 111.167 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -111.07 110.32 20.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.766 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.843 HD13 HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.49 147.59 12.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.3 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -118.97 159.33 24.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 86' ' ' THR . 40.2 m -76.12 -6.09 49.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.697 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.1 p -145.83 71.57 1.27 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.702 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -156.59 160.52 39.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.079 0.466 . . . . 0.0 111.208 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.857 HG21 ' CD1' ' A' ' 116' ' ' LEU . 38.3 mm -86.94 146.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.489 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.643 HD13 HG22 ' A' ' 84' ' ' ILE . 1.4 mt -150.41 171.14 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.241 0.543 . . . . 0.0 111.631 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.716 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.07 124.37 34.67 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.429 178.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG12 ' CA ' ' A' ' 104' ' ' VAL . 16.9 m -122.69 160.26 25.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.351 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.93 135.77 12.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.447 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 47' ' ' GLU . 2.8 mt -100.45 159.1 15.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 60.87 22.82 12.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.178 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.04 -47.37 7.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 110.674 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.416 ' CE2' ' CD2' ' A' ' 73' ' ' HIS . 46.2 m-85 -96.95 4.15 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.136 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 65.82 29.71 10.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.722 0.296 . . . . 0.0 110.796 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -154.61 175.32 13.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.021 0.438 . . . . 0.0 111.109 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -17.58 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.109 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -77.67 124.79 28.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 0.0 111.369 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.478 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -111.5 156.16 22.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.053 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.409 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 13.1 p30 -102.82 120.67 41.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.881 0.372 . . . . 0.0 111.426 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.67 ' CA ' HG12 ' A' ' 92' ' ' VAL . 80.3 t -52.62 111.41 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.325 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.408 ' HB ' ' HG ' ' A' ' 91' ' ' LEU . 32.6 mm -79.02 -33.25 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.266 0.555 . . . . 0.0 109.81 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.04 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.6 pp -159.1 166.83 30.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.442 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.54 ' N ' HD12 ' A' ' 106' ' ' LEU . 1.6 tttt -109.9 116.94 32.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.061 0.457 . . . . 0.0 112.145 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.04 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.3 m-85 -79.23 106.12 11.04 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -73.44 177.15 5.45 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -176.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.671 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -76.03 -40.16 54.03 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.001 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.07 -40.81 97.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.678 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.9 mt-10 -67.76 -28.1 67.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.381 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -43.44 -49.13 7.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.829 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -56.39 -29.21 61.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.31 0.576 . . . . 0.0 109.489 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -78.32 -22.56 47.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.181 178.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.857 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -51.08 -33.86 27.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 121.137 -0.225 . . . . 0.0 111.024 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -33.76 61.54 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 175.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.637 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.2 -21.01 43.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.729 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.702 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.0 m-30 -66.73 -8.44 28.08 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.122 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 57.89 23.46 51.18 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.418 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 2.9 mm-40 -109.93 -51.55 2.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.703 0.287 . . . . 0.0 111.124 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.724 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -97.99 125.21 44.85 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.545 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 35.6 Cg_exo -57.27 179.0 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.327 2.018 . . . . 0.0 112.15 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.59 -28.63 67.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 10.3 p-80 -80.78 -23.28 39.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.222 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.545 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -55.39 141.21 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.284 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -124.14 146.51 48.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.863 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.6 mt -99.98 152.51 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.02 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -67.1 164.69 17.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -61.76 127.15 30.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.455 HG23 ' HB3' ' A' ' 110' ' ' ALA . 20.7 m -58.5 -22.0 53.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.195 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.7 t0 65.04 42.22 4.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.922 0.391 . . . . 0.0 110.81 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.4 m -83.11 97.34 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.59 114.2 0.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.18 99.14 2.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.481 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.74 101.86 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.471 2.114 . . . . 0.0 112.213 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.21 -28.28 64.0 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t70 62.15 97.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.839 0.352 . . . . 0.0 110.883 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -100.22 145.25 28.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.13 -178.82 3.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.47 -63.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.47 67.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.57 117.11 29.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -104.64 126.83 52.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.767 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.93 111.93 1.67 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -144.19 128.66 17.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 147' ' ' ILE . 6.4 tp -100.44 82.91 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.151 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -95.74 171.19 28.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.43 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -110.83 -37.19 5.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.783 0.325 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -65.75 114.04 4.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.34 101.7 11.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.45 31.54 5.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -111.75 -69.49 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.6 tp -145.17 144.55 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -159.76 83.64 0.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 66.66 -71.25 0.1 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.516 HD12 ' H ' ' A' ' 157' ' ' ILE . 3.5 mp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.078 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.923 0.392 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -74.58 100.37 3.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.844 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.39 43.5 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.459 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.18 152.11 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.862 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.33 120.0 4.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.973 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -170.72 57.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.762 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -87.88 -31.14 19.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 61.54 -167.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 1.5 m80 63.04 -79.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.067 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -120.83 58.24 0.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.822 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.6 156.52 19.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -151.36 63.16 5.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.42 97.45 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.561 2.174 . . . . 0.0 112.167 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--O 1.231 0.159 0 CA-C-O 120.786 0.244 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.95 56.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.04 -39.27 42.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.2 153.2 34.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.51 72.98 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.574 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -80.14 119.18 22.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.849 0.357 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 99.16 101.57 2.31 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.46 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.96 134.0 14.28 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -107.68 -29.1 9.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.76 0.315 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -56.27 175.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.3 mmt-85 -63.03 99.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.879 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -117.81 121.94 42.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -115.58 91.14 3.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.85 27.44 19.59 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.539 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -109.72 -172.17 1.99 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 0.0 110.845 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.3 m120 61.97 105.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -127.65 42.21 3.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.8 m120 60.65 -174.63 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -167.49 58.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 t -97.38 113.32 24.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.806 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 62.09 -161.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.594 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.4 tttt 73.9 60.38 0.09 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.937 0.399 . . . . 0.0 110.88 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 59.98 101.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.39 88.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.477 HD21 ' CB ' ' A' ' 115' ' ' SER . 13.7 tp -118.9 130.51 55.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.549 HG11 ' CD2' ' A' ' 106' ' ' LEU . 17.7 t -121.84 139.58 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.097 0.475 . . . . 0.0 111.402 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 119' ' ' TYR . 53.8 m-85 -115.22 171.7 7.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.499 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -39.44 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.066 0.46 . . . . 0.0 111.979 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -133.81 158.49 43.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 126.78 28.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.74 78.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.97 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.656 ' OE1' HD11 ' A' ' 91' ' ' LEU . 3.0 mt-30 -115.12 143.77 44.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.824 0.312 . . . . 0.0 110.658 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.865 ' HB2' HD11 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -119.22 166.21 13.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.951 0.405 . . . . 0.0 111.129 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.597 ' CZ ' ' CE2' ' A' ' 108' ' ' TYR . 3.8 m-85 -84.78 156.82 21.21 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.706 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 64' ' ' CYS . . . -149.5 142.75 25.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.681 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -116.29 108.43 16.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.946 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 60' ' ' LEU . 21.5 t -55.42 137.56 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.12 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.461 HD11 ' C ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -116.13 -42.62 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.15 151.95 41.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.68 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.462 ' C ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -99.47 134.04 42.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.679 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD12 ' HD2' ' A' ' 59' ' ' ARG . 1.2 mt -93.72 -35.63 12.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.825 0.345 . . . . 0.0 110.772 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 157.25 -132.35 3.2 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -112.6 89.52 3.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.779 0.324 . . . . 0.0 110.976 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 147.75 -24.21 1.48 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.822 ' HD2' HD12 ' A' ' 55' ' ' LEU . 14.6 ptt180 -152.87 160.25 43.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.634 0.254 . . . . 0.0 110.534 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.838 HD22 ' CD1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -147.21 150.05 34.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.859 0.361 . . . . 0.0 111.367 -179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.682 ' HB2' HD21 ' A' ' 55' ' ' LEU . 4.3 tt0 -91.72 121.64 33.55 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.461 ' C ' HD11 ' A' ' 52' ' ' ILE . . . -137.56 166.11 24.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.237 0.541 . . . . 0.0 112.318 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.478 ' HE3' ' CG ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -115.17 95.92 5.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.095 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 18.7 t -45.8 125.91 6.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.88 ' CZ ' HD22 ' A' ' 122' ' ' LEU . 0.7 OUTLIER -48.46 -23.35 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.91 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -13.2 60.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.599 0.238 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.43 34.36 4.2 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.687 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.19 124.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.867 0.365 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' CG ' ' HE3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -85.86 112.47 21.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.449 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -145.58 165.77 27.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.907 0.385 . . . . 0.0 111.304 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.705 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -97.12 108.01 20.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.484 ' SG ' HG11 ' A' ' 92' ' ' VAL . 29.6 m -84.24 125.76 32.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.614 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.75 137.08 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.697 HD11 HG13 ' A' ' 82' ' ' VAL . 8.1 tt -68.87 140.3 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.821 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.421 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -74.31 145.69 43.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.913 0.387 . . . . 0.0 111.348 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.89 -51.23 15.61 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.272 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -31.56 64.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.986 0.422 . . . . 0.0 110.501 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.5 mm? -85.9 -31.71 22.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.453 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.526 ' HA ' HG12 ' A' ' 82' ' ' VAL . 8.1 mtp180 -49.01 -28.84 4.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.314 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -56.9 -27.48 60.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.404 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -169.37 49.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.857 0.36 . . . . 0.0 111.165 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 107' ' ' LYS . 9.4 p -123.0 122.94 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.644 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -111.03 109.58 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.673 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.838 ' CD1' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -81.12 123.77 38.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 179.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.497 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.4 OUTLIER -84.72 152.82 23.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.724 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 86' ' ' THR . 63.0 m -79.92 -5.92 56.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.047 0.451 . . . . 0.0 111.512 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.0 p -146.54 51.77 1.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.409 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -133.71 165.0 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 111.57 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.841 HG21 ' CD1' ' A' ' 116' ' ' LEU . 1.5 mp -87.72 146.58 6.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.875 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.75 HG23 ' HA ' ' A' ' 107' ' ' LYS . 1.3 mt -150.42 170.5 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.054 0.454 . . . . 0.0 111.195 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.667 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -123.27 122.4 38.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.93 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 104' ' ' VAL . 19.4 m -120.55 154.26 23.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.676 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -97.04 153.81 20.38 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.851 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -137.17 131.25 32.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.708 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 179.55 -68.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.094 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -76.28 -15.02 60.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 101' ' ' LYS . 16.8 m-85 -72.58 -11.4 60.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.582 0.229 . . . . 0.0 111.556 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 64.87 29.72 12.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.857 0.36 . . . . 0.0 110.807 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 0.9 OUTLIER 62.85 97.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 99' ' ' ASP . 4.3 t-20 165.12 -28.82 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.717 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . 24.3 mttt -141.94 162.39 35.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.474 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.651 ' HB1' ' HB ' ' A' ' 92' ' ' VAL . . . -139.29 170.99 14.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.93 0.395 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -128.79 111.33 13.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.71 ' HA ' HG12 ' A' ' 92' ' ' VAL . 68.5 t -49.94 112.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.921 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.3 mm -83.94 -43.29 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.175 0.512 . . . . 0.0 109.764 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.027 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.0 pp -144.46 165.82 26.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.421 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.816 ' HG2' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -111.87 120.7 42.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.86 0.362 . . . . 0.0 111.923 -179.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.027 ' CE1' HD11 ' A' ' 106' ' ' LEU . 27.3 m-85 -83.11 105.91 14.47 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.97 166.77 4.31 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -73.12 -35.96 66.63 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.402 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.96 -40.22 97.03 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.738 ' O ' HD23 ' A' ' 116' ' ' LEU . 51.7 mt-10 -64.18 -28.19 69.58 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.561 177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.954 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.58 -38.43 2.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.675 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.48 -33.98 77.16 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.647 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 5.1 p -77.58 -23.09 50.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.867 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.954 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -52.54 -31.36 35.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.869 -0.333 . . . . 0.0 111.18 -179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -33.11 62.69 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 175.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.31 -21.79 42.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.691 -1.595 . . . . 0.0 110.731 177.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.736 ' CD2' HD22 ' A' ' 116' ' ' LEU . 4.1 m-30 -67.44 -7.55 26.23 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.858 0.361 . . . . 0.0 110.218 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.53 35.11 84.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.003 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.479 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 38.2 mm-40 -125.83 -56.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 0.0 111.274 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.88 HD22 ' CZ ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -93.62 118.64 67.51 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HB2' ' CE1' ' A' ' 125' ' ' HIS . 51.2 Cg_exo -54.3 178.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.504 2.136 . . . . 0.0 112.206 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.28 -31.07 71.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.463 ' CE1' ' HB2' ' A' ' 123' ' ' PRO . 10.0 p-80 -77.23 -17.85 58.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.246 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -52.62 128.73 27.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.363 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -106.76 133.03 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.853 HD13 ' HB1' ' A' ' 113' ' ' ALA . 5.4 mt -101.77 155.74 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.418 ' N ' HG22 ' A' ' 128' ' ' ILE . 12.0 p-10 -72.39 63.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 54.34 -174.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.128 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.7 m -117.73 -64.41 1.3 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.98 88.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.5 p -99.13 174.4 6.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.965 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 134' ' ' PHE . 16.0 p90 -124.42 100.37 6.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 178.79 98.18 0.11 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.473 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.42 179.23 2.61 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.507 2.138 . . . . 0.0 112.335 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 83.87 -144.63 22.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.482 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.77 131.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.765 0.317 . . . . 0.0 110.993 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 61.63 117.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.024 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -60.16 103.36 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.98 -46.41 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 22.8 mt -140.67 118.88 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.223 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -100.14 -15.76 18.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.203 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -53.79 -43.92 69.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.802 0.334 . . . . 0.0 111.016 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.28 42.04 15.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.53 76.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 147' ' ' ILE . 0.7 OUTLIER -151.42 109.81 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.078 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.17 -179.25 51.7 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 61.54 155.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.861 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.94 131.97 38.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -136.35 43.33 2.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.71 106.48 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -103.28 -24.03 13.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.695 ' N ' HD13 ' A' ' 154' ' ' ILE . 0.1 OUTLIER -132.79 68.2 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.919 0.39 . . . . 0.0 111.072 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -144.09 121.14 11.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.845 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -139.89 125.23 18.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 27.3 mm . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.141 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.79 0.328 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 62.29 159.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.797 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.08 42.6 0.19 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.529 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.82 70.66 1.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.893 0.378 . . . . 0.0 110.869 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -119.42 32.35 6.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.89 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -133.19 174.6 10.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.846 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -164.01 107.48 0.96 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.842 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.96 145.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 33.7 m170 60.72 -178.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 62.08 29.59 17.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.002 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 51.2 m -87.05 70.09 10.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.786 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.45 76.36 0.51 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 172.82 11.84 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.54 2.16 . . . . 0.0 112.327 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 -179.977 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo . . . . . 0 C--O 1.231 0.151 0 CA-C-O 120.739 0.224 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.9 -64.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 64.37 73.69 0.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.773 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -110.5 -23.24 11.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.135 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -51.42 122.73 16.3 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.716 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -82.45 -59.47 2.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.36 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.44 -56.72 0.38 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.507 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.45 -102.83 0.65 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.453 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? 61.09 29.21 18.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.708 0.289 . . . . 0.0 110.929 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -176.39 37.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.753 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 62.24 50.06 4.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.99 89.41 0.08 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 28.12 0.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.014 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.95 -29.38 3.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.424 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 67.66 -70.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.752 0.31 . . . . 0.0 111.061 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.94 86.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.39 -57.57 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 m120 64.97 -78.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.821 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -92.61 -11.67 33.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.283 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 p 64.93 110.92 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.845 0.355 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.38 43.77 1.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -59.63 -32.8 70.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.23 102.84 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.41 137.23 53.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD21 ' CB ' ' A' ' 115' ' ' SER . 16.4 tp -127.21 123.73 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.4 140.23 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.755 ' CE1' ' CD1' ' A' ' 119' ' ' TYR . 2.6 m-85 -111.04 170.06 8.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.085 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -69.48 149.13 48.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.685 179.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.25 176.41 7.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 0.0 111.346 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -49.64 134.1 20.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.081 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.45 -15.09 60.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.504 HE22 HG21 ' A' ' 105' ' ' ILE . 0.0 OUTLIER -134.12 139.42 45.9 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -125.06 157.2 36.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.07 0.462 . . . . 0.0 111.496 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.486 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 2.9 p90 -84.6 158.12 20.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.034 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.37 173.65 13.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.233 0.539 . . . . 0.0 111.997 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.446 ' HB2' ' CE1' ' A' ' 65' ' ' PHE . 38.4 tp60 -128.64 108.94 10.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.92 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.518 HG21 HD11 ' A' ' 90' ' ' ILE . 12.0 t -60.98 136.14 24.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.047 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 63' ' ' MET . 1.2 mp -116.2 -40.88 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.703 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 157.95 44.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.644 ' C ' HD23 ' A' ' 55' ' ' LEU . 1.5 ttt -116.9 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.66 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -117.35 -167.62 1.35 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.729 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.37 -178.53 19.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.441 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.36 39.89 1.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 57.73 52.15 53.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.76 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.544 ' HG3' HD12 ' A' ' 55' ' ' LEU . 8.2 ptt180 -154.81 162.66 41.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.752 0.311 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -147.06 152.26 38.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.291 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.895 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.5 tt0 -94.02 121.82 35.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.907 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.29 161.36 30.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.235 0.54 . . . . 0.0 112.093 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.654 ' HB3' HD13 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -119.97 101.65 8.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.146 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.05 129.22 40.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.37 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 3.4 m-85 -50.63 -24.54 3.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.468 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.25 -8.42 56.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.03 35.63 5.0 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.685 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.6 t -127.23 124.72 64.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.377 . . . . 0.0 111.087 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HB2' ' HE1' ' A' ' 63' ' ' MET . 9.8 tptm -96.36 115.21 27.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -141.48 160.99 39.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.799 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.038 HD12 HD11 ' A' ' 55' ' ' LEU . 2.4 mm? -95.67 110.79 22.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.464 ' HB3' HG11 ' A' ' 92' ' ' VAL . 12.5 m -84.25 119.02 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.503 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -79.85 141.49 36.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.373 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.65 HD11 HD11 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -68.63 126.76 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.05 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -179.23 -168.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.027 0.441 . . . . 0.0 111.645 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.47 171.16 40.97 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.298 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -21.6 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.848 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.5 HD12 ' HG2' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -68.71 -10.81 58.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.412 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -47.6 -28.52 2.36 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.611 0.243 . . . . 0.0 111.48 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -61.96 -26.28 68.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 110.717 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.43 ' HE3' ' CZ2' ' A' ' 83' ' ' TRP . 10.2 mtpt -170.31 52.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.621 ' O ' HG13 ' A' ' 82' ' ' VAL . 14.3 p -81.97 111.07 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.43 ' CZ2' ' HE3' ' A' ' 81' ' ' LYS . 10.3 m0 -111.62 109.62 19.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.606 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.033 HD13 HD22 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -97.06 147.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.63 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 2.4 m-80 -119.58 153.38 35.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.927 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 86' ' ' THR . 55.9 m -80.25 -6.4 57.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 111.675 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.7 62.37 1.32 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.747 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.98 165.73 34.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.261 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 116' ' ' LEU . 37.2 mm -86.93 145.7 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.29 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.675 HD13 HG22 ' A' ' 84' ' ' ILE . 1.1 mt -150.84 171.17 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.156 0.503 . . . . 0.0 111.421 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.72 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -129.01 122.24 29.62 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.536 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.636 HG12 ' CA ' ' A' ' 104' ' ' VAL . 10.1 m -115.18 164.14 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -108.92 123.21 6.86 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.532 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -109.98 119.76 40.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.755 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -163.96 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.54 -12.16 60.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -84.81 10.99 10.02 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.685 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 66.79 26.79 9.36 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.637 0.256 . . . . 0.0 111.185 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 72.8 -57.22 0.64 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.462 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -40.71 -32.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.717 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -123.61 158.96 30.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 72' ' ' CYS . . . -153.07 156.34 38.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.91 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -107.23 126.5 52.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.636 ' CA ' HG12 ' A' ' 92' ' ' VAL . 87.2 t -52.5 111.53 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.686 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.504 HG21 HE22 ' A' ' 46' ' ' GLN . 12.7 mm -80.93 -58.4 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.867 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.048 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -129.67 167.22 18.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.358 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.636 ' N ' HD12 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -110.84 119.31 38.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.048 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.3 m-85 -84.01 106.38 15.62 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -70.46 172.84 7.74 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.675 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -75.61 -51.05 13.71 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.636 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -61.32 -39.14 89.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.534 ' CG ' ' CD1' ' A' ' 39' ' ' LEU . 23.6 tt0 -67.1 -29.94 69.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.158 -1.383 . . . . 0.0 109.607 177.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.859 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -45.84 -42.87 12.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.543 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.88 -41.89 58.65 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.279 0.561 . . . . 0.0 110.149 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.629 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -61.87 -21.32 64.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.516 178.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.914 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -50.7 -33.35 22.43 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.369 -179.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -55.24 -34.74 64.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.3 -20.58 44.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.009 177.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.755 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 4.2 m-30 -66.58 -8.28 25.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.876 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 58.94 22.93 56.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.493 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 66.6 mm-40 -109.77 -61.0 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.912 0.387 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.637 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -82.18 139.45 45.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.745 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 126' ' ' ALA . 64.3 Cg_endo -73.78 178.03 7.32 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.549 2.166 . . . . 0.0 112.331 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.45 -29.8 70.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.441 ' CE1' ' CG ' ' A' ' 123' ' ' PRO . 27.3 p-80 -84.19 2.48 39.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.5 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.623 ' HB2' ' HD2' ' A' ' 123' ' ' PRO . . . -74.15 126.37 30.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 110.994 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -123.59 127.58 48.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.859 HD13 ' HB1' ' A' ' 113' ' ' ALA . 5.7 mt -91.95 156.38 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.932 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.455 ' N ' HG22 ' A' ' 128' ' ' ILE . 70.2 m-20 -78.81 151.03 32.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.98 133.06 55.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.622 HG23 ' HB3' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -62.08 139.12 58.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.26 -45.29 2.88 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.842 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.81 -175.97 4.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.952 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -162.27 93.72 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.974 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 116.46 -93.9 0.62 Allowed Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.633 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.6 -178.66 3.16 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.542 2.161 . . . . 0.0 112.52 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.25 -95.54 0.11 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.438 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 59.03 77.85 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.797 0.332 . . . . 0.0 110.97 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.404 ' OD1' HD13 ' A' ' 147' ' ' ILE . 10.0 t70 -160.5 52.02 0.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.5 -28.82 68.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -87.3 160.53 18.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.94 -31.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.466 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -50.35 94.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 111.26 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 62.51 122.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -137.26 142.18 41.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -164.52 47.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 147' ' ' ILE . 3.8 mp -101.18 38.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.12 -175.57 13.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.517 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.35 136.38 54.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.774 0.321 . . . . 0.0 110.949 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -168.62 169.97 9.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.837 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 t0 62.11 39.09 13.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -85.92 129.45 34.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.14 147.98 37.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 154' ' ' ILE . 1.6 pp -113.83 171.49 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.102 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.1 t0 61.69 97.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.852 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.0 t0 62.9 -168.04 0.2 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.427 HD12 ' OXT' ' A' ' 157' ' ' ILE . 1.5 pp . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.11 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.731 0.3 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -37.5 79.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.827 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 109.78 113.75 3.57 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.431 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.1 p -146.57 105.85 3.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.33 . . . . 0.0 110.908 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -170.9 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.949 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -137.9 161.81 35.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -113.85 86.09 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -63.03 -179.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -104.8 116.23 31.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -153.17 111.78 3.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.442 HG22 ' HD3' ' B' ' 13' ' ' PRO . 35.0 m -95.75 127.91 42.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.854 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -143.06 83.37 11.23 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.442 ' HD3' HG22 ' B' ' 11' ' ' THR . 51.6 Cg_endo -69.18 -177.87 1.87 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.625 2.217 . . . . 0.0 112.261 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.797 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.816 0.257 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -84.4 81.34 8.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -87.42 153.32 21.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -87.5 -24.43 24.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.02 125.99 34.7 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.644 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.96 -172.18 2.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 0.0 110.9 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.74 34.62 78.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.557 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.0 85.59 0.11 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -156.03 66.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -173.63 121.05 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.797 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -100.31 170.07 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 mpp_? -70.22 110.42 5.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 106.9 1.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.899 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 163.9 43.39 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -70.56 -20.18 62.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.697 0.284 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.6 m120 65.03 133.0 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.872 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 59.4 101.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.83 112.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -111.32 71.67 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.849 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -115.0 153.34 30.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.98 71.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.924 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -157.21 -72.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -176.8 147.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.821 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -100.04 98.5 9.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.047 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.66 HD11 ' CE1' ' A' ' 119' ' ' TYR . 23.3 tp -103.29 118.38 36.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.471 ' HB ' HD22 ' A' ' 106' ' ' LEU . 19.1 t -108.08 139.11 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.243 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.628 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 66.9 m-85 -112.75 170.43 8.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.711 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.597 ' HA ' HD22 ' A' ' 91' ' ' LEU . 3.0 ttpt -48.28 143.42 4.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.47 156.17 19.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.269 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -56.1 129.85 41.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.838 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.23 -15.35 62.31 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.391 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.624 ' OE1' HD11 ' A' ' 91' ' ' LEU . 15.7 mt-30 -116.38 152.95 32.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.636 0.255 . . . . 0.0 110.401 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' A' ' 94' ' ' LEU . 5.9 tt0 -125.93 154.48 42.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.024 0.44 . . . . 0.0 111.335 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 121' ' ' GLU . 10.0 p90 -84.34 157.87 21.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.76 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.83 173.42 15.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.327 0.584 . . . . 0.0 112.204 -178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.689 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 2.3 tm0? -123.77 142.43 51.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.813 179.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.597 HG13 HD13 ' A' ' 60' ' ' LEU . 22.7 t -92.16 139.02 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 111.799 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 63' ' ' MET . 1.0 OUTLIER -115.85 -48.12 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.274 179.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -141.77 162.2 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.699 ' SD ' HD12 ' A' ' 84' ' ' ILE . 26.0 mmm -113.96 137.09 52.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.872 HD11 HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -106.19 -69.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.896 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.23 179.65 16.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.565 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -72.37 -13.99 61.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.565 0.221 . . . . 0.0 111.259 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -118.78 8.85 12.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.824 ' HD2' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -155.4 155.98 34.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.752 0.311 . . . . 0.0 111.0 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.849 ' CD2' HD13 ' A' ' 84' ' ' ILE . 1.6 pp -147.89 164.1 34.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.939 0.4 . . . . 0.0 111.379 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.859 ' HB2' HD21 ' A' ' 55' ' ' LEU . 40.4 tt0 -104.23 121.42 43.25 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 50' ' ' GLN . . . -133.05 165.96 23.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.274 0.559 . . . . 0.0 112.262 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.876 ' HB2' HD11 ' A' ' 52' ' ' ILE . 3.7 tpp -130.14 110.92 11.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.078 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.1 t -59.25 133.5 56.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 2.4 m-85 -49.33 -27.27 3.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.502 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.37 -13.24 60.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.359 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.58 43.04 1.9 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.497 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.05 117.8 48.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.197 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.6 OUTLIER -90.64 112.99 24.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.1 156.84 44.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.872 HD12 HD11 ' A' ' 55' ' ' LEU . 2.7 mm? -92.66 107.89 19.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.856 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.6 ' HB3' HG11 ' A' ' 92' ' ' VAL . 32.3 m -84.17 118.42 24.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.376 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -82.84 123.7 29.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.765 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.69 HD12 HG12 ' A' ' 84' ' ' ILE . 5.5 tt -68.73 140.54 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 176.73 -161.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.793 0.33 . . . . 0.0 111.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.3 168.93 39.01 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.028 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -27.72 2.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.951 0.405 . . . . 0.0 110.575 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.47 ' O ' HG12 ' A' ' 82' ' ' VAL . 1.2 mm? -64.47 -34.57 78.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.784 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.504 ' HA ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -49.01 -27.16 3.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.292 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.3 tptt -56.76 -37.66 71.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -157.64 48.18 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.196 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.8 p -123.51 121.19 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.261 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -110.55 109.86 20.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.775 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.849 HD13 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.38 147.17 12.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.086 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.42 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -108.75 152.84 24.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.957 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 86' ' ' THR . 70.3 m -80.17 -6.36 57.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.047 0.451 . . . . 0.0 111.69 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 p -146.2 61.69 1.24 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.687 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.96 168.52 22.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.186 0.517 . . . . 0.0 111.45 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.778 HG21 ' CD1' ' A' ' 116' ' ' LEU . 47.6 mm -91.81 146.78 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.213 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.64 ' CG2' HG13 ' A' ' 104' ' ' VAL . 1.2 mt -150.9 170.7 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.469 . . . . 0.0 111.449 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.684 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -128.68 121.66 29.05 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.519 178.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 104' ' ' VAL . 15.3 m -118.66 148.4 21.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.13 128.4 8.93 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -114.83 111.54 21.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.735 0.302 . . . . 0.0 110.73 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.33 -75.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -55.35 -23.22 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.335 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -85.28 4.88 32.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.633 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 65.78 30.02 10.32 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.804 0.335 . . . . 0.0 110.74 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 76.36 178.86 0.17 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.563 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 73.28 -60.67 0.53 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.809 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -102.26 151.05 22.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.674 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.464 ' HB3' ' CG2' ' A' ' 92' ' ' VAL . . . -148.83 151.22 34.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.991 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -99.44 127.96 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.751 ' HA ' HG12 ' A' ' 92' ' ' VAL . 62.0 t -54.86 111.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.471 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -82.73 -56.74 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.091 0.472 . . . . 0.0 109.923 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.08 HD11 ' CE1' ' A' ' 108' ' ' TYR . 1.7 pp -130.91 166.08 21.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.48 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.628 ' N ' HD12 ' A' ' 106' ' ' LEU . 10.4 tttt -111.74 117.93 34.22 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.08 ' CE1' HD11 ' A' ' 106' ' ' LEU . 23.2 m-85 -84.15 106.55 15.88 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -87.48 -178.94 6.26 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.637 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -68.38 -45.35 72.99 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.363 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.86 -39.48 77.88 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 116' ' ' LEU . 54.2 mt-10 -71.15 -28.7 64.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.593 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.891 ' HA ' ' HG ' ' A' ' 116' ' ' LEU . . . -43.81 -47.46 8.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.637 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.85 -28.98 64.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 109.399 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.638 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -79.7 -22.86 42.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.253 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.891 ' HG ' ' HA ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -51.74 -34.07 37.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 121.163 -0.215 . . . . 0.0 111.095 -179.527 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -55.18 -33.22 62.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 175.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.27 -21.1 43.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 113.91 -1.496 . . . . 0.0 110.806 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.706 ' HE2' ' CD1' ' A' ' 108' ' ' TYR . 4.0 m-30 -66.57 -9.95 40.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.11 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 59.25 22.55 56.11 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.595 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.494 ' HB3' ' CE1' ' A' ' 48' ' ' TYR . 3.0 mm-40 -108.95 -52.74 2.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 0.0 111.055 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.708 HD11 HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.06 130.65 35.4 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.825 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 178.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.346 2.031 . . . . 0.0 112.138 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -73.42 -28.15 61.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -84.04 1.39 44.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.57 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.94 138.12 55.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.878 0.371 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.71 125.32 44.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.869 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.3 mt -94.75 142.94 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.44 162.37 23.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.829 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -61.13 -170.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 2.0 m -61.55 -59.34 5.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.67 91.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.81 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.0 m -143.9 62.11 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.8 41.05 2.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.825 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -52.5 107.28 0.49 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.733 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.12 88.91 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.438 2.092 . . . . 0.0 112.239 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.13 -97.17 1.02 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.527 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 62.0 116.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.905 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -173.72 160.48 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.932 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -168.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -152.77 42.97 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.62 HG23 ' HG3' ' A' ' 143' ' ' GLN . 11.2 tt -56.56 -38.99 59.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.257 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.62 ' HG3' HG23 ' A' ' 142' ' ' ILE . 30.6 mt-30 -86.01 145.94 26.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.916 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -65.56 130.81 44.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.11 38.29 1.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -136.32 106.04 6.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.65 ' N ' HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -125.15 79.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.992 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.43 162.81 36.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.368 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -168.67 133.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -76.66 -42.31 42.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -79.48 179.07 7.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.8 134.47 47.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -81.77 149.77 28.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.9 mt 63.56 81.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -110.63 56.1 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -108.19 68.35 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.147 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.84 0.352 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.12 179.07 6.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 125.83 135.51 4.3 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.501 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.87 112.0 14.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.89 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -119.37 60.58 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 61.2 99.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -170.33 131.68 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -162.84 44.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 56.5 m170 60.64 83.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -115.04 -44.49 3.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 10.1 t -162.64 36.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -135.85 110.44 10.17 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.68 -11.36 31.86 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.437 2.092 . . . . 0.0 112.544 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' MET . . . . . . . . . . . . . 24.5 tpp . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.922 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.807 0.253 . . . . 0.0 112.309 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -74.75 78.9 2.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -81.63 78.45 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mttp 64.12 -77.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.098 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.59 -120.52 15.02 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.46 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -109.93 65.92 0.62 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.9 0.381 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.5 92.91 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.519 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.1 -123.25 7.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.517 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.44 -68.54 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 111.002 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -57.86 89.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -156.42 138.83 14.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -131.98 91.08 2.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.5 89.67 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.88 -97.46 2.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.91 -78.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.762 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 57.5 -165.45 0.16 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 65.36 52.9 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 59.06 179.57 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.057 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.58 -168.44 1.9 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 p -138.58 137.83 37.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -170.96 48.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.82 31.86 18.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.912 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 -104.08 73.26 1.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.878 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -129.04 81.44 2.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 115' ' ' SER . 13.0 tp -68.56 105.74 2.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.903 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' CG1' HD22 ' A' ' 106' ' ' LEU . 17.8 t -97.78 139.35 20.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.047 0.451 . . . . 0.0 111.204 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 119' ' ' TYR . 78.6 m-85 -108.58 170.72 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.995 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.447 ' HA ' HD22 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -44.31 158.28 0.05 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.43 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -123.0 156.17 35.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.087 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.86 126.2 26.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.85 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.94 -15.35 62.02 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.604 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.56 ' HB2' HD11 ' A' ' 91' ' ' LEU . 3.4 mm-40 -111.21 152.61 26.91 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.871 ' HB2' HD11 ' A' ' 94' ' ' LEU . 35.8 tt0 -122.89 150.6 42.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 111.504 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 4.4 p90 -84.79 157.86 20.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.295 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.82 174.0 12.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.245 0.545 . . . . 0.0 112.335 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.434 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 1.5 tm0? -127.58 114.4 17.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.298 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.582 HG21 HD11 ' A' ' 90' ' ' ILE . 38.4 t -68.64 131.06 33.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.036 0.446 . . . . 0.0 111.907 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 63' ' ' MET . 30.4 mt -116.04 -37.14 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.875 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -141.14 155.86 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.905 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.608 ' C ' HD23 ' A' ' 55' ' ' LEU . 2.7 mtp -117.16 146.94 42.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.819 HD12 ' CD ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -110.68 -46.13 3.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.8 0.334 . . . . 0.0 110.802 -179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.7 -137.51 2.49 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -109.73 -26.8 9.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.666 0.269 . . . . 0.0 110.982 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.548 ' HA2' HG22 ' A' ' 74' ' ' ILE . . . -103.57 3.72 46.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.075 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.819 ' CD ' HD12 ' A' ' 55' ' ' LEU . 6.3 ptp180 -155.28 156.37 35.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.905 0.353 . . . . 0.0 111.036 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.807 ' CD2' HD13 ' A' ' 84' ' ' ILE . 2.3 pp -148.08 167.19 25.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.057 0.456 . . . . 0.0 111.505 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.799 ' HB2' HD21 ' A' ' 55' ' ' LEU . 17.8 tt0 -112.9 121.25 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.161 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 51' ' ' VAL . . . -135.85 164.91 26.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.213 0.53 . . . . 0.0 112.293 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 69' ' ' LYS . 8.0 tpp -118.24 110.3 17.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.165 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.4 t -59.14 133.25 55.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' CD1' ' CE2' ' A' ' 48' ' ' TYR . 5.8 m-85 -48.04 -24.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.864 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.07 -11.31 60.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.367 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.24 42.21 2.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.729 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.11 133.01 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.313 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 63' ' ' MET . 0.5 OUTLIER -103.86 112.5 25.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -145.54 164.81 30.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.003 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.73 HD12 HD11 ' A' ' 55' ' ' LEU . 2.9 mm? -98.35 108.9 21.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.737 ' HB3' HG11 ' A' ' 92' ' ' VAL . 37.4 m -89.92 118.8 29.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.922 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.43 132.67 36.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.67 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.673 HD12 HG12 ' A' ' 84' ' ' ILE . 10.8 tt -68.93 140.99 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -56.24 174.0 0.15 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.074 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.15 -49.82 2.0 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.229 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.3 -33.52 49.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.436 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -71.18 -45.98 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.639 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.485 ' HA ' HG12 ' A' ' 82' ' ' VAL . 11.4 ptm180 -56.59 -25.7 53.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -28.41 64.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm -137.35 8.24 2.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.851 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.589 HG21 ' CB ' ' A' ' 107' ' ' LYS . 0.5 OUTLIER -124.35 124.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.956 0.407 . . . . 0.0 111.487 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -110.79 110.41 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.807 HD13 ' CD2' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -64.32 147.73 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 111.416 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -117.51 157.76 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.04 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.1 m -76.06 -6.36 50.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.751 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 72.2 m -144.45 73.55 1.38 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.649 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.79 162.28 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.157 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.928 HG21 ' CD1' ' A' ' 116' ' ' LEU . 33.5 mm -86.94 147.31 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.603 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.681 HD13 HG22 ' A' ' 84' ' ' ILE . 1.0 OUTLIER -150.7 171.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.43 . . . . 0.0 111.438 179.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.657 HD23 ' CD2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -130.12 122.92 29.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.9 178.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.779 HG12 ' HA ' ' A' ' 104' ' ' VAL . 31.0 m -121.6 157.34 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.994 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -96.62 136.14 12.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.862 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -118.27 110.27 17.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.663 0.268 . . . . 0.0 110.743 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.67 -68.31 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 111.108 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.2 -27.77 23.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.245 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -85.71 -0.24 54.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.65 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 65.8 30.27 10.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.91 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 100' ' ' ASN . 5.6 m-20 77.88 162.55 0.22 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER 85.56 -23.34 0.16 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.36 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -141.22 157.01 45.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.662 0.268 . . . . 0.0 110.449 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.779 ' HB2' HD23 ' A' ' 94' ' ' LEU . . . -148.54 174.28 12.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 0.0 111.141 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -128.64 124.22 35.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.589 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.779 ' HA ' HG12 ' A' ' 92' ' ' VAL . 49.8 t -52.55 111.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.667 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -83.41 -37.44 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 109.819 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.04 HD11 ' CE1' ' A' ' 108' ' ' TYR . 2.4 pp -152.48 164.08 38.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.419 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 90' ' ' ILE . 4.8 tmtt? -109.32 118.21 36.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.905 0.383 . . . . 0.0 111.911 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 1.04 ' CE1' HD11 ' A' ' 106' ' ' LEU . 22.4 m-85 -79.83 106.6 11.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 112' ' ' GLU . 9.8 m-20 -60.17 166.91 2.62 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.705 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -78.0 -50.66 11.69 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.62 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -62.31 -42.91 99.76 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' OE2' ' HA ' ' A' ' 108' ' ' TYR . 0.6 OUTLIER -68.85 -26.6 65.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.517 -1.22 . . . . 0.0 109.01 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 1.005 ' HB1' HD13 ' A' ' 128' ' ' ILE . . . -45.68 -34.06 3.3 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.305 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -55.82 -39.56 71.54 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.421 0.629 . . . . 0.0 109.396 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.702 ' HB3' HD21 ' A' ' 39' ' ' LEU . 12.0 m -61.01 -20.85 62.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.089 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.928 ' CD1' HG21 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -49.55 -34.89 18.71 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.38 -178.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -55.03 -34.96 63.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 115' ' ' SER . . . -80.29 -21.39 42.68 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.78 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.701 ' CG ' ' HA ' ' A' ' 116' ' ' LEU . 3.9 m-30 -66.82 -10.53 48.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.64 27.55 66.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.588 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 7.8 mm-40 -114.02 -51.87 2.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.685 0.279 . . . . 0.0 111.035 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.611 ' N ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.89 139.86 21.57 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.44 ' CB ' ' CE1' ' A' ' 125' ' ' HIS . 35.1 Cg_exo -59.21 179.41 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.415 2.077 . . . . 0.0 112.103 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -72.76 -27.74 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.984 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.44 ' CE1' ' CB ' ' A' ' 123' ' ' PRO . 9.2 p-80 -79.1 -18.83 52.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.379 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -53.57 135.86 39.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.827 0.346 . . . . 0.0 111.411 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.46 131.1 45.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.005 HD13 ' HB1' ' A' ' 113' ' ' ALA . 3.7 mt -102.38 158.72 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.271 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 128' ' ' ILE . 0.8 OUTLIER -109.47 171.45 7.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.94 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 59.74 45.8 12.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.975 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 m -81.35 165.7 21.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.68 139.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.7 m -67.54 156.61 36.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.04 88.19 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.32 -91.03 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.05 98.48 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.538 2.159 . . . . 0.0 112.346 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 115.51 -140.3 16.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.478 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.0 t0 60.1 71.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.83 32.33 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.28 67.14 4.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.41 175.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.6 tt -91.03 146.25 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.066 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -75.25 -179.66 4.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.04 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 59.17 177.9 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -142.03 -175.82 4.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.956 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.2 t0 62.61 48.31 4.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.565 HG23 ' O ' ' A' ' 147' ' ' ILE . 12.0 tt -148.83 111.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.082 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.64 -130.56 1.4 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.448 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.02 137.67 53.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.832 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -177.22 -172.04 0.37 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.4 t0 65.01 122.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -123.63 161.66 24.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.46 88.17 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.82 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 154' ' ' ILE . 16.8 tt -173.52 116.72 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.034 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 33.2 t0 60.87 77.9 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.484 ' O ' HG22 ' A' ' 157' ' ' ILE . 8.8 m-20 -155.38 142.41 19.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.913 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 156' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.507 -179.98 . . . . . . . . 2 2 . 1 stop_ save_